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General	Introduction	and	outline
GeNerAL INtroduCtIoN
Worldwide,	populations	are	aging.	As	a	result,	this	will	lead	to	an	increase	in	preva-
lence	of	common	age-related	brain	diseases	such	as	cognitive	decline,	dementia	and	
neurovascular	 diseases.	 These	 diseases	 pose	 a	 high	 burden	 on	 our	 society,	 both	 in	
terms	 of	 suffering	 as	well	 as	 financially.	 From	 a	 perspective	 of	 disease	 prevention,	
the	 search	 for	potentially	modifiable	 etiologic	 factors	 and	a	better	understanding	of	
the	pathophysiological	pathways	of	age-related	brain	diseases	is	of	major	importance.	
One	 approach	 in	 this	 is	 to	 study	 brain	 disease	 in	 its	 earliest	 stage,	 before	 clinical	
symptoms	arise.	Subclinical	brain	changes	are	thought	to	occur	years,	if	not	decades,	
prior	to	onset	of	clinical	symptoms	of	many	age-related	diseases1,	and	with	advanced,	
non-invasive	 imaging	methods	we	are	able	 to	 study	 these	 subclinical	brain	changes	
directly.	In	the	past,	research	has	mainly	focused	on	cerebral	grey	matter	in	age-related	
diseases.	Nowadays,	 also	 an	 important	 role	 of	 cerebral	white	matter	 in	 age-related	
diseases	has	been	established.	White	matter	constructs	approximately	50%	of	the	brain	
volume	and	consumes	43.8%	of	brain’s	total	energy.2	White	matter	is	important	for	the	
connection	of,	and	the	communication	between	different	cortical	regions	and	consists	
of	different	white	matter	tracts,	which	play	a	different	role	in	different	brain	functions.
Macrostructural	white	matter	damage	such	as	white	matter	atrophy	and	white	matter	
hyperintensity	load,	is	visible	on	a	conventional	MRI.	However	these	macrostructural	
changes	constitute	only	the	tip	of	the	iceberg	of	the	white	matter	pathology	that	have	
occurred.3	To	 improve	 understanding	 of	 the	 pathophysiology	 and	 pathways	 of	 age-
related	brain	 diseases	 it	 is	 important	 to	 identify	white	matter	 pathology	 in	 an	 early	
and	preclinical	phase.	More	recently,	microstructural	white	matter	changes,	not	visible	
for	 the	 naked	 eye	 has	 therefore	 gained	 interest	 and	 is	 thought	 of	 as	 an	 earlier	 and	
potentially	more	sensitive	marker	of	white	matter	damage.3
Diffusion	tensor	imaging	(DTI)	is	a	non-invasive	magnetic	resonance	imaging	suitable	
to	quantitatively	assessing	white	matter	microstructural	changes.4	DTI	is	sensitive	to	
the	random	movement	of	water	molecules,	which	is	dependent	on	the	underlying	tissue	
properties	or	microstructure.	DTI	can	not	only	be	used	to	characterize	the	underlying	
white	matter	microstructure,	but	also	 to	reveal	 the	anatomical	paths	of	white	matter	
tracts	by	connecting	voxels	with	analogous	directional	diffusion-profiles,	the	so	called	
tractography.5 
Imaging	 data	 of	 white	matter	 microstructural	 changes	 from	 the	 general	 population	
might	help	to	disambiguate	between	normal	and	abnormal,	help	to	understand	underly-
ing	mechanisms	of	pathology	and	may	help	 to	 identify	persons	at	 risk	 for	a	certain	
disease.	However,	 population	 data	 on	 determinants	 of	white	matter	microstructural	
changes	globally	but	 in	particular	 in	 specific	white	matter	 tracts	 in	 the	middle-aged	
and	elderly	are	scarce.
Chapter	1.1
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AIM of thIS theSIS
The	 objectives	 of	 this	 thesis	were	 two-fold:	 Firstly,	 to	 study	 determinants	 of	white	
matter	microstructural	changes.	The	brain	 is	not	an	organ	on	 itself	but	 is	connected	
with	all	other	organs	in	our	body	and	therefore	we	are	in	particular	interested	in	the	
systemic	influences	on	the	brain	of	different	organs.	Secondly,	to	investigate	the	link	
between	white	matter	microstructural	 and	 age-related	 brain	 diseases.	 In	 both	 aims,	
I	 focused	both	on	 the	white	matter	microstructural	 changes	 across	 the	whole	brain,	
but	also	across	different	white	matter	 tracts.	My	 research	was	embedded	within	 the	
Rotterdam	Study,	which	is	a	population-based	cohort	study	since	1990,	investigating	
causes	and	consequences	of	diseases	in	the	elderly.6	From	2005	onwards,	MRI	scan-
ning	including	DTI	was	added	to	the	core	study	protocol.7	The	entire	Rotterdam	Study	
population	undergoes	regular	cognitive	assessments	and	is	continuously	monitored	for	
major	events,	including	dementia	and	vascular	brain	disease.
outLINe of thIS theSIS
Chapter 2	discusses	determinants	of	white	matter	microstructural	damage.	In	chapter 
2.1	 I	describe	the	change	in	DTI-measures	in	aging.	In	chapter 2.2 and 2.3	 I	focus	
on	the	association	between	kidney	function	and	white	matter	microstructural	integrity	
and	 retinal	microvasculature	 and	white	matter	microstructural	 changes	 respectively.	
Chapter 2.4	is	dedicated	to	the	relation	between	lung	function	and	white	matter	mi-
crostructure.	In	chapter 2.5	I	examined	the	association	between	thyroid	function	and	
white	matter	microstructural	changes.
In	chapter 3	I	present	the	association	of	global	white	matter	microstructural	changes	
but	also	 in	 specific	 tracts	with	different	age-related	brain	diseases.	 In	chapter 3.1	 I	
focus	on	a	transitional	stage	between	normal	aging	and	dementia,	namely	mild	cogni-
tive	 impairment	 and	 studied	 the	 determinants,	MRI	markers	 and	 prognosis	 of	mild	
cognitive	 impairment.	Chapter 3.2	 describes	 the	 link	 between	 tract-specific	 white	
matter	microstructural	integrity	and	cognitive	functioning.	In	chapter 3.3	I	examined	
the	relation	between	white	matter	microstructural	integrity	and	risk	of	dementia	in	a	
longitudinal	study.	Chapter 3.4	describes	the	association	of	white	matter	tract	micro-
structural	integrity	and	hearing	impairment	in	the	elderly.	Chapter 3.5	addresses	the	
relation	between	white	matter	microstructural	integrity	and	risk	of	mortality.	Chapter 
3.6	focuses	on	the	genetic	variation	underlying	cognition	and	the	relation	with	clini-
cal	outcomes	and	 imaging	markers.	 In	chapter 3.7	 I	 applied	a	previously	proposed	
prediction	tool,	namely	the	Disease	State	Index,	to	evaluate	the	prediction	of	cognitive	
decline	using	several	features	including	DTI-measures.	
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General	Introduction	and	outline
Finally,	in	chapter 4	the	main	findings	of	this	thesis	are	summarized.	Additionally,	I	
discuss	in	more	detail	possible	underlying	pathways	and	methodological	considerations	
of	the	performed	studies	and	of	diffusion	tensor	imaging	in	general.	Furthermore,	I	will	
consider	implications	of	the	findings	with	respect	to	clinical	practice,	after	which	I	will	
discuss	future	perspectives.	
Chapter	1.1
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ABStrACt
Purpose To	determine	longitudinally	the	rate	of	change	in	diffusion	tensor	imaging	
(DTI)	parameters	of	white	matter	microstructure	in	aging,	and	to	investigate	whether	
cardiovascular	risk	factors	influence	this	longitudinal	change.
Materials and methods	A	dedicated	ethics	committee	overseen	by	national	govern-
ment	 approved	 this	 prospective,	 population-based	 cohort	 study	 and	 all	 participants	
gave	 written	 informed	 consent.	 Non-demented,	 community-dwelling	 participants	
were	scanned	using	a	research-dedicated	1.5T	MRI	scanner	on	two	separate	visits,	on	
average	2.0	years	apart.	Out	of	810	persons	who	were	eligible	for	scanning	at	base-
line,	longitudinal	imaging	was	available	for	501	persons,	mean	age	69.9	years	(range	
64.1-91.1	years).	Changes	of	normal-appearing	white	matter	DTI	characteristics	in	the	
tract-centers	were	analyzed	first	globally	to	investigate	diffuse	patterns	of	change,	then	
locally	using	voxelwise	multi-linear	regressions.	We	assessed	the	influence	of	cardio-
vascular	risk	factors	by	treating	them	as	additional	determinants	in	both	analyses.	
Results	Over	 the	2.0	year	follow-up	interval,	global	fractional	anisotropy	(FA)	de-
creased	by	0.0042	(p<10-6),	while	mean	diffusivity	(MD)	increased	by	8.1	x	10-6mm2/s 
(p<10-6).	Voxelwise	 analysis	 of	 the	 brain	white	matter	 skeleton	 showed	 an	 average	
decrease	of	FA	of	0.0082	(pmean=	0.002)	 in	57%	of	skeleton	voxels.	The	sensorimo-
tor	pathway,	however,	demonstrated	an	increase	of	FA	of	0.0078	(pmean=	0.009).	MD	
increased	on	average	10.8	x	10-6mm2/s	(pmean<	0.001),	in	79%	of	white	matter	skeleton	
voxels.	Additionally,	we	found	that	white	matter	degeneration	was	more	pronounced	in	
higher	age.	Cardiovascular	risk	factors	were	generally	not	associated	with	longitudinal	
changes	in	white	matter	microstructure.	
Conclusions Longitudinal	 diffusion	 analysis	 indicates	 widespread	microstructural	
deterioration	of	the	normal-appearing	white	matter	in	normal	aging,	with	relative	spar-
ing	of	sensorimotor	fibers.	
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White	matter	degeneration	in	aging,	a	longitudinal	diffusion	MRI	analysis
INtroduCtIoN 
It	has	been	recognized	that	not	only	grey	matter	loss,	but	also	white	matter	deterioration	
plays	an	important	role	in	brain	aging	and	cognitive	decline1	and	a	vascular	etiologi-
cal	pathway	is	often	hypothesized.2	Diffusion	tensor	imaging	(DTI)	is	a	non-invasive	
magnetic	 resonance	 imaging	 (MRI)	 technique	 that	measures	diffusion	of	water,	 and	
that	 can	 quantify	 subtle	 changes	 of	white	matter	 tissue	 organization	 not	 visible	 on	
structural	MRI.	DTI	provides	multiple	descriptors	of	diffusion,	with	fractional	anisot-
ropy	(FA)	and	mean	diffusivity	(MD)	most	widely	used.	FA	describes	the	directionality	
of	diffusion	and	a	lower	value	typically	reflects	reduced	microstructural	organization	
in	regions	where	white	matter	fibers	are	aligned.	MD	represents	the	overall	magnitude	
of	water	diffusion	and	generally	a	higher	value	reflects	reduced	microstructural	organi-
zation.3	Reduced	microstructural	white	matter	organization	possibly	impedes	commu-
nication	within	and	between	neurocognitive	networks,	which	might	result	in	cognitive	
impairment.4	In	order	to	identify	persons	at	a	higher	risk	of	neurodegenerative	disease,	
it	 is	 important	 to	 quantify	 changes	 in	 brain	 tissue	 in	 an	 early	 stage.5	This	 however	
also	 requires	 characterization	 of	 baseline	 age-related	 changes.	 The	 quantitative	 na-
ture	makes	DTI	very	suitable	for	 longitudinal	analyses,	which	are	 likely	to	be	more	
sensitive	in	the	early	detection	of	changes	in	white	matter	microstructure.	However,	
longitudinal	 data	 are	 still	 scarce	 and	 studies	 are	mostly	 performed	 in	 small	 sample	
sizes	and	in	patients	with	cognitive	impairment	or	Alzheimer’s	disease.6-9	The	sparse	
longitudinal	findings	in	‘normal’	aging	did	however	corroborate	evidence	from	cross-
sectional	studies,	which	showed	that	during	normal	aging	white	matter	demonstrates	
lower	FA,	with	less	uniform	observations	for	regions	with	crossing	fibers,	combined	
with	higher	MD6-11,	and	that	those	aging	effects	differ	across	brain	regions.8,9,12,13	Yet,	
these	results	need	to	be	corroborated	in	larger	longitudinal	studies.
In	the	current	study,	we	therefore	aimed	to	longitudinally	determine	the	rate	of	change	
in	DTI	parameters	of	white	matter	microstructure	in	aging,	and	to	investigate	whether	
cardiovascular	risk	factors	influence	this	longitudinal	change.14-15
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MethodS
Study population
This	 study	 is	 based	 on	 participants	 from	 the	 Rotterdam	 Study,	 a	 prospective,	 pop-
ulation-based	cohort	 study	 that	 investigates	causes	and	consequences	of	age-related	
diseases.16	The	original	study	population	consisted	of	7983	participants	aged	55	years	
and	older	within	Ommoord,	a	suburb	of	Rotterdam.	In	2000,	the	cohort	was	expanded	
with	3011	persons	(≥55	years)	living	in	the	study	area	and	not	included	before	(16).	
Since	2005,	brain	MRI	is	incorporated	in	the	core	protocol	of	the	study.	In	2005	and	
2006,	a	group	of	1073	participants	was	randomly	selected	from	the	cohort	expansion	
to	participate	 in	 the	Rotterdam	Scan	Study.17	Participants	were	scanned	 three	 times,	
in	2005-2006,	2008-2009	and	 in	2011-2012.	The	 latter	 two	 time	points	 included	an	
upgraded	DTI	acquisition	 that	was	used	 for	 the	current	analysis,	defining	 the	2008-
2009	scan	as	baseline,	and	the	2011-2012	scan	as	follow-up.	We	excluded	individuals	
who	 (at	 either	 time	 point)	were	 demented	 or	 had	MRI	 contraindications	 (including	
claustrophobia).	For	the	2008-2009	scan,	899	out	of	the	original	1073	persons	could	be	
invited,	of	whom	810	were	eligible	and	741	participated.	At	follow	up	in	2011-2012,	
649	out	of	741	were	re-invited,	625	were	eligible	and	548	participated.	We	excluded	
participants	with	 an	 incomplete	 acquisition	 (n=5),	 persons	with	MRI-defined	 corti-
cal	infarcts	(n=20),	and	scans	with	artifacts	hampering	automated	processing	(n=22),	
resulting	 in	 501	 participants	with	 longitudinal	DTI	 data	 available	 for	 analysis.	The	
Rotterdam	Population	Study	Act	Rotterdam	Study,	executed	by	the	Ministry	of	Health,	
Welfare	and	Sports	of	the	Netherlands.	Written	informed	consent	was	obtained	from	
all	participants.
MrI acquisition
Multi-sequence	MRI	was	 performed	with	 identical	 scan	 parameter	 settings	 at	 both	
time	 points	 on	 a	 1.5T	 scanner	 (GE	Signa	Excite)	 dedicated	 to	 the	 study	 and	main-
tained	 without	 major	 hardware	 or	 software	 updates.17 In	 short,	 imaging	 included	 a	
T1-weighted	3D	Fast	RF	Spoiled	Gradient	Recalled	Acquisition	in	Steady	State	with	
an	 inversion	 recovery	 pre-pulse	 (FASTSPGR-IR)	 sequence,	 a	 proton	 density	 (PD)	
weighted	sequence,	and	a	T2-weighted	fluid-attenuated	 inversion	 recovery	 (FLAIR)	
sequence.17	 For	 DTI,	 we	 performed	 a	 single	 shot,	 diffusion-weighted	 spin	 echo	
echo-planar	 imaging	 sequence	 (repetition	 time=8575	ms,	 echo	 time=82.6	ms,	field-
of-view=210×210	mm,	matrix=96×64	 (phase	 encoding)	 (zero-padded	 in	 k-space	 to	
256×256)	slice	thickness=3.5	mm,	35	contig	uous	slices).	Maximum	b-value	was	1000	
s/mm2	in	25	non-collinear	directions;	three	volumes	were	acquired	without	diffusion	
weighting	(b-value=0	s/mm2).
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tissue segmentation
Baseline	 scans	 were	 segmented	 into	 grey	 matter,	 white	 matter,	 cerebrospinal	 fluid	
(CSF)	and	background	tissue	using	an	automatic	segmentation	method.18	An	automatic	
post-processing	step	distinguished	normal-appearing	white	matter	from	white	matter	
lesions	(WML),	based	on	the	FLAIR	image	and	the	tissue	segmentation.19 Intracranial	
volume	 (ICV)	 (excluding	 the	 cerebellum	with	 surrounding	 CSF)	was	 estimated	 by	
summing	total	grey	and	white	matter,	and	CSF	volumes.	The	WML	segmentation	was	
mapped	into	DTI	image	space	using	boundary	based	registration20	performed	on	the	
white	matter	segmentation,	the	b=0	and	T1-weighted	image.
dtI processing
Diffusion	data	was	pre-processed	using	a	standardized	processing	pipeline.21	In	short,	
DTI	data	was	corrected	for	subject	motion	and	eddy	currents	by	affine	co-registration	
of	the	diffusion-weighted	volumes	to	the	b=0	volumes,	including	correction	of	gradi-
ent	vector	directions.	Diffusion	tensors	were	estimated	using	a	non-linear	Levenberg-
Marquardt	 estimator,	 available	 in	 ExploreDTI.22	 FA	 and	 MD,	 measures	 of	 tissue	
microstructure,	were	computed	from	the	tensor	images.	Tensor	fits	were	inspected	for	
artifacts	 by	 reviewing	 axial	 slices	 of	 the	 FA	 images	 (MG,	 researcher	 with	 5	 years	
experience	in	diffusion	image	analysis	and	LGMC,	radiologist	in	training	with	2	years	
experience	in	diffusion	image	analysis).
Image registration
Intra-subject	 correspondence	 (between	 the	 two	 time	 points),	 and	 correspondence	
between	 subjects	 was	 achieved	 by	 image	 registration.	 Improved	 tract-based	 spatial	
statistics	(TBSS)	was	used	with	optimized	high	degree-of-freedom	registration	in	lieu	
of	 the	 two	stage	 registration-projection	approach	 implemented	 in	 the	original	TBSS	
method.23,24	All	registrations	were	inspected	by	reviewing	axial	compilations	of	super-
positioned	moving	and	target	images	(MG	and	LGMC).	Following	the	registration,	in-
dividual	change	in	diffusion	measures	could	be	computed	in	standard	space	(MNI152,	
as	provided	with	the	FSL	software25)	by	subtracting	baseline	from	follow-up	images.
A	study	specific	white	matter	skeleton	was	constructed	using	the	TBSS	skeletonization	
procedure	on	the	average	FA	image	composed	of	all	subject	images	at	both	time	points	
combined	in	standard	space;	thresholding	the	FA	skeleton	at	0.25.	This	skeleton	was	
then	used	to	mask	the	difference	images	for	longitudinal	statistical	analysis.
Assessment of risk factors
The	following	cardiovascular	risk	factors	were	assessed	based	on	information	derived	
from	 home	 interviews	 and	 physical	 examinations16,	 at	 a	 single	 time	 point	 prior	 to	
baseline	MRI-scanning.	Blood	pressure	was	measured	twice	in	sitting	position	using	a	
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random-zero	sphygmomanometer.	Use	of	anti-hypertensive	drugs	was	recorded.	Dia-
betes	mellitus	status	was	determined	on	fasting	serum	glucose	level	(>=	7.0	mmol/l),	
non-fasting	serum	glucose	level	(>=11.1	mmol/l)	or	the	use	of	anti-diabetic	medication.	
Smoking	was	assessed	by	interview	and	coded	as	never,	former	and	current.	Total	and	
high-density	 lipoprotein	 (HDL)	 cholesterol	were	 determined	 in	 blood	 serum,	while	
recording	 the	 use	 of	 lipid	 lowering	medication.	Apolipoprotein E (APOE)-ε4	 allele	
carriership	was	assessed	on	coded	genomic	DNA	samples.	Assessment	of	risk	factors	
predated	the	baseline	MRI	on	average	3	years.
Statistical analysis
Changes	in	diffusion	characteristics	were	investigated	in	two	ways:	globally	and	lo-
cally,	both	using	 the	skeletonized	difference	measurements.	For	 the	global	analysis,	
we	investigated	the	average	change	in	FA	and	MD	over	the	entire	skeleton	per	subject,	
excluding	 voxels	 labeled	 as	WML	 in	 the	 baseline	 scan.	We	 assessed	whether	 there	
was	a	global	change	in	diffusion	measures	with	multiple	linear	regression	using	three	
models.	In	model	1,	we	adjusted	for	age,	sex,	scan-interval	and	ICV.	We	additionally	
considered	alternatives	to	model	1	in	which	we	corrected	for	individual	measures	of	
white	matter	macrostructure:	white	matter	atrophy	(using	normal-appearing	white	mat-
ter	volume)	or	WML	load	(natural	log-transformed	to	correct	for	the	skewed	volume	
distribution)	instead	of	age.	In	model	2,	we	additionally	adjusted	for	both	white	matter	
atrophy	and	WML	load	to	identify	changes	to	white	matter	microstructure,	indepen-
dent	from	the	macrostructural	white	matter	changes	that	may	also	affect	the	diffusivity	
measurements.	In	model	3,	we	added	the	different	cardiovascular	risk	factors	individu-
ally	to	model	1	to	separately	investigate	the	effect	of	these	on	change	in	white	matter	
microstructure.	For	analyses	with	blood	pressure	and	cholesterol,	medication	use	was	
considered	a	confounder	and	added	to	the	model.	For	the	analysis	of	total	cholesterol,	
HDL	cholesterol	was	additionally	included	as	a	confounder.	All	global	analyses	were	
performed	using	SPSS	(version	20).
For	the	localized	TBSS	analyses,	we	performed	voxelwise	multiple	linear	regressions	
for	 the	 same	models	 as	 for	 the	 global	 analysis,	 also	 restricting	 the	 analyses	 to	 the	
(baseline)	normal-appearing	white	matter.	 If	 significant	 associations	were	 found	 for	
tests	 in	model	 3,	we	 additionally	 performed	 an	 analysis	 correcting	 for	measures	 of	
macrostructural	white	matter	 degeneration	 to	 rule	 out	 confounding	by	white	matter	
atrophy	and	WML.	We	used	threshold-free	cluster	enhancement25	with	default	settings	
for	skeletonized	data	to	promote	spatially	clustered	findings	and	controlled	the	family	
wise	error	 rate	by	using	a	permutation	based	approach	(using	5000	permutations).27 
All	analyses	were	performed	using	an	in-house	adapted	version	of	the	Randomise	tool	
available	in	FSL25,	effectively	performing	a	voxelwise	available-case	analysis.
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reSuLtS
table 1	 shows	 the	 population	 characteristics	 of	 the	 501	 participants.	Mean	 age	 at	
baseline	MRI	 was	 69.9	 years	 (ranging	 from	 64.1	 to	 91.1	 years),	 and	 253	 (50.5%)	
participants	were	female.	The	global	analyses,	corrected	for	age,	sex,	scan	interval	and	
ICV,	showed	an	average	decrease	of	FA	in	the	normal-appearing	white	matter	skeleton	
of	0.0042	(p<10-6)	and	an	average	 increase	of	MD	of	8.1	x	10-6mm2/s	 (p<10-6)	over	
the	follow-up	interval	(model	1).	The	same	changes	were	observed	when	additionally	
controlling	for	white	matter	atrophy	and	WML	load	(model	2).	As	can	be	seen	in	table 
2,	 these	 two	additional	 confounding	variables	were	also	associated	with	 changes	 in	
MD	–	higher	WML	load,	less	normal	appearing	white	matter	and	higher	age	resulted	
in	an	additional	increase	in	MD	–	but	not	with	FA.
table 1 Baseline	characteristics	of	included	participants
N=501
Age	(y) 69.9	(4.3)
Female 253	(50.5)
Follow	up	time	(y) 2.0	(0.5)
NAWM	baseline	FA 0.322	(0.016)
NAWM	baseline	MD	(10-3mm2/s) 0.726	(0.022)
Brain	volume	(mL) 1125	(114)
NAWM	volume	(mL) 394	(58)
WML	volume	(mL)	† 3.74	(2.28-7.39)
Systolic	blood	pressure	(mmHg) 142.3	(16.5)
Diastolic	blood	pressure	(mmHg) 81.0	(9.7)
Use	of	blood	pressure	lowering	medication 168	(33.7)
Diabetes	mellitus 34	(6.9)
Smoking
			never 162	(32.7)
			former 270	(54.4)
			current 64	(12.9)
Total	serum	cholesterol	(mmol/L) 5.73	(0.94)
Serum	HDL	cholesterol	(mmol/L) 1.45	(0.40)
Use	of	lipid	lowering	medication 107	(21.4)
APOE-ε4	carriership 118	(23.1)
Data	is	presented	as	mean	(SD)	for	continuous	variables	and	number	(%)	for	categorical	variables.	†	White	
matter	lesion	volume	presented	as	median	(interquartile	range).	The	following	variables	had	missing	data:	cho-
lesterol	(n=3),	lipid	lowering	medication	(n=2,	not	overlapping	with	cholesterol),	blood	pressure	(n=4),	blood	
pressure	lowering	medication	(n=2,	overlapping	with	blood	pressure)	APOE-ε4	carriership	(n=15),	diabetes	
(n=5),	smoking	(n=5).	NAWM	indicates	normal-appearing	white	matter;	FA	fractional	anisotropy;	MD	mean	
diffusivity,	WML	white	matter	lesion.
Chapter	2.1
30
Voxelwise	analyses,	visualized	in	figure 1	for	model	2,	showed	decrease	in	FA	over	
the	 two-years	 follow-up	 interval	 in	 the	 majority	 of	 the	 brain	 white	 matter,	 except	
in	most	 of	 the	 sensorimotor	 tracts.	 Change	 over	 time	 for	models	 1	 and	 2	 was	 not	
materially	different.	Increase	in	FA	was	found	in	the	motor	tracts	extending	from	the	
brain	stem,	through	the	internal	capsule	(both	the	anterior	and	posterior	limbs)	and	the	
corona	radiata	up	into	the	motor	cortex	(figure 1).	The	MD	increased	throughout	the	
brain,	with	most	marked	increase	periventricularly	and	around	the	fornix.	No	voxels	
showed	a	significant	decrease	 in	MD.	Amongst	 the	voxels	expressing	increased	FA,	
MD	mostly	 increased.	Constraining	 the	voxelwise	 analysis	 to	 the	normal-appearing	
white	 matter	 meant	 that	 the	 number	 of	 degrees-of-freedom	 of	 the	 analysis	 varied	
from	voxel	to	voxel,	but	variation	was	smooth	and	the	minimum	number	of	subjects	
included	per	voxel	for	models	1	and	2	was	295.
table 2. Demographic	characteristics	and	global	change	in	white	matter	microstructure
variable change in fA
(x 10-3)
p value change in Md
(x 10-6mm2/s)
p value
Age -0.12 0.09 0.20 0.01
Sex 0.37 0.57 -0.07 0.93
Brain	volume -0.18 0.69 0.91 0.08
NAWM	volume 0.27 0.51 -1.43 2	x	10-3
ln(WML	volume) -0.29 0.31 1.21 2	x	10-4
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changes.	The	top	row	shows	regions	of	significant	change	in	fractional	anisotropy	
(FA)	 over	 time,	 color	 coded	 blue	 to	 indicate	 increase,	 and	 red	 and	 yellow	 to	
indicate	 decrease	 in	FA.	The	 bottom	 row	 shows	 regions	 of	 significant	 change	 in	
mean	 diffusivity	 (MD),	 color-coded	 blue	 for increase	 (no	 voxels	 showed	 a	
significant	decrease	in	MD).	Results	shown	are	p<0.05,	the	family	wise	error	rate	
was	 controlled	 using	 a	 permutation	 approach.	 P values	 are	 presented	 in	
Supplementary	Figure	2.	Results	are	overlaid	on	a	population	specific	average-FA	
image	in	MNI	coordinates,	showing	non-significant	(ns)	skeleton	voxels	in	black.	 
 
  
figure 1.	Change	in	diffusion	characteristics	over	two-years	of	follow-up,	corrected	for	age,	sex,	scan	interval,	
intra	cranial	volume	and	macroscopic	WM	changes.	The	top	row	shows	regions	of	significant	change	in	frac-
tional	anisotropy	(FA)	over	time,	color	coded	blue	to	indicate	increase,	and	red	and	yellow	to	indicate	decrease	
in	FA.	The	bottom	row	shows	regions	of	significant	change	in	mean	diffusivity	(MD),	color-coded	blue	for	
increase	(no	voxels	showed	a	significant	decrease	in	MD).	Results	shown	are	p<0.05,	the	family	wise	error	rate	
was	controlled	using	a	permutation	approach.	P	values	are	presented	in	Supplementary	Figure	2.	Results	are	
overlaid	on	a	population	specific	average-FA	image	in	MNI	coordinates,	showing	non-significant	(ns)	skeleton	
voxels	in	black.	
31
White	matter	degeneration	in	aging,	a	longitudinal	diffusion	MRI	analysis
figures 2 and 3	show	how	changes	in	FA	(figure 2)	and	MD	(figure 3)	depended	on	
various	parameters	included	in	models	1	and	2.	For	model	1,	we	observed	associations	
between	 age	 and	FA	 (decrease)	 or	MD	 (increase).	These	 associations	were	 reduced	
both	in	strength	and	in	extent,	when	additionally	adding	measures	of	macrostructural	
white	matter	changes	(atrophy	and	WML	load)	 in	 the	model.	The	figures	also	show	
associations	between	white	matter	atrophy	and	WML	load,	and	change	in	FA	and	MD	
in	model	2	No	difference	in	change	in	diffusion	characteristics	was	observed	for	men	
and	women.
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figure 2. Age	and	macrostructural	white	matter	changes	at	baseline	and	change	in	
fractional	 anisotropy	 (FA)	 over	 two-years	 of	 follow-up.	 The	 top	 row	 shows	 in	
yellow-to-red	 regions	 of	 decrease	 in	 FA	 that	 relate	 to	 higher	 age	 at	 baseline	
(adjusted	 for	 sex,	 scan	 interval	 and	 intracranial	 volume	 (ICV)).	 The	 second	 and	
third	 row	 show	 FA	 changes	 that	 are	 associated	 with	 respectively	 a	 decrease	 in	
normal-appearing	white	matter	(NAWM)	volume	and	an	increase	in	white	matter	
lesion	 (WML)	volume	 (both	 adjusted	 for	age,	 sex,	 scan	 interval,	 ICV).	The	 final	
row	 shows	 regions	 of	 decrease	 in	 FA	 related	 to	 higher	 age,	 when	 additionally	
adjusted	for	NAWM	volume	and	WML	volume.	 Inverse	directions	of	association	
showed	no	 significant	 voxels	 (not	 shown).	Results	 shown	 are	p<0.05,	 the	 family	
wise	error	rate	was	controlled	using	a	permutation	approach.	P values	are	presented	
in	Supplementary	Figure	3.	Results	are	overlaid	on	a	population	specific	average-
FA	 image	 in	 MNI	 coordinates,	 showing	 non-significant	 (ns)	 NAWM	 skeleton	
voxels	in	black. 
 
 
  
figure 2.	Age	and	macrostructural	white	matter	changes	at	baseline	and	change	in	fractional	anisotropy	(FA)	
over	two-years	of	follow-up.	The	top	row	shows	in	yellow-to-red	regions	of	decrease	in	FA	that	relate	to	higher	
age	at	baseline	(adjusted	for	sex,	scan	interval	and	intracranial	volume	(ICV)).	The	second	and	third	row	show	
FA	changes	that	are	associated	with	respectively	a	decrease	in	normal-appearing	white	matter	(NAWM)	vol-
ume	and	an	increase	in	white	matter	lesion	(WML)	volume	(both	adjusted	for	age,	sex,	scan	interval,	ICV).	The	
final	row	shows	regions	of	decrease	in	FA	related	to	higher	age,	when	additionally	adjusted	for	NAWM	volume	
and	WML	volume.	Inverse	directions	of	association	showed	no	significant	voxels	(not	shown).	Results	shown	
are p<0.05,	the	family	wise	error	rate	was	controlled	using	a	permutation	approach.	P	values	are	presented	in	
Supplementary	Figure	3.	Results	are	overlaid	on	a	population	specific	average-FA	image	in	MNI	coordinates,	
showing	non-significant	(ns)	NAWM	skeleton	voxels	in	black.
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Investigating	cardiovascular	risk	factors	in	relation	to	longitudinal	DTI	changes,	we	
only	found	associations	for	APOE ε4	carriership	and	for	total	serum	cholesterol	level.	
Specifically,	ε4	carriers	showed	localized	increases	in	FA	in	comparison	to	non-carriers,	
but	no	changes	globally.	These	local	differences	were	more	prominent	in	the	right	than	
in	the	left	hemisphere	and	primarily	in	the	centrum	semiovale	and	in	the	white	matter	
adjacent	to	the	trigone	of	the	lateral	ventricle.	In	contrast,	we	observed	lower	MD	only	
in	 a	 small	 peritrigonal	 cluster	 in	 carriers	 compared	 to	 non-carriers.	These	 observed	
associations	 persisted	when	 additionally	 correcting	 for	macrostructural	measures	 of	
white	matter	 degeneration.	 Similarly,	we	 observed	 that	 global	 increase	 in	MD	 to	 a	
lesser	degree	associated	with	APOE ε4	carriership	(table 3).	Total	serum	cholesterol	
level	was	associated	locally	with	more	increase	in	MD	in	the	left	hemisphere.	Regions	
included	the	corona	radiata	and	white	matter	around	the	posterior	and	anterior	horns	of	
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figure 3. Age	and	macrostructural	white	matter	changes	at	baseline	and	change	in	
mean	 diffusivity	 (MD)	 over	 two-years	 of	 follow-up.	 The	 top	 row	 shows	 in	 blue	
regions	of	 increase	 in	MD	 that	 relate	 to	higher	 age	 at	 baseline	 (adjusted	 for	 sex,	
scan	interval	and	intracranial	volume	(ICV)).	The	second	and	third	row	show	MD	
changes	that	are	associated	with	respectively	a	decrease	in	normal-appearing	white	
matter	 (NAWM)	 volume	 and	 an	 increase	 in	white	matter	 lesion	 (WML)	 volume	
(both	 adjusted	 for	 age,	 sex,	 scan	 interval,	 ICV).	The	 final	 row	 shows	 regions	 of	
decrease	 in	 MD	 related	 to	 higher	 age,	 when	 additionally	 adjusted	 for	 NAWM	
volume	and	WML	volume.	Inverse	directions	of	association	showed	no	significant	
voxels	 (not	 shown).	 Results	 shown	 are	 p<0.05,	 the	 family	 wise	 error	 rate	 was	
controlled	using	a	permutation	approach.	P values	are	presented	in	Supplementary	
Figure	4.	Results	are	overlaid	on	a	population	specific	average-FA	image	in	MNI	
coordinates,	showing	non-significant	(ns)	NAWM	skeleton	voxels	in	black.	 
 
 
 
 
 
figure 3.	Age	and	macrostructural	white	matter	changes	at	baseline	and	change	 in	mean	diffusivity	 (MD)	
over	two-years	of	follow-up.	The	top	row	shows	in	blue	regions	of	increase	in	MD	that	relate	to	higher	age	at	
baseline	(adjusted	for	sex,	scan	interval	and	intracranial	volume	(ICV)).	The	second	and	third	row	show	MD	
changes	that	are	associated	with	respectively	a	decrease	in	normal-appearing	white	matter	(NAWM)	volume	
and	an	increase	in	white	matter	lesion	(WML)	volume	(both	adjusted	for	age,	sex,	scan	interval,	ICV).	The	final	
row	shows	regions	of	decrease	in	MD	related	to	higher	age,	when	additionally	adjusted	for	NAWM	volume	
and	WML	volume.	Inverse	directions	of	association	showed	no	significant	voxels	(not	shown).	Results	shown	
are p<0.05,	the	family	wise	error	rate	was	controlled	using	a	permutation	approach.	P	values	are	presented	in	
Supplementary	Figure	4.	Results	are	overlaid	on	a	population	specific	average-FA	image	in	MNI	coordinates,	
showing	non-significant	(ns)	NAWM	skeleton	voxels	in	black.	
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the	lateral	ventricle.	These	observed	associations	persisted	when	additionally	correct-
ing	for	macrostructural	measures	of	white	matter	degeneration.	Other	cardiovascular	
risk	factors	were	associated	with	neither	global	nor	local	changes	in	tissue	microstruc-
ture.	Results	on	global	DTI	characteristics	are	presented	in	table 3.
Investigating	cardiovascular	risk	factors	in	relation	to	longitudinal	DTI	changes,	we	
only	found	associations	for	APOE ε4	carriership	and	for	total	serum	cholesterol	level.	
Specifically,	ε4	carriers	showed	localized	increases	in	FA	in	comparison	to	non-carriers,	
but	no	changes	globally.	These	local	differences	were	more	prominent	in	the	right	than	
in	the	left	hemisphere	and	primarily	in	the	centrum	semiovale	and	in	the	white	matter	
adjacent	to	the	trigone	of	the	lateral	ventricle.	In	contrast,	we	observed	lower	MD	only	
in	 a	 small	 peritrigonal	 cluster	 in	 carriers	 compared	 to	 non-carriers.	These	 observed	
associations	 persisted	when	 additionally	 correcting	 for	macrostructural	measures	 of	
white	matter	 degeneration.	 Similarly,	we	 observed	 that	 global	 increase	 in	MD	 to	 a	
lesser	degree	associated	with	APOE ε4	carriership	(table 3).
Total	 serum	 cholesterol	 level	 was	 associated	 locally	 with	 more	 increase	 in	MD	 in	
the	 left	 hemisphere.	 Regions	 included	 the	 corona	 radiata	 and	 white	 matter	 around	
the	posterior	and	anterior	horns	of	 the	lateral	ventricle.	These	observed	associations	
persisted	when	additionally	correcting	for	macrostructural	measures	of	white	matter	
degeneration.	Other	 cardiovascular	 risk	 factors	were	 associated	with	 neither	 global	
nor	 local	changes	in	tissue	microstructure.	Results	on	global	DTI	characteristics	are	
presented	in	table 3.
table 3. Cardiovascular	risk	factors	and	global	change	in	white	matter	microstructure
risk / protective factor change in fA
(x 10-3)
p value change in Md
(x 10-6mm2/s)
p value
Systolic	blood	pressure	 -0.46 0.09 0.33 0.29
Diastolic	blood	pressure	 -0.01 0.98 0.10 0.76
Diabetes	mellitus 0.08 0.77 0.46 0.13
Smoking	(never	-	current) -0.15 0.86 0.22 0.83
Total	serum	cholesterol	 -0.42 0.15 -0.09 0.78
Serum	HDL	cholesterol	 0.31 0.28 -0.23 0.49
APOE-ε4	carriership 1.12 0.07 -1.51 0.04
Cardiovascular	 risk	 factors	and	global	change	 in	white	matter	microstructure	computed	with	 respect	 to	 the	
population	mean	 change	 of	 -0.0042	 in	 FA	 (p<10-6)	 and	 8.1	 x	 10-6mm2/s	 in	MD	 (p<10-6).	Values	 represent	
change	in	diffusion	measure,	per	SD	of	change	for	continuous	variables,	or	absolute	for	categorical	variables.	
Significant	results	are	shown	in	bold	instead	of	italic.
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dISCuSSIoN
In	 this	 large,	 population-based	 longitudinal	 sample	 of	 elderly	 persons,	 we	 found	
changes	 to	microstructural	 tissue	organization	congruent	with	microstructural	white	
matter	deterioration.	Over	a	 two-year	 follow-up	 interval,	 loss	of	microstructure	was	
globally	reflected	in	decreases	in	FA	and	increases	in	MD,	independent	of	severity	of	
white	matter	atrophy	and	WML	load.	On	a	voxelwise	level,	we	found	regional	differ-
ences	in	white	matter	changes,	with	decreased	FA	in	most	of	the	brain,	but	increased	
FA	in	most	of	the	sensorimotor	pathway,	running	from	the	brainstem	up	to	the	motor	
cortex.	In	contrast,	MD	was	increased	throughout	the	white	matter	skeleton,	without	
any	significant	decreases.	We	found	that	white	matter	deterioration	was	locally	more	
pronounced	with	higher	age,	indicating	that	older	persons	show	more	change	in	white	
matter	microstructure	over	the	same	follow-up	time	than	younger	persons.	This	could	
partly	be	explained	by	macroscopic	measures	of	white	matter	degeneration,	i.e.	white	
matter	atrophy	and	WML	load,	which	also	increase	with	age.	We	only	identified	few	
associations	 between	 known	 (cardiovascular)	 determinants	 of	white	matter	 atrophy	
and	WML	load	and	changes	in	diffusion	characteristics	over	time,	both	globally	and	
locally.	These	findings	contribute	to	our	understanding	of	age	related	brain	changes,	
and	thereby	may	aid	in	the	future	identification	of	early	pathology	leading	to	disease.
Cross-sectional	studies	of	normal	aging	of	white	matter	have	generally	shown	lower	FA	
and	higher	MD	with	higher	age1,11,12	which	is	in	line	with	our	results.	In	a	cross-sectional	
analysis	of	an	earlier	time	point	for	the	same	population	we	found	a	similar	effect	with	
age	itself,	i.e.	most	of	the	associations	with	age	were	driven	by	macroscopic	measures	
of	white	matter	degeneration.10	Both	 results	 indicate	 that	white	matter	degeneration	
with	aging	 is	not	 intrinsically	due	 to	aging	alone	nor	purely	driven	by	macroscopic	
measures	of	white	matter	degeneration.	Longitudinal	analyses,	which	are	necessary	to	
reliably	characterize	change	over	time,	have	found	reductions	in	FA	and	increases	in	
MD.6,9	Our	findings	confirm	much	of	these	longitudinal	and	cross	sectional	findings,	
and	extend	on	these	for	the	normal	appearing	white	matter,	in	a	larger	population.
In	 the	sensorimotor	pathway,	we	 identified	a	seemingly	paradoxical	 increase	of	FA,	
which	may	 relate	 to	partial	 volume	mixing	of	multiple	fiber	 tracts	 (e.g.	 crossing	or	
touching	fibers)	within	these	voxels.	Selective	degeneration	of	one	fiber	bundle	with	
relative	sparing	of	the	other	bundle	may	lead	to	an	increase	in	FA,	with	concomitant	
increase	in	MD.	This	effect	was	previously	observed	in	a	study	on	Wallerian	degenera-
tion28,	and	described	in	detail	in	a	cross-sectional	study	on	Alzheimer’s	disease.29	The	
increased	 FA,	 ascending	 from	 the	 brain	 stem,	 through	 the	 internal	 capsule	 and	 the	
corona	radiata	up	into	the	motor	cortex	–	regions	with	either	crossing	fibers	or	closely	
spaced	adjacent	fibers30-31 –	thereby	seems	to	indicate	a	relative	sparing	of	sensorimo-
tor	fibers.	Inside	the	fornix	we	found	the	strongest	increase	in	MD.	This	may	reflect	
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loss	of	microstructural	organization	in	this	limbic	fiber,	but	we	should	note	that	this	
tract	is	small	compared	to	our	imaging	matrix	and	surrounded	by	CSF.	These	findings	
therefore	 likely	 represent	a	combination	of	microstructural	and	macrostructural	 (i.e.	
tract	thinning)	changes.32
	We	did	observe	counter-intuitive	associations	with	APOE ε4	carriership.	Globally	we	
observed	a	decrease	in	MD	in	carriers	compared	to	non-carriers.	Locally,	we	observed	
in	APOE ε4 carriers	increases	in	FA	in	comparison	to	non-carriers,	in	regions	with	a	
high	prevalence	of	WML.	These	observations	are	in	contrast	to	cross-sectional	stud-
ies	with	APOE	 genotype,	which	 have	 generally	 shown	widespread	 deterioration	 of	
white	matter	microstructure	associated	with	the	ε4	allele.33,34	On	closer	inspection	this	
paradoxical	 increase	 in	FA	was	 largely	explained	by	 lower	baseline	FA	for	carriers,	
and	 a	 larger	 decrease	 in	 FA	 for	 non-carriers.	Higher	 serum	 cholesterol	was	 associ-
ated	to	stronger	increases	in	MD	over	time	in	the	left	hemisphere.	When	investigating	
other	 cardiovascular	 risk	 factors,	 we	 observed	 associations	with	 neither	 global	 nor	
local	changes	to	white	matter	microstructure,	which	is	in	line	with	another	longitudinal	
study6	 but	 in	 disagreement	 to	 cross-sectional	 observations.2,35	 These	 discrepancies,	
both	for	APOE	and	cardiovascular	factors,	might	be	due	to	the	relatively	short	follow-
up	 interval,	which	 translates	 in	 the	 (clustered)	voxelwise	and	global	 statistics	being	
relatively	underpowered.	Another	possibility	is	that	changes	induced	by	cardiovascular	
risk	factors	may	be	more	prominent	in	the	periphery	of	white	matter	tracts,	whereas	
the	TBSS	method	we	used	focused	on	 tract	centers.	Most	 importantly	however,	our	
longitudinal	design	only	probes	differential	effects,	and	not	the	difference	accumulated	
over	 the	 total	 exposure	 time,	which	 precludes	 the	 analysis	 from	finding	 subtle	 dif-
ferential	changes	with	cardiovascular	risk	factors.		
Limitations	 of	 our	 study	 are:	 1.	The	 relatively	 short	 follow-up	 interval,	which	may	
have	limited	the	sensitivity	to	detect	differences	over	time.	Especially	in	the	case	of	
differential	 effects	with	 risk	 factors	 (as	mentioned	 above),	 this	meant	we	 could	 not	
disambiguate	 the	 risk	 factor-related	changes	 from	the	 large	changes	associated	with	
aging.	This	also	impedes	direct	translation	of	our	findings	to	individual	subjects,	e.g.	
for	use	in	clinical	care.	2.	The	study	protocol	was	defined	in	2005-2006	and	therefore	
the	spatial	resolution	for	the	diffusion	acquisition	was	relatively	poor	for	current	day	
standards.23	Although	 the	use	of	TBSS	mitigates	partial	volume	effects	 in	 the	major	
white	matter	 tracts	 and	we	 adjusted	 for	 overall	white	matter	 atrophy,	we	will	 have	
been	less	sensitive	to	detect	change	in	very	thin	tracts.	We	did	nevertheless	identify	
widespread	deterioration	of	white	matter	microstructure	within	 the	 studied	 interval.	
We	excluded	participants	with	dementia	at	either	time	point,	but	we	did	not	exclude	
persons	with	mild	cognitive	impairment	(MCI),	since	MCI	contributes	to	the	continu-
ous	spectrum	of	age	related	pathologies	that	we	aim	to	investigate.	This	may	have	led	
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to	inclusion	of	some	persons	with	preclinical	dementia,	which	could	have	affected	our	
results.
In	conclusion,	in	this	large	longitudinal	analysis	of	brain	white	matter	microstructure	
in	 normal	 aging,	we	 found	widespread	microstructural	 deterioration	 of	 the	 normal-
appearing	white	matter,	with	relative	sparing	of	sensorimotor	fibers.	We	found	changes	
to	be	more	prominent	in	older	persons,	which	were	partly	explained	by	concomitant	
macroscopic	 white	 matter	 pathology.	 Cardiovascular	 risk	 factors	 did	 not	 generally	
relate	to	white	matter	microstructure.	These	insights	into	white	matter	degeneration	in	
aging	may	help	in	understanding	the	pathophysiology	of	neurodegenerative	diseases.
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ABStrACt
Objective To	investigate	the	association	of	kidney	function	with	white	matter	micro-
structural	integrity.
Methods	 We	 included	 2726	 participants	 with	 a	 mean	 age	 of	 56.6	 years	 (45%	
men)	 from	 the	 population-based	Rotterdam	Study.	Albumin-to-creatinine	 ratio,	 and	
glomerular	filtration	 rate	 (eGFR),	using	 serum	cystatin	C	 (eGFRcys)	 and	creatinine	
(eGFRcr),	 were	measured	 to	 evaluate	 kidney	 function.	 Diffusion-MRI	was	 used	 to	
assess	microstructural	integrity	of	the	normal-appearing	white	matter.	Multiple	linear	
regression	 models,	 adjusted	 for	 macrostructural	 MRI-markers	 and	 cardiovascular	
risk	factors	were	used	to	model	the	association	of	kidney	function	with	white	matter	
microstructure.
Results Participants	had	average	eGFRcr	of	86.1	mL/min/1.73	m2,	average	eGFRcys	
of	86.2	mL/min/1.73	m2,	and	median	albumin-to-creatinine	ratio	of	3.4	mg/g.	Lower	
eGFRcys	 was	 associated	 with	 worse	 global	 white	 matter	 microstructural	 integrity,	
reflected	as	lower	fractional	anisotropy	(FA)	(standardized	difference	per	SD:	-0.053,	
95%CI:	 -0.092,	 -0.014)	 and	 higher	 mean	 diffusivity	 (MD)	 (0.036,	 95%CI:	 0.001,	
0.070).	 Similarly,	 higher	 albumin-to-creatinine	 ratio	 was	 associated	 with	 lower	 FA	
(-0.044,	95%CI:	-0.078,	-0.011).	There	was	no	linear	association	between	eGFRcr	and	
white	matter	integrity.	Subgroup	analyses	showed	attenuation	of	the	associations	after	
excluding	 subjects	 with	 hypertension.	 The	 associations	 with	 global	 DTI-measures	
didn’t	seem	to	be	driven	by	particular	tracts,	but	rather	spread	across	multiple	tracts	in	
various	brain	regions.
Conclusions	Reduced	kidney	function	is	associated	with	worse	white	matter	micro-
structural	 integrity.	Our	findings	 highlight	 the	 importance	 for	 clinicians	 to	 consider	
concomitant	macro-	 and	microstructural	 changes	of	brain	 in	 subjects	with	 impaired	
kidney	function.
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INtroduCtIoN
The	brain	and	the	kidney	are	both	vulnerable	to	vascular	and	hemodynamic	alterations	
due	to	similar	high	flow	and	low	resistance	circulation.1	Therefore,	vascular	damage	in	
the	kidney	could	mirror	cerebrovascular	changes	in	the	brain.1	Accordingly,	a	higher	
prevalence	of	cerebrovascular	diseases	such	as	stroke	and	vascular	dementia	among	
patients	with	chronic	kidney	disease	 (CKD)	has	been	 reported.2,	3	Beyond	clinically	
evident	 cerebrovascular	 diseases,	 previous	 studies	 showed	 an	 association	 between	
kidney	function	and	subclinical	cerebrovascular	diseases	including	brain	atrophy	and	
white	matter	lesions.2,	4,	5	However,	subclinical	cerebrovascular	diseases	have	a	wide	
spectrum	 and	 conventional	MRI	 sequences	 are	 not	 capable	 of	 capturing	 this	 entire	
spectrum.	Diffusion	tensor	imaging	(DTI)	is	an	advanced	MRI	technique	that	provides	
quantitative	information	of	microscopic	changes	of	the	cerebral	white	matter.	Recogni-
tion	of	early	changes	in	white	matter	structural	integrity	is	of	importance	as	it	might	
help	to	prevent	further	progression	of	brain	pathologies	before	reaching	an	irreversible	
stage.6	Despite	 the	current	evidence	indicating	that	advanced	impairments	 in	kidney	
function	are	associated	with	brain	pathologies,2,	3	 it	 is	unknown	whether	changes	 in	
kidney	 function	 and	 glomerular	 integrity	 are	 linked	 to	more	 subtle,	microstructural	
changes	 in	 the	brain.	 In	 this	 study,	we	hypothesized	 that	 loss	 of	 kidney	 function	 is	
associated	with	microstructural	changes	of	the	white	matter.
MethodS
Study population
The	present	study	is	embedded	within	the	second	extension	of	 the	population-based	
Rotterdam	Study	 (2005-2009),	 including	participants	of	45	years	and	older.	For	 the	
current	study,	we	included	2825	individuals	with	DTI	data,	of	whom	2680	had	urine	
albumin	and	urine	creatinine	measurements,	2717	had	serum	creatinine	measurements,	
and	2726	had	available	data	on	serum	cystatin	C	measurements	(figure e-1).
Standard Protocol Approvals, registrations, and Patient Consents
The	Rotterdam	Study	has	been	approved	by	the	medical	ethics	committee	according	
to	 the	 Population	 Study	Act	Rotterdam	Study,	 executed	 by	 the	Ministry	 of	Health,	
Welfare	and	Sports	of	the	Netherlands.	Written	informed	consent	was	obtained	from	
all	participants.7
kidney function
Estimated	 glomerular	 filtration	 rate	 (eGFR)	was	 calculated	 for	 creatinine	 (eGFRcr)	
and	cystatin	C	(eGFRcys)	measurements	separately	as	well	as	for	both	measurements	
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combined	(eGFRcrcys),	according	to	the	Chronic	Kidney	Disease	Epidemiology	Col-
laboration	(CKD-EPI)	formula.8	Albumin-to-creatinine	ratio	was	estimated	by	dividing	
albumin	by	creatinine	(mg/g).9	Since	measures	of	albumin-to-creatinine	ratio	were	not	
normally	distributed,	albumin-to-creatinine	ratio	values	were	natural	log	transformed	
(further	 details	 about	 kidney	 function	measurements	 in	 supplemental	material).	We	
defined	 three	 categories	 of	 kidney	 function	 using	 information	 from	both	 eGFR	and	
albumin-to-creatinine	ratio.	This	categorization	is	based	on	the	cutoffs	of	the	Kidney	
Disease:	Improving	Global	Outcomes	(KDIGO)	2013,10	and	has	been	applied	in	 the	
research	setting	before.11	Categories	were	defined	on	the	basis	of	two	criteria:	eGFR-
crcys	>	60	mL/min/1.73	m2	and	albumin-to-creatinine	ratio	<	30	mg/g.	First	category	
included	participants	that	met	both	criteria.	Second	category	included	participants	that	
met	only	one	criterion.	Participants	that	met	none	of	the	criteria	were	classified	as	the	
third	category.11
Brain dtI-MrI
Brain	MRI	scanning	was	performed	on	a	1.5	 tesla	MRI	scanner	 (GE	Signa	Excite).	
Scan	protocol	and	sequence	details	are	described	extensively	elsewhere.12	For	DTI,	we	
performed	a	single	shot,	diffusion-weighted	spin	echo	echo-planar	imaging	sequence.	
Maximum	b-value	was	1000	s/mm2	in	25	non-collinear	directions;	three	volumes	were	
acquired	without	diffusion	weighting	 (b-value	=	0	s/mm2).12	All	diffusion	data	were	
pre-processed	using	a	standardized	pipeline,	including	correction	for	motion	and	eddy	
currents,	estimation	of	the	diffusion	tensor,	and	registration	to	tissue	segmentation	to	
obtain	global	mean	DTI-measures	in	the	normal-appearing	white	matter.	These	mea-
sures	includes	fractional	anisotropy	(FA),	mean	diffusivity	(MD),	and	axial	and	radial	
diffusivities.13	In	general,	lower	values	of	FA	and	higher	values	of	MD	are	indicative	of	
worse	microstructural	integrity	of	the	white	matter.	Next,	white	matter	tracts	were	seg-
mented	using	a	diffusion	tractography	approach	described	previously.14	We	identified	
14	different	white	matter	tracts	(11	tracts	were	defined	for	left	and	right	hemispheres)	
in	subject	native	space.	Tracts	were	categorized	into	brainstem	tracts,	projection	fibers	
association	fibers,	 limbic	 system	fibers	and	callosal	fibers.15	Tract-specific	measure-
ments	of	microstructure	were	obtained	by	taking	median	measures	inside	each	white	
matter	 tract,	with	 subsequent	 combination	of	 left	 and	 right	measures.14	DTI	values,	
both	global	and	tract-specific,	were	measured	using	fully	automated	methods	(no	read-
ers	involved).	Since	these	measures	are	not	observer	dependent,	no	observer	bias	was	
introduced.	However,	 there	might	 be	 some	 random	measurement	 noise	 in	 the	 scan	
protocol.	The	average	tract-specific	reproducibility	of	our	multi-step	method	was	87%.	
More	details	about	 the	reproducibility	of	 tract-specific	DTI-parameters	are	provided	
elsewhere.14
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Cardiovascular risk factors
Information	related	to	smoking	and	alcohol	consumption	was	acquired	using	question-
naires.	Alcohol	consumers	were	categorized	into	non,	moderate	and	heavy	drinkers.	
Smoking	 was	 categorized	 in	 never,	 former	 and	 current	 smoking.	 Information	 on	
medication	use	was	based	on	home	interviews.	Hypertension	was	defined	as	a	systolic	
blood	pressure	≥140	mmHg	or	a	diastolic	blood	pressure	≥	90	mmHg	or	 the	use	of	
antihypertensive	medication.	Cardiovascular	 disease	was	 considered	 as	 a	 history	 of	
myocardial	 infarction,	 stroke	 or	 coronary	 revascularization	 procedures.16	 Diabetes	
mellitus	was	 defined	by	 use	 of	 blood	glucose	 lowering	medication	 and/or	 a	 fasting	
serum	glucose	level	equal	to	or	greater	than	7.0	mmol/l.
Statistical analysis
Associations	between	kidney	function	markers	and	DTI-parameters	were	evaluated	us-
ing	multiple	linear	regression	models.	Subject-specific	global	and	tract-specific	DTI-
parameters	were	standardized	to	z	scores.	Betas	and	95%	confidence	intervals	(CI)	for	
difference	in	DTI	parameters	were	estimated	per	standard	deviation	increase	of	mea-
sures	of	the	kidney	function.	We	performed	the	analyses	in	four	steps.	The	first	model	
was	performed	unadjusted.	In	the	second	model	analyses	were	adjusted	for	age,	sex,	
and	macrostructural	MRI-markers	including	white	matter	volume,	intracranial	volume,	
and	WML	(also	known	as	white	matter	hyperintensities)	volume.	In	the	third	model	we	
additionally	adjusted	the	analyses	for	cardiovascular	risk	factors	(systolic	blood	pres-
sure,	diastolic	blood	pressure,	alcohol	intake,	smoking,	total	cholesterol,	high	density	
lipoprotein	cholesterol,	diabetes	mellitus,	history	of	cardiovascular	disease,	and	body	
mass	index)	and	antihypertensive	and	lipid-lowering	medication.	In	the	fourth	model,	
analyses	 with	 eGFR	 as	 determinants	 were	 adjusted	 for	 albumin-to-creatinine	 ratio,	
and	analyses	with	albumin-to-creatinine	ratio	as	determinant	were	further	adjusted	for	
eGFRcrcys.	Based	on	previous	literature17	suggesting	a	U-shaped	association	between	
serum	creatinine	and	brain	outcomes,	we	further	checked	 the	non-linear	association	
of	eGFRcr	with	DTI-parameters	of	white	matter	integrity	by	including	the	quadratic	
term	 in	 the	model.	We	 performed	 an	 analysis	 of	 covariance	where	mean	 values	 of	
FA	 and	MD	were	 compared	 across	 three	 categories	 of	 kidney	 function.	Moreover,	
we	performed	a	series	of	sensitivity	analyses,	excluding	subjects	with	chronic	kidney	
disease	(defined	as	eGFRcrcys	<	60	mL/min/1.73	m2),	diabetes	mellitus,	hypertension,	
and	with	a	history	of	cardiovascular	disease.	To	 investigate	whether	 the	association	
between	 kidney	 function	 and	white	matter	 integrity	 differs	 in	 participants	with	 and	
without	hypertension,	we	assessed	the	interactions	between	kidney	function	markers	
and	hypertension	in	relation	to	DTI-parameters.	In	exploratory	analyses,	we	evaluated	
if	the	associations	between	kidney	function	and	white	matter	integrity	is	independent	
of	C-reactive	protein	levels.	Furthermore,	to	compare	the	magnitude	of	the	association	
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with	age,	as	an	established	risk	factor	for	 impairments	 in	white	matter	 integrity,	we	
calculated	the	effect	estimates	for	the	association	of	age	with	FA	and	MD.	Then,	we	
divided	the	betas	(per	standard	deviation)	of	kidney	function	markers	by	the	betas	of	
age	in	relation	to	DTI-parameters	and	reported	the	corresponding	ratios.
In	all	analyses,	we	treated	the	phase	encoding	direction	of	the	diffusion	scan	as	a	po-
tential	confounder.	In	tract	specific	analyses	of	the	medial	lemniscus,	we	additionally	
corrected	for	its	varying	coverage	inside	the	field	of	view	of	the	diffusion	acquisition	
across	participants.	All	analyses	were	carried	out	using	SPSS	20.0.2	for	windows	or	R	
version	2.15.0.
reSuLtS
table 1	presents	the	characteristics	of	the	2726	study	participants.	Average	age	of	the	
participants	was	56	±6.4	years	and	45	%	were	male.	table 2	presents	baseline	charac-
teristics	of	participants	in	different	categories	based	on	participants’	kidney	function.
The	association	between	kidney	function	markers	and	global	DTI-parameters	of	white	
matter	microstructural	 integrity	 are	 presented	 in	table 3.	 In	 the	 unadjusted	model,	
higher	albumin-to-creatinine	ratio	was	associated	with	lower	FA	and	higher	MD	(stan-
dardized	difference	FA:	-0.102,	95%	confidence	interval	(CI):	-0.139,	-0.066;	standard-
ized	difference	MD:	0.096,	95%CI:	0.061,	0.132).	Higher	albumin-to-creatinine	ratio	
was	also	associated	with	higher	 radial	diffusivity	 (0.063,	95%CI:	0.027,	0.100)	and	
higher	axial	diffusivity	(0.103,	95%CI:	0.067,	0.139).	Adjustments	for	age,	sex,	and	
macrostructural	MRI-markers	(white	matter	volume,	 intracranial	volume,	and	WML	
volume)	attenuated	 the	association	of	albumin-to-creatinine	ratio	with	FA,	MD,	and	
radial	diffusivity	 (table 3).There	was	no	association	between	albumin-to-creatinine	
ratio	and	axial	diffusivity	in	the	second	model.	After	further	adjustments	for	cardio-
vascular	 risk	 factors,	 in	 the	 third	model,	 associations	 of	 albumin-to-creatinine	 ratio	
with	FA	and	 radial	diffusivity	did	not	 change,	but	 the	association	with	MD	became	
non-significant	(p:	0.09).	Adjustment	for	eGFRcrcys	in	the	fourth	model	didn’t	change	
the	results	(table 3).
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table 1. Population	Characteristics
Characteristics n= 2726
Age,	years 56.6	(6.4)
Men 1225	(44.9)
Systolic	blood	pressure,	mmHg 131.9	(18.5)
Diastolic	blood	pressure,	mmHg 82.3	(10.8)
Antihypertensive	medication 595	(21.8)
Alcohol
			Moderate	drinker 1640	(60.4)
			Heavy	drinker 806	(29.6)
Smoking
			Current 715	(26.2)
			Former 1190	(43.7)
Total	cholesterol,	mmol/l 5.6	(1.0)
HDL	cholesterol,	mmol/l 1.4	(0.4)
Lipid-lowering	medication 570	(20.9)
Diabetes	mellitus 214	(7.9)
History	of	cardiovascular	disease 128	(4.7)
Hypertension 1191	(43.7)
Body	mass	index,	kg/m2 27.5	(4.3)
Albumin-to-creatinine	ratio,	mg/g 3.4	(2.2,	6.2)
eGFRcr,	mL/min/1.73	m2 86.1	(13.5)
eGFRcys,	mL/min/1.73	m2 86.2	(16.0)
eGFRcrcys,	mL/min/1.73	m2 86.3	(13.4)
Intracranial	volume,	mL 1128.6	(122.0)
White	matter	volume,	mL 416.8	(59.9)
White	matter	lesion	volume,	mL 2.0	(1.3,	3.5)
Fractional	anisotropy 0.33	(0.01)
Mean	diffusivity,	10-3 mm2/s 0.74	(0.02)
Axial	diffusivity,	10-3 mm2/s 1.01	(0.03)
Radial	diffusivity,	10-3 mm2/s 0.60	(0.02)
Categorical	variables	are	presented	as	numbers	(percentages),	continuous	variables	as	means	(standard	devia-
tions)	and	white	matter	lesions	and	albumin-to-creatinine	ratio	are	presented	as	medians	(interquartile	ranges).
The	following	variables	had	missing	data:	blood	pressure	(n=9),	smoking	(n=5),	alcohol	(n=12),	lipid-lowering	
medication	 (n=	 24),	 antihypertensive	medication	 (n=24),	HDL:	 high	 density	 lipoprotein	 cholesterol	 (n=7),	
Total	cholesterol	(n=	5),	albumin-to-creatinine	ratio	(n=141),	history	of	cardiovascular	disease	(n=28),	body	
mass	index	(n=2),	hypertension	(n=24).
Abbreviations:	eGFRcys:	cystatin	C	based	estimated	glomerular	filtration	rate,	eGFRcr:	creatinine	based	es-
timated	glomerular	filtration	rate,	eGFRcrcys:	creatinine	and	cystatin	C	based	estimated	glomerular	filtration	
rate
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table 2. Population	characteristics	in	categories	of	kidney	function
Characteristics*
first category Second category third category
eGfr>60 and ACr<30
N=2320
eGfr<60 or ACr>30
N=179
eGfr<60 and ACr >30
N=14
Age,	years 56.4	(5.9) 60.5	(9.6) 65.4	(9.2)
Men 1040	(44.8) 76	(42.5) 7	(50.0)
SBP,	mmHg 131.4	(18.1) 139.6	(21.1) 145.5	(23.5)
DBP,	mmHg 82.1	(10.7) 85.1	(12.0) 85.1	(11.2)
Anti-HTN	Med 476	(20.5) 68	(38.0) 11	(78.6)
Alcohol
			Moderate	drinker 1393	(60.0) 111	(62.0) 6	(42.9)
			Heavy	drinker 694	(29.0) 45	(25.1) 4	(28.6)
Smoking
			Current 590	(25.4) 49	(27.4) 4	(28.6	)
			Former 1014	(43.7) 80	(44.7) 7	(50.0)
Total	chol,	mmol/l 5.6	(1.0) 5.4	(1.1) 5.8	(1.3)
HDL	chol,	mmol/l 1.4	(0.4) 1.3	(0.4) 1.4	(0.5)
Lipid	lowering	Med 469	(20.2) 53	(29.6) 6	(42.9)
DM 155	(6.7) 34	(19.0) 2	(14.3)
CVD 99	(4.3) 19	(10.6) 2	(14.3)
HTN 982	(42.3) 116	(64.8) 14	(100)
BMI,	kg/m2 27.4	(4.2) 29.0	(5.1) 28.4	(4.6)
ACR,	mg/g 3.3	(2.1,	5.5) 39.0	(8.4,	74.4) 130.1	(73.4,	229.1)
eGFRcr,	mL/min/1.73	m2 87.0	(11.9) 77.3	(18.9) 44.8	(16.7)
eGFRcys,	mL/min/1.73	m2 87.4	(14.3) 74.2	(21.4) 38.1	(13.3)
eGFRcrcys,	mL/min/1.73	m2 87.4	(11.7) 75.6	(20.0) 40.2	(13.9)
ICV,	mL 1127.6	(121.1) 1125.3	(136.9) 1103.7	(133.5)
WMV,	mL 417.3	(58.7) 408.7	(68.5) 385.9	(93.1)
WMLV,	mL 2.0	(1.3,	3.4) 2.9	(1.6,	5.5) 8.9	(3.1,	13.0)
FA 0.33	(0.01) 0.33(0.01) 0.32	(0.02)
MD,	10-3 mm2/s 0.74	(0.02) 0.75	(0.03) 0.76	(0.03)
Axial	diffusivity,	10-3 mm2/s 1.01	(0.03) 1.02	(0.03) 1.03	(0.03)
Radial	diffusivity,	10-3 mm2/s 0.60	(0.02) 0.61	(0.03) 0.63	(0.04)
*Sample	size	in	this	table	is	based	on	participants	with	available	data	for	both	eGFRcrcys	and	ACR	(n=2513).
Categorical	variables	are	presented	as	numbers	(percentages),	continuous	variables	as	means	(standard	devia-
tions)	and	white	matter	lesions	and	albumin-to-creatinine	ratio	are	presented	as	medians	(interquartile	ranges).
Abbreviations: SBP: systolic blood pressure, DBP: diastolic blood pressure, Anti-HTN Med: antihypertensive 
medication, Total chol: total cholesterol, HDL chol: high density lipoprotein cholesterol, DM: diabetes mel-
litus, CVD: cardiovascular disease, HTN: hypertension, BMI: body mass index, ACR: Albumin-to-creatinine 
ratio, eGFRcys: cystatin C based estimated glomerular filtration rate, eGFRcr: creatinine based estimated 
glomerular filtration rate, eGFRcrcys: creatinine and cystatin C based estimated glomerular filtration rate, 
ICV: intracranial volume, WMV: white matter volume, WMLV: white matter lesion volume. FA: fractional 
anisotropy, MD: mean diffusivity.
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In	the	unadjusted	model,	each	standard	deviation	higher	eGFRcys	was	associated	with	
higher	FA	and	lower	MD	(FA:	0.204,	95%	CI:	0.168,	0.240;	MD:	-0.248,	95%CI:	-0.283,	
-0.213).	Likewise,	each	standard	deviation	higher	eGFRcys	was	associated	with	lower	
radial	 diffusivity	 (-0.268,	 95%CI:	 -0.303,	 -0.233)	 and	 lower	 axial	 diffusivity	 (-0.157,	
95%CI:	-0.194,	-0.120).	The	association	of	eGFRcys	with	FA,	MD,	and	radial	diffusiv-
ity	 attenuated	after	 adjustment	 for	 age,	 sex,	 and	macrostructural	MRI-markers.	There	
was	no	association	between	eGFRcys	and	axial	diffusivity	in	the	second	model.	Further	
adjustments	for	cardiovascular	risk	factors,	in	the	third	model,	did	not	change	the	asso-
ciations	of	eGFRcys	with	DTI-parameters	of	white	matter	integrity.	After	adjustment	for	
albumin-to-creatinine	ratio	in	the	fourth	model,	the	association	of	eGFRcys	with	FA	and	
MD	attenuated	and	became	non-significant	(p:	0.061	and	0.068,	respectively)	(table 3).
Each	standard	deviation	higher	eGFRcr	was	associated	with	higher	FA,	lower	MD,	and	
lower	radial	and	axial	diffusivity	(all	p	<	0.05).	There	was	no	linear	association	be-
table 3. The	association	of	kidney	function	parameters	with	DTI-parameters	of	white	matter	microstructural	
integrity
fractional anisotropy Mean diffusivity Axial diffusivity Radial diffusivity
Difference*(95% CI) Difference*(95% CI) Difference*(95% CI) Difference*(95% CI)
Albumin-to-creatinine ratio N= 2680
			Model	I -0.102 (-0.139, -0.066) 0.096 (0.061, 0.132) 0.063 (0.027, 0.100) 0.103 (0.067, 0.139)
			Model	II -0.049 (-0.081, -0.016) 0.033(0.004, 0.062) 0.018	(-0.015,	0.050) 0.037 (0.008, 0.066)
			Model	III -0.044 (-0.078, -0.011) 0.026(-0.004,	0.056) 0.010	(-0.024,	0.044) 0.031 (0.001, 0.061)
			Model	IV -0.043 (-0.078, -0.008) 0.027	(-0.004,	0.058) 0.013	(-0.022,	0.049) 0.031 (0.001, 0.062)
eGfrcys N=2726
			Model	I 0.204 (0.168, 0.240) -0.248 (-0.283, -0.213) -0.157 (-0.194, -0.120) -0.268 (-0.303, -0.233)
			Model	II 0.053(0.016, 0.090) -0.040 (-0.073, -0.007) -0.001	(-0.038,	0.036) -0.057 (-0.091, -0.024)
			Model	III 0.053(0.014, 0.092) -0.036 (-0.070, -0.001) 0.006	(-0.033,	0.045) -0.056 (-0.090, -0.021)
			Model	IV 0.039	(-0.002,	0.079) -0.033	(-0.069,	0.003) 0.003	(-0.038,	0.044) -0.050 (-0.087, -0.014)
eGfrcr N= 2717
			Model	I 0.100 (0.063, 0.136) -0.136 (-0.171, -0.100) -0.092 (-0.129, -0.055) -0.143 (-0.179, -0.107)
			Model	II -0.007	(-0.041,	0.027) 0.011	(-0.020,	0.041) 0.015	(-0.020,	0.049) 0.007	(-0.024,	0.038)
			Model	III 0.002	(-0.033,	0.036) 0.003	(-0.028,	0.034) 0.008	(-0.027,	0.043) -0.001	(-0.032,	0.031)
			Model	IV -0.013	(-0.049,	0.023) 0.009	(-0.023,	0.041) 0.008	(-0.029,	0.044) 0.009	(-0.024,	0.041)
*Differences	(betas),	and	95%	CI	are	calculated	using	the	per	standard	deviation	increase	in	log-transformed	
albumin-to-creatinine	ratio/	eGFRcys/	eGFRcr	and	subject-specific	mean	standardized	z	scores	for	fractional	
anisotropy,	mean	diffusivity,	and	axial	and	radial	diffusivity.	Model	I:	crude	model.	Model	II:	adjusted	for	age,	
sex,	intracranial	volume,	white	matter	volume,	and	log	transformed	white	matter	lesion	volume.	Model	III:	ad-
ditionally	adjusted	for	systolic	blood	pressure,	diastolic	blood	pressure,	antihypertensive	medication,	alcohol	
intake,	 smoking,	 total	 cholesterol,	 high	density	 lipoprotein	 cholesterol,	 lipid-lowering	medication,	 diabetes	
mellitus,	history	of	cardiovascular	disease,	and	body	mass	index.	Model	IV:	additionally	adjusted	for	eGFR-
crcys	in	analyses	with	albumin-to-creatinine	ratio	as	determinant,	and	additionally	adjusted	for	albumin-to-cre-
atinine-ratio	in	analyses	with	eGFRcr	or	eGFRcys.	Abbreviations: CI: confidence interval, eGFRcys: cystatin 
C based estimated glomerular filtration rate, eGFRcr: creatinine based estimated glomerular filtration rate, 
eGFRcrcys: creatinine and cystatin C based estimated glomerular filtration rate.
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tween	eGFRcr	and	DTI-parameters	of	white	matter	integrity	after	adjustment	for	age,	
sex,	and	macrostructural	MRI-markers	(all	p>0.05)	(table 3).	Including	the	quadratic	
term	of	eGFRcr	in	the	model	suggested	a	U-shaped	association	between	eGFRcr	and	
markers	of	white	matter	integrity	(all	P-values	<0.05	for	test	of	quadratic	term)	(table 
e-1).	After	excluding	the	participants	with	4	standard	deviation	lower/higher	eGFRcr	
(n=9)	 the	 U-shaped	 association	 was	 not	 present	 anymore.	 Performing	 the	 analyses	
with	 eGFRcrcys	as	 the	determinant,	 the	 effect	 estimates	were	 intermediate	between	
two	separate	equations	of	eGFRcr	and	eGFRcys	and	resulted	in	borderline	significant	
findings	(table e-2).
figure 1	 shows	 age	 and	 sex	 adjusted	means	 of	 FA	 and	MD	 in	 three	 categories	 of	
kidney	 function.	We	observed	 a	 linear	 trend	between	different	 categories	 of	 kidney	
function	 and	 white	 matter	 microstructural	 DTI-parameters,	 reflecting	 worse	 white	
matter	microstructure	in	persons	with	worse	kidney	function	(p	for	trend	0.001	for	FA	
and	0.002	for	MD).
Excluding	 individuals	with	 chronic	 kidney	 disease,	 diabetes	mellitus,	 or	 history	 of	
cardiovascular	disease	yielded	similar	findings.	Excluding	individuals	with	hyperten-
sion	attenuated	the	association	of	kidney	function	with	DTI	parameters	(figure e-2).	
In	the	stratified	analyses,	the	association	between	eGFRcys	and	MD	was	stronger	in	
hypertensive	participants	 (P	 for	 interaction,	 0.001).	A	 similar,	 borderline	 significant	
trend	was	observed	for	the	interaction	between	albumin-to-creatinine	ratio	and	hyper-
tension	in	relation	to	FA	(P	for	interaction	0.059)	(table e-3).	Adjusting	the	association	
between	markers	of	kidney	function	and	DTI-parameters	of	white	matter	integrity	for	
C-reactive	protein	didn’t	substantially	change	the	associations	(data	not	shown).
In	an	extra	analysis,	we	observed	that	each	year	increase	in	age	was	associated	with	
lower	 FA	 and	 higher	MD	 (table e-4).	 Comparing	 the	 effect	 estimates	 of	 age	with	
eGFRcys	in	relation	to	FA,	we	showed	that	each	standard	deviation	lower	eGFRcys	
had	the	magnitude	equal	to	4.1	years	of	increase	in	age.	Similarly,	each	standard	devia-
tion	lower	eGFRcys	in	relation	to	MD	had	the	magnitude	equal	to	1.5	years	increase	
in	age.
Associations	between	kidney	 function	and	 tract-specific	diffusion	measures	are	pre-
sented	in	figure 2 and	table e-5.	Higher	albumin-to-creatinine	ratio	was	associated	
with	higher	MD	in	all	tracts	(projection	fibers,	association	fibers,	limbic	system	fibers,	
and	callosal	fibers).	Likewise,	higher	eGFRcys	was	related	to	MD	in	all	tracts,	except	
for	brain	stem	tracts.	We	did	not	observe	any	linear	association	between	eGFRcr	and	
tract-specific	DTI-measures.
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dISCuSSIoN
In	this	cross-sectional	study,	we	demonstrated	that	reduced	kidney	function	was	inde-
pendently	associated	with	worse	microstructural	integrity	of	cerebral	white	matter.	The	
associations	did	not	seem	to	be	confined	to	specific	white	matter	tracts.
Most	of	previous	studies	that	investigated	the	association	of	kidney	function	with	brain	
outcomes	have	focused	either	on	cerebrovascular	accidents,	conventional	macrostruc-
tural	MRI-markers	such	as	brain	atrophy,	or	manifestations	of	cerebral	small	vessel	
disease.2,	4,	5	 In	this	study	we	show	that	reduced	kidney	function	is	related	to	loss	of	
white	matter	microstructural	 integrity,	which	may	be	considered	a	more	sensitive	or	
subtle	measure	 of	white	matter	 disease	 compared	 to	macrostructural	MRI-markers.	
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figure 1. Means	of	A) fractional	anisotropy	B) and	mean	diffusivity	 in	different	
categories	of	kidney	function 
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first category: indicates	 eGFRcrcys	 >	 60	 mL/min/1.73	 m2 AND	 albumin-to-
creatinine	ratio	<	30	mg/g	(N=2320) 
Second category: indicates	 eGFRcrcys	 >	 60	mL/min/1.73	m2 AND	 albumin-to-
creatinine	ratio	>	30	mg/g	OR	eGFRcrcys	<	60	mL/min/1.73	m2 AND	albumin-to-
creatinine	ratio	<	30	mg/g	(N=179) 
third category: indicates	 eGFRcrcys	 <	 60	 mL/min/1.73	 m2	 AND	 albumin-to-
creatinine	ratio	>	30	mg/g	(N=	14) 
 
Means	are	adjusted	for	age	and	sex. 
Abbreviations: eGFRcrcys:	 creatinine	 and	 cystatin	C	based	 estimated	 glomerular	
filtration	rate 
 
figure 1.	Means	of	A)	fractional	anisotropy	B)	and	mean	diffusivity	in	different	categories	of	kidney	function
first category:	 indicates	 eGFRcrcys	 >	 60	 mL/min/1.73	 m2	AND	 albumin-to-creatinine	 ratio	 <	 30	 mg/g	
(N=2320)
Second category:	indicates	eGFRcrcys	>	60	mL/min/1.73	m2	AND	albumin-to-creatinine	ratio	>	30	mg/g	OR	
eGFRcrcys	<	60	mL/min/1.73	m2	AND	albumin-to-creatinine	ratio	<	30	mg/g	(N=179)
third category:	indicates	eGFRcrcys	<	60	mL/min/1.73	m2	AND	albumin-to-creatinine	ratio	>	30	mg/g	(N=	14)
Means	are	adjusted	for	age	and	sex.
Abbreviations:	eGFRcrcys:	creatinine	and	cystatin	C	based	estimated	glomerular	filtration	rate
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The	 associations	 persisted	 after	 adjusting	 for	 history	 of	 stroke	 and	 conventional	
MRI-markers,	 indicating	 that	 decrease	 in	 kidney	 function	might	 reflect	 early	 brain	
microstructural	changes	independent	of	co-existing	comorbidities	and	pathologies.
A	linear	association	between	eGFRcys	and	white	matter	microstructure	was	present;	
however,	we	observed	a	U-shaped	association	between	eGFRcr	and	DTI-parameters	
of	white	matter	integrity.	This	discrepancy	could	be	explained	by	the	fact	that	subjects	
with	very	low	creatinine	are	also	at	increased	risk	because	of	malnutrition	and	loss	of	
muscle	mass.18	In	line	with	this	explanation,	Seliger	et	al.	reported	a	linear	association	
between	higher	levels	of	serum	cystatin	C	and	prevalence	of	subclinical	brain	infarcts.17 
In	contrast,	they	found	that	the	prevalence	of	subclinical	brain	infarcts	was	higher	in	
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figure 2. Association	of	A) ACR	and	B) eGFRcys with	FA	and	MD	in	specific	
tracts. Adjusted	 for	 age,	 sex,	 white	matter	 volume,	 intracranial	 volume,	 and	 log	
transformed	white	matter	lesion	volume. 
Tracts	with	 significant	 associations	 (after	 Bonferroni	 correction:	 p<3.6×10-3)	 are	 labelled	
and	coloured. 
Abbreviations: ACR:	 albumin-to-creatinine	 ratio,	 eGFRcys:	 cystatin	 C	 based	 estimated	
glomerular	 filtration	rate,	FA:	fractional	anisotropy,	MD:	mean	diffusivity,	ATR:	anterior	
thalamic	 radiation,	 IFO:	 inferior	 fronto-occipital	 fasciculus,	 ILF:	 inferior	 longitudinal	
fasciculus,	PTR:	posterior	thalamic	radiation,	SLF:	superior	longitudinal	fasciculus,	UNC:	
uncinate	fasciculus,	FMA:	forceps	major,	FMI:	forceps	minor,	CGC:	cingulate	gyrus	part	of	
cingulum,	CGH:	parahippocampal	part	of	cingulum,	CST:	corticospinal	tract,	MCP:	middle	
cerebellar	peduncle,	ML:	medial	lemniscus,	STR:	superior	thalamic	radiation. 
 
figure 2.	Association	of	A)	ACR	and	B)	eGFRcys	with	FA	and	MD	in	specific	tracts.	Adjusted	for	age,	sex,	
white	matter	volume,	intracranial	volume,	and	log	transformed	white	matter	lesion	volume.
Tracts	with	significant	associations	(after	Bonferroni	correction:	p<3.6×10-3)	are	labelled	and	coloured.
Abbreviations:	ACR:	albumin-to-creatinine	ratio,	eGFRcys:	cystatin	C	based	estimated	glomerular	filtration	
rate,	FA:	fractional	anisotropy,	MD:	mean	diffusivity,	ATR:	anterior	thalamic	radiation,	IFO:	inferior	fronto-
occipital	 fasciculus,	 ILF:	 inferior	 longitudinal	 fasciculus,	 PTR:	 posterior	 thalamic	 radiation,	 SLF:	 superior	
longitudinal	fasciculus,	UNC:	uncinate	fasciculus,	FMA:	forceps	major,	FMI:	forceps	minor,	CGC:	cingulate	
gyrus	part	of	cingulum,	CGH:	parahippocampal	part	of	cingulum,	CST:	corticospinal	tract,	MCP:	middle	cer-
ebellar	peduncle,	ML:	medial	lemniscus,	STR:	superior	thalamic	radiation.
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both	subjects	with	low	and	high	serum	creatinine	suggesting	a	U-shaped	association.17 
Levels	of	serum	cystatin	C	are	reported	to	be	independent	of	muscle	mass;	neverthe-
less,	some	cardiovascular	 risk	factors	such	as	obesity	and	diabetes	can	be	non-GFR	
determinants	of	serum	cystatin	C	levels.19	In	addition,	previous	reports	proposed	that	
underlying	inflammation	can	influence	levels	of	cystatin	C.19	Since	inflammation	itself	
is	 a	 vascular	 risk	 factor,	 cystatin	C	may	 reflect	 inflammatory	 status	 independent	 of	
eGFR.	However,	in	this	study	adjusting	for	cardiovascular	risk	factors	as	well	as	an	
inflammatory	marker	(C-reactive	protein)	did	not	change	the	associations.
Several	 explanations	 can	 be	 proposed	 for	 the	 association	 of	 kidney	 function	 with	
degeneration	of	white	matter.	First,	kidney	and	the	brain	share	several	cardiovascular	
risk	factors.	Therefore,	existence	of	these	risk	factors	can	simultaneously	damage	the	
vasculature	of	both	kidney	and	brain.1	While	in	this	study	adjusting	for	conventional	
cardiovascular	risk	factors	such	as	blood	pressure	and	excluding	participants	with	dia-
betes,	and	cardiovascular	disease	did	not	change	our	findings,	excluding	participants	
with	hypertension	attenuated	the	associations.	This	might	indicate	that	history	of	hy-
pertension	plays	a	role	as	an	effect	modifier	and	not	as	a	confounder	in	the	association	
between	kidney	function	and	white	matter	integrity.	Future	studies	are	needed	to	ex-
plore	whether	subjects	with	hypertension	are	more	vulnerable	to	detrimental	influences	
of	impaired	kidney	function	on	white	matter	microstructural	integrity.	Second,	it	has	
been	suggested	that	vascular	damage	is	a	diffuse	phenomenon.20	Given	that	the	brain	
and	kidney	have	similar	circulation	systems,	and	endothelial	cells	play	a	crucial	role	
in	both	blood	brain	barrier	and	glomerular	integrity,1	it	is	possible	that	this	association	
can	originate	from	a	systemic	process	affecting	vascular	beds	in	both	organs.20	Third,	it	
is	possible	that	impaired	kidney	function	can	lead	to	brain	vascular	injury	via	increase	
in	pro-inflammatory	factors	and	decrease	in	serum	nitric	oxide.5	Nitric	oxide	regulates	
the	 function	of	 the	cerebral	microcirculation	and	 the	blood	brain	barrier,	which	can	
contribute	to	cerebral	hypoperfusion	and	subsequently	white	matter	damage.1
In	 the	 tract-specific	analyses,	MD	seemed	 to	be	a	more	sensitive	marker	 for	 loss	of	
white	matter	microstructural	 integrity	 in	 relation	 to	 kidney	 function.	This	might	 be	
explained	by	the	prevailing	theory	that	less	uniform	changes	in	FA	are	seen	in	deterio-
ration	of	crossing	fibers	regions,21	in	contrast	to	MD	that	may	show	more	consistent	
changes	 in	areas	of	white	matter	 loss.	This	 is	 further	supported	by	 the	considerable	
estimates	for	the	prevalence	of	crossing	fiber	regions	in	the	brain.21
The	integrity	of	white	matter	is	of	great	importance	in	normal	functioning	of	the	brain.	
Complex	cognitive	tasks	are	coordinated	by	interactions	between	different	regions	of	
the	 brain	 and	 intact	 white	 matter	 integrity	 plays	 an	 essential	 role	 in	 these	 interac-
tions.14,	 22	 In	 line	with	 this	 notion,	we	 previously	 showed	 that	 early	 changes	 in	 the	
white	 matter	 microstructure,	 as	 reflected	 in	 DTI-measures	 of	 the	 white	 matter,	 are	
associated	with	impaired	cognitive	function.22	These	associations	were	independent	of	
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macrostructural	brain	abnormalities	such	as	white	matter	lesions.	Our	findings	might	
suggest	 that	 impairments	 in	white	matter	 integrity	can	be	an	underlying	mechanism	
behind	the	association	between	impaired	kidney	function	and	cognitive	dysfunction.
Strengths	of	our	study	include	the	large	sample	size	and	availability	of	extensive	data	
on	various	cardiovascular	risk	factors,	and	macrostructural	MRI-markers	that	enabled	
us	to	control	for	several	potential	confounders.	Nevertheless,	a	number	of	limitations	
should	be	acknowledged.	First,	due	to	the	cross-sectional	design	of	the	study,	we	can-
not	draw	conclusions	about	 the	directionality	and	causality.	Second,	 the	cerebellum	
was	 not	 being	 fully	 incorporated	 in	 the	field	 of	 view	of	 the	 diffusion	 scan,	making	
conclusion	on	brain	stem	tracts	less	reliable.	In	addition,	our	findings	are	based	on	a	
population-based	study	including	relatively	young	and	healthy	individuals.	Prevalence	
of	kidney	disease	 in	 this	population	 is	 low	and	hence	 the	associations	are	based	on	
minor	 degrees	 of	 kidney	 dysfunction.	Therefore,	 it	 is	 possible	 that	 the	 associations	
would	be	more	prominent	in	older	populations	and	in	patients	with	kidney	disease.	In	
this	study	we	did	not	have	enough	power	to	perform	the	analyses	in	participants	with	
eGFR<60	mL/min/1.73	m2.Further	patient-based	studies	are	needed	to	investigate	this	
link	in	high	risk	individuals	with	lower	eGFR	levels.
In	 this	 study	 we	 showed	 that	 kidney	 function	 is	 related	 to	 impaired	 white	 matter	
microstructural	integrity,	suggesting	that	both	kidney	biomarkers	and	microstructural	
changes	of	white	matter	are	biologically	related.	Our	findings	suggest	that	clinicians	
need	to	consider	concomitant	macro-	and	microstructural	changes	in	the	brain	among	
subjects	with	impaired	kidney	function.
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ABStrACt
Objective	To	investigate	whether	retinal	microvascular	damage	is	related	to	normal-
appearing	white	matter	microstructure	on	diffusion	tensor	MRI.
Methods We	included	2,436	participants	(age	≥45	years)	from	the	population-based	
Rotterdam	Study	(2005-2009)	who	had	gradable	retinal	images	and	brain	MRI	scans.	
Retinal	 arteriolar	 and	 venular	 calibers	were	measured	 semiautomatically	 on	 fundus	
photographs.	White	matter	microstructure	was	assessed	using	diffusion	 tensor	MRI.	
We	used	 linear	 regression	models	 to	 investigate	 the	 associations	 of	 retinal	 vascular	
calibers	with	markers	of	normal-appearing	white	matter	microstructure,	adjusting	for	
age,	sex,	the	fellow	vascular	caliber,	and	additionally	for	structural	MRI	markers	and	
cardiovascular	risk	factors.
Results	Narrower	arterioles	and	wider	venules	were	associated	with	poor	white	mat-
ter	microstructure:	adjusted	difference	in	fractional	anisotropy	per	standard	deviation	
decrease	 in	 arteriolar	 caliber	 -0.061	 (95%	 confidence	 interval	 (CI):	 -0.106;	 -0.016)	
and	 increase	 in	venular	 caliber	 -0.054	 (-0.096;	 -0.011),	 adjusted	difference	 in	mean	
diffusivity	per	standard	deviation	decrease	in	arteriolar	caliber	0.048	(0.007;	0.088),	
and	increase	in	venular	caliber	0.047	(0.008;	0.085).	The	associations	for	venules	were	
more	prominent	in	women.
Conclusions	Retinal	vascular	calibers	are	related	to	normal-appearing	white	matter	
microstructure.	This	suggests	that	microvascular	damage	in	the	white	matter	is	more	
widespread	than	visually	detectable	as	white	matter	lesions.
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INtroduCtIoN
With	aging	populations,	the	number	of	persons	with	age-related	neurologic	disorders	
such	as	stroke	and	dementia	will	rise	substantially.1	Vascular	brain	pathology	has	been	
recognized	as	an	important	contributor	to	the	development	of	both	these	disorders.2-4 
Besides	large	vessel	disease,	pathology	of	 the	cerebral	small	vessels	(<200	µm)	has	
also	been	implicated	as	a	crucial	substrate.5	However,	the	direct	examination	of	cerebral	
small	vessels	is	difficult	with	current	neuroimaging	modalities.	Alternatively,	the	retinal	
microvasculature	is	thought	to	reflect	the	condition	of	the	cerebral	microvasculature,	
and	is	therefore	increasingly	being	used	to	study	vascular	brain	pathology.6,	7	Indeed,	
several	studies	have	shown	a	link	of	retinal	vascular	calibers	with	stroke	and	demen-
tia.8,	9	By	extension,	these	retinal	markers	have	also	been	associated	with	brain	MRI	
markers	such	as	white	matter	lesions,	lacunar	infarcts,	and	cerebral	microbleeds.10,	11
However,	these	structural	MRI-markers	of	microvascular	damage	are	considered	the	
tip	of	the	iceberg	of	a	more	widespread	vascular	brain	pathology.12	In	the	last	decade,	
advanced	MRI	techniques	such	as	diffusion	tensor	MRI	(DT-MRI)	have	enabled	us	to	
visualize	and	quantify	the	microstructure	of	normal-appearing	white	matter,	which	is	
presumed	to	be	affected	already	in	earlier	stages	of	vascular	brain	damage.13	However,	
the	exact	 link	of	microvascular	damage	with	such	microstructural	MRI-markers	has	
never	been	investigated.
Therefore,	 our	primary	 aim	was	 to	 investigate	 the	 relation	between	 retinal	 vascular	
calibers	and	microstructure	of	normal-appearing	white	matter.	As	a	secondary	aim,	we	
examined	the	association	of	retinal	vascular	calibers	with	structural	MRI	markers	of	
cerebral	microvascular	damage.
MethodS
Study population
This	study	is	embedded	within	the	second	extension	of	 the	Rotterdam	Study	(2005-
2009),	 a	 prospective	 population-based	 cohort	 study	 in	 the	Ommoord	 district	 in	 the	
city	Rotterdam,	the	Netherlands,	including	3,932	participants	aged	≥45	years.14	A	total	
of	976	participants	did	not	undergo	a	MRI	for	the	following	reasons:	did	not	visited	
the	research	center	(n=410),	refused	or	physically/mentally	unable	to	attend	(n=277),	
nonrespondent	 (n=108),	 had	MRI	 contraindications	 (n=154),	 or	 could	 not	 complete	
MRI	(n=27).	From	the	remaining	2,956	participants	who	underwent	a	multi-sequence	
MRI,	we	excluded	persons	with	cortical	infarcts	(n=76)	and	those	who	had	scans	with	
artifacts	that	hampered	automated	analysis	(n=55).	This	left	2,825	persons	with	avail-
able	DT-MRI	data,	of	whom	a	further	389	had	no	(gradable)	fundus	photographs.	For	
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the	 current	 study,	 2,436	 persons	were	 included	With	 available	DT-MRI	 and	 retinal	
data.
Standard protocol approvals, registrations, and patient consents
The	Rotterdam	Study	has	been	approved	by	the	medical	ethics	committee	according	
to	 the	 Population	 Study	Act	Rotterdam	Study,	 executed	 by	 the	Ministry	 of	Health,	
Welfare	and	Sports	of	the	Netherlands.	All	participants	gave	written	informed	consent.	
Baseline	home	interviews	and	examinations	were	performed	between	2005	and	2009.
Grading of retinal vascular calibers
A	full	ophthalmic	examination	was	done	 including	fundus	color	photography	of	 the	
optic	disc	with	a	20º	visual	field	camera	(TRC-50VT,	Tokyo	Optical	Co.,	Tokyo,	Japan)	
after	pharmacological	mydriasis.	We	analyzed	for	each	participant	the	fundus	photo-
graph	of	one	eye	with	the	best	quality	with	a	semiautomated	system	(IVAN,	University	
of	Wisconsin-Madison,	Madison,	Wisconsin).	Then	we	calculated	one	summary	value	
for	 the	arteriolar	calibers	 (in	μm)	and	one	 for	 the	venular	calibers	 (in	μm)	 for	each	
participant.15	Subsequently,	we	adjusted	these	summary	measures	for	refractive	errors	
to	approximate	absolute	measures.11	We	verified	in	a	random	sub-sample	(n=100)	that	
individual	measurements	 in	 both	 eyes	were	 similar.	Measurements	were	 performed	
by	two	trained	raters	masked	for	participant	characteristics.	Pearson	correlation	coef-
ficients	for	interrater	and	intrarater	reliability	(n=100)	were	0.85	and	0.86	for	arteriolar	
calibers,	and	0.87	and	0.87	for	venular	calibers,	respectively.
Assessment of dt-MrI parameters
All	 brain	MRI	 scanning	was	 performed	 on	 a	 single	 1.5	Tesla	MRI	 scanner	 (Signa	
Excite,	GE	Healthcare,	Milwaukee,	Wisconsin).	Scan	protocol	details	 are	described	
extensively	elsewhere.16	For	DT-MRI,	we	performed	a	single	shot,	diffusion-weighted	
spin	 echoplanar	 imaging	 sequence	 with	 maximum	 b	 value	 of	 1,000	 s/mm2	 in	 25	
non-collinear	directions.	A	standardized	pipeline	was	used	to	preprocess	all	diffusion	
data,	 including	 correction	 for	 motion	 and	 eddy	 currents,	 and	 registration	 to	 tissue	
segmentation	to	obtain	global	mean	DT-MRI	measures	of	the	normal-appearing	white	
matter.	The	 normal-appearing	white	matter	 is	 being	 considered	 as	 the	white	matter	
volume	without	white	matter	lesion	volumes.	The	global	DT-MRI	measures	included	
fractional	anisotropy	(FA),	mean	diffusivity	(MD),	axial	diffusivity	(AxD),	and	radial	
diffusivity	(RD).	In	general,	lower	values	of	FA	and	higher	values	of	MD	are	indicative	
of	poorer	white	matter	microstructure.	Besides,	changes	in	AxD	and	RD	values	may	
give	extra	information	about	the	underlying	cause	of	poor	white	matter	microstructure.	
In	1,338	participants,	the	diffusion	acquisition	scheme	was	rotated	with	the	phase	and	
frequency	encoding	directions	swapped,	which	led	to	a	mild	ghost	artifact	in	the	phase	
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encoding	direction.	Therefore,	we	treated	the	phase	encoding	direction	as	a	covariate	
in	the	analyses.17
other MrI markers
Volumetric	measures	of	normal-appearing	white	matter	volume,	intracranial	volume,	
and	white	matter	lesion	volume	(in	milliliters)	were	obtained	supratentorially,	using	a	
validated	tissue	segmentation	approach	that	included	conventional	k-nearest-neighbor	
brain	 tissue	 classification	 and	 white	 matter	 lesion	 segmentation.18,	 19	 The	 presence	
of	 cerebral	 microbleeds	 and	 lacunar	 infarcts	 was	 rated	 by	 1	 of	 5	 trained	 research	
physicians,	blinded	 to	 the	participants’	data,	on	a	3D	T2-weighted	gradient-recalled	
echo	MRI.	The	presence	of	lacunes	of	presumed	ischemic	origin	was	rated	on	fluid-
attenuated	inversion	recovery,	proton	density-weighted	and	T1-weighted	sequences.20 
We	defined	lacunes	as	focal	lesions	≥3	and	<15	mm	in	size	with	the	same	signal	inten-
sity	as	cerebrospinal	fluid	on	all	sequences	and	a	hyperintense	rim	on	fluid-attenuated	
inversion	recovery.
Assessment of cardiovascular risk factors
We	measured	 the	 systolic	 and	 diastolic	 blood	 pressure	 twice	 in	 sitting	 position	 at	
the	right	upper	arm	with	a	random-zero	sphygmomanometer.	The	mean	of	these	two	
readings	was	used	for	further	analysis.	We	calculated	the	body	mass	index	as	weight	
divided	 by	 height	 squared.	An	 automated	 enzymatic	 procedure	 measured	 the	 non-
fasting	 serum	 concentrations	 of	 total	 and	 high-density	 lipoprotein	 cholesterol.21	We	
defined	diabetes	mellitus	as	present	if	fasting	serum	glucose	concentration	was	≥7.0	
mmol/L,	 or	 if	 participants	 reported	 anti-diabetic	medication	 use.	C-reactive	 protein	
serum	concentration	was	measured	by	the	Rate	Near	Infrared	Particle	Immunoassay	
method	(Immage®,	Beckman	Coulter	Inc.,	Brea,	California	).	We	determined	the	pres-
ence	of	atherosclerotic	plaques	at	the	carotid	artery	bifurcation,	common	carotid	artery,	
and	internal	carotid	artery	on	both	sides	by	ultrasound.	Presence	of	these	plaques	was	
defined	as	 focal	 thickening	of	 the	vessel	wall	≥2mm	with	or	without	calcified	com-
ponents	relative	to	adjacent	segments.	We	retrieved	data	on	smoking	(non,	former,	or	
current)	and	antihypertensive	medication	use	by	a	computerized	questionnaire.
Statistical analysis
We	used	analysis	of	covariance,	adjusted	for	age	and	sex,	to	assess	difference	in	popu-
lation	 characteristics	 between	 participants	 and	 nonparticipants.	White	matter	 lesion	
volumes	were	transformed	using	natural	logarithm	to	account	for	a	skewed	distribu-
tion.	We	calculated	z-scores	for	retinal	vascular	calibers,	log-transformed	white	matter	
lesion	volumes,	and	DT-MRI	parameters	to	better	compare	the	arteriolar	and	venular	
effects	on	imaging	parameters.	Associations	of	retinal	vascular	calibers	with	DT-MRI	
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parameters	were	evaluated	using	linear	regression	models.	Mean	differences	and	cor-
responding	95%	confidence	intervals	(CI)	in	DT-MRI	parameters	were	estimated	per	
standard	deviation	 (SD)	decrease	 in	arteriolar	caliber	or	 increase	 in	venular	caliber,	
and	in	tertiles	of	retinal	vascular	calibers.	We	adjusted	for	age,	sex,	and	the	other	vas-
cular	caliber	(model	1),	and	additionally	for	white	matter	volume,	intracranial	volume,	
white	matter	lesion	volume,	lacunar	infarcts,	and	cerebral	microbleeds	(model	2).	We	
further	adjusted	for	systolic	and	diastolic	blood	pressure,	antihypertensive	medication,	
body	 mass	 index,	 total	 and	 high-density	 lipoprotein	 cholesterol,	 diabetes	 mellitus,	
C-reactive	protein,	atherosclerotic	plaque	and	smoking	(model	3).	We	explored	effect	
modification	 by	 stratifying	 for	 age	 (median:	 56	 years),	 sex,	 hypertension,	 diabetes	
mellitus,	 and	 smoking,	 and	by	adding	 interaction	 terms	 to	 the	 statistical	models.	 In	
all	analyses,	we	treated	the	phase	encoding	direction	for	the	diffusion	acquisition	as	a	
confounder.	We	compared	the	effect	estimates	of	arterioles	and	venules	with	age	–	an	
established	risk	factor	for	poor	white	matter	microstructure	–	to	have	an	impression	
about	the	magnitude	of	these	associations.	First,	we	calculated	the	effect	estimates	for	
the	association	of	age	with	FA	and	MD.	Then,	we	divided	the	betas	(per	SD)	of	retinal	
vascular	calibers	by	the	betas	of	age	in	relation	to	DT-MRI	measures	and	reported	the	
corresponding	 ratios.	Furthermore,	 to	assess	 the	 relation	of	 retinal	vascular	calibers	
with	white	matter	lesion	volumes,	cerebral	microbleeds	and	lacunar	infarcts,	we	used	
linear	and	logistic	regression	models.	Missing	values,	if	present,	were	less	than	in	4%	of	
the	cases,	which	we	dealt	with	using	5-fold	multiple	imputations	based	on	determinant,	
outcome,	and	covariates.	Given	 the	Pearson	correlation	coefficient	between	systolic	
and	diastolic	blood	pressure	(r=0.77),	we	examined	the	possibility	of	collinearity	by	
calculating	 the	 variance	 inflation	 factor,	 but	 none	was	 identified	 (variance	 inflation	
factor	<2.9).	Statistical	tests	were	performed	at	the	0.05	significance	level	(two-tailed)	
using	SPSS	21.0	for	Windows	(IBM	corp.,	Armonk,	New	York).
reSuLtS
table 1	shows	the	characteristics	of	the	study	population.	Of	the	total	3,932	partici-
pants,	1,496	(38%)	did	not	participate	in	this	study.	After	adjusting	for	age	and	sex	(if	
applicable),	 nonparticipants	were	 on	 average	 older,	 had	 higher	 blood	 pressure,	 had	
higher	body	mass	index,	had	higher	C-reactive	protein	levels,	and	were	more	smokers	
compared	to	participants.	Of	the	2,436	(62%)	participants,	56%	were	women	and	the	
average	age	was	56.5	years	(SD:	6.2).
table 2	 shows	 the	 associations	 between	 retinal	 vascular	 calibers	 and	white	matter	
microstructure.	Both	narrower	arterioles	and	wider	venules	were	associated	with	lower	
FA,	higher	MD,	higher	AxD,	and	higher	RD.	After	adjusting	for	other	MRI	markers,	
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the	associations	between	retinal	vascular	calibers	and	DT-MRI	parameters	attenuated,	
but	 remained	 statistically	 significant.	Additional	 adjustments	 for	 cardiovascular	 risk	
factors	marginally	changed	the	results.
table 1. Characteristics	of	the	eligible	study	cohort
Characteristics Participants (n=2,436) Non-participants (n=1,496)
Age,	years 56.5	(6.2) 58.2	(8.6)*
Female 1374	(56) 878	(59)
Systolic	blood	pressure,	mmHg 131.9	(18.5) 134.1	(20.3)*
Diastolic	blood	pressure,	mmHg 82.3	(10.8) 83.2	(11.4)*
Antihypertensive	medication 406	(28) 523	(22)*
Hypertension 1,117	(46) 726	(56)*
Body	mass	index,	kg/m2 27.5	(4.3) 28.4	(5.2)*
Total	cholesterol,	mmol/L 5.6	(1.1) 5.5	(1.1)
High-density	lipoprotein	cholesterol,	mmol/L 1.4	(0.4) 1.4	(0.4)
Diabetes	mellitus	type	2 190	(8) 131	(9)
C-reactive	protein,	mg/L 2.5	(4.4) 3.0	(5.3)*
Atherosclerotic	plaque 604	(25) 476	(32)
Smoking	status
Non-smoker 786	(32) 459	(31)
Former	smoker 1,116	(46) 608	(41)*
Current	smoker 534	(22) 417	(28)*
Arteriolar	caliber,	µm 158.7	(15.4) -
Venular	caliber,	µm 239.8	(22.7) -
White	matter	volume,	ml 418.7	(57.3) -
Intracranial	volume,	ml 1,129.0	(119.2) -
White	matter	lesion	volume†,	ml 2.0	(1.3-3.5) -
Cerebral	microbleeds 302	(12) -
Lacunar	infarcts 87	(4) -
Fractional	anisotropy 0.34	(0.01) -
Mean	diffusivity,	10-3 mm2/s 0.73	(0.02) -
Axial	diffusivity,	10-3 mm2/s 1.01	(0.02) -
Radial	diffusivity,	10-3 mm2/s 0.59	(0.02) -
Values	are	presented	as	means	(standard	deviation)	or	as	numbers	(percentages).	*Significantly	different	from	
included	persons	(age	and	sex	adjusted	p-value<	0.05).	†Presented	as	median	(interquartile	range)	because	of	
skewed	distribution.	The	following	variables	had	missing	values:	systolic	and	diastolic	blood	pressure	(n=7),	
use	of	antihypertensive	medication	(n=18),	body	mass	index	(n=2),	total	cholesterol	(n=27),	high-density	lipo-
protein	cholesterol	(n=29),	diabetes	mellitus	(n=18),	C-reactive	protein	(n=92),	atherosclerotic	plaque	(n=6),	
smoking	(n=5).
Chapter	2.3
66
figure 1	shows	absolute	mean	differences	in	FA	and	MD	by	tertiles	of	arteriolar	and	
venular	calibers	(adjusted	for	age	and	sex).	In	stratified	analyses	(figure 2),	adjusted	
for	variables	 in	model	3,	we	 found	 that	 the	 association	 for	 arterioles	with	MD	was	
modified	 by	 hypertension	 (P-value	 for	 interaction=0.021),	whereas	 for	 venules,	 the	
associations	with	FA	and	MD	were	in	both	cases	modified	by	sex	(P-value	for	interac-
tion=0.006,	and	0.034,	respectively).	With	respect	to	diabetes	mellitus,	we	observed	
that	the	effects	of	arterioles	and	venules	on	DT-MRI	parameters	were	more	pronounced	
in	persons	with	diabetes	mellitus.	However,	p-values	for	the	formal	interaction	terms	
were	not	significant:	for	arterioles	these	were	0.180	for	FA	and	0.172	for	MD,	whereas	
for	venules	these	were	0.091	for	FA	and	0.097	for	MD.
In	an	additional	analysis	to	compare	the	magnitude	of	the	associations	with	age,	we	
observed	that	each	year	increase	in	age	was	associated	with	lower	FA	(-0.009	(-0.016;	
-0.002))	 and	 higher	 MD	 (0.023	 (0.016;	 0.029)).	We	 found	 that	 each	 SD	 narrower	
arterioles	and	wider	venules	in	relation	to	FA	had	the	magnitude	equal	to	6.8	years	and	
6.0	years	of	increase	in	age,	respectively.	Similarly,	each	SD	narrower	arterioles	and	
wider	venules	in	relation	to	MD	had	the	magnitude	equal	to	2.1	and	2.0	years	increase	
in	age,	respectively.
table 2. The	association	between	retinal	vascular	calibers	and	white	matter	microstructure
fractional anisotropy Mean diffusivity Axial diffusivity Radial diffusivity
Arteriolar caliber, per Sd decrease
			Model	1 -0.121	(-0.166;	-0.077)	 0.108	(0.065;	0.150) 0.065	(0.022;	0.108) 0.119	(0.075;	0.162)
			Model	2 -0.061	(-0.104;	-0.018) 0.054	(0.015;	0.092) 0.032	(-0.006;	0.070) 0.059	(0.019;	0.099)
			Model	3 -0.061	(-0.106;	-0.016) 0.048	(0.007;	0.088) 0.025	(-0.016;	0.065) 0.055	(0.013;	0.097)
Venular caliber, per Sd increase
			Model	1 -0.086	(-0.130;	-0.043) 0.080	(0.038;	0.123) 0.045	(0.003;	0.087) 0.090	(0.048;	0.133)
			Model	2 -0.060	(-0.101;	-0.019) 0.054	(0.016;	0.091) 0.027	(-0.010;	0.064) 0.062	(0.023;	0.101)
			Model	3 -0.054	(-0.096;	-0.011) 0.047	(0.008;	0.085) 0.023	(-0.016;	0.061) 0.054	(0.015;	0.094)
Values	represent	difference	in	z-scores	of	DT-MRI	parameters	with	95%	confidence	interval.
Model	1:	adjusted	for	age,	sex	and	the	other	vascular	caliber.
Model	2:	as	model	1,	additionally	adjusted	for	white	matter	volume,	intracranial	volume,	white	matter	lesion	
volume,	lacunar	infarcts	and	cerebral	microbleeds.
Model	3:	as	model	2,	additionally	adjusted	for	systolic	blood	pressure,	diastolic	blood	pressure,	antihyperten-
sive	medication,	body	mass	 index,	 total	 cholesterol,	high-density	 lipoprotein	cholesterol,	diabetes	mellitus,	
C-reactive	protein,	plaque	and	smoking.
Abbreviations:	SD=standard	deviation.
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table 3	shows	the	associations	between	retinal	vascular	calibers	and	structural	MRI	
markers	 of	 cerebral	microvascular	 damage.	Both	 narrower	 arterioles	 and	wider	 ve-
nules	were	significantly	associated	with	larger	white	matter	lesion	volumes.	Additional	
adjustments	 for	 cardiovascular	 risk	 factors	 (model	 3)	 attenuated	 these	 associations.	
Narrower	arterioles	and	wider	venules	were	also	associated	with	the	presence	of	cere-
bral	microbleeds	and	lacunar	infarcts	in	model	1.	These	associations	disappeared	after	
adjusting	for	other	MRI	markers	and	cardiovascular	risk	factors.
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figure 1. Absolute	mean	difference	in	(A)	fractional	anisotropy	and	(B)	mean	
diffusivity	by	tertiles	of	retinal	vascular	calibers. 
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figure 1.	Absolute	mean	difference	in	(A)	fractional	
anisotropy	 and	 (B)	 mean	 diffusivity	 by	 tertiles	 of	
retinal	vascular	calibers.
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figure 2. Stratified	analyses	on	the	association	of	(A)arteriolar	and	(B)venular	
calibers	with	white	matter	microstructure	measures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  figure 2. Stratifi	ed	analyses	on	the	association	of	(A)	arteriolar	and	(B)	venular	calibers	with	white	matter	
microstructure	measures.
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table 3.	The	association	between	retinal	vascular	calibers	and	markers	of	cerebral	small	vessel	disease.
white matter lesion volume Presence of cerebral 
microbleeds
Presence of lacunar infarcts
Difference in z-score (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
Arteriolar caliber, per Sd decrease
			Model	1 0.145	(0.100;	0.189) 1.20	(1.04;	1.40) 1.34	(1.03;	1.75)
			Model	2 0.146	(0.104;	0.188) 1.15	(0.99;	1.34) 1.10	(0.84;	1.43)
			Model	3 0.101	(0.057;	0.145) 1.14	(0.97;	1.33) 1.10	(0.83;	1.45)
Venular caliber, per Sd increase
			Model	1 0.061	(0.018;	0.104) 1.09	(0.95;	1.26) 1.31	(1.02;	1.68)
			Model	2 0.059	(0.018;	0.100) 1.07	(0.92;	1.24) 1.17	(0.90;	1.52)
			Model	3 0.030	(-0.012;	0.071) 1.09	(0.94;	1.27) 1.15	(0.88;	1.51)
White	matter	lesion	volumes	are	natural	log	transformed.
Abbreviations:	CI=confidence	interval;	SD=	standard	deviation.
Model	1:	adjusted	for	age,	sex	and	the	other	vascular	caliber.
Model	2:	as	model	1,	additionally	adjusted	for	intracranial	volume,	white	matter	lesion	volume,	lacunar	infarcts	
and	cerebral	microbleeds	(if	applicable).
Model	3:	as	model	2,	additionally	adjusted	for	systolic	blood	pressure,	diastolic	blood	pressure,	antihyperten-
sive	medication,	body	mass	 index,	 total	 cholesterol,	high-density	 lipoprotein	cholesterol,	diabetes	mellitus,	
C-reactive	protein,	plaque	and	smoking.
dISCuSSIoN
In	this	study,	we	found	that	retinal	microvascular	pathology	is	related	to	poorer	micro-
structure	of	normal-appearing	cerebral	white	matter.
With	respect	to	retinal	vascular	imaging	as	a	tool	in	assessing	vascular	brain	pathology,	
several	 large	 population-based	 studies	 have	 shown	 that	 retinal	microvascular	 dam-
age	 is	 related	 to	 subclinical	 and	 clinical	 vascular	 brain	 diseases.	Community-based	
cohorts	of	predominantly	healthy	people	have	shown	that	retinopathy	signs	were	as-
sociated	with	incident	stroke,	cognitive	decline	and	dementia.22,	23	Apart	from	clinical	
outcomes,	 these	 studies	 also	 showed	 that	 persons	with	 retinopathy	 signs	 had	more	
often	subclinical	microvascular	brain	damages	such	as	white	matter	lesions,	cerebral	
infarcts	and	cerebral	microbleeds.22-26	Overall	these	findings	suggest	that	both	retinal	
and	 cerebral	microvascular	 damage	may	 appear	 simultaneously	 as	 part	 of	 systemic	
microvascular	 disease	 with	 common	 pathogenesis.26	 However,	 signs	 of	 retinopathy	
are	 relatively	 late	manifestations	of	organ	damage	and	presumably	 reflect	advanced	
stages	of	microvascular	damage	including	blood-retina	barrier	disruption.27	There	are	
ongoing	efforts	to	unravel	earlier	retinal	markers	(e.g.	narrower	arterioles	and	wider	
venules),	as	they	likely	represent	a	point	in	the	pathophysiologic	cascade	that	is	poten-
tially	reversible,	offering	great	potential	for	the	development	of	preventive	strategies	
or	surrogate	markers	for	trials.
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Interestingly,	 cross-sectional	 data	 from	 the	 Rotterdam	 Study	 showed	 that	 the	 as-
sociation	 of	 retinal	 vascular	 calibers	with	markers	 of	 cerebral	 small	 vessel	 disease	
was	not	significant.28	In	contrast,	longitudinal	data	from	the	same	study	showed	that	
wider	venular	caliber	was	associated	with	progression	of	white	matter	lesions	in	both	
periventricular	and	subcortical	regions,	and	with	incident	lacunar	infarcts	on	MRI.28 
Overall,	these	findings	indicate	that	changes	in	retinal	vascular	calibers	may	precede	
the	development	of	white	matter	lesions	and	lacunar	infarcts.	Findings	from	our	cur-
rent	study	are	in	line	with	these	observations.	We	found	that	retinal	vascular	calibers	
were	strongly	related	to	markers	of	normal-appearing	white	matter	on	DT-MRI,	inde-
pendently	of	structural	MRI	markers	of	cerebral	small	vessel	disease.	Moreover,	the	
joint	effect	of	narrower	arterioles	and	wider	venules	on	white	matter	microstructure	
appears	to	be	much	stronger	than	their	individual	effect.
Pathophysiologically,	 a	 narrow	 retinal	 arteriolar	 caliber	may	 reflect	 not	 only	 active	
vasoconstriction,	 but	 also	 systemic	 structural	 changes	 such	 as	 arteriolosclerosis.29 
These	 processes	may	 concomitantly	 occur	 in	 the	 brain,	 where	 they	 affect	 the	 abil-
ity	 of	 cerebral	 arterioles	 to	maintain	 control	 of	 local	 blood	flow.	Thus,	 predisposed	
areas	 as	 served	by	 these	vessels	may	 lead	 to	 ischemic	damage,	 and	 eventually	 to	 a	
state	of	chronic	hypoperfusion	of	the	white	matter	with	subsequent	demyelination	and	
axonal	 damage.12	 It	 has	 been	 shown	 that	 subtle	 changes	 in	 the	white	matter	 due	 to	
demyelination	and	axonal	damage	can	be	detected	using	DT-MRI.30	With	respect	to	the	
venous	system,	several	histopathological	studies	have	reported	venular	abnormalities	
such	as	venous	collagenosis	 in	areas	affected	by	white	matter	 lesions.31	 In	 line	with	
these	observations,	our	findings	show	that	subtle	changes	in	retinal	venular	calibers	are	
associated	with	DT-MRI	markers	of	normal-appearing	white	matter.
A	growing	body	of	evidence	now	suggests	that	microvascular	damage	primarily	affects	
women.32	Indeed,	narrower	arterioles	were	found	to	increase	the	risk	of	coronary	heart	
disease	in	women,	but	not	in	men.33	In	addition,	cardiovascular	risk	factors	typically	
associated	 with	 female	 sex	 such	 as	 an	 unfavorable	 lipid	 profile	 and	 inflammatory	
markers	were	also	found	to	be	associated	with	wider	venules.7	Our	findings	provide	
further	evidence	suggesting	that	the	pathogenesis	of	vascular	brain	diseases	is	different	
in	men	and	women.
Furthermore,	we	found	that	the	relation	of	retinal	microvasculature	with	white	matter	
microstructure	is	more	pronounced	in	persons	with	diabetes	mellitus.	It	is	well-known	
that	diabetes	mellitus	primarily	affects	small	vessels	due	to	chronic	exposure	to	hyper-
glycemia,	which	can	lead	to	impaired	function	of	endothelium	as	well	as	pericytes.34 
It	is	conceivable	that	such	more	severe	damage	to	the	microcirculation	might	translate	
into	stronger	associations	among	diabetics	compared	to	nondiabetics.	At	the	same	time,	
persons	with	diabetes	mellitus	very	often	have	other	cardiometabolic	comorbidities,	
such	as	dyslipidemia	and	subclinical	inflammation,	all	of	which	can	further	aggravate	
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the	small	vessel	damage.35	Although	we	did	adjust	for	covariates	that	are	considered	
proxies	for	these	processes,	a	substantial	residual	effect	remains	likely	and	may	explain	
the	stronger	associations	among	diabetics	compared	to	nondiabetics.
DT-MRI	is	highly	sensitive	to	changes	in	water	diffusion	in	the	white	matter	micro-
structure	and	thus	a	robust	method	to	detect	microstructural	changes.30	Experimental	
studies	have	suggested	that	perpendicular	diffusivity	may	reflect	myelin	loss,	whereas	
axial	diffusivity	may	point	towards	axonal	degeneration.36	Although	it	is	not	completely	
clear	which	pathophysiological	processes	underlie	alterations	in	white	matter	DT-MRI	
measures,	possible	mechanisms	besides	microvascular	lesions	include	inflammation,	
demyelination	and	blood-brain	barrier	disruption.	Nevertheless,	DT-MRI	 is	a	useful	
research	tool	to	probe	not	only	cerebrovascular	pathology,	but	also	other	brain	diseases	
such	as	multiple	sclerosis	and	other	inflammatory	demyelinating	diseases.	With	respect	
to	our	study,	given	the	rarity	of	these	other	diseases,	it	is	unlikely	that	our	findings	may	
have	been	affected	by	these	conditions.
Several	methodological	issues	need	to	be	discussed.	First,	the	cross-sectional	design	
of	our	study	prevented	us	from	assessing	the	temporal	link	between	the	retinal	micro-
vasculature	 and	 white	 matter	 microstructure.	 Second,	 persons	 excluded	 from	 these	
analyses	had	a	slightly	worse	cardiovascular	risk	profile,	suggesting	a	limited	role	for	
selection	bias.	Third,	retinal	caliber	measurements	were	assessed	at	a	single	timepoint	
and	were	not	 synchronized	 to	 the	 cardiac	 cycle.	Hence,	we	were	not	 able	 to	 assess	
dynamic	changes	in	the	microcirculation.	This	random	misclassification	suggests	that	
the	true	effect	sizes	may	have	been	larger.	Fourth,	we	were	unable	to	measure	some	
confounding	factors	such	as	previous	blood	pressure	or	cholesterol	levels,	which	could	
have	 influenced	our	associations	by	 introducing	 residual	confounding.	Furthermore,	
participants	 in	 the	 Rotterdam	 Study	 are	 mainly	 middle-class	 white	 persons,	 which	
limits	 the	 generalizability	 of	 our	 findings.	Also,	 due	 to	 the	 low	number	 of	 incident	
clinical	 endpoints	 (stroke/dementia)	 in	 this	 extended	 cohort,	 we	 were	 not	 able	 to	
examine	the	association	between	retinal	vascular	calibers	and	DT-MRI-markers	with	
these	endpoints.	Finally,	we	acknowledge	 that	 the	sensitivity	of	DT-MRI	 to	a	broad	
spectrum	of	other	factors	(e.g.	noise,	artifacts,	and	crossing	white	matter	tracts)	makes	
interpretation	difficult,	thus	inferences	should	be	drawn	carefully.
Strengths	of	our	study	are	the	population-based	setting	including	relatively	young	and	
healthy	 individuals,	 the	 large	 study	 size	 and	 available	 data	 on	macrostructural	 and	
microstructural	brain	imaging	markers,	enabling	us	to	assess	independent	associations.
In	 this	 study,	we	have	 shown	 that	 retinal	 vascular	 calibers	 are	 associated	with	 poorer	
white	matter	microstructure	in	normal-appearing	white	matter.	These	findings	suggest	that	
microvascular	damage	in	the	white	matter	is	more	widespread	than	visually	detectable	on	
MRI.	Future	studies	with	longitudinal	data	on	incident	clinical	cerebrovascular	diseases	
are	needed	to	examine	the	clinical	implications	of	these	retinal	and	DT-MRI	markers.
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ABStrACt
Background	Brain	pathology	is	a	presumed	link	between	Chronic	Obstructive	Pul-
monary	Disease	 (COPD)	 and	 cognitive	 impairment.	We	 assessed	 the	 association	 of	
lung	function	with	the	microstructural	 integrity	of	cerebral	white	matter	 tracts	 in	an	
aging	population.	In	addition,	we	studied	the	link	between	white	matter	microstructure	
and	global	cognition	in	participants	with	and	without	COPD.
Methods We	included	2,405	participants	free	of	stroke	and	dementia	(mean	age	68.4±	
9.0	years,	52.6%	female),	who	performed	spirometry	and	diffusing	capacity	within	the	
Rotterdam	Study,	 a	 population-based	 cohort	 study.	Diffusion-MRI	 and	probabilistic	
tractography	 was	 used	 to	 assess	 the	 microstructural	 integrity	 of	 15	 different	 white	
matter	tracts.	We	furthermore	obtained	a	marker	of	global	cognition	(g-factor)	using	a	
cognitive	test	battery.
Results Out	of	2,405	participants,	363	persons	were	classified	as	having	COPD.	In	the	
overall	population,	lower	forced	expiratory	volume	in	1	second	and	a	lower	diffusing	
capacity	were	associated	with	reduced	white	matter	microstructural	integrity	through-
out	the	brain,	but	mainly	in	the	association	tracts.	This	remained	after	excluding	persons	
with	overt	COPD.	Persons	with	severe	COPD	had	poorer	tract-specific	microstructural	
integrity	than	those	without	COPD,	again	particularly	in	the	association	tracts.	Though	
formal	interaction	was	absent,	the	link	between	white	matter	microstructural	integrity	
and	global	cognition	seemed	stronger	in	persons	with	COPD	versus	persons	without	
COPD.
Conclusions Reduced	 lung	 function	 (even	within	 the	 normal	 range)	 is	 related	 to	
regional	 microstructural	 white	 matter	 damage	 throughout	 the	 brain,	 but	 especially	
in	the	association	tracts.	This	may	underlie	the	relation	between	COPD	and	reduced	
cognition.
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INtroduCtIoN
Patients	with	 chronic	 obstructive	 pulmonary	 disease	 (COPD)	 have	 progressive	 and	
largely	irreversible	airflow	limitation	that	is	associated	with	an	abnormal	response	of	
the	lungs	to	noxious	particles	or	gases1.	However,	COPD	is	not	limited	to	the	lungs	and	
an	important	extrapulmonary	effect	is	cognitive	dysfunction2-4.	Furthermore,	patients	
with	COPD	have	an	increased	risk	of	dementia.5	The	exact	pathway	linking	COPD	and	
cognitive	impairment	and	dementia	remains	unclear.	Brain	changes	may	be	considered	
an	intermediate	in	the	association	between	COPD	and	these	endpoints.
Previous	research	found	that	total	grey	and	white	matter	volumes	seem	to	be	similar	
between	persons	with	and	without	COPD,6,7	whereas	other	studies	found	reduced	re-
gional	grey	matter	volume,8,9	and	a	higher	white	matter	lesion	load,10,11	in	patients	with	
COPD.	Also,	in	patients	with	hypoxemic	COPD	there	was	evidence	of	hypoperfusion	
in	 the	 anterior	 and	 subcortical	 regions	 of	 the	 brain	 compared	 to	 healthy	 controls.12 
All	 these	 findings	 suggest	 a	more	 regional	 degeneration	 pattern	 in	COPD	 patients.	
Regional	 imaging	markers	may	be	 therefore	more	 insightful	 than	global	assessment	
of	brain	morphology.	Previous	studies	investigating	regional	brain	changes	in	COPD	
patients	mainly	 focused	on	cerebral	grey	matter.	Studies	 focusing	on	cerebral	white	
matter	 are	 sparse	 and	 have	 been	 performed	 in	 small	 samples.7,13,14	 Regional	 white	
matter	changes	can	be	evaluated	at	a	macrostructural	level,	such	as	by	investigating	
atrophy	and	a	higher	white	matter	lesion	load.	However,	regional	white	matter	changes	
can	also	be	assessed	at	a	level	not	visible	for	the	naked	eye,	by	means	of	diffusion-
MRI	allowing	quantitative	evaluation	of	the	microstructural	integrity	of	white	matter.	
Fractional	anisotropy	(FA)	and	mean	diffusivity	(MD)	are	the	two	measures	most	com-
monly	derived	from	diffusion-MRI.	In	general	lower	values	of	FA	and	higher	values	
of	MD	are	 indicative	of	a	poorer	white	matter	microstructural	 integrity.	Also,	white	
matter	can	be	studied	even	more	in	depth	by	considering	different	white	matter	tracts.
The	aim	of	this	study	was	to	determine	the	effect	of	reduced	lung	function	(both	within	
the	 normal	 range	 and	 overt	 COPD)	 on	 tract-specific	 white	 matter	 microstructural	
integrity	 in	 a	 large	 population	 of	 2,405	middle	 aged	 and	 elderly	 persons	 from	 the	
population-based	Rotterdam	Study.15	We	hypothesized	 that	 reduced	 lung	 function	 is	
related	 to	poor	microstructural	 integrity,	 in	particular	 in	 the	association	 tracts,	since	
these	 tracts	 are	 typically	 vulnerable	 to	 vascular	 damage.16	 Furthermore,	we	 studied	
whether	the	relation	between	white	matter	microstructural	integrity	and	global	cogni-
tion	differed	between	participants	with	and	without	COPD.
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MethodS
Study population
This	study	was	embedded	within	the	framework	of	Rotterdam	Study,	an	ongoing,	pro-
spective,	population-based	cohort	study	including	participants	of	45	years	and	older	
living	in	Ommoord,	a	suburb	of	Rotterdam.15,17,18	Since	2005,	MRI-scanning,	includ-
ing	 diffusion-MRI,	was	 implemented	 in	 the	 study	 protocol.18	 For	 the	 current	 study	
we	 included	4,493	non-demented	participants	with	 lung	function	data.	We	excluded	
468	 participants	with	 asthma.	Out	 of	 4,025	 participants,	 3,184	 had	 an	 interpretable	
forced	expiratory	volume	 in	one	 second	 (FEV1	 )	measurement.	Of	 them,	2,700	had	
a	 good	 quality	MRI	 scan.	We	 additionally	 excluded	 participants	 with	 a	 history	 of	
clinical	stroke	(N=65),	and	MRI-defined	cortical	 infarcts	 (N=13),	 resulting	 in	2,405	
participants	 in	 the	FEV1	analysis.	For	 the	COPD	analysis,	we	additionally	excluded	
participants	 with	 a	 spirometry	 report	 suggestive	 of	 a	 restrictive	 syndrome	 [	 FEV1/
forced	 expiratory	 vital	 capacity	 (FVC)	 ≥	 70%	 and	 FVC	<	 80%	predicted]	 (N=91),	
so	2,314	persons	were	included	in	the	COPD	analysis.	Out	of	2,314	participants	363	
persons	had	a	diagnosis	of	COPD.	Out	of	2,405	participants	2,125	persons	had	analyz-
able	 diffusing	 data.	The	Rotterdam	Study	 has	 been	 approved	 by	 the	medical	 ethics	
committee	according	to	the	Population	Study	Act	Rotterdam	Study,	executed	by	the	
Ministry	of	Health,	Welfare	and	Sports	of	the	Netherlands.	Written	informed	consent	
was	obtained	from	all	participants.15
Assessment of CoPd
Spirometry	and	diffusing	capacity	were	performed	around	 the	 time	of	 the	scan	date	
using	a	Master	Screen®	PFT	Pro	(CareFusion,	San	Diego,	CA)	by	trained	paramedical	
personnel	 according	 to	 the	ATS/ERS	 guidelines.19,20,21	The	 diffusing	 capacity	 of	 the	
lungs	measured	using	carbon	monoxide	was	corrected	for	the	haemoglobin	concentra-
tion	(DLCO,c).	Additional	details	on	the	assessment	of	COPD	is	provided	in	an	online	
data	supplement.
MrI acquisition and processing
Multi-sequence	MR	 imaging	was	performed	on	a	1.5	 tesla	MRI	scanner	 (GE	Signa	
Excite).	The	imaging	protocol,	sequence	details	and	segmentation	methods	have	been	
described	extensively	elsewhere.18	The	conventional	scan	protocol	consisted	of	a	T1-
weighted	image,	a	T2-weighted	fluid-attenuated	inversion	recovery	(FLAIR)	sequence,	
a	 proton	 density	 weighted	 image.	 For	 diffusion-MRI,	 we	 performed	 a	 single	 shot,	
diffusion-weighted	spin	echo	echo-planar	 imaging	sequence.	Maximum	b-value	was	
1000 s/mm2	in	25	non-collinear	directions	and	three	volumes	were	acquired	without	
diffusion	weighting	(b-value	=	0	s/mm2).	Using	a	probabilistic	diffusion	tractography	
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approach	15	different	white	matter	tracts	(12	tracts	were	present	in	both	left	and	right	
hemisphere)	were	segmented.22	Participant	specific	mean	FA	and	MD	inside	each	white	
matter	tract	were	obtained,	and	left	and	right	measures	were	averaged.22	Subsequently,	
we	computed	z-scores	for	the	tract-specific	parameters	(by	subtracting	the	mean	and	
dividing	by	the	SD)	to	facilitate	comparison	of	associations.	We	combined	the	tissue	
and	tract	segmentations	to	obtain	tract-specific	white	matter	volumes	and	tract-specific	
WMH	volumes	(natural-log	transformed	to	account	for	their	skewed	distribution).	See	
the	online	data	supplement	for	further	details.
Voxel-based Analysis
We	also	performed	voxel-based	analyses	on	white	matter	tracts	to	investigate	whether	
lung	function	was	associated	with	the	microstructure	of	sub-regions	of	specific	tracts.	
Voxel-based	analysis	 (VBA)	of	diffusion-MRI	data	was	performed	using	 the	voxel-
based	morphometry	method23	as	previously	described.24	See	the	online	supplement	for	
more	details	on	the	VBA	data	processing.
Assessment of global cognitive function
Global	 cognitive	 function	 was	 assessed	 constructing	 a	 g-factor	 using	 a	 principal	
component	analysis	based	on	5	different	cognitive	tests	tapping	into	different	cogni-
tive	domains	namely	 the	delayed	recall	 score	of	 the	15-Word	Learning	Test,	Stroop	
interference	Test,	Letter-Digit	Substitution	Task,	Word	Fluency	Test,	and	the	Purdue	
Pegboard	test.25	The	explained	variance	was	50.4	%.
other measurements
Cardiovascular	 risk	 factors	 (systolic	 and	 diastolic	 blood	 pressure,	 serum	 and	HDL-
cholesterol,	medication	use,	smoking,	diabetes)	were	assessed	based	on	 information	
derived	 from	home	 interviews	 and	 physical	 examinations	 during	 the	 center	 visit	 as	
previously	described.15	We	used	the	validated	Dutch	version	of	the	Center	for	Epide-
miology	Depression	Scale	(CES-D)	for	assessment	of	depressive	symptoms.26	More	
details	can	be	read	in	the	online	data	supplement.
Statistical analysis
Associations	of	lung	function	and	tract-specific	diffusion	measurements	were	evaluated	
using	multivariable	linear	regression	models.	Z-scores	and	95%	confidence	intervals	
(CI)	of	tract-specific	diffusion-MRI	measures	were	estimated	per	unit	increase	of	lung	
function	parameters.	Also,	the	g-factor	was	estimated	per	unit	increase	of	lung	function	
measures	using	multivariable	linear	regression	models.	We	furthermore	assessed	the	
relation	between	tract-specific	diffusion-MRI	measures	and	global	cognition	(g-factor)	
stratified	based	on	COPD	status.	Analyses	were	adjusted	for	age,	sex,	intracranial	vol-
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ume,	tract-specific	white	matter	volume,	log-transformed	tract-specific	WMH	volume,	
CES-D	score,	smoking	and	other	cardiovascular	risk	factors	such	as	blood	pressure,	
serum	cholesterol,	HDL-cholesterol,	diabetes,	antihypertensive	medication	and	lipid-
lowering	medication.	Since	the	cerebellum	could	not	always	be	fully	incorporated	in	
the	diffusion	scan,	 leading	 to	varying	coverage	of	one	of	 the	15	 tracts	 (medial	 lem-
niscus),	we	additionally	controlled	for	 the	varying	field	of	view	in	 the	 tract-specific	
analyses	of	the	medial	lemniscus,	by	treating	this	as	a	potential	confounder.22
Missing	covariates	(<	2%)	for	all	covariates	were	imputed	using	multiple	imputations	
creating	5	data	sets	according	to	the	Markov	Chain	Monte	Carlo	method	and	pooled	
subsequently	(IBM	SPSS	Statistics	for	Windows,	version	21.0.	Armonk,	NY).
Sensitivity analysis
We	performed	a	sensitivity	analysis	 repeating	 the	 tract-specific	analysis	with	exclu-
sion	 of	 all	 persons	with	COPD.	We	 performed	 this	 analysis	 to	 investigate	whether	
lung	 function	measures	 within	 the	 normal	 range	 also	 associated	 with	 white	matter	
microstructural	damage.	We	also	repeated	the	tract-specific	analysis	for	FEV1	and	the	
diffusing	capacity	with	the	exclusion	of	the	participants	with	a	spirometry	suggestive	
of	a	 restrictive	syndrome,	 to	 investigate	whether	 the	associations	found	with	FEV1,	
diffusing	capacity	and	white	matter	microstructure	were	driven	by	participants	with	a	
restrictive	syndrome.
For	the	tract-specific	analyses,	we	corrected	the	p-value	(alpha	level	of	0.05)	for	mul-
tiple	comparisons	by	estimating	the	number	of	independent	tests	by	using	the	variance	
of	the	eigenvalues	of	the	correlation	matrix	of	the	33	variables	used	in	the	main	analysis	
(FEV1,	DLCOc,	COPD	and	FA	and	MD	for	the	15	tracts)	with	the	following	formula:	
Meff=	1	+(M-1)(1-var	(λobs)/M)	with	M	is	number	of	variables,	Meff	is	the	number	of	
independent	variables.27,28	Based	on	this	formula	Meff	was	20.534.	Afterwards,	using	
the	Šidák	formula:	α	sidak	=	1	-	((1	-	α)^(1/Meff))	we	calculated	a	significance	level	of	
p<	0.0025.27	All	analyses	were	carried	out	using	R	version	2.15.0.
reSuLtS
table 1	 presents	 the	 characteristics	 of	 the	 study	 population.	Mean	 age	 of	 the	 par-
ticipants	was	68.4	±	9.0	years,	and	52.6	%	were	women.	Persons	with	COPD	were	
older	(mean	age	69.8±	9.4),	and	more	often	used	antihypertensive	and	lipid-lowering	
medication	and	had	smoked	significantly	more	pack-years	than	persons	without	COPD	
(median	31	±	13.8-50.0	versus	12.1	±	4.3-25.0).
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White matter tract-specific analysis
figure 1	and	table 2	present	the	association	of	lung	function	(FEV1,	diffusing	capacity),	
and	COPD	status	with	tract-specific	diffusion-MRI	measures	(FA,	MD)	after	adjusting	for	
age,	sex,	macrostructural	MRI	markers,	CES-D	score,	smoking,	and	other	cardiovascular	
risk	factors.	A	higher	FEV1	and	a	higher	diffusing	capacity	were	associated	with	higher	
FA	and	 lower	MD	 throughout	 the	brain,	but	most	prominently	 in	 the	association	 tracts	
(figure 2).	For	FEV1,	 the	mean	difference	 in	FA	 (z-score)	 in	 the	 association	 tracts	per	
table 1. Population	characteristics
Characteristic n= 2,405
Age,	years 68.4	(9.0)
Female	 1,264	(52.6)
Systolic	blood	pressure,	mmHg 142.1	(21.3)
Diastolic	blood	pressure,	mmHg 83.1	(10.9)
Antihypertensive	medication 865	(36.0)
Smoking	
			Never 850
			Former 1273
			Current 282
Packyears	in	current	and	past	smokers 15	(5.0-30.0)
Total	cholesterol,	mmol/l 5.5	(1.1)
HDL	cholesterol,	mmol/l 1.5	(0.4)
Lipid-lowering	medication 687	(28.6)
Diabetes	mellitus 327	(13.6)
CES-D	score 12	(10.0-14.0)
COPD 363	(15.7)
			GOLD	A	 186	(8.2)
			GOLD	B 114	(5.0)
   GOLD C 11	(0.5)
   GOLD D 20	(0.9)
FEV1,	L 2.7	(0.80)
DLCO,c,	mmol/min/kPa/L 1.5	(0.24)
Intracranial	volume,	mL 1141.6	(115.9)
White	matter	volume,	mL 396.5	(58.9)
White	matter	hyperintensities	volume,	mL 3.42	(1.8-7.3)
Categorical	variables	are	presented	as	numbers	 (percentages),	 continuous	variables	as	means	 (standard	de-
viations)	and	packyears,	CES-D	score	and	white	matter	lesions	volume	are	presented	as	median(interquartile	
range).	The	following	variables	had	missing	data:	DLCO,c	(n=280),	COPD	classification	(n=91),	COPD	GOLD	
classification	(n=32)
Abbreviations: COPD: chronic obstructive pulmonary disease; GOLD: Global initiative for chronic Obstruc-
tive Lung Disease criteria; FEV1: forced expiratory volume during the first second; DLCO,c: diffusing capacity 
of the lungs using carbon monoxide corrected for the haemoglobin concentration; HDL: high-density lipopro-
tein; CES-D: Center for Epidemiology Depression Scale.
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liter	increase	of	FEV1	ranged	from	0.07	(CI:0.00;0.13)	to	0.09	(CI:	0.03;0.15),	the	mean	
difference	 in	MD	(z-score)	 in	 the	association	 tracts	 ranged	from	-0.06	 (CI:	 -0.11;-0.01)	
to	-0.10	(CI:	-0.15;-0.04).	For	the	diffusing	capacity,	the	mean	difference	in	FA	(z-score)	
in	the	association	tracts	per	unit	increase	of	the	diffusing	capacity	ranged	from	0.21	(CI:	
0.06;0.35)	to	0.29	(CI:0.14;0.44),	the	mean	difference	in	MD	(z-score)	ranged	from	-0.27	
(CI:	-0.39;-0.14)	to	-0.32	(CI:	-0.46;-0.18).	We	found	no	statistically	significant	differences	
in	white	matter	microstructure	comparing	persons	with	and	without	COPD	(table 2).
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figure 1. Association	 of	 lung	 function	 measures	 and	 tract-specific	 diffusion-MRI	
measures.	Colors	reflect	t-values	of	the	linear	regression	model	per	unit	increase	of	the	lung	
function	 marker	 after	 adjustments	 for	 age,	 sex,	 macrostructural	 MRI	 markers,	 CES-D,	
score,	 smoking	 pack-years	 and	 other	 cardiovascular	 risk	 factors.	 Higher	 strength	 of	
association	 is	 depicted	 in	 darker	 red	 for	 positive	 associations,	 darker	 blue	 for	 negative	
associations.	 
 
Abbreviations: MCP: middle cerebellar peduncle, ML: medial lemniscus, CST: cortico-
spinal tract, ATR: anterior thalamic radiation, STR: superior thalamic radiation, PTR: 
posterior thalamic radiation, SLF: superior longitudinal fasciculus, ILF: inferior 
longitudinal fasciculus, IFO: inferior-fronto-occipital fasciculus, UNC: uncinate 
fasciculus, CGC: cingulate gyrus part of cingulum, CGH: parahippocampal part of 
cingulum, FMA: forceps major, FMI: forceps minor. FA: fractional anisotropy, MD: mean 
diffusivity, FEV1: forced expiratory volume in one second, DLCOc: diffusing capacity, 
COPD: ch onic obstructive pulmonary disease, FA  fractional anisotropy, MD: mean 
diffusivity, CES-D: Center for Epidemiology Depression Scale. 
 *p<0.05 **p<0.01	***p<0.0025 
 
 
 
figure 1.	Association	of	 lung	 function	measures	 and	 tract-specific	diffusion-MRI	measures.	Colors	 reflect	
t-values	of	the	linear	regression	model	per	unit	increase	of	the	lung	function	marker	after	adjustments	for	age,	
sex,	macrostructural	MRI	markers,	CES-D,	score,	smoking	pack-years	and	other	cardiovascular	risk	factors.	
Higher	strength	of	association	is	depicted	in	darker	red	for	positive	associations,	darker	blue	for	negative	as-
sociations.	
Abbreviations: MCP: middle cerebellar peduncle, ML: medial lemniscus, CST: cortico-spinal tract, ATR: an-
terior thalamic radiation, STR: superior thalamic radiation, PTR: posterior thalamic radiation, SLF: superior 
longitudinal fasciculus, ILF: inferior longitudinal fasciculus, IFO: inferior-fronto-occipital fasciculus, UNC: 
uncinate fasciculus, CGC: cingulate gyrus part of cingulum, CGH: parahippocampal part of cingulum, FMA: 
forceps major, FMI: forceps minor. FA: fractional anisotropy, MD: mean diffusivity, FEV1: forced expiratory 
volume in one second, DLCOc: diffusing capacity, COPD: chronic obstructive pulmonary disease, FA: frac-
tional anisotropy, MD: mean diffusivity, CES-D: Center for Epidemiology Depression Scale.
	*p<0.05	**p<0.01	***p<0.0025
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table 2. Lung	function	and	tract-specific	diffusion-MRI	measures	of	white	matter	microstructural	integrity
fractional anisotropy Mean diffusivity
feV1 dLCoc CoPd feV1 dLCoc CoPd
Brain stem tracts
Middle	cerebellar	
peduncle
0.03 
(-0.04;0.10)
0.12	
(-0.06;0.29)
0.03 
(-0.08;0.14)
0.02	
(-0.05;0.09)
-0.12	
(-0.29;0.04)
-0.07 
(-0.18;0.03)
Medial	lemniscus	a 0.17 
(0.10;0.23)*
-0.03 
(-0.18;0.13)
0.08 
(-0.02;0.17)
-0.01 
(-0.08;0.07)
-0.23  
(-0.42;-0.05)
0.09 
(-0.03;0.20)
Projection tracts
Corticospinal	tract 0.00 
(-0.07;0.07)
0.10 
(-0.08;0.28)
0.01 
(-0.10;0.12)
-0.09  
(-0.15;-0.04)*
-0.10 
(-0.23;0.04)
0.01 
(-0.07;0.10)
Anterior	thalamic	
radiation
0.05 
(-0.01;0.10)
0.07 
(-0.06;0.20)
0.05 
(-0.04;0.13)
-0.04  
(-0.08;-0.01)
-0.13  
(-0.22;-0.04)
-0.01 
(-0.07;0.05)
Superior	thalamic	
radiation
-0.02	
(-0.09;0.04)
0.19 
(0.03;0.35)
-0.01 
(-0.11;0.09)
-0.06 
(-0.13;0.00)
0.02	
(-0.14;0.18)
-0.01 
(-0.11;0.08)
Posterior	thalamic	
radiation
0.04 
(-0.02;0.10)
0.11 
(-0.04;0.25)
0.07 
(-0.02;0.16)
-0.05 
(-0.11;0.00)
-0.09 
(-0.23;0.04)
-0.06 
(-0.14;0.03)
Association tracts
Superior	longitudinal	
fasciculus
0.09 
(0.03;0.15)
0.05 
(-0.10;0.21)
0.00 
(-0.10;0.09)
-0.10  
(-0.15;-0.04)*
-0.11 
(-0.24;0.02)
0.01 
(-0.08;0.09)
Inferior	longitudinal	
fasciculus
0.07 
(0.00;0.13)
0.22 
(0.06;0.38)
-0.02	
(-0.12;0.07)
-0.06  
(-0.11;-0.01)
-0.29  
(-0.41;-0.16)*
0.03 
(-0.05;0.11)
Inferior	fronto-occipital	
fasciculus
0.07 
(0.01;0.13)
0.21 
(0.06;0.35)
0.05 
(-0.04;0.13)
-0.04 
(-0.09;0.01)
-0.27  
(-0.39;-0.14)*
0.02	
(-0.06;0.09)
Uncinate	fasciculus 0.04 
(-0.02;0.10)
0.29 
(0.14;0.44)*
0.06 
(-0.03;0.15)
-0.04 
(-0.10;0.02)
-0.32  
(-0.46;-0.18)*
0.04 
(-0.05;0.12)
Limbic system tracts
Cingulate	gyrus	part	of	
cingulum
0.09 
(0.03;0.16)
0.24 
(0.07;0.41)
-0.02	
(-0.12;0.09)
-0.12  
(-0.19;-0.05)*
-0.17 
(-0.34;0.00)
0.06 
(-0.05;0.17)
Parahippocampal	part	of	
cingulum
0.05 
(-0.01;0.12)
0.12	
(-0.04;0.29)
0.07 
(-0.03;0.17)
0.03 
(-0.04;0.11)
-0.26  
(-0.44;-0.08)
-0.03 
(-0.14;0.08)
Fornix 0.05 
(-0.02;0.11)
0.03 
(-0.13;0.20)
0.07 
(-0.04;0.17)
0.00 
(-0.05;0.05)
-0.14  
(-0.25;-0.02)
-0.04 
(-0.11;0.03)
Callosal tracts
Forceps	major 0.03 
(-0.03;0.08)
0.13 
(-0.01;0.26)
0.04 
(-0.04;0.13)
-0.02	
(-0.07;0.04)
-0.11 
(-0.25;0.03)
0.01 
(-0.07;0.10)
Forceps	minor 0.11 
(0.05;0.16)*
0.09 
(-0.04;0.23)
0.04 
(-0.05;0.12)
-0.08  
(-0.14;-0.01)
-0.26  
(-0.42;-0.11)*
0.02	
(-0.08;0.11)
Data	are	presented	as	differences	in	Z-scores	of	tract-specific	diffusion-MRI	measures	(95%	CI).	Results	in	bold	
were	significant	after	p<0.05.	Results	in	bold	and	*	were	significant	after	correction	for	multiple	testing	(p<0.0025).	
Adjusted	for	age,	sex,	intracranial	volume,	WM	and	log-transformed	WMH	volumes	of	the	investigated	tract,	
and	additionally	for	CES-D	score,	smoking	pack-years	and	other	cardiovascular	risk	factors	(systolic	blood	
pressure,	diastolic	blood	pressure,	antihypertensive	medication,	serum	cholesterol,	HDL-cholesterol,	lipid	lowering	
medication,	diabetes).
Abbreviations: COPD: chronic obstructive pulmonary disease; FEV1: forced expiratory volume during the 
first second in l; DLCOc= diffusing capacity of the lungs using carbon monoxide corrected for the haemoglobin 
concentration; CI: confidence interval; WM: white matter; WMH: white matter hyperintensities; CES-D: Center for 
Epidemiology Depression Scale.
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Voxel-based analysis
In	 the	voxel-based	analyses,	 a	higher	FEV1	 associated	with	both	a	higher	FA	and	a	
lower	MD	 in	 voxels	 of	 the	 corticospinal	 tract,	 anterior	 thalamic	 radiation,	 superior	
thalamic	radiation,	(all	projection	tracts),	inferior	longitudinal	fasciculus	(association	
tract),	forceps	major	(callosal	tract),	and	with	the	cingulate	gyrus	(limbic	system	tract).	
Furthermore,	 a	 higher	FEV1	 associated	with	 a	 lower	MD	 in	voxels	of	 the	posterior	
thalamic	radiation	(projection	tract),	superior	longitudinal	fasciculus,	inferior	fronto-
occipital	fasciculus,	uncinate	fasciculus	(all	association	tracts),	and	with	voxels	of	the	
forceps	minor	(callosal	tract)	(figure 3, panel A and B, Supplementary table 3).
A	higher	diffusing	capacity	associated	with	a	higher	FA	in	voxels	in	periventricular	and	
subcortical	white	matter,	and	with	a	lower	MD	in	subcortical	white	matter	(figure 3, 
panel C and d).	However,	these	voxels	did	not	belong	to	one	of	the	predefined	tracts	
of	the	anatomical	template.	We	found	no	voxels	significantly	associated	with	COPD	
(Supplementary table 3).
table 3	presents	the	results	for	the	association	between	COPD	severity	based	on	the	
2013	GOLD	classification	and	mean	diffusivity	 after	 adjusting	 for	 age,	 sex,	macro-
structural	MRI	markers,	CES-D	score,	smoking	and	other	cardiovascular	risk	factors.	
We	observed	that	persons	with	severe	COPD	(GOLD	group	D)	compared	to	persons	
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figure 2. Overview	of	the	association	tracts	(top	view) 
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without	COPD	had	poorer	tract-specific	microstructural	integrity	throughout	the	brain,	
again	most	prominently	in	the	association	tracts.
 Lung	function	and	white	matter	microstructure    
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figure 3. Association	of	lung	function	measures	and	voxel-wise	diffusion-MRI	measures.	
(voxel-wise	linear	regression	analysis)	with	adjustments	for	age,	sex,	macrostructural	MRI	
markers,	CES-D	score,	smoking	pack-years	and	other	cardiovascular	risk	factors).	P-value	
threshold	 for	 significance	was	defined	based	on	permutation	 tests.	Significant	 voxels	 (for	
FA	 p<	 5.91	 x	 10-8 for	MD	 p<	 6.49	 x	 10-8)	 are	 color-coded.	 Colors	 reflect	 t-values	 and	
higher	 strength	 of	 association	 is	 depicted	 in	 darker	 red/yellow	 for	 positive	 associations,	
lighter	blue	for	negative	associations.	Significant	voxels	cluster	mainly	 in	association	and	
projection	tracts. 
 
Panel	A:	Association	of	FEV1 and	voxel-wise	fractional	anisotropy. 
Panel	B:	Association	of	FEV1 and	voxel-wise	mean	diffusivity. 
Panel	C:	Association	of	diffusing	capacity	and	voxel-wise	fractional	anisotropy. 
Panel	D:	Association	of	diffusing	capacity	and	voxel-wise	mean	diffusivity. 
 
 
 
figure 3.	Association	of	lung	function	measures	and	voxel-wise	diffusion-MRI	measures.	(voxel-wise	linear	
regression	analysis)	with	adjustments	for	age,	sex,	macrostructural	MRI	markers,	CES-D	score,	smoking	pack-
years	and	other	cardiovascular	risk	factors).	P-value	threshold	for	significance	was	defined	based	on	permu-
tation	tests.	Significant	voxels	(for	FA	p<	5.91	x	10-8	for	MD	p<	6.49	x	10-8)	are	color-coded.	Colors	reflect	
t-values	and	higher	strength	of	association	is	depicted	in	darker	red/yellow	for	positive	associations,	lighter	
blue	for	negative	associations.	Significant	voxels	cluster	mainly	in	association	and	projection	tracts.
Panel	A:	Association	of	FEV1	and	voxel-wise	fractional	anisotropy.
Panel	B:	Association	of	FEV1	and	voxel-wise	mean	diffusivity.
Panel	C:	Association	of	diffusing	capacity	and	voxel-wise	fractional	anisotropy.
Panel	D:	Association	of	diffusing	capacity	and	voxel-wise	mean	diffusivity.
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Global cognition
table 4	presents	the	results	of	the	association	between	lung	function	(FEV1,	diffusing	
capacity),	COPD	and	global	cognition.	Higher	lung	function	measures	associated	with	
a	better	global	cognition.	Per	liter	increase	of	FEV1,	the	g-factor	increased:	b	(95%	CI	
)	0.19	 (0.13;0.26).	Per	unit	 increase	of	 the	diffusing	capacity	 the	g-factor	 increased	
with	b	(95%	CI	):	0.18	(0.02;0.35),	after	adjustments	for	after	adjusting	for	age,	sex,	
intracranial	 volume,	 CES-D	 score,	 smoking,	 and	 other	 cardiovascular	 risk	 factors.	
Participants	with	COPD	had	a	lower	global	cognition:	b	(95%	CI	)	-0.11	(-0.21;0.00).	
table 5	presents	 the	 results	of	 the	association	between	 tract-specific	mean	diffusiv-
ity	and	global	cognition	stratified	based	on	COPD	status	Though	 formal	 interaction	
table 3. COPD	severity	and	tract-specific	diffusion-MRI	measures	of	white	matter	microstructural	integrity
Mean diffusivity 
GoLd A GoLd B GoLd C GoLd d
Brainstem tracts    
Middle	cerebellar	peduncle -0.04	(-0.18;0.09) -0.05	(-0.21;0.12) 0.27	(-0.24;0.78) 0.01	(-0.37;0.39)
Medial	lemniscus	 0.02	(-0.13;0.17) 0.13	(-0.06;0.32) 0.31	(-0.27;0.89) 0.62 (0.18;1.06)
Projection tracts 
Corticospinal	tract -0.02(-0.13;0.09) 0.07	(-0.04;0.15) 0.10	(-0.31;0.51) 0.39	(0.08;0.71)
Anterior	thalamic	radiation -0.04	(-0.11;0.03) 0.05	(-0.04;0.15) -0.25	(-0.53;0.03) 0.08	(-0.13;0.30)
Superior	thalamic	radiation -0.03	(-0.16;0.09) 0.04	(-0.12;0.20) -0.06	(-0.54;0.42) 0.18	(-0.18;0.54)
Posterior	thalamic	radiation -0.03	(-0.14;0.08) -0.07	(-0.21;0.06) 0.03	(-0.39;0.45) 0.10	(	-0.21;0.42)
Association tracts
Superior	longitudinal	fasciculus -0.04	(-0.14;0.07) 0.03	(-0.11;0.16) -0.09	(	-0.52;0.35) 0.49 (0.18;0.80)*
Inferior	longitudinal	fasciculus 0.02	(-0.08;0.12) -0.01	(-0.14;0.12) 0.23	(	-0.17;0.62) 0.37 (0.07;0.67)
Inferior	fronto-occipital	fasciculus 	0.00	(-0.10;0.11) 0.05	(-0.08;0.17) -0.11	(-0.49;0.28) 0.36 (0.08;0.66)
Uncinate	fasciculus -0.02	(-0.13;0.10) 0.10	(-0.04;0.25) -0.19	(-0.64;0.26) 0.48 (0.14;0.81)
Limbic system tracts
Cingulate	gyrus	part	of	cingulum 0.02	(-0.12;0.15) 0.09	(-0.09;0.26) -0.25	(-0.79;0.28) 0.69 (0.28;1.09)*
Parahippocampal	part	of	cingulum -0.01	(-0.15;0.14) -0.03	(-0.21;0.15) -0.01	(-0.57;0.55) 0.01	(-0.42;0.43)
Fornix -0.03	(-0.12;0.06) 0.00	(-0.11;0.11) -0.06	(-0.40;0.29) -0.07	(-0.34;0.20)
Callosal tracts
Forceps	major 0.03	(-0.08;0.14) 0.00	(-0.14;0.14) 0.11	(-0.32;0.54) 0.11	(-0.22;0.43)
Forceps	minor 0.00	(-0.13;0.12) 0.01	(-0.17;0.14) -0.09	(-0.57;0.40) 0.48 (0.11;0.84)
Data	are	presented	as	differences	in	Z-scores	of	tract-specific	diffusion-MRI	measures	(95%	CI).	Results	in	
bold	were	significant	after	p<0.05.	Results	 in	bold	and	*	were	significant	after	correction	for	multiple	 test-
ing	(p<0.0025).	Adjusted	for	age,	sex,	intracranial	volume,	WM	and	log-transformed	WMH	volumes	of	the	
investigated	 tract	and	additionally	adjusted	 for	CES-D	score,	 smoking	pack-years	and	other	cardiovascular	
risk	factors	(systolic	blood	pressure,	diastolic	blood	pressure,	antihypertensive	medication,	serum	cholesterol,	
HDL-cholesterol,	lipid	lowering	medication,	diabetes).	
Abbreviations: GOLD:Global Initiative for Chronic Obstructive Lung Disease criteria; CI: confidence inter-
val; WM: white matter; WMH: white matter hyperintensities; CES-D: Center for Epidemiology Depression 
Scale; HDL: high-density lipoprotein. 
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was	absent	(Supplementary table 1),	the	link	between	white	matter	microstructural	
integrity	and	global	cognition	seemed	stronger	in	persons	with	COPD	versus	persons	
without	COPD.
Sensitivity analysis
We	repeated	the	tract-specific	analysis	with	exclusion	of	all	participants	with	COPD.	
Reduced	lung	function	within	the	normal	range	associated	with	tract-specific	micro-
structural	damage	throughout	the	brain,	but	again	most	prominently	in	the	association	
tracts.	The	estimates	changed	only	slightly	compared	to	the	analysis	including	persons	
with	 COPD,	 however	 some	 of	 the	 associations	 were	 not	 (statistically)	 significant	
anymore	upon	multiple	comparisons	correction	(Supplementary table 2).
We	 furthermore	 repeated	 the	 tracts-specific	 analysis	 with	 FEV1	 and	 the	 diffusing	
capacity	as	determinant,	with	the	exclusion	of	all	participants	with	a	spirometry	sug-
gestive	of	a	restrictive	syndrome	(N=91).	The	estimates	did	not	change	substantially.	
However,	 again,	 some	of	 the	 associations	were	not	 statistically	 significant	 anymore	
(Supplementary table 3).
table 4. Association	of	lung	function	and	global	cognition	(g-factor)
Variable G-factor Model 1
b (95% CI )
G-factor Model 2
b (95% CI )
fev 0.25	(0.18;0.31) 0.19	(0.13;0.26)
DLCOc 0.24	(0.08;0.40) 0.18	(0.02;0.35)
COPD -0.18	(-0.28;-0.08) -0.11	(-0.21;0.00)
Values	represent	the	mean	differences	(95%	CI)	of	the	g-factor	per	unit	increase	of	lung	function	parameters.	
Model	 I:	Adjusted	 for	 age,	 sex,	 intracranial	volume.	Model	 II:	Model	 I	 and	additionally	 for	CES-D	score,	
smoking	pack-years	and	other	cardiovascular	risk	factors	(systolic	blood	pressure,	diastolic	blood	pressure,	
antihypertensive	medication,	serum	cholesterol,	HDL-cholesterol,	lipid	lowering	medication,	diabetes).	
Abbreviations: COPD: Chronic Obstructive Pulmonary disease; CI: confidence interval; DLCOc= diffusing 
capacity of the lungs using carbon monoxide corrected for the haemoglobin concentration; FEV1: forced ex-
piratory volume during the first second in l; DLCOc= diffusing capacity of the lungs using carbon monoxide 
corrected for the haemoglobin concentration. WM: white matter; WMH: white matter hyperintensities; 
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table 5. Tract-specific	mean	diffusivity	and	global	cognition	(g-factor)
Model I Model II
G-factor in CoPd + G-factor in CoPd – G-factor in CoPd + G-factor in CoPd -
Brainstem tracts   
Middle	cerebellar	peduncle -0.05	(-0.15;0.06) 0.01	(-0.04;0.05) -0.05	(-0.15;0.05) 0.00	(-0.05;0.04)
Medial	lemniscus -0.07	(-0.17;0.02) 0.00	(-0.04;0.04) -0.06	(-0.15;0.04) 0.00	(-0.04;0.04)
Projection tracts
Corticospinal	tract -0.23 (-0.36;-0.10)* -0.08 (-0.14;-0.02) -0.21 (-0.35;-0.07) -0.06 (-0.12;0.00)
Anterior	thalamic	radiation -0.28 (-0.49;-0.08) -0.16 (-0.25;-0.07)* -0.27 (-0.47;-0.07) -0.15 (-0.23;-0.06)*
Superior	thalamic	radiation -0.32 (-0.54;-0.11) -0.11 (-0.19;-0.02) -0.27 (-0.47;-0.06) -0.08	(-0.17;0.01)
Posterior	thalamic	radiation -0.13	(-0.27;0.00) -0.05	(-0.10;0.01) -0.12	(-0.25;0.01) -0.04	(-0.10;0.01)
Association tracts
Superior	longitudinal	
fasciculus -0.14 (-0.28;-0.01) -0.07 (-0.12;-0.01) -0.13	(-0.26;0.01) -0.05	(-0.11;0.00)
Inferior	longitudinal	
fasciculus -0.11	(-0.24;0.03) -0.11 (-0.17;-0.06)* -0.10	(-0.23;0.03) 0.10 (0.16;0.04)*
Inferior	fronto-occipital	
fasciculus -0.10	(-0.23;0.03) -0.10 (-0.15;-0.04)* -0.11	(-0.24;0.03) -0.08 (-0.14;-0.03)*
Uncinate	fasciculus -0.14 (-0.25;-0.02) -0.10 (-0.15;-0.05)* -0.12	(-0.24;0.00) -0.09 (-0.14;-0.04)*
Limbic system tracts
Cingulate	gyrus	part	of	
cingulum -0.14 (-0.24;-0.04) -0.07 (-0.11;-0.03)* -0.13 (-0.23;-0.03) -0.06 (-0.10;-0.01)
Parahippocampal	part	of	
cingulum -0.06	(-0.17;0.04) -0.06 (-0.10;-0.02) -0.06	(-0.16;0.04) -0.06 (-0.10;-0.02)
Fornix -0.21 (-0.38;-0.04) -0.07	(-0.13;0.00) -0.19 (-0.36;-0.03) -0.06	(-0.13;0.01)
Callosal tracts
Forceps	major -0.04	(-0.17;0.09) -0.05	(-0.10;0.01) -0.07	(-0.20;0.05) -0.04	(-0.10;0.01)
Forceps	minor -0.13 (-0.25;-0.01) -0.11 (-0.16;-0.06)* -0.11	(-0.21;0.01) -0.10 (-0.15;-0.05)*
Values	represent	 the	mean	differences	 in	g-factor	(95%	CI)	per	SD	increase	of	mean	diffusivity.	Results	 in	
bold	were	significant	after	p<0.05.	Results	in	bold	and	*	were	significant	after	correction	for	multiple	testing	
(p<0.0027).	Model	I	is	adjusted	for	age,	sex,	intracranial	volume,	WM	and	log-transformed	WMH	volumes	of	
the	investigated	tract.	Model	II	is	model	I,	and	additionally	adjusted	for	CES-D	score,	smoking	pack-years	and	
other	cardiovascular	risk	factors	(systolic	blood	pressure,	diastolic	blood	pressure,	antihypertensive	medica-
tion,	serum	cholesterol,	HDL-cholesterol,	lipid	lowering	medication,	diabetes).
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dISCuSSIoN
We	showed	that	in	middle	aged	and	elderly	persons	reduced	lung	function	(even	within	
the	normal	range)	indicated	by	a	lower	FEV1	and	a	lower	diffusing	capacity	was	related	
to	lower	FA	and	higher	MD	indicating	a	reduced	microstructural	integrity	throughout	
the	 brain.	 More	 specifically,	 among	 the	 15	 white	 matter	 tracts	 examined,	 reduced	
lung	function	most	strongly	associated	with	poorer	tract-specific	white	matter	micro-
structure	in	the	association	tracts.	We	observed	significant	differences	in	white	matter	
microstructure,	again	mainly	in	the	associations	tracts,	comparing	persons	with	severe 
COPD	classified	as	GOLD	D	to	persons	without	COPD.	In	the	voxel-based	analyses,	
FEV1	most	strongly	associated	with	the	microstructure	of	the	voxels	of	association	and	
projection	 tracts.	All	 associations	were	 independent	 from	 age,	 sex,	macrostructural	
white	matter	pathology,	CES-D	score,	smoking	pack-years	and	other	cardiovascular	
risk	factors.	We	also	found	that	the	link	between	white	matter	microstructural	integrity	
and	global	cognition	seemed	stronger	among	COPD	patients	than	in	persons	without	
COPD,	however	there	was	no	significant	interaction	on	the	multiplicative	scale.
Research	focusing	on	the	relation	of	lung	function	and	cerebral	white	matter	micro-
structural	integrity	using	diffusion-MRI	is	limited.	In	line	with	our	results,	a	previous	
study	showed	reduced	white	matter	integrity	throughout	the	brain	in	25	COPD	patients	
compared	 to	25	controls.29	However,	 the	differences	 in	white	matter	microstructural	
damage	between	 these	COPD	patients	 and	controls	were	no	 longer	 significant	 after	
adjustments	 for	 smoking,	 cerebrovascular	 comorbidity	 and	 cognition.	 Two	 other	
diffusion-MRI	 studies,	 using	 a	 voxel-based	 approach	 concluded	 that	 COPD	 could	
affect	white	matter	microstructural	 integrity	mainly	 in	 frontoparietal	 periventricular	
white	matter,13	mainly	in	the	visual	cortex	of	the	occipital	lobe,	the	posterior	part	of	the	
parietal	lobe	as	well	in	the	temporal	lobe.14	However,	differences	between	COPD	cases	
and	controls	were	not	statistically	significant,	which	might	be	due	to	the	small	number	
of	participants	in	these	studies.
The	pathophysiology	of	white	matter	damage	in	persons	with	COPD	is	not	fully	eluci-
dated.	Possible	mechanisms	are	neuronal	damage	caused	by	free	radicals	generated	in	
chronic	hypoxia.30	Furthermore	metabolic	decreases	and	decline	of	cerebral	perfusion	
due	to	hypoxia	may	cause	morphologic	brain	changes.12	Another	possible	mechanism	
is	systemic	inflammation	which	may	induce	chronic	inflammation	in	the	vascular	wall	
contributing	 to	both	microvascular	 and	macrovascular	 damage.31	However,	 it	 is	 not	
known	 to	what	 extent	 these	mechanisms	 can	 also	 explain	 the	 association	we	 found	
between	reduced	lung	function	parameters	within	the	normal	range	and	poorer	white	
matter	microstructure.
The	main	novelty	of	our	paper	 is	 that	we	 investigated	 the	association	between	 lung	
function	measures	 (spirometry	 and	 diffusing	 capacity)	 as	well	 as	 COPD	 and	white	
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matter	microstructure	of	functionally	different	white	matter	tracts	obtained	with	trac-
tography,	 but	 also	 on	 a	 voxel-wise	 level.	 In	 the	 tract-specific	 analysis,	 we	 showed	
that	a	lower	FEV1	and	lower	diffusing	capacity	had	a	varying	effect	on	different	white	
matter	tracts,	and	were	associated	with	a	lower	microstructural	integrity	in	particular	
of	the	association	tracts.	In	our	study	we	did	not	find	significant	associations	compar-
ing	participants	with	and	without	COPD	and	only	observed	significant	differences	in	
white	matter	microstructure	comparing	persons	with	severe	COPD	to	persons	without	
COPD.	This	may	be	explained	by	the	fact	that	this	is	a	population-based	study	in	which	
most	persons	classified	as	having	COPD	only	have	mild	COPD.	Also,	as	a	consequence	
of	this	population-based	setting	only	20	COPD	patients	were	classified	as	GOLD	D.	In	
this	GOLD	D	group	we	observed	significant	differences	in	white	matter	microstructure	
(mainly	 in	 the	association	 tracts)	compared	 to	persons	without	COPD.	This	finding,	
together	with	 the	fact	 that	 the	strongest	associations	between	diffusing	capacity	and	
white	matter	microstructure	are	seen	in	the	association	tracts,	points	toward	hypoxia/
ischemia	 as	 a	 plausible	 underlying	mechanism.	Another	 underlying	mechanism	 ex-
plaining	why	persons	with	COPD	GOLD	D	have	a	poorer	white	matter	microstructure	
compared	to	persons	without	COPD,	may	be	that	persons	with	severe	COPD	(GOLD	
D)	have	a	high	exacerbation	rate	(2	or	more/year)	and	it	is	possible	that	in	particular	
these	exacerbations	may	cause	brain	changes,	since	especially	exacerbations	of	COPD	
have	been	correlated	with	cognitive	decline.32-34	However,	it	must	be	noted	that	in	our	
study	only	20	participants	with	COPD	were	classified	as	GOLD	D.
For	MD,	we	found	similar	results	with	FEV1	and	white	matter	microstructure	compar-
ing	 the	 results	 of	 the	 tract-specific	 analysis	with	 the	 voxel-based	 analysis.	 For	 FA,	
however,	 we	 found	 in	 the	 tract-specific	 analysis	 different	 significant	 associations	
between	FEV1	and	white	matter	microstructure	compared	to	the	voxel-based	analysis	
(mainly	no	significant	associations	with	the	projection	tracts,	but	more	significant	as-
sociations	with	 the	associations	 tracts	and	callosal	 tracts).	Furthermore,	 for	both	FA	
and	MD,	we	 found	 in	 the	 tract-specific	 analysis	 with	 diffusing	 capacity	 significant	
associations,	 in	 particular	 in	 the	 association	 tracts,	 and	 there	 we	 no	 significant	 as-
sociations	in	the	voxel-based	analysis.	Explanations	for	these	differences	may	be	that	
by	 averaging	 positive	 and	 negative	 voxels,	 as	we	 did	 in	 the	 tract-specific	 analysis,	
significant	 associations	can	go	undetected.	On	 the	other	hand,	 a	major	downside	of	
exploring	associations	on	a	voxel-wise	level	is	multiple	comparisons	corrections,	mak-
ing	this	method	less	sensitive	to	very	small	changes.	Therefore,	we	chose	to	conduct	
both	methods	 and	 present	 them	 in	 parallel,	 as	we	 feel	 they	 convey	 complementary	
information.
Different	 white	 matter	 tracts	 have	 a	 variable	 susceptibility	 to	 decline,35,36	 possibly	
caused	by	 the	 location	of	 different	 tracts.	Association	 tracts	 connect	 different	 corti-
cal	 regions	 of	 the	 same	hemisphere	 and	 arise	 in	watershed	 areas	which	means	 that	
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their	blood	supply	relies	on	small	and	deep	lenticulostriate	arteries.	Association	tracts	
may	therefore	be	more	vulnerable	to	insult	and	vascular	damage.16	This	is	in	line	with	
previous	studies	which	showed	that	COPD	patients	are	particularly	prone	to	vascular	
damage.37	Association	tracts,	but	also	the	projection	tracts	play	a	critical	role	in	cogni-
tive	 performance.38	 Poor	 white	matter	microstructural	 integrity	 of	 these	 tracts	may	
therefore	be	an	important	link	between	COPD	and	cognitive	impairment.
Strengths	 of	 our	 study	 include	 the	 population-based	 design,	 the	 large	 sample	 size	
and	the	ability	to	control	for	several	potential	confounders	due	to	the	availability	of	
extensive	data	on	cardiovascular	 risk	 factors	and	macrostructural	MRI-markers.	We	
performed	a	tract-specific	analysis	in	15	main	white	matter	tracts,	and,	the	tract-specific	
measurements	 were	 performed	 with	 fully	 automated,	 publicly	 available	 methods.39 
Furthermore,	we	also	included	a	voxel-based	analysis.	However,	also	some	limitations	
should	 be	 acknowledged.	Due	 to	 the	 cross-sectional	 design,	 no	 conclusions	 can	 be	
drawn	on	the	directionality	of	causality	of	the	associations..	We	used	mean	FA	and	MD	
aggregated	over	each	white	matter	tract	eventually	missing	some	spatial	information	
which	is	retained	in	voxel-based	techniques.	Also,	tractography	in	general	is	influenced	
by	crossing	fiber	regions,	possibly	resulting	in	unreliable	diffusion-MRI	measures	in	
some	areas,	in	particular	for	fractional	anisotropy.40	The	cerebellum	could	not	be	fully	
incorporated	in	the	field	of	view,	making	analyses	on	brain	stem	tracts	 less	reliable.	
Furthermore,	we	cannot	exclude	residual	confounding,	even	with	adjustments	for	the	
large	number	of	potential	confounders	performed	in	our	analyses.	Finally,	only	a	very	
small	proportion	of	our	participants	presented	with	clinically	abnormal	lung	function	
and	only	20	COPD	patients	were	classified	as	GOLD	D.
In	conclusion,	we	show	that	tract-specific	diffusion-MRI	parameters	and	voxel-based	
analyses	provide	additional	insight	into	the	association	between	reduced	lung	function	
and	the	patterns	of	microstructural	white	matter	damage	beyond	global	diffusion-MRI	
parameters.	We	found	that	persons	with	reduced	lung	function	(even	within	the	normal	
range)	have	more	regional	microstructural	white	matter	damage,	especially	in	the	asso-
ciation	tracts.	Further	studies	should	evaluate	whether	cognitive	impairment	in	COPD	
patients	is	mediated	through	poorer	regional	white	matter	microstructural	integrity.
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ABStrACt
Background	Thyroid	 hormone	 (TH)	 is	 crucial	 during	 neurodevelopment	 but	 high	
levels	of	TH	have	been	linked	to	neurodegenerative	disorders.	No	data	on	the	associa-
tion	of	thyroid	function	with	brain	imaging	in	the	general	population	are	available.
Methods	We	therefore	 investigated	 the	association	of	 thyroid-stimulating	hormone	
and	 free	 thyroxine	 (FT4)	 with	 MRI-derived	 total	 intracranial	 volume,	 brain	 tissue	
volumes	and	diffusion	tensor	imaging	(DTI)	measures	of	white	matter	microstructure	
in	4,683	dementia-	and	stroke-free	participants	(mean	age	60.2,	range	45.6-89.9	years).
Results	 Higher	 FT4	 levels	 were	 associated	 with	 larger	 total	 intracranial	 volumes	
(b=6.73mL,	95%	confidence	interval	2.94-9.80).	Higher	FT4	levels	were	also	associ-
ated	with	larger	total	brain	and	white	matter	volumes	in	younger	individuals,	but	with	
smaller	total	brain	and	white	matter	volume	in	older	individuals	(p-interaction	0.02).	
There	was	a	similar	interaction	by	age	for	the	association	of	FT4	with	mean	diffusivity	
on	DTI	(p-interaction	0.026).
Conclusions	These	results	are	in	line	with	differential	effects	of	TH	during	neurode-
velopmental	and	neurodegenerative	processes	and	can	improve	understanding	of	the	
role	of	thyroid	function	in	neurodegenerative	disorders.
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INtroduCtIoN
Thyroid	hormone	impacts	different	essential	neuronal	processes	including	neurogen-
esis,	myelination,	and	neural	differentiation	in	childhood	and	throughout	adulthood.1,2 
Already	during	 intrauterine	neurodevelopment,	 thyroid	hormone	 impacts	on	 several	
processes	including	neuronal	cell	proliferation,	differentiation	and	migration.1,3	Subop-
timal	thyroid	hormone	availability	during	early	life	can	have	profound	impact	on	brain	
function	later	in	life.	This	is	illustrated	by	the	link	between	congenital	hypothyroidism	
and	 cretinism,	 a	 condition	 characterized	 by	 severely	 impaired	 physical	 and	mental	
development.	Mild	forms	of	both	low	and	high	thyroid	function	during	the	gestational	
period	have	been	associated	with	a	lower	child	IQ	and	differences	in	brain	morphology	
during	later	life.4
However,	 the	effects	of	 thyroid	hormone	on	 the	brain	are	age	dependent	because	 in	
addition	 to	 its	 effects	 during	 development,	 thyroid	 hormone	 is	 also	 related	 to	 neu-
rodegeneration.	 In	 older	 adults,	 higher	 thyroid	 function	 has	 been	 associated	with	 a	
higher	 risk	 of	 neurodegenerative	 disorders	 and	 poorer	 cognition.5,6	A	meta-analysis	
of	cohort	studies	showed	that	higher	thyroid	function	is	associated	with	higher	risk	of	
cognitive	 impairment.7	We	previously	described	 an	 increased	 risk	of	 dementia	with	
high-normal	 to	high	 thyroid	function	and	a	protective	effect	of	 low	and	 low-normal	
thyroid	function.8	This	risk	did	not	seem	to	be	explained	by	cardiovascular	risk	fac-
tors	 or	 subclinical	 vascular	 brain	 damage.	 The	 underlying	 mechanisms	 explaining	
the	link	between	thyroid	function	and	dementia	are	yet	unclear,	but	possible	and	yet	
unexplored	pathways	are	through	subclinical	changes	in	microstructural	organization	
or	brain	tissue	atrophy.
Owing	to	the	link	with	cognitive	impairment,	we	hypothesized	that	thyroid	hormone	
could	have	adverse	effects	on	processes	affecting	brain	volumes	and	white	matter	mi-
crostructure	in	older	age.	We	also	hypothesized	that	this	effect	could	be	age-dependent,	
due	to	the	different	effects	of	thyroid	hormone	during	the	neurodevelopmental	period.	
Therefore,	we	investigated	the	association	of	thyroid	function	with	intracranial	brain	
volume	(as	a	marker	of	development),	total	brain,	white	matter	and	grey	matter	vol-
umes	on	MRI	(as	markers	of	neurodegeneration).	Furthermore,	we	tested	whether	the	
association	of	 thyroid	function	and	diffusion	 tensor	 imaging	(DTI)	measures	related	
to	white	matter	microstructural	 organization	were	 different	 in	 younger	 versus	 older	
participants.
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MethodS
Setting
The	study	was	performed	in	the	context	of	the	Rotterdam	Study	(RS),	a	prospective	
population-based	cohort	 study	 that	 investigates	determinants	and	occurrence	of	car-
diovascular,	neurological,	ophthalmologic,	psychiatric,	and	endocrine	diseases	in	the	
middle-aged	and	elderly	population.	The	aims	and	design	of	the	Rotterdam	Study	have	
been	described	in	detail	elsewhere.9	We	included	participants	from	three	independent	
cohorts	within	the	Rotterdam	Study.	The	RS	Cohort	1	(RSI)	includes	participants	aged	
55	years	and	older	and	baseline	data	were	collected	during	1990-1993.	RS	Cohort	II	
(RSII)	includes	participants	aged	55	years	and	older	and	baseline	data	were	collected	
from	2000-2001.	For	the	RS	Cohort	3	(RSIII),	persons	included	were	aged	45	years	and	
over	and	baseline	data	were	collected	from	2006	to	2008.	Thyroid	function	assessment	
was	determined	in	a	random	subset	of	9,689	participants	in	all	three	cohorts	and	brain	
MRI	was	included	in	the	core	protocol	of	the	Rotterdam	Study	since	2005.	The	study	
protocol	was	approved	by	the	Medical	Ethics	Committee	of	the	Erasmus	University	
and	by	 the	Ministry	of	Health,	Welfare	and	Sport	of	 the	Netherlands,	 implementing	
the	“Wet	Bevolkingsonderzoek:	ERGO	(Population	Studies	Act:	Rotterdam	Study)”.	
All	included	participants	provided	a	written	informed	consent	in	accordance	with	the	
Declaration	of	Helsinki	to	participate	in	the	study	and	to	obtain	information	from	their	
family	physicians.
Study population
We	 included	 all	 participants	 from	 the	Rotterdam	 Study,	 cohort	 I	wave	 3,	 cohort	 II	
wave	 I	 and	 cohort	 III	 wave	 I,	 with	 thyroid	 function	measurements,	MRI	measure-
ments	and	free	of	dementia	at	baseline	(n=5104).	We	excluded	248	participants	with	
prevalent	 stroke	 and	 with	MRI-defined	 cortical	 infarcts	 and	 173	 participants	 using	
thyroid	 function	 altering	medication	 (levothyroxine,	 anti-thyroid	drugs,	 amiodarone	
or	corticosteroids).	Final	study	population	included	4,683	participants	of	which	3,852	
also	had	DTI	measurements.
Assessment of thyroid function
Thyroid	function	was	measured	through	thyroid-stimulating	hormone	(TSH)	and	free	
thyroxine	(FT4)	using	the	same	methods	and	assay	for	all	cohorts	(The	electrochemilu-
minescence	immunoassay	for	thyroxine	and	thyrotropine,	“ECLIA”,	Roche)	in	serum	
samples	stored	at	-80°C.	We	determined	the	reference	values	for	normal	range	TSH	
as	0.4-4.0	mIU/L	and	FT4	as	11-25	pmol/L	(=	0.85-1.95	ng/dL)	according	to	national	
guidelines	as	well	as	our	previous	studies.8,10
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MrI acquisition and analysis
Multi-sequence	brain	MR	 Imaging	was	performed	on	 a	 1.5	 tesla	MRI	 scanner	 (GE	
Signa	Excite).	The	imaging	protocol	and	sequence	details	were	described	extensively	
elsewhere.11	Scans	were	automatically	 segmented	supra	 tentorially	 into	grey	matter,	
white	matter,	 cerebrospinal	 fluid	 (CSF)	 and	 background	 tissue.	 Intracranial	 volume	
(ICV)	 (excluding	 the	cerebellum	and	 surrounding	CSF)	was	estimated	by	 summing	
total	 grey	 and	white	matter	 and	CSF	 volumes.12	Total	 brain	 volume	was	 estimated	
by	 summing	 total	 grey	 and	white	matter	 volumes.12	A	post-processing	white	matter	
lesion	classification,	based	on	the	FLAIR	image	and	the	tissue	segmentation,	was	used	
to	 obtain	white	matter	 lesion	 volumes	 (natural-log	 transformed	 to	 account	 for	 their	
skewed	distribution).13	All	segmentations	were	visually	inspected	and	were	corrected	
if	needed.	Cortical	infarcts	were	visually	rated	on	structural	sequences,	and	were	clas-
sified	as	cortical	infarcts	in	case	of	involvement	of	cortical	grey	matter.	In	a	subset	of	
our	study	population	(N=2,449)	cerebellar	volume	was	processed	automatically	using	
FreeSurfer	 4.5.	This	 procedure,	 based	 on	 probabilistic	 information	 obtained	 from	 a	
manually	 labeled	 training	 set,	 assigns	 a	 neuroanatomical	 label	 to	 each	 voxel	 in	 an	
MRI	volume.	This	is	explained	in	more	detail	elsewhere.14	In	this	subset	we	computed	
intracranial	volume,	including	cerebellar	volume,	and	total	cerebellar	volume.
Diffusion-MRI processing
For	characterization	of	white	matter	microstructural	organization	with	DTI,	a	single	
shot,	 diffusion-weighted	 spin	 echo	 echo-planar	 imaging	 sequence	 was	 performed.	
Maximum	b-value	was	1000	s/mm2	in	25	non-collinear	directions	and	three	volumes	
were	 acquired	 without	 diffusion	 weighting	 (b-value	 =	 0	 s/mm2).	 For	 the	 diffusion	
acquisition,	 due	 to	 technical	 issues	 1165	 participants	 were	 scanned	with	 the	 phase	
and	frequency	encoding	directions	swapped	leading	to	a	mild	ghost	artifact.15	We	cor-
rected	for	this	potential	confounder	in	our	analyses.	Diffusion	data	were	pre-processed	
using	a	standardized	pipeline	(including	correction	for	motion	and	eddy	currents)	as	
previously	described.16	A	diffusion	tensor	model	was	estimated	in	each	voxel,	and	co-
registration	between	 structural	 imaging	and	diffusion	 image	 space	was	performed.15 
Through	averaging	of	the	diffusion	measurements	inside	the	normal	appearing	white	
matter	(voxels	with	white	matter	lesions	were	excluded	from	the	analysis)	we	obtained	
global	mean	fractional	anisotropy	(FA),	mean	diffusivity	(MD),	radial	diffusivity,	and	
axial	diffusivity.15	The	median	time	between	thyroid	function	measurement	and	MRI	
scan	was	0.21	years	(interquartile	range:	0.06-10.16).
Assessment of other variables
Blood	pressure	was	measured	at	the	right	brachial	artery	using	a	random-zero	sphyg-
momanometer	after	5	minutes	of	rest	with	the	participants	in	sitting	position.	The	mean	
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of	 two	consecutive	measurements	was	used.	Information	regarding	the	use	of	blood	
pressure	 lowering	 medication	 for	 the	 indication	 of	 hypertension	 was	 derived	 from	
structured	 home	 interviews	 and	 linkage	 to	 pharmacy	 records.	 Serum	 total	 and	 high	
density	lipoprotein	(HDL)	cholesterol	were	measured	in	fasting	serum	by	enzymatic	
method.	Smoking	information	was	derived	from	baseline	questionnaires	and	catego-
rized	in	never,	previous	and	current	smokers.	Alcohol	consumption	was	documented	as	
intake	in	grams	per	day.	Body-mass	index	(BMI)	was	calculated	as	weight	kilograms	
divided	by	height	 in	meters	 squared.	History	 of	 diabetes	mellitus	was	 defined	by	 a	
repeated	 (two	measurements	within	one	year)	 impaired	 fasting	glucose	≥	7	mmol/L	
or	a	non-fasting	glucose	of	≥	11	mmol/L	(when	fasting	samples	were	absent)	or	use	
of	 anti-glycemic	medication	 at	 baseline.17	 Educational	 level	 was	 assessed	 during	 a	
baseline	home	interview	and	people	were	classified	into	7	categories:	from	low	level	
of	education	(primary	only)	to	high	(university).	Prevalent	dementia	and	clinical	stroke	
were	ascertained	as	previously	described.18,19	In	short,	participants	were	evaluated	for	
dementia	using	a	three	strep	protocol.	All	participants	were	screened	using	the	Mini-
Mental	State	Examination	 (MMSE)20	 and	Geriatric	Mental	State	 schedule	 (GMS).21 
Persons	 scoring	≤	 25	 on	 the	MMSE	or	 >0	 on	 the	GMS	underwent	 an	 examination	
and	informant	interview	with	the	Cambridge	Examination	for	Mental	Disorders	of	the	
Elderly.	Persons	suspicious	of	having	dementia	underwent	further	neuropsychological	
testing	if	necessary.	Furthermore,	in	addition	to	the	above	screening	method,	persons	
were	continuously	monitored	for	the	dementia	diagnosis	through	computerized	linkage	
of	the	study	database	and	medical	records	of	the	general	practitioner’s	office	and	Re-
gional	Institute	for	Outpatient	Mental	Health	Care	(RIAGG).	The	accepted	DSM-III-R	
criteria	were	used	for	the	dementia	diagnosis22.
Statistical analysis
We	used	ordinary	least	squares	linear	regression	models	with	restricted	cubic	splines	
at	 three	knots,23	which	provided	the	best	fit	with	the	data	without	overfitting,	for	all	
analyses,	 to	account	for	possible	non-linear	associations.	Primary	analyses	for	brain	
volume	measurements	were	 adjusted	 for	 age,	 sex,	 cohort,	 time	 between	 laboratory	
measurement	and	MRI	scan	and	intracranial	volume.	We	included	intracranial	volume	
as	a	covariate	in	our	model	to	correct	for	the	inter-individual	variability	in	head	size.24 
In	 a	 second	model,	we	 additionally	 adjusted	 for	 several	 cardiovascular	 risk	 factors	
including	total	cholesterol,	HDL-cholesterol,	systolic	blood	pressure,	diastolic	blood	
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pressure,	 smoking,	 prevalent	 diabetes	 mellitus,	 BMI,	 alcohol	 use	 and	 educational	
level.	For	the	analyses	of	intracranial	volume,	we	did	not	adjust	for	the	variable	itself.
Primary	analyses	for	diffusion	measurements	adjusted	for	age,	sex,	cohort,	time	between	
laboratory	measurement	and	MRI	scan,	intracranial	volume,	white	matter	volume	and	
white	matter	lesion	volume.	A	second	model	additionally	adjusted	for	total	cholesterol,	
HDL-cholesterol,	systolic	blood	pressure,	diastolic	blood	pressure,	smoking,	prevalent	
diabetes,	BMI,	alcohol	use	and	educational	 level.	TSH	was	natural	 log-transformed	
for	all	analyses	to	approximate	normality	and	interaction	of	TSH	or	FT4	with	age	(as	a	
continuous	measure)	or	sex	was	tested	for	all	analyses.	We	conducted	sensitivity	analy-
ses	1)	constricting	analyses	to	the	reference	range	of	thyroid	function	(n=4141)	and	2)	
excluding	participants	with	 time	 interval	above	1	year	between	 laboratory	measure-
ment	and	MRI	scan	(n=2527).	In	order	to	quantify	the	effects	in	different	age	groups	
we	additionally	stratified	our	main	analyses	by	the	mean	age	of	our	population	(~	60	
years	of	age).	Missing	covariates	 (<	5%	for	all	covariates	but	alcohol	 [6.7%])	were	
imputed	using	multiple	imputations	creating	5	data	sets	according	to	the	Markov	Chain	
Monte	 Carlo	method	 and	 pooled	 subsequently	 (IBM	SPSS	 Statistics	 for	Windows,	
version	21.0.	Armonk,	NY).	In	our	multiple	comparisons	correction	we	took	the	main	
analyses	 (FT4,	TSH	with	 the	 9	 different	 outcomes	 (intracranial	 volume,	 total	 brain	
volume,	total	white	matter	volume,	total	grey	matter	volume,	cerebellar	volume,	FA,	
MD,	radial	diffusivity,	and	axial	diffusivity)	into	account.	We	estimated	the	number	of	
independent	tests	by	using	the	variance	of	the	eigenvalues	of	the	correlation	matrix	of	
the	11	variables	used	in	our	main	analyses.	We	calculated	the	number	of	independent	
tests	using	 the	following	formula:	Meff=	1	+(M-1)(1-var	(λobs)/M)	with	M	is	number	
of	 tests,	Meff	 is	 the	number	of	 independent	 tests.
25,26	Based	on	 this	 formula	Meff	was	
5.668331474.	Afterwards,	using	the	Šidák	formula:	α	sidak	=	1	-	((1	-	α)^(1/Meff))	our	
corrected	significance	level	was	p<	0.0081.25	Statistical	analyses	were	conducted	and	
plots	 were	 produced	 using	 R	 statistical	 software	 (rms,	 Himsc,	 visreg	 packages,	 R-
project,	Institute	for	Statistics	and	Mathematics,	R	Core	Team	(2013),	Vienna,	Austria,	
version	3.0.2).
reSuLtS
We	 included	 a	 total	 of	 4683	participants,	with	 an	 average	 age	 of	 60.2	 years	 (range	
45.6-89.9)	 of	which	54.9%	were	 female	 (table 1).	As	 the	 results	 of	 the	 two	 tested	
models	are	comparable	we	present	both	for	illustration,	but	only	report	the	most	ad-
justed	model	in	the	manuscript.	Linearity	assumption	was	met	for	all	main	analyses	
and	indicated	in	tables	if	otherwise.
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Brain tissue volumes and intracranial volume
Higher	FT4	 levels	were	associated	with	 larger	 intracranial	volume	with	a	beta	 (b)	of	
6.23	mL	per	one	unit	increase	of	FT4	pmol/L	(95%	Confidence	Interval	[CI],	2.80,	9.66,	
table 2),	 and	 the	 association	was	 not	 different	 according	 to	 age	 (figure 1,	Supple-
mental table 1,	Supplemental table 2).	There	was	no	association	of	TSH	levels	with	
intracranial	volume.	Higher	FT4	levels	were	associated	with	larger	brain	volume	overall	
(b	2.26,	CI,	1.10,	3.43,	table 2)	and	white	matter	volume	in	particular	(b	1.43,	CI,	0.25,	
2.62,	table 2),	but	not	in	elderly	(figure 1,	Supplemental table 2).	The	p	for	interac-
tion	of	age	with	 total	brain	volume	was	0.002	and	 for	age	with	white	matter	volume	
was	0.038	(Supplemental table 1).	The	associations	of	FT4	and	TSH	with	total	brain	
volume	were	mainly	attributable	to	white	matter	and	not	gray	matter	volume	(table 2).	
Higher	levels	of	TSH	were	associated	with	smaller	brain	volumes	(b	-1.35,	CI,	-2.26,	
table 1 Characteristics	of	the	4,683	study	participants
Variable Mean (Sd) a
Age,	years 60.2	(7.3)
Female	sex	n,	% 2,571	(54.9)
TSH,	ImU/L	median	(IQR) 1.97	(1.36	-	2.78)
FT4,	pmol/L 15.5	(2.1)
Intracranial	volume,	mL 1140.0	(115.5)
Grey	matter	volume,	mL 529.4	(53.6)
White	matter	volume,	mL 409.2	(59.1)
White	matter	lesion	volume,	mL,	median,	IQR 2.9	(1.7-6.0)
Mean	fractional	anisotropy 0.34	(0.02)
Mean	diffusivity,	10-3 mm2/s 0.74	(0.03)
BMI,	kg/m2 27.1	(4.0)
Total	cholesterol,	mmol/L 5.70	(1.02)
HDL-cholesterol,	mmol/L 1.42	(0.41)
Systolic	blood	pressure,	mmHg 134.8	(19.3)
Diastolic	blood	pressure,	mmHg 79.9	(10.9)
Prevalent	diabetes	n,	% 399	(8.5)
Smoking
			Current	n,	% 1,029	(22.0)
			Past	n,	% 2,211	(47.2)
			Never	n,	% 1,443	(30.8)
Alcohol	use,	grams	per	day,	median,	IQR 15.0	(6.3-21.4)
Time	between	thyroid	function	measurement	and	scan	(in	years)	median,	IQR 0.21	(0.06-10.16)
a	Values	are	means	and	(standard	deviation)	unless	otherwise	specified.
There	were	13	participants	with	missing	values	for	BMI,	5	total	cholesterol,	17	HDL-cholesterol,	14	systolic	
and	diastolic,	17	smoking,	18	for	prevalent	diabetes	and	313	for	alcohol	use.	
Abbreviations: BMI = body-mass index; TSH = thyroid-stimulating hormone, FT4 = free thyroxine; SD = 
Standard deviation; IQR = inter-quartile range
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-0.45,	table 2).	Higher	FT4	levels	were	associated	with	a	larger	white	matter	volume	(b 
1.43,	CI,	0.24,	2.62),	but	not	gray	matter	volume	(b	0.78,	CI,	-0.25,	1.80).	Higher	TSH	
levels	were	associated	with	a	smaller	white	matter	volume	(b	-	1.58,	CI,-2.50,	-	0.67),	but	
not	grey	matter	volume	(b	0.19,	CI,	-0.61,	0.99).	Constricting	analyses	to	the	reference	
range	of	thyroid	function	or	excluding	participants	with	time	interval	between	laboratory	
measurement	and	MRI	scan	>	1	year	did	not	change	effect	estimates	(table 3).	There	
was	no	significant	interaction	of	FT4	or	TSH	with	sex	on	the	association	with	any	of	the	
studied	outcomes	(p>	0.10).	There	was	no	significant	interaction	of	TSH	with	age	on	the	
association	with	any	of	the	studied	outcomes	(p>	0.35,	Supplemental table 1).
total cerebellar volume
The	additional	analysis	using	a	subgroup	of	2249	persons	with	cerebellar	volume	data	
measured	with	FreeSurfer,	yielded	a	similar	albeit	a	more	pronounced	association	of	
FT4	with	intracranial	volume	(b	10.13,	CI,	3.61,	16.64,	Supplemental table 3).	FT4	
was	positively	associated	with	cerebellar	volume	(b	0.68.13,	CI,	3.61,	16.64,	Supple-
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figure 2 Total	intracranial	and	brain	volume	according	to	FT4	serum	values 
 
 
 
Plot	 A)	 depicts	 the	 association	 of	 FT4with	 intracranial	 volume	 and	 plot	 B)	 depicts	 the	
association	of	FT4	with	total	brain	volume.	Plot	C)	depicts	the	interaction	of	FT4	with	age	
continuously	 for	 the	 intracranial	 volume	 analysis	 and	D)	 depicts	 interaction	 of	 FT4	with	
age	continuously	for	the	total	brain	volume	analysis.	All	analyses	are	adjusted	for	age,	sex,	
cohort	 and	 time	 between	 laboratory	measurements	 and	MRI	 scan,	 and	 the	 analyses	with	
brain	volume	were	additionally	adjusted	for	intracranial	volume. 
figure 1. Total	intracranial	and	brain	volume	according	to	FT4	serum	values
Plot	 )	 epicts	the	association	of	 T4with	intracranial	volume	and	plot	B)	depicts	the	association	of	FT4	with	
total	brain	volume.	Plot	C)	depicts	the	interaction	of	FT4	with	age	continuously	for	the	intracranial	volume	
analysis	and	D)	depicts	interaction	of	FT4	with	age	continuously	for	the	total	brain	volume	analysis.	All	analy-
ses	are	adjusted	for	age,	sex,	cohort	and	time	between	laboratory	measurements	and	MRI	scan,	and	the	analyses	
with	brain	volume	were	additionally	adjusted	for	intracranial	volume.
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mental table 3).	No	associations	were	observed	for	TSH	with	intracranial	volume	or	
cerebellar	volume	(Supplemental table 3).
table 2 Association	of	TSH	or	FT4	with	intracranial,	total,	white	and	grey	matter	brain	volume	measurements
Variable total intracranial 
volume 
b (95% CI )
total brain  
volume
b (95% CI )
total white matter 
volume
b (95% CI )
total grey matter 
volume
b (95% CI )
TSH
			Model	1 0.39	(-2.32,	3.09) -1.37	(-2.28,	-0.46) -1.58	(-2.50,	-0.67) 0.21	(-0.59,	1.01)
			Model	2 0.64	(-2.04,	3.32) -1.37	(-2.27,	-0.47) -1.55	(-2.47,	-0.63) 0.18	(-0.61,	0.98)
FT4
			Model	1 7.23	(3.78,	10.67) 1.95	(0.78,	3.12)* 1.43	(0.25,	2.61) 0.47	(-0.55,	1.49)
			Model	2 6.23	(2.80,	9.66) 2.26	(1.10,	3.43) 1.43	(0.25,	2.62) 0.78	(-0.24,	1.81)
Model	1:	age,	sex,	cohort,	time	between	laboratory	measurement	and	MRI	scan	and	intracranial	volume	Model	
2=	Model	1	+	total	cholesterol,	HDL-cholesterol,	systolic	blood	pressure,	diastolic	blood	pressure,	smoking,	
prevalent	diabetes,	BMI,	alcohol	use	and	educational	level.	*	p	for	non-linearity	0.054;	Abbreviations:	CI	=	
confidence	interval;	FT4	=	free	thyroxine;	MRI=	Magnetic	resonance	imaging;	OR	=	odds	ratio;	TSH	=	thyroid	
stimulating	hormone
table 3 Sensitivity	analyses	of	association	of	TSH	or	FT4	with	MRI	intracranial	and	brain	volume	measure-
ments
Variable total intracranial 
volume 
b (95% CI)
total brain volume
b (95% CI)
total white matter 
volume
b (95% CI)
total grey matter 
volume
b (95% CI)
Reference range* (n= 4,141)
TSH		Model	1 -0.91	(-5.40,	3.58) -1.40	(-2.89,	0.09) -1.88	(-3.40,	-0.35) 0.48	(-0.84,	1.81)
					Model	2 -0.87	(-5.34,	3.59) -1.30	(-2.78,	0.17) -1.76	(-3.28,	-0.22) 0.45	(-0.87,	1.78)
FT4		Model	1 8.31	(4.25,	12.36) 2.32	(0.87,	3.76)** 1.56	(0.07,	3.04) 0.60	(-0.60,	1.80)
					Model	2 7.17	(3.12,	11.22) 2.53	(1.09,	3.97)** 1.41	(-0.08,	2.90) 0.99	(-0.22,	2.20)
Excluding participants with time interval between laboratory measurement and MRI scan > 1 years (n= 2,527)
TSH		Model	1 1.42	(-2.7,	5.56) -1.41	(-2.74,	-0.08) -1.22	(-2.55,	0.11) -0.24	(-1.42,	0.49)
						Model	2 1.54	(-2.57,	5.65) -1.50	(-2.82,	-0.17) -1.23	(-2.57,	0.11) -0.30	(-1.48,	0.88)
FT4		Model	1 6.78	(1.95,	11.61) 2.57	(1.01,	4.13)** 2.36	(0.79,	3.93) 0.08	(-1.29,	1.46)
	Model	2 5.40	(0.57,	10.22) 2.95	(1.39,	4.52)** 2.42	(0.83,	4.00) 0.43	(-0.96,	1.82)
Model	1:	age,	sex,	cohort,	time	between	laboratory	measurement	and	MRI	scan	and	intracranial	volume	Model	
2=	Model	1	+	total	cholesterol,	HDL-cholesterol,	systolic	blood	pressure,	diastolic	blood	pressure,	blood	pres-
sure	lowering	medication	with	indication	of	hypertension,	smoking,	prevalent	diabetes,	BMI,	alcohol	use	and	
educational	level.	
*	Reference	ranges	for	TSH	were	0.4-4.0	mIU/L	and	for	FT4	were	11-25	pmol/L.	**	non-linearity	of	associa-
tion	p	<	0.05.	Abbreviations:	CI	=	confidence	interval;	FT4	=	free	thyroxine;	MRI=	Magnetic	resonance	imag-
ing;	OR	=	odds	ratio;	TSH	=	thyroid	stimulating	hormone
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White matter microstructural organization
There	was	no	overall	 association	of	TSH	or	FT4	with	diffusion	properties	of	white	
matter,	 neither	 FA	 nor	MD	 (table 4).	However,	 there	was	 a	 significant	 interaction	
with	 age	 for	 the	 association	 of	 FT4	 and	 MD	 (p	 for	 interaction	 0.026,	 figure 2,	
Supplemental table 1).	In	older	participants,	higher	FT4	values	were	associated	with	
a	 lower	FA	 (albeit	not	 statistically	 significant	 interaction,	p	=	0.052,	Supplemental 
table 1)	and	higher	MD,	generally	indicating	reduced	matter	microstructural	integrity	
(Supplemental table 4).	In	contrast,	in	younger	participants,	higher	FT4	levels	were	
associated	with	a	higher	FA	and	lower	MD,	generally	indicating	increased	white	matter	
integrity.	The	associations	 for	 radial	and	axial	diffusivity	 followed	 the	same	pattern	
as	mean	diffusivity	(figure 2).	All	results	survive	the	threshold	for	significance	after	
multiple	 comparisons	 correction	 except	 for	 the	 association	of	FT4	 in	 the	 full	 range	
with	white	matter	volume.
table 4 Association	of	full	range	TSH	or	FT4	with	Z-scores	of	Diffusion	Tensor	Imaging	parameters	of	white	
matter	(n=3,852)
fA b (95% CI ) Md b (95% CI ) rd b (95% CI ) Ad b (95% CI )
TSH
			Model	1 -0.00(-0.03,	0.03) 0.01(-0.01,	0.03) 0.01(-0.01,	0.03) 0.01(-0.01,	0.03)
			Model	2 -0.00(-0.03,	0.03) 0.01(-0.01,	0.03) 0.01(-0.01,	0.03) 0.01(-0.01,	0.03)
FT4
			Model	1 -0.01(-0.05,	0.02) 0.02(-0.01,	0.04) 0.01(-0.01,	0.04) 0.02(-0.01,	0.04)
			Model	2 -0.01(-0.04,	0.03) 0.01(-0.02,	0.04)	 0.01(-0.02,	0.04) 0.01(-0.01,	0.04)
Model	1:	age,	sex,	cohort,	time	between	laboratory	measurement	and	MRI	scan,	intracranial	volume,	white	
matter	 volume	 and	white	matter	 lesions.	Model	 2=	Model	 1	+	 total	 cholesterol,	HDL-cholesterol,	 systolic	
blood	pressure,	diastolic	blood	pressure,	blood	pressure	lowering	medication	with	indication	of	hypertension,	
smoking,	prevalent	diabetes,	BMI,	alcohol	use	and	educational	level.	Abbreviations: CI = confidence interval; 
FA = fractional anisotropy; FT4 = free thyroxine; MD = mean diffusivity; RD = radial diffusivity; AD = axial 
diffusivityTSH = thyroid stimulating hormone
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dISCuSSIoN
We	report	an	association	of	higher	FT4	with	larger	intracranial	volume,	independent	
of	age.	Higher	FT4	levels	are	also	associated	with	a	larger	total	brain	volume,	mainly	
attributable	to	white	matter	volume.	However	this	association	was	age-dependent.	In	
older	participants	(over	~70	years	old)	higher	FT4	levels	were	associated	with	a	smaller	
total	brain	volume,	primarily	white	matter.	We	also	found	a	differential	effect	of	age	on	
the	association	of	FT4	with	DTI	measures	that	can	be	linked	to	white	matter	integrity.	
In	older	participants,	higher	FT4	were	associated	with	DTI	measures	reflecting	poorer	
white	matter	 integrity.	 In	 younger	 participants	 (especially	 those	 <50	 years),	 higher	
FT4	levels	were	associated	with	DTI	measures	reflecting	better	white	matter	integrity,	
primarily	lower	MD.	These	findings	could	indicate	an	age-dependent	effect	of	thyroid	
hormone	on	brain	morphology	and	microstructural	organization,	beneficial	in	younger	
                 Thyroid	function	and	white	matter	microstructure  
 
figure 3 DTI	measurements	according	to	FT4	serum	values 
 
 
 
 
Plot	depicting	the	interaction	of	FT4	with	age	for	z-scores	of	A)	fractional	anisotropy,	B)	
mean	diffusivity,	C)	radial	diffusivity	and	D)	axial	diffusivity	.	All	analyses	are	adjusted	for	
age,	 sex,	 cohort,	 time	 between	 laboratory	 measurements	 and	 MRI	 scan,	 intracranial	
volume,	white	matter	and	white	matter	lesion	volume.	 
 
dISCuSSIoN 
 
We	 report	 an	 association	 of	 higher	 FT4	 with	 larger	 intracranial	 volume,	
independent	of	age.	Higher	FT4	levels	are	also	associated	with	a	larger	total	brain	
volume,	mainly	attributable	to	white	matter	volume.	However	this	association	was	
age-dependent.	 In	older	participants	 (over	~70	years	old)	higher	FT4	levels	were	
associated	with	a	smaller	total	brain	volume,	primarily	white	matter.	We	also	found	
figure 2. DTI	measurements	according	to	FT4	serum	values
Plot	depicting	the	interaction	of	FT4	with	age	for	z-scores	of	A)	fractional	anisotropy,	B)	mean	diffusivity,	C)	
radial	diffusivity	and	D)	axial	diffusivity	.	All	analyses	are	adjusted	for	age,	sex,	cohort,	time	between	labora-
tory	meas rements	and	MRI	scan,	intracrani l	volume,	white	matter	and	white	matter	lesion	volume.	
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age	 and	 deleterious	 in	 older	 age.	 To	 our	 knowledge,	 there	 are	 no	 previous	 studies	
assessing	 the	 association	 of	 thyroid	 function	 with	 brain	 volumes	 and	 white	 matter	
microstructure	 in	 the	general	population.	Based	on	our	 results,	we	hypothesize	 that	
the	findings	 in	younger	participants	could	reflect	a	positive	role	of	 thyroid	hormone	
balance	in	myelination,	sustainability	and	protection	of	neurons	during	early	stages	of	
life.	 In	contrast,	 in	older	age,	high	 thyroid	function	could	be	deleterious	by	causing	
neuronal	damage	and	in	turn	neurodegeneration.
Thyroid	hormone	is	 important	for	growth,	development	and	metabolism	in	virtually	
all	organs	and	effects	on	 the	brain	are	numerous.	Fetal	neurogenesis	 is	 thyroid	hor-
mone	dependent	and	both	lack	and	excess	of	thyroid	hormone	availability	can	hamper	
brain	development	and	has	deleterious	effects	on	brain	morphology.1,2,27	In	older	age,	
mainly	 high	 thyroid	 function	 has	 been	 linked	 to	 neurodegeneration	 and	 cognitive	
impairment.6,7,10	Higher	thyroid	hormone	levels	are	related	to	a	higher	basal	metabolic	
rate	and	oxygen	consumption.	 In	 turn,	 this	 can	affect	oxidative	 stress,	 either	due	 to	
increased	reactive	oxygen	species	production	or	lower	activity	of	antioxidants,	poten-
tially	leading	to	oxidative	damage.28,29	These	effects	are	reported	to	be	tissue	specific,	
but	oxidative	damage	may	be	most	pronounced	in	metabolic	active	organs	such	as	the	
brain	possibly	leading	to	negative	effects	on	neuronal	 integrity.29	Free	radical	 injury	
has	been	suggested	to	associate	with	white	matter	changes	on	DTI.30	With	microstruc-
tural	 changes	 thought	 to	accumulate	 to	macrostructural	 tissue	change,	 this	could	be	
one	of	the	pathways	explaining	the	association	of	thyroid	function	with	lower	white	
matter	volume	and	poorer	integrity	in	elderly,	potentially	also	the	previously	described	
relation	with	the	risk	of	dementia.	The	pathophysiology	of	dementia	is	multifactorial,	
but	implication	of	oxidative	stress	has	also	been	proposed.31,32	Alternatively,	a	common	
genetic	predisposition	could	underlie	the	association	of	thyroid	function	with	dementia	
and	white	matter	integrity.
Thyroid	 function	 is	 known	 to	 affect	 several	 cerebrovascular	 risk	 factors.	 However,	
deleterious	cardiovascular	risk	factors,	such	as	dyslipidemia	and	increased	blood	pres-
sure,	 are	mainly	consequences	observed	 in	hypothyroidism.	Furthermore,	we	previ-
ously	described	 lack	of	association	of	 thyroid	function	with	small	vessel	disease	on	
MRI,	including	white	matter	lesions,	lacunar	infarcts	and	cerebral	microbleeds.8	Also,	
adjusting	for	various	cardiovascular	 risk	 factors	 in	 the	current	study	did	not	change	
the	 associations	meaningfully.	This,	 together	with	 the	 current	 results,	 suggests	 that	
the	association	of	 thyroid	 function	with	measures	of	white	matter	microstructure	 in	
elderly	is	independent	of	these	risk	factors	and	mediated	through	other	pathways	(e.g.	
oxidative	stress).	Thyroid	hormone	also	has	distinct	effects	on	myelin	formation	and	
regeneration.33,34	However,	thyroid	hormone	and	thyroid	hormone	repletion	is	mainly	
associated	 with	 acceleration	 of	 myelination	 and	 remyelination	 in	 different	 animal	
studies	and	patient	populations.33-35	This	demonstrates	the	potential	complexity	of	the	
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pathophysiology2	and	more	research	is	needed	to	unravel	the	exact	pathophysiological	
link	between	thyroid	function,	white	matter	microstructure	and	dementia.	Discovery	
of	underlying	pathways	is	not	only	needed	to	understand	the	pathophysiology	of	de-
mentia,	but	also	to	identify	persons	at	risk	and	determine	promising	treatment	targets.
Another	 implication	of	our	study	may	lie	 in	 the	possible	effects	of	overtreatment	of	
hypothyroidism.	In	recent	years,	physicians	have	commenced	levothyroxine	treatment	
in	people	at	lower	serum	TSH	thresholds,	i.e.	milder	cases	of	hypothyroidism.36	It	was	
found	that	in	patients	treated	with	levothyroxine	for	hypothyroidism,	a	substantial	pro-
portion	was	not	within	treatment	target,	with	over	10%	being	overtreated	and	actually	
classifying	as	iatrogenic	hyperthyroidism.36	Our	study	results	suggest	that	endogenous	
high	 FT4	 values	may	 negatively	 affect	 brain	 volume	 and	 brain	 tissue	 in	 older	 age.	
Although	we	have	not	investigated	whether	high	thyroid	function	due	to	levothyroxine	
(i.e.	exogenous	thyroxine)	use	has	comparable	effects	on	brain	volumes	and	DTI	mea-
surements	as	endogenous	thyroid	hormone,	we	speculate	that	this	is	plausible.	Further	
research	is	needed	to	confirm	this	hypothesis.
Strengths	of	our	study	include	the	large	sample	size	and	availability	of	detailed	phe-
notypical	information.	Also,	we	were	able	to	adjust	for	a	wide	variety	of	confounders.	
Nevertheless,	residual	confounding	cannot	be	excluded	in	an	observational	study,	even	
with	adjustments	for	the	large	number	of	potential	confounders	performed	in	our	analy-
ses.	Another	limitation	of	our	study	is	that	thyroid	function	was	measured	only	once,	
which	is	a	limitation	for	most	observational	cohort	studies,	and	therefore	changes	over	
time	could	not	be	assessed.	A	sensitivity	analysis	limited	to	participants	with	thyroid	
function	within	the	reference	range	(n=4141),	which	are	known	to	be	relatively	stable	
over	time,37,38	yielded	similar	results.	Nevertheless,	our	results	need	to	be	confirmed	in	
study	preferably	with	a	longitudinal	design.	Furthermore;	no	conclusions	can	be	drawn	
on	the	causality	of	the	associations	due	to	the	cross-sectional	design.	We	used	averaged	
diffusion	parameters,	aggregated	over	all	 the	normal-appearing	white	matter	voxels.	
This	did	not	allow	us	 to	assess	brain	changes	on	a	more	 regional	 level.	Finally,	 the	
Rotterdam	Study	constitutes	of	mainly	Caucasian	participants	of	45	years	and	older,	so	
our	results	may	be	less	generalizable	to	younger	or	other	ethnic	populations.
Conclusions
In	summary,	our	study	shows	that	higher	FT4	levels	are	associated	with	larger	brain	
volumes	and	higher	white	matter	microstructural	integrity	in	younger	individuals,	but	
not	in	elderly.	Furthermore,	our	results	highlight	the	need	for	caution	in	overtreatment	
in	mild	 hypothyroidism.	Thyroid	 hormone	 excess	 is	 a	 risk	 factor	 for	 dementia	 and	
further	studies	should	evaluate	whether	this	is	indeed	mediated	through	poorer	white	
matter	microstructural	integrity.
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ABStrACt
Mild	 cognitive	 impairment	 (MCI)	 marks	 a	 transitional	 stage	 between	 healthy	 ag-
ing	 and	 dementia,	 but	 the	 understanding	 of	MCI	 in	 the	 general	 population	 remains	
limited.	We	investigated	determinants,	MRI-correlates,	and	prognosis	of	MCI	within	
the	population-based	Rotterdam	Study.	Firstly,	we	studied	age,	APOE-ɛ4	carriership,	
waist	circumference,	hypertension,	diabetes	mellitus,	total	and	HDL-cholesterol	lev-
els,	smoking,	and	stroke	as	potential	determinants	of	MCI.	Determinants	were	assessed	
cross-sectionally	at	baseline	 (2002-2005)	and	up	 to	7	years	prior	 to	baseline	 (1997-
2001).	Secondly,	we	compared	volumetric,	microstructural,	and	focal	MRI-correlates	
in	 persons	 with	 and	 without	 MCI.	 Thirdly,	 we	 followed	 participants	 for	 incident	
dementia	and	mortality	until	2012.	Out	of	4,198	participants,	417	had	MCI,	of	whom	
163	amnestic	and	254	non-amnestic	MCI.	At	baseline,	older	age,	APOE-ɛ4	carriership,	
lower	total	cholesterol	levels,	and	stroke	were	associated	with	MCI.	Additionally,	lower	
HDL-cholesterol	levels	and	smoking	were	related	to	MCI	when	assessed	7	years	prior	
to	baseline.	Persons	with	MCI,	particularly	those	with	non-amnestic	MCI,	had	larger	
white	 matter	 lesion	 volumes,	 worse	 microstructural	 integrity	 of	 normal-appearing	
white	matter,	 and	 a	 higher	 prevalence	 of	 lacunes,	 compared	 to	 cognitively	 healthy	
participants.	MCI	was	associated	with	an	increased	risk	of	dementia	(hazard	ratio	(HR)	
3.98,	 95%	 confidence	 interval	 (CI)	 2.97;5.33),	Alzheimer’s	 disease	 (HR	 4.03,	 95%	
CI	2.92;5.56),	and	mortality	(HR	1.54,	95%	CI	1.28;1.85).	 In	conclusion,	we	found	
that	several	vascular	risk	factors	and	MRI-correlates	of	cerebrovascular	disease	were	
related	to	MCI	in	the	general	population.	Participants	with	MCI	had	an	increased	risk	
of	dementia,	including	Alzheimer’s	disease,	and	mortality.
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INtroduCtIoN
Although	 the	 etiology	 of	 dementia	 is	 largely	 unknown,	 it	 is	 well	 established	 that	
neuropathology	related	to	dementia	slowly	accumulates	over	decades.	Consequently,	
identifying	persons	at	a	higher	risk	of	dementia	could	postpone	or	even	prevent	demen-
tia	by	timely	targeting	modifiable	risk	factors.1	In	this	light,	mild	cognitive	impairment	
(MCI)	has	been	identified	as	the	transitional	stage	between	normal	aging	and	dementia.
Thus	far,	several	studies	have	focused	on	identifying	determinants,	magnetic	resonance	
imaging	(MRI)-correlates,	and	prognosis	of	MCI.	Various	studies	have	established	the	
role	 of	 amyloid	 pathology	 in	MCI,	 but	 emerging	 evidence	 also	 implicates	 vascular	
factors	as	risk	factors	for	MCI.2-4	However,	findings	on	determinants,	MCI-correlates,	
and	 prognosis	 of	MCI	 vary	 greatly	 due	 to	 differences	 in	 study	 populations,	 defini-
tions	of	MCI,	and	determinants	under	investigation.2,	5-11	Studying	MCI	in	the	general	
population	may	strengthen	previous	findings	on	determinants	and	prognosis	of	MCI.	
More	importantly,	clinical	studies	may	suffer	from	referral	bias	and	reverse	causality.	
In	 the	general	population	referral	bias	 is	 less	present	and	investigating	determinants	
years	before	MCI	could	overcome	the	problem	of	reverse	causality.
In	 the	population-based	Rotterdam	Study	we	 investigated	determinants,	MRI-corre-
lates,	and	prognosis	of	MCI.	Firstly,	we	focused	on	several	vascular	risk	factors	that	
were	measured	not	only	cross-sectionally,	but	also	up	to	7	years	prior	to	diagnosis	of	
MCI.	Secondly,	we	investigated	the	relation	between	MCI	and	volumetric,	microstruc-
tural,	and	focal	imaging	markers.	Thirdly,	we	followed	participants	over	a	period	of	9	
years	to	determine	the	risk	of	incident	dementia,	Alzheimer’s	disease,	and	mortality.
MethodS
Setting and study population
The	Rotterdam	Study	 is	a	prospective	population-based	cohort	 that	 started	 in	1990.	
Inhabitants,	aged	55	years	and	older,	of	Ommoord,	a	district	of	Rotterdam,	the	Nether-
lands	were	invited	to	participate	in	the	study.12	Out	of	10,215	invited	inhabitants,	7,983	
(78%)	agreed	to	participate.	In	2000,	this	cohort	was	extended	with	3,011	participants	
(67%	 of	 invitees)	who	 had	 become	 55	 years	 of	 age	 or	 had	moved	 into	 the	 district	
since	the	start	of	the	study.	Every	4	years,	participants	are	re-invited	to	undergo	home	
interviews	and	various	examinations	at	the	research	center.12
Between	2002-2005,	which	was	the	fourth	examination	round	of	the	original	cohort	and	
the	second	examination	round	of	the	extended	cohort,	an	extensive	neuropsychological	
test	battery	was	implemented	in	the	Rotterdam	Study.12	Given	that	extensive	neuropsy-
chological	testing	is	required	to	assess	MCI,	2002-2005	was	set	as	baseline	for	MCI	
screening	in	our	study.	Of	the	6,061	study	participants	 that	underwent	examinations	
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between	2002-2005,	192	participants	were	excluded	because	they	were	demented,	67	
because	they	were	not	sufficiently	screened	for	dementia,	and	another	250	participants	
because	they	did	not	answer	the	questions	regarding	subjective	cognitive	complaints.	
An	additional	1,354	participants	were	excluded	because	they	missed	one	or	more	cog-
nitive	test	scores	or	had	unreliable	test	scores.	Eventually,	4,198	persons	were	eligible	
to	participate	in	this	study.	Because	MRI	was	implemented	from	2005	onwards,13	only	
a	random	subset	of	697	out	of	4,198	persons	underwent	MRI,	which	was	on	average	
1.01	years	(0.46	standard	deviation	(SD))	after	MCI	screening.	Persons	with	cortical	
infarcts	were	excluded	(N=15)	as	tissue	loss	and	gliosis	surrounding	cortical	infarcts	
may	cause	unreliable	white	matter	lesion	segmentations.	Eventually,	682	participants	
were	included	in	the	analyses	of	MRI-correlates.
determinants of MCI and other measurements
Determinants	of	MCI	were	selected	based	on	biological	plausibility	and	literature	on	
established	risk	factors	of	dementia.14-18	Educational	level	was	assessed	at	study	entry	
by	 interview	and	categorized	 into	 seven	groups:	primary	education	only	or	primary	
education	 with	 an	 unfinished	 higher	 education,	 lower	 vocational	 education,	 lower	
secondary	education,	intermediate	vocational	education,	general	secondary	education,	
higher	vocational	education,	and	university.	Since	educational	level	was	required	for	
assessment	 of	 the	MCI	diagnosis,	we	 imputed	missing	values	 for	 education	 (1.8%)	
based	on	age	and	sex.
Information	 on	 APOE	 genotype	 was	 obtained	 using	 polymerase	 chain	 reaction	 on	
coded	 DNA	 samples	 without	 knowledge	 of	MCI	 diagnosis.	 This	 method	 has	 been	
described	 in	 detail	 previously.19,	 20 APOE-ε4	 carrier	 status	was	 defined	 as	 carrier	 of	
one	or	two	ε4	alleles.	Waist	circumference	was	measured	in	centimeters	at	the	level	
midway	between	the	lower	rib	margin	and	the	iliac	crest,	with	participants	in	standing	
position	without	heavy	outer	garments	and	with	emptied	pockets	while	breathing	out	
gently.	Blood	pressure	was	measured	 in	sitting	position	on	 the	 right	arm	and	calcu-
lated	as	the	average	of	two	measurements	using	a	random-zero	sphygmomanometer.	
Hypertension	was	defined	as	a	blood	pressure	≥140/90	mmHg	or	use	of	blood	pressure	
lowering	medication,	prescribed	for	the	indication	of	hypertension.	Diabetes	mellitus	
was	defined	as	a	fasting	serum	glucose	level	≥7.0	mmol/L,	non-fasting	serum	glucose	
level	≥11.1	mmol/L,	or	use	of	anti-diabetic	medication.	Serum	glucose,	total	choles-
terol,	and	HDL-cholesterol	levels	were	acquired	by	an	automated	enzymatic	procedure	
(Boehringer	Mannheim	System).	Smoking	habits	were	assessed	by	interview	and	cat-
egorized	as	current,	former,	and	never	smoking.	At	study	entry,	history	of	stroke	was	
assessed	using	home	 interviews	and	confirmed	by	 reviewing	medical	 records.	After	
entering	the	Rotterdam	Study,	participants	were	continuously	followed-up	for	stroke	
through	 automatic	 linkage	of	 general	 practitioner	files	with	 the	 study	database.	For	
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potential	strokes,	additional	 information	was	collected	from	hospital,	nursing	home,	
and	general	practitioner	records.	An	experienced	neurologist	adjudicated	the	strokes	
using	standardized	definitions,	as	described	in	detail	previously.21
Apart	from	educational	level	and	APOE-ε4	carrier	status,	all	measurements	were	as-
sessed	at	each	examination	round	of	the	Rotterdam	Study.	We	used	the	measurements	
that	were	assessed	at	the	baseline	of	this	study	(2002-2005),	and	the	measurements	that	
were	assessed	at	the	previous	examination	round,	which	was	up	to	7	years	(mean	4.4	
years,	SD	0.55)	prior	to	baseline	(1997-2001)	(Supplementary figure 1).
Assessment of MCI
MCI	was	defined	using	the	following	criteria:	1)	presence	of	subjective	cognitive	com-
plaints,	2)	presence	of	objective	cognitive	impairment,	and	3)	absence	of	dementia.
Subjective	cognitive	complaints	were	evaluated	by	interview.	This	interview	included	
three	questions	on	memory	(difficulty	remembering,	forgetting	what	one	had	planned	
to	do,	and	difficulty	finding	words),	and	three	questions	on	everyday	functioning	(dif-
ficulty	managing	finances,	problems	using	a	telephone,	and	difficulty	getting	dressed).	
Subjective	cognitive	complaints	were	scored	positive	when	a	subject	answered	“yes”	
to	at	least	one	of	these	questions.	We	assessed	objective	cognitive	impairment	using	a	
cognitive	test	battery	comprising	letter-digit	substitution	task,	Stroop	test,	verbal	flu-
ency	test,	and	15-word	verbal	learning	test	based	on	Rey’s	recall	of	words.22	To	obtain	
more	robust	measures,	we	constructed	compound	scores	for	various	cognitive	domains	
including	memory	function,	information-processing	speed,	and	executive	function.22,	23 
Briefly,	 compound	 score	 for	memory	was	 calculated	 as	 the	 average	of	Z-scores	 for	
the	immediate	and	delayed	recall	of	the	15-word	verbal	learning	test.	For	information	
processing	speed	averaged	Z-scores	for	the	Stroop	reading	and	Stroop	colour-naming	
subtask	 and	 the	 letter-digit	 substitution	 task	were	 used.	 Finally,	 executive	 function	
included	Z-scores	of	the	Stroop	interference	subtask,	the	letter-digit	substitution	task,	
and	the	verbal	fluency	test.	We	classified	persons	as	cognitively	impaired	if	they	scored	
below	1.5	SD	of	 the	age	and	education	adjusted	means	of	 the	study	population.	We	
subsequently	classified	the	MCI	subtypes	amnestic	and	non-amnestic	MCI.	Amnestic	
MCI	was	defined	as	persons	with	MCI	who	had	an	 impaired	 test	 score	on	memory	
function	(irrespective	of	other	domains).	Non-amnestic	MCI	was	defined	as	persons	
with	MCI	having	normal	memory	function,	but	an	 impaired	 test	 score	on	executive	
function	or	information-processing	speed.
Brain MrI and post-processing
We	performed	a	multisequence	MRI	protocol	on	a	1.5-Tesla	scanner	(GE	Healthcare).	
The	sequences	in	the	imaging	protocol	consisted	of	three	high	resolution	axial	scans,	
i.e.,	a	T1-weighted	sequence	(slice	 thickness	1.6	mm,	zero-padded	 to	0.8),	a	proton	
Chapter	3.1
122
density-weighted	sequence	(slice	thickness	1.6	mm),	and	a	fluid-attenuated	inversion	
recovery	(FLAIR)	sequence	(slice	thickness	2.5	mm).13	For	cerebral	microbleed	detec-
tion,	we	used	a	custom-made	accelerated	three-dimensional	T2*-weighted	gradient-re-
called	echo	(3D	T2*	GRE	(slice	thickness	1.6	mm,	zero-padded	to	0.8).24	For	diffusion	
tensor	 imaging	scans	we	used	a	2D	acquisition	and	EPI	readout	 (slice	 thickness	for	
DTI	was	3.5	mm).	Maximum	b-value	was	1000	s/mm2	in	25	non-collinear	directions	
(number	 of	 excitations	 (NEX)=1)	 and	 one	 volume	 was	 acquired	 without	 diffusion	
weighting	(b-value=	0	s/mm2).
We	used	an	automated	tissue	segmentation,	including	conventional	k-nearest-neighbor	
brain	 tissue	 classifier	 extended	with	white	matter	 lesion	 (WML)	 segmentation,25	 to	
segment	scans	into	grey	matter	volume,	white	matter	volume,	WML	volume,	cerebro-
spinal	fluid,	and	background.	Total	brain	volume	was	defined	as	the	sum	of	total	grey	
matter	volume,	white	matter	volume,	 and	WML	volume.	Hippocampal	volume	was	
determined	using	an	automated	method,	as	described	extensively	before.26
The	segmentation	was	brought	to	the	DTI	image	space	using	boundary	based	registra-
tion	performed	on	the	white	matter	segmentation,27	the	b=0	and	T1-weighted	images.
Diffusion	data	was	pre-processed	using	a	standardized	processing	pipeline.28	In	short,	
DTI	data	was	corrected	for	subject	motion	and	eddy	currents	by	affine	co-registration	
of	the	diffusion	weighted	volumes	to	the	b=0	volume,	including	correction	of	gradi-
ent	vector	directions.	Diffusion	tensors	were	estimated	using	a	non-linear	Levenberg	
Marquadt	estimator,	available	in	ExploreDTI.29	Global	fractional	anisotropy	(FA)	and	
mean	 diffusivity	 (MD),	measures	 of	microstructural	 integrity,	were	 computed	 from	
the	 estimated	 tensor	 images	 over	 the	 entire	 normal-appearing	white	matter	 in	 each	
subject.	The	final	registration	result	of	each	scan	was	checked	visually	for	errors.30,	31 
Partial	volume	effects	and	presence	of	multiple	white	matter	fibre	orientation	within	a	
voxel	were	thus	minimized.	Sixteen	subjects	had	to	be	excluded	from	the	white	matter	
microstructural	 integrity	analyses	due	 to	 scanning	artifacts	or	 excessive	motion.	FA	
and	MD	were	standardized	to	echo	time	(TE)	values,	because	TE	was	not	constant	for	
all	participants.
All	scans	were	rated	by	1	of	5	 trained	research-physicians	 to	determine	presence	of	
microbleeds	 and	 lacunes	 of	 presumed	 vascular	 origin.32	Microbleeds	were	 rated	 as	
focal	areas	of	signal	loss,	on	3D	T2*	Gradient	Recalled	Echo-weighted	MR	imaging.	
Lacunes	were	rated	on	FLAIR,	proton-density-weighted	and	T1-weighted	sequences,	
and	were	 defined	 as	 focal	 lesions	 ≥3mm	and	<15mm	 in	 size,	with	 the	 same	 signal	
intensity	as	cerebrospinal	fluid	on	all	sequences	and	a	hyperintense	rim	on	the	FLAIR	
(when	located	supratentorially).33	Infarcts	showing	involvement	of	grey	matter	were	
classified	as	cortical	infarcts.
123
Determinants,	MRI	correlates,	and	prognosis	of	mild	cognitive	impairment:	The	Rotterdam	Study
Assessment of dementia
Participants	were	screened	for	dementia	at	baseline	and	at	follow-up	examinations	us-
ing	a	three-step	protocol.	Screening	was	done	using	the	Mini-Mental	State	Examination	
(MMSE)	and	the	Geriatric	Mental	Schedule	(GMS)	organic	level.34,	35	Screen-positives	
(MMSE	<26	or	GMS	organic	level	>0)	subsequently	underwent	an	examination	and	
informant	 interview	 with	 the	 Cambridge	 Examination	 for	 Mental	 Disorders	 in	 the	
Elderly	 (CAMDEX).36	During	 this	 interview,	more	 information	on	 functional	 status	
and	cognitive	performance	was	collected.	Participants	who	were	suspected	of	having	
dementia	 underwent	 extra	 neuropsychological	 testing	 if	 necessary.	Additionally,	 for	
persons	not	visiting	the	research	center,	the	total	cohort	was	continuously	monitored	
for	dementia	through	computerized	linkage	of	the	study	database	and	digitized	medical	
records	 from	general	 practitioners	 and	 the	Regional	 Institute	 for	Outpatient	Mental	
Health	Care.	When	information	on	neuroimaging	was	required	and	available,	 it	was	
used	 for	decision	making	on	 the	diagnosis.	 In	 the	 end,	 a	 consensus	panel,	 led	by	 a	
neurologist,	 decided	 on	 the	 final	 diagnosis	 in	 accordance	with	 standard	 criteria	 for	
dementia	 (Diagnostic	 and	 Statistical	 Manual	 of	 Mental	 Disorders,	 Third	 Edition,	
Revised	 (DSM-III-R))	 and	Alzheimer’s	Disease	 (National	 Institute	 of	Neurological	
and	Communicative	Diseases	and	Stroke/Alzheimer’s	Disease	and	Related	Disorders	
Association	(NINCDS-ADRDA)).37,	38	Follow-up	for	incident	dementia	was	complete	
until	January	1st,	2012.
Assessment of mortality
Deaths	were	continuously	reported	through	automatic	linkage	with	general	practitioner	
files.	In	addition,	municipal	health	records	were	checked	bimonthly	for	information	on	
vital	 status.	 Information	about	cause	and	circumstances	of	death	was	obtained	from	
general	practitioner	and	hospital	records.39	Follow-up	for	mortality	was	complete	until	
January	1st,	2012.
Statistical analysis
Firstly,	we	examined	whether	risk	factors	of	dementia	were	related	to	MCI	using	mul-
tivariate	logistic	regression	models	adjusted	for	age	and	sex	cross-sectionally.	Since	
vascular	 risk	 factors	 often	 correlate,17	 we	 estimated	 the	 independent	 effect	 of	 each	
risk	 factor	by	 including	all	 risk	 factors	 into	 the	 same	model.	Age	was	 included	per	
5	 year	 increase	 into	 the	model	 and	waist	 circumference,	 total	 and	HDL-cholesterol	
levels	were	included	per	SD	increase	into	the	model.	Persons	with	missing	values	were	
excluded	from	these	analyses.	We	investigated	whether	excluded	persons	had	different	
characteristics	than	persons	who	were	included	in	the	analysis	using	Univariate	Analy-
sis	of	Variance,	adjusting	for	age	and	sex	where	appropriate.	The	same	models	as	in	the	
cross-sectional	analysis	were	used	to	examine	the	relation	with	risk	factors	assessed	
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up	to	7	years	prior	to	MCI	diagnosis.	Secondly,	we	used	linear	and	logistic	regression	
to	 investigate	 the	relation	of	MCI	with	volumetric	markers	(i.e.,	 total	brain	volume,	
hippocampal	 volume,	WML	 volume),	 microstructural	 integrity	 markers	 (i.e.,	 mean	
FA,	MD)	and	focal	markers	(i.e,	cerebral	microbleeds,	lacunes)	of	brain	pathology	on	
MRI	cross-sectionally.	Hippocampal	volume	was	studied	as	the	mean	of	the	left	and	
right	hippocampal	volume.	WML	was	log-transformed	due	to	the	skewed	distribution.	
Volumetric	 and	 microstructural	 measures	 were	 modeled	 continuously.	 Microbleeds	
and	 lacunes	 were	 dichotomized	 into	 present	 versus	 absent.	 These	 analyses	 were	
adjusted	for	age	and	sex	(model	1),	and	additionally	for	APOE-ɛ4	carriership,	waist	
circumference,	hypertension,	diabetes	mellitus,	total	and	HDL-cholesterol	levels,	and	
smoking	(model	2).	In	model	2	we	investigated	whether	irrespective	of	the	presence	
of	vascular	risk	factors,	persons	with	MCI	had	more	volumetric,	microstructural,	and	
focal	changes	in	the	brain	compared	to	cognitively	healthy	participants.	Analyses	of	
volumetric	and	microstructural	integrity	measures	were	also	adjusted	for	intracranial	
volume.	 In	 addition	we	performed	 a	 sensitivity	 analysis	 for	 the	 imaging	 correlates,	
excluding	participants	who	became	demented	 in	 the	period	between	MCI	screening	
and	MRI	 scanning	 (N=12).	Thirdly,	we	used	Cox	proportional	hazards	 to	 study	 the	
association	 between	MCI	 and	 risk	 of	 dementia,	Alzheimer’s	 disease,	 and	mortality	
longitudinally.	These	models	were	 adjusted	 for	 the	 same	 determinants	 as	 described	
in	model	2	but	with	addition	of	prevalent	stroke	and	educational	 level.	All	analyses	
were	repeated	investigating	the	amnestic	and	non-amnestic	MCI	subtypes	separately.	
Analyses	 were	 performed	 using	 statistical	 software	 package	 SPSS	 20.0,	 using	 an	
α-value	of	0.05.
reSuLtS
Characteristics	of	the	study	population	are	presented	in	table 1.	Out	of	4,198	partici-
pants,	417	(9.9%)	had	MCI.	Of	these,	163	had	amnestic	MCI	and	254	had	non-amnestic	
MCI.	Missing	 values	 for	 determinants	 of	MCI	 occurred	 in	 268	 participants	 (6.4%)	
in	2002-2005	 (baseline)	 and	 in	615	participants	 (14.6%)	 in	1997-2001.	Participants	
excluded	 from	 the	 baseline	 analyses	 were	 more	 often	 female,	 suffered	 more	 from	
hypertension,	and	had	a	larger	waist	circumference	than	participants	included	in	the	
analyses.	Participants	excluded	due	to	missing	data	in	1997-2001	were	also	more	often	
female	and	more	often	hypertensive	but	had	lower	cholesterol	levels	than	participants	
included	in	our	analyses	(Supplementary table 1).
At	baseline,	older	age	(odds	ratio	(OR)	per	5	year	increase	in	age	1.20,	95%	confidence	
interval	 (CI)	 1.11;1.29),	APOE-ε4	 carriership	 (OR	 1.26,	 95%	CI	 1.00;1.59),	 lower	
total	cholesterol	 levels	 (OR	0.87,	95%	CI	0.78;0.98),	and	stroke	 (OR	2.12,	95%	CI	
1.40;3.19)	were	independently	related	to	MCI	(table 2).	Male	gender	and	APOE-ε4	
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carriership	 were	 only	 related	 to	 amnestic	MCI,	 whereas	 older	 age	 and	 lower	 total	
cholesterol	levels	were	only	related	to	non-amnestic	MCI.
Older	age	(OR	per	5	year	increase	in	age	1.18,	95%	CI	1.11;1.29),	APOE-ε4	carrier-
ship	(OR	1.35,	95%	CI	1.06;1.72),	lower	HDL-cholesterol	levels	(OR	0.86,	95%	CI	
0.75;0.98),	current	smoking	(OR	1.49,	95%	CI	1.06;2.09)	and	prevalent	stroke	(OR	
2.50,	95%	CI	1.48;4.23)	were	related	to	MCI	when	assessed	up	to	7	years	(mean	4.4	
years,	SD	0.55)	prior	to	MCI	diagnosis	(table 3).	APOE-ε4	carriership	and	former	and	
current	 smoking	were	 related	 to	amnestic	MCI,	whereas	older	age	and	 lower	HDL-
cholesterol	levels	were	related	to	non-amnestic	MCI.
Out	 of	 682	 participants	with	MRI	 scanning,	 49	 screened	 positive	 for	MCI.	 Partici-
pants	with	MCI,	particularly	those	with	non-amnestic	MCI,	had	larger	WML	volumes	
compared	 to	 cognitively	 healthy	 participants	 (mean	 difference	 in	 log-transformed	
WML	 volume:	 0.36,	 95%	CI	 0.05;0.68).	 Persons	with	 non-amnestic	MCI	 also	 had	
worse	microstructural	 integrity	 of	 normal-appearing	white	matter	 after	 adjustments	
for	cardiovascular	risk	(mean	difference	in	mean	FA:	-0.007,	95%	CI	-0.014;-0.001,	
mean	difference	in	mean	MD:	0.013,	95%	CI	0.001;0.024)	(table 4,	model	II).	As	for	
focal	markers	of	vascular	brain	pathology,	microbleeds	were	more	frequent	in	persons	
with	MCI,	however	this	association	was	not	significant.	Lacunes	however,	were	more	
frequent	in	participants	with	MCI,	again	particularly	in	those	with	non-amnestic	MCI	
(age	and	sex	adjusted	OR	3.16,	95%	CI	0.98;10.19)	(table 4).	MRI	scanning	was	per-
formed	on	average	1.0	years	(SD	0.46)	after	MCI	screening.	During	this	time-interval,	
12	 of	 682	 participants	who	 underwent	MRI	were	 diagnosed	with	 dementia.	Out	 of	
these,	6	were	initially	screened	as	having	MCI.	Excluding	participants	with	dementia	
at	time	of	MRI	scanning	did	not	change	our	results	(data	not	shown).
During	24,934	person-years	of	follow-up,	215	participants	developed	incident	demen-
tia,	 of	whom	177	had	Alzheimer’s	disease.	During	29,096	persons-years	of	 follow-
up,	827	persons	died.	Participants	with	MCI	had	an	increased	risk	of	dementia	(age	
and	 sex	 adjusted	hazard	 ratio	 (HR)	3.98,	 95%	CI	2.97;5.33)	 (table 5).	The	 risk	of	
dementia	was	especially	increased	in	persons	with	amnestic	MCI	(HR	6.89,	95%	CI	
4.74;10.01),	but	was	also	increased	in	persons	with	non-amnestic	MCI	(HR	2.65,	95%	
CI	1.79;3.92).	Results	were	similar	for	Alzheimer’s	disease.	We	found	that	participants	
with	MCI	also	had	an	increased	risk	of	mortality	(HR	1.54,	95%	CI	1.28;1.85)	(table 
5).	These	results	did	not	change	across	MCI-subtypes	and	additional	adjustments	did	
not	change	our	results.
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table 1. Characteristics	of	the	study	population
examinations at baseline
2002-2005
examinations before baseline
1997-2001
No MCI
N=3,781
MCI
N=417
No MCIa
N=3,730
MCIa
N=401
Age,	years 71.5	(7.1) 73.5	(7.5) 67.1	(7.0) 68.9	(7.4)
Females 58.2% 52.0% 58.1% 51.1%
APOE-ε4	carrier 26.2% 29.7% 26.2% 30.8%
Educational	level
			Primary	education 16.8% 24.8% 16.4% 23.8%
			Lower	vocational	education 20.2% 22.4% 20.3% 22.5%
			Lower	secondary	education 17.5% 9.2% 17.6% 9.4%
			Intermediate	vocational		education 26.7% 28.2% 26.8% 28.6%
			General	secondary	education 4.6% 1.9% 4.7% 2.0%
			Higher	vocational	education 12.7% 11.4% 12.7% 11.6%
			University 1.6% 1.9% 1.6% 2.0%
Waist	circumference,	cm 93.4	(11.8) 94.6	(12.4) 93.0	(11.5) 94.1	(11.9)
Hypertension 80.6% 83.0% 65.2% 70.9%
Diabetes	mellitus 14.1% 19.2% 8.3% 9.6%
Cholesterol,	mmol/l 5.65	(1.00) 5.43	(0.96) 5.84	(0.97) 5.75	(0.90)
HDL-cholesterol,	mmol/l 1.46	(0.40) 1.41	(0.40) 1.40	(0.39) 1.32	(0.36)
Smoking
			Former 55.1% 55.6% 50.4% 50.6%
			Current 15.1% 17.5% 19.0% 23.4%
Stroke 3.4% 8.2% 2.0% 5.0%
MRI	imaging	markersb
			Total	brain	volume,	ml
			Hippocampal	volume,	ml
			White	matter	lesions,	ml
			Fractional	anisotropy
			Mean	diffusivity,	10-3 mm2/sec
			Cerebral	microbleeds
			Lacunes
923.9	(89.6)
3.0	(0.3)
3.5	(2.0-6.5)
0.35	(0.02)
0.77	(0.05)
20.9%
5.7%
906.3	(119.9)
3.0	(0.4)
4.5	(2.6-12.4)
0.34	(0.02)
0.79	(0.05)
28.6%
16.3%
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
aMCI	as	assessed	at	baseline	(2002-2005)	bMR	imaging	was	performed	in	a	randomly	selected	subset	(N=682).
Continuous	variables	are	presented	as	means	(standard	deviations)	and	categorical	variables	as	percentages.	
White	matter	lesions	are	presented	as	median	(interquartile	range).
Abbreviations:	 MCI=mild	 cognitive	 impairment,	 N=number	 of	 participants,	 APOE=apolipoprotein	 E,	
HDL=high-density	lipoprotein.	
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table 2. Associations	between	risk	factors	of	dementia	and	MCI	at	baseline	(cross-sectional).
MCI Amnestic MCI Non-amnestic MCI
Odds ratio (95% CI)
n/N 389/3,541
Odds ratio (95% CI)
n/N 154/3,541
Odds ratio (95% CI)
n/N 235/3,541
Age,	per	5	years 1.20	(1.11;1.29) 1.04	(0.92;1.17) 1.30	(1.19;1.43)
Females 0.91	(0.70;1.17) 0.66	(0.45;0.98) 1.11	(0.80;1.54)
APOE-ε4	carrier 1.26	(1.00;1.59) 1.43	(1.01;2.02) 1.17	(0.86;1.58)
Waist	circumference,	per	SD 1.04	(0.92;1.18) 1.03	(0.84;1.25) 1.05	(0.90;1.24)
Hypertension 0.94	(0.70;1.25) 1.03	(0.66;1.59) 0.88	(0.61;1.28)
Diabetes	mellitus 1.24	(0.93;1.65) 1.44	(0.94;2.20) 1.11	(0.77;1.59)
Cholesterol,	per	SD 0.87	(0.78;0.98) 0.94	(0.79;1.11) 0.84	(0.73;0.97)
HDL-cholesterol,	per	SD 0.94	(0.83;1.06) 1.02	(0.84;1.23) 0.88	(0.75;1.04)
Smoking
			Former 0.96	(0.74;1.25) 1.08	(0.71;1.66) 0.90	(0.65;1.25)
			Current 1.21	(0.86;1.70) 1.37	(0.81;2.31) 1.13	(0.73;1.74)
Stroke 2.12	(1.40;3.19) 2.68	(1.51;4.76) 1.78	(1.04;3.03)
Values	represent	odds	ratios	and	95%	confidence	intervals,	adjusted	for	all	other	risk	factors.	
Abbreviations: MCI=mild cognitive impairment, CI=confidence interval, n=number of cases, N=number of 
controls, APOE=apolipoprotein E, SD=standard deviation, HDL=high-density lipoprotein.
table 3. Associations	between	risk	factors	of	dementia,	assessed	7	years	prior,	and	MCI.
MCI Amnestic MCI Non-amnestic MCI
Odds ratio (95% CI)
n/N 348/3,235
Odds ratio (95% CI)
n/N 140/3,235
Odds ratio (95% CI)
n/N 208/3,235
Age,	per	5	years 1.18	(1.11;1.29) 1.08	(0.95;1.23) 1.25	(1.13;1.38)
Females 0.93	(0.71;1.21) 0.75	(0.50;1.11) 1.08	(0.77;1.51)
APOE-ε4	carrier 1.35	(1.06;1.72) 1.54	(1.08;2.22) 1.23	(0.90;1.69)
Waist	circumference,	per	SD 1.02	(0.90;1.16) 1.02	(0.84;1.24) 1.03	(0.87;1.21)
Hypertension 1.17	(0.90;1.52) 1.00	(0.68;1.45) 1.33	(0.94;1.87)
Diabetes	mellitus 1.05	(0.72;1.54) 0.87	(0.46;1.62) 1.16	(0.73;1.84)
Total	cholesterol,	per	SD 0.95	(0.85;1.07) 0.94	(0.78;1.12) 0.96	(0.83;1.11)
HDL-cholesterol,	per	SD 0.86	(0.75;0.98) 0.95	(0.78;1.16) 0.80	(0.67;0.95)
Smoking
			Former 1.12	(0.84;1.49) 1.66	(1.01;2.73) 0.92	(0.65;1.31)
			Current 1.49	(1.06;2.09) 2.45	(1.41;4.24) 1.12	(0.73;1.73)
Stroke 2.50	(1.48;4.23) 2.91	(1.40;6.06) 2.22	(1.14;4.33)
Values	 represent	odds	 ratios	and	95%	confidence	 intervals,	adjusted	 for	all	other	 risk	 factors	and	addition-
ally	 for	 time	 between	measurements	 and	MCI	 diagnosis.	Abbreviations: MCI=mild cognitive impairment, 
CI=confidence interval, n=number of cases, N=number of controls, APOE=apolipoprotein E, SD=standard 
deviation, HDL=high-density lipoprotein.
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table 5. Associations	between	MCI	and	risk	of	dementia,	Alzheimer’s	disease,	and	mortality	(longitudinal)
dementia Alzheimer’s disease Mortality
n/N Hazard ratio 
(95% CI)
n/N Hazard ratio 
(95% CI)
n/N Hazard ratio 
(95% CI)
Model I
No	MCI 149/3,781 	Reference 122/3,781 Reference 695/3,781 Reference
MCI 66/417 3.98	(2.97;5.33) 55/417 4.03	(2.92;5.56)	 132/417 1.54	(1.28;1.85)
			Amnestic	MCI 35/163 6.89	(4.74;10.01) 29/163 7.21	(4.77;10.89) 50/163 1.74	(1.30;2.31)
			Non-amnestic	MCI 31/254 2.65	(1.79;3.92) 26/254 2.69	(1.75;4.12) 82/254 1.44	(1.14;1.81)
Model II
No	MCI 140/3,541 Reference 114/3,541 Reference 653/3,541 Reference
MCI 59/389 3.70	(2.70;5.05) 49/389 3.75	(2.66;5.30) 123/389 1.48	(1.22;1.80)
			Amnestic	MCI	 33/154 6.76	(4.55;10.03) 27/154 7.20	(4.64;11.18) 46/154 1.58	(1.17;2.14)
			Non-amnestic	MCI 26/235 2.30	(1.50;3.54) 22/235 2.38	(1.49;3.80) 77/235 1.41	(1.12;1.80)
Model	I:	adjusted	for	age	and	sex.	Model	II:	adjusted	for	age,	sex,	apolipoprotein E-ɛ4	carriership,	waist	cir-
cumference,	hypertension,	diabetes	mellitus,	total	and	high-density	lipoprotein	cholesterol,	smoking,	stroke,	
and	educational	level.	Values	represent	hazard	ratios	and	95%	confidence	intervals.
Abbreviations: n=number of cases, N=number of persons at risk, CI=confidence interval, MCI=mild cognitive 
impairment.
dISCuSSIoN
We	 found	 that	 in	 the	 general	 population,	 older	 age,	 APOE-ε4	 carriership,	 lower	
total	cholesterol	levels,	and	prevalent	stroke	were	associated	with	MCI.	Lower	HDL-
cholesterol	 levels	 and	current	 smoking	were	only	 related	 to	MCI	when	assessed	up	
to	 7	 years	 prior	 to	 MCI	 screening.	 Compared	 to	 cognitively	 healthy	 participants,	
participants	with	MCI	had	 larger	WML	volumes,	worse	microstructural	 integrity	of	
normal-appearing	white	matter,	and	a	higher	frequency	of	lacunes.	MCI	was	associ-
ated	with	an	increased	risk	of	dementia,	Alzheimer’s	disease,	and	mortality.	
Major	strengths	of	our	study	are	its	population-based	setting,	large	sample	size,	and	
extensive	data	collection.	Some	limitations	of	our	study	need	to	be	considered.	Firstly,	
the	 extensive	 neuropsychological	 test	 battery	 required	 for	 the	 MCI	 diagnosis	 was	
implemented	in	2002-2005	(baseline),	and	therefore	we	were	not	able	to	assess	MCI	
status	on	the	examination	rounds	prior	to	baseline.	Therefore,	it	is	possible	that	some	
persons	may	already	have	had	MCI	at	the	previous	examination	round.	Secondly,	the	
cross-sectional	 setting	 in	 the	 analyses	 of	 risk	 factors	 prevented	 inferring	 causality.	
However,	 the	 extensive	 data	 collection	 enabled	 us	 to	 investigate	 determinants	 both	
cross-sectionally	at	baseline	and	7	years	prior	to	baseline,	overcoming	reverse	causal-
ity	in	our	study.	Thirdly,	we	did	not	measure	visuospatial	ability,	and	could	therefore	
not	include	this	component	in	our	diagnostic	criteria	for	MCI.	Finally,	MRI	scanning	
was	 performed	 on	 average	 1.01	 years	 (SD	0.46)	 later	 than	 the	 initial	 screening	 for	
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MCI,	and	misclassification	of	participants	may	be	present.	Nonetheless,	90%	of	our	
study	participants	underwent	MRI	within	1.5	years	of	MCI	screening,	and	if	present	
this	non-differential	misclassification	would	have	led	to	an	underestimation	of	the	true	
association.	Also,	we	repeated	 the	analyses	after	excluding	 incident	dementia	cases,	
and	found	that	results	did	not	change	materially.	We	found	that	some	determinants	of	
MCI	differed	over	time.	Lower	HDL-cholesterol	levels	and	current	smoking	were	only	
related	to	MCI	when	assessed	up	to	7	years	prior	to	MCI	screening.	There	is	a	possibil-
ity	that	persons	with	a	declining	cognitive	ability	change	their	daily	habits,	including	
dietary	and	smoking	habits,	which	could	result	in	reverse	causality	in	cross-sectional	
analysis.	Another	explanation	is	that	these	associations	indeed	differ	over	time,	as	has	
been	shown	for	several	risk	factors	for	dementia.4,	40 
In	line	with	previous	clinical	and	population-based	studies,	we	found	that	people	with	
MCI	had	larger	WML	volumes,	worse	microstructural	integrity	of	normal-appearing	
white	 matter,	 and	 a	 higher	 prevalence	 of	 lacunes	 compared	 to	 cognitively	 healthy	
participants.23,	41-43	As	regional	measurements	of	DTI	were	not	available	in	our	study,	
we	examined	DTI	measures	averaged	over	the	entire	normal	appearing	white	matter.	
For	 future	 investigations	 however,	 it	 would	 be	 interesting	 to	 study	 regional	 differ-
ences	in	FA	and	MD.	MCI	was	not	associated	with	total	brain	volume,	hippocampal	
volume,	 and	 cerebral	microbleeds.	These	 imaging	markers	 have	 been	 implicated	 in	
persons	with	MCI	before,44-49	 but	 relatively	 small	 sample	 size	hampered	our	 ability	
to	 investigate	 these	 associations	more	 thoroughly.	Also,	 smaller	 total	 brain	volume,	
hippocampal	 volume	 and	microbleeds	may	mark	more	downstream	neuropathology	
and	as	such	would	be	a	better	marker	for	clinical	dementia	rather	than	the	transitional	
stage	of	MCI.50
Participants	 with	MCI	 had	 an	 increased	 risk	 of	 dementia	 and	 an	 increased	 risk	 of	
mortality,	 independently	of	 several	 risk	 factors	of	dementia.	Because	of	 this	poorer	
prognosis,	our	findings	underline	the	importance	of	identifying	persons	with	MCI.
It	 is	hypothesized	that	different	subtypes	of	dementia	are	preceded	by	different	sub-
types	of	MCI.	Amnestic	MCI	is	supposed	to	especially	increase	the	risk	of	Alzheimer’s	
disease,	whereas	non-amnestic	MCI	more	likely	increases	the	risk	of	vascular	demen-
tia	 and	 other	 dementia	 subtypes,	 such	 as	 Lewy	 body	 dementia	 and	 frontotemporal	
dementia.51,	52	This	would	suggest	 that	determinants	might	also	differ	per	subtype	of	
MCI.	However,	our	findings	propose	that	this	distinction	is	not	as	unambiguous.	On	
the	one	hand,	we	found	that	there	are	indeed	some	differences	in	determinants	for	am-
nestic	and	non-amnestic	subtypes;	e.g.	APOE-ε4	carriership	and	smoking	were	related	
to	amnestic	MCI	only	and	MRI-correlates	of	vascular	damage,	such	as	larger	WML	
load,	 altered	 diffusion	 tensor	 imaging	 measures,	 and	 lacunes,	 were	 more	 strongly	
related	 to	 non-amnestic	MCI.	On	 the	 other	 hand,	we	 found	 that	 persons	with	MCI	
who	converted	to	dementia,	most	often	converted	to	Alzheimer’s	disease,	regardless	of	
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the	MCI	subtype.	Moreover,	stroke	was	related	to	both	subtypes	of	MCI.	Our	results	
therefore	 suggest	 that	 accumulating	 vascular	 damage	 plays	 a	 role	 in	 both	 amnestic	
and	non-amnestic	MCI.	This	is	consistent	with	the	fact	that	vascular	disease	not	only	
plays	an	important	role	in	vascular	dementia,	but	also	in	Alzheimer’s	disease.2-4,	17,	53,	54 
Therefore,	we	propose	that	timely	targeting	modifiable	vascular	risk	factors	might	con-
tribute	to	the	prevention	of	MCI	and	dementia.	Nonetheless,	it	should	be	kept	in	mind	
that	the	cross-sectional	setting	of	our	study	in	the	analyses	of	risk	factors	prevents	us	
from	drawing	any	conclusions	regarding	causality.	
We	found	that	persons	with	amnestic	MCI	had	a	larger	risk	of	dementia	than	persons	
with	 non-amnestic	MCI.	This	 difference	might	 be	 a	 consequence	 of	 the	 definitions	
of	 the	MCI	 subtypes.	Study	participants	with	 amnestic	MCI	may	have	 experienced	
difficulties	on	other	cognitive	domains	besides	memory	alone,	while	participants	with	
non-amnestic	MCI	per	definition	did	not	 experience	any	memory	problems.	Hence,	
persons	with	amnestic	MCI	may	have	been	cognitively	more	 impaired	 than	persons	
with	non-amnestic	MCI.	
In	conclusion,	in	our	population-based	study	we	found	that	several	vascular	risk	fac-
tors	and	MRI-correlates	of	cerebrovascular	disease	were	associated	with	MCI.	Persons	
with	MCI	had	an	increased	risk	of	dementia,	Alzheimer’s	disease,	and	mortality.	
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Supplementary table 1.	Characteristics	of	the	included	and	excluded	participants
examinations at baseline 
2002-2005
examinations before baseline
1997-2001
Included 
in analysis
N=3,930
excluded from 
analysis
N=268
Included 
in analysis
N=3,583
excluded from 
analysis
N=615
Age,	years 71.8	(7.2) 71.2	(7.2) 67.5	(7.0) 67.3	(7.0)
Females 57.0% 66.0%	a 56.3% 64.4%	a
APOE-ε4	carrier 26.5% 26.3% 26.9% 23.9%
Waist	circumference,	cm 93.5	(11.8) 94.5	(12.8)a 93.0	(12.3) 93.1	(11.5)
Hypertension 80.4% 86.9%	a 64.9% 72.1%	a
Diabetes	mellitus 14.4% 17.9% 8.6% 7.5%
Cholesterol,	mmol/l 5.62	(0.99) 5.79	(1.03) 5.84	(0.96) 5.76	(1.00)	a
HDL-cholesterol,	mmol/l 1.45	(0.40) 1.45	(0.40) 1.40	(0.39) 1.33	(0.36)
Smoking
			Former 55.5% 50.0% 51.2% 44.8%
			Current 15.2% 18.3% 19.0% 22.7%
Stroke 3.9% 3.0% 2.3% 1.6%
a	Significantly	different	(p<0.05)	between	included	participants	and	excluded	participants,	after	sex	and	age	
adjustment	–	if	applicable.	Participants	excluded	from	the	analysis	missed	at	least	one	value	of	the	determinants	
mentioned	in	the	table.
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Supplementary figure 1. Assessment of determinants, MCI and MrI examination 
 
 
In	red:	baseline	measurement	of	determinants	and	MCI assessed	in	2002-2005. In	blue:	measurement	of	determinants	assessed	in	the	
examination	round	7	years	prior	to	baseline.	In	yellow:	a	random	subset	of	682	persons	with	MCI	screening	at	baseline	and	brain	MRI	
examination	performed	on	average	1.01	years	after	baseline	(2005	onwards).	Abbreviations:	MCI=	mild	cognitive	impairment,	
MRI=magnetic	resonance	imaging,	RS	=	Rotterdam	Study.	 
Supplementary figure 1.	Assessment	of	determinants,	MCI	and	MRI	examination
In	red:	baseline	measurement	of	determinants	and	MCI	assessed	in	2002-2005.	In	blue:	measurement	of	deter-
minants	assessed	in	the	examination	round	7	years	prior	to	baseline.	In	yellow:	a	random	subset	of	682	persons	
with	MCI	screening	at	baseline	and	brain	MRI	examination	performed	on	average	1.01	years	after	baseline	
(2005	onwards).	Abbreviations:	MCI=	mild	cognitive	impairment,	MRI=magnetic	resonance	imaging,	RS	=	
Rotterdam	Study.	
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ABStrACt
White	matter	microstructural	integrity	has	been	related	to	cognition.	Yet,	the	potential	
role	 of	 specific	 white	 matter	 tracts	 on	 top	 of	 a	 global	 white	 matter	 effect	 remains	
unclear,	 especially	when	 considering	 specific	 cognitive	 domains.	Therefore,	we	 de-
termined	 the	 tract-specific	effect	of	white	matter	microstructure	on	global	cognition	
and	 specific	 cognitive	 domains.	 In	 4,400	 nondemented	 and	 stroke-free	 participants	
(mean	 age	 63.7,	 55.5%	 female)	we	 obtained	 diffusion	magnetic	 resonance	 imaging	
parameters	(fractional	anisotropy	and	mean	diffusivity)	in	14	white	matter	tracts	us-
ing	 probabilistic	 tractography	 and	 assessed	 cognitive	 performance	with	 a	 cognitive	
test	battery.	Tract-specific	white	matter	microstructure	in	all	supratentorial	tracts	was	
associated	with	 poorer	 global	 cognition.	 Lower	 fractional	 anisotropy	 in	 association	
tracts,	primarily	the	inferior-fronto-occipital	fasciculus,	and	higher	mean	diffusivity	in	
projection	tracts,	in	particular	the	posterior	thalamic	radiation,	most	strongly	related	
to	poorer	cognition.	Altered	white	matter	microstructure	related	to	poorer	information	
processing	speed,	executive	functioning,	and	motor	speed,	but	not	to	memory.	Tract-
specific	microstructural	 changes	may	 aid	 in	 better	 understanding	 the	mechanism	of	
cognitive	impairment	and	neurodegenerative	diseases.
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INtroduCtIoN
Brain	white	matter	damage	 is	 increasingly	 recognized	as	 an	 important	 factor	 in	 the	
pathophysiology	of	cognitive	impairment	and	dementia.1-4	Evidence	shows	that	mac-
rostructural	white	matter	changes,	such	as	white	matter	lesions,	white	matter	atrophy	
and	lacunes	relate	to	poorer	cognitive	performance.	Studies	have	already	suggested	a	
regional	 pattern	 of	 association	 between	 these	macrostructural	white	matter	 changes	
and	specific	cognitive	domains.5-7	At	the	same	time,	it	is	thought	that	such	conventional	
markers	only	 represent	 the	 tip	of	 the	 iceberg	of	white	matter	 changes.	Focusing	on	
microstructural	changes	by	means	of	the	microstructural	integrity	of	the	white	matter,	
may	provide	a	more	in-depth	insight	of	alterations	in	the	white	matter.	Perhaps	more	
importantly,	 the	white	matter	 is	not	a	bulk	substance	but	consists	of	different	white	
matter	 tracts,	 which	 are	 important	 for	 the	 connection	 of	 different	 cortical	 regions.8 
Changes	in	white	matter	microstructural	integrity	are	accompanied	by	changes	in	dif-
fusion	magnetic	resonance	imaging	(diffusion-MRI)	parameters.	Fractional	anisotropy	
(FA)	is	generally	lower,	mean	diffusivity	(MD)	is	generally	higher	(with	exceptions)	in	
older	or	diseased	brains,	which	is	thought	to	reflect	reduced	white	matter	microstruc-
ture.9,10
Altered	microstructure	of	white	matter	 tracts,	e.g.	as	a	 result	of	aging	or	pathologic	
processes,	is	presumed	to	lead	to	loss	of	communication	between	cortical	regions,	re-
sulting	in	poorer	cognitive	performance,	the	so-called	“disconnection	hypothesis”.6,11-14 
Information	 processing	 speed	 and	 executive	 function	 are	 the	most	 consistently	 im-
paired	cognitive	functions	that	have	been	related	to	white	matter	damage.15-17	However	
the	potential	role	of	specific	white	matter	tracts	on	top	of	a	global	white	matter	effect	in	
cognitive	performance	remains	unclear,	especially	when	considering	specific	cognitive	
domains.	It	 is	necessary	to	investigate	these	potential	roles	for	specific	white	matter	
tracts	to	elucidate	probable	mechanism	of	cognitive	impairment	and	neurodegenerative	
diseases.	Therefore,	the	purpose	of	this	study	was	to	determine	the	tract-specific	effect	
of	white	matter	microstructure	on	global	cognition	and	specific	cognitive	domains	in	a	
large,	middle	aged	and	elderly	population	of	4400	persons	from	the	population-based	
Rotterdam	Study,18	using	diffusion-MRI.
MethodS
Study population
This	study	is	based	on	participants	from	the	Rotterdam	Study,	an	ongoing,	prospective,	
population-based	cohort	study	 including	participants	of	45	years	and	older	 living	 in	
Ommoord,	a	suburb	of	Rotterdam.19	From	2005	onwards,	MRI-scanning	was	included	
in	the	study	protocol.20	Between	2006	and	2011,	5,430	nondemented	participants	with-
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out	contraindications	for	MRI	(including	claustrophobia)	were	eligible	for	scanning.	
Among	these	persons,	4,841	underwent	a	multi-sequence	MRI	acquisition	of	the	brain,	
including	 diffusion-weighted	 MRI-scanning.	 We	 excluded	 scans	 with	 incomplete	
acquisitions	 (N=53),	 scans	with	artifacts	hampering	automated	processing	 (N=112),	
and	scans	with	MRI-defined	cortical	infarcts	(N=160).	We	additionally	excluded	116	
participants	 with	 history	 of	 clinical	 stroke.	 This	 resulted	 in	 4400	 individuals	 with	
analyzable	MRI	data.	Of	these,	3876	participants	had	fully	available	cognition	data.	
MRI-scanning	and	cognitive	assessment	took	place	at	the	same	visit,	apart	from	677	
participants	who	underwent	MRI-scanning	on	average	1.9	years	 (standard	deviation	
(SD)	0.6)	before	cognitive	assessment.	The	Rotterdam	Study	has	been	approved	by	
the	medical	ethics	committee	according	to	the	Population	Study	Act	Rotterdam	Study,	
executed	by	the	Ministry	of	Health,	Welfare	and	Sports	of	the	Netherlands.	All	partici-
pants	gave	written	informed	consent.
MrI acquisition and processing
We	performed	multi-sequence	MR	 imaging	 on	 a	 1.5	 tesla	MRI	 scanner	 (GE	Signa	
Excite),	undergoing	a	QA	protocol	keeping	the	system	unchanged	(no	major	updates	or	
upgrades)	for	the	period	of	inclusion.	The	imaging	protocol	was	described	extensively	
elsewhere.20	Due	to	a	technical	problem	between	February	2007	and	May	2008,	1338	
subjects	were	scanned	with	the	phase	and	frequency	encoding	directions	swapped	for	
the	diffusion	acquisition,	which	led	to	a	mild	ghosting	artifact	in	the	phase	encoding	
direction.21	This	was	treated	as	a	potential	confounder	in	the	analysis	(see	statistical	
analysis).	An	automated	tissue	segmentation	approach	was	used	to	classify	scans	into	
grey	matter,	white	matter,	cerebrospinal	fluid	(CSF)	and	background	tissue.	Intracra-
nial	volume	(ICV)	(excluding	the	cerebellum	and	surrounding	CSF)	was	estimated	by	
summing	total	grey	and	white	matter	and	CSF	volumes,	and	used	to	correct	for	head	
size.22	White	matter	lesions	(WML)	were	identified	using	an	automated	post-processing	
step	based	on	the	FLAIR	image	and	the	tissue	segmentation.23	We	visually	assessed	
the	presence	of	infarcts	on	structural	MRI	sequences,	and	in	case	of	involvement	of	
cortical	grey	matter	we	classified	them	as	cortical	infarcts.
Diffusion-MRI processing and tractography
For	diffusion-MRI,	we	performed	a	 single	 shot,	diffusion-weighted	 spin	echo	echo-
planar	 imaging	 sequence.	 Maximum	 b-value	 was	 1000	 s/mm2	 in	 25	 non-collinear	
directions;	 three	volumes	were	acquired	without	diffusion	weighting	(b-value	=	0	s/
mm2).	All	diffusion	data	were	pre-processed	using	a	standardized	pipeline.24	In	short,	
eddy	current	and	head-motion	correction	were	performed	on	 the	diffusion	data.	The	
resampled	data	was	used	 to	fit	 diffusion	 tensors,	 allowing	 (in	 combination	with	 the	
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tissue	segmentation)	computation	of	global	mean	FA	and	MD	in	the	normal-appearing	
white	matter	.
The	diffusion	data	was	also	used	to	segment	white	matter	tracts	using	a	diffusion	trac-
tography	approach	described	previously.21	For	14	different	white	matter	tracts	(11	of	
which	segmented	bilaterally)	tract-specific	white	matter	microstructural	diffusion-MRI	
parameters	(median	FA,	and	MD)	were	obtained	with	subsequent	combination	of	left	
and	right	measures	(figure 1).21	The	average	reproducibility	of	our	tract-specific	mea-
surements	was	 87%,	which	 is	 good.21	We	 standardized	 tract-specific	 diffusion-MRI	
parameters	(zero	mean,	unit	SD)	to	facilitate	comparison	of	associations.	Tracts	were	
categorized,	 based	 on	 anatomy,	 into	 brainstem	 tracts,	 projection	 tracts,	 association	
tracts,	limbic	system	tracts	and	callosal	tracts.21
                                                    White	matter	microstructure	and	cognition 
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figure 1. Overvie 	of	white	matter	tracts  
Abbreviations:	MCP:	middle	cerebellar	peduncle,	ML:	medial	lemniscus,	CST:	cortico-spinal	tract,	ATR:	anterior	
thalamic	radiation,	STR:	superior	thalamic	radiation,	PTR:	posterior	thalamic	radiation,	SLF:	superior	longitudinal	
fasciculus,	ILF:	inferior	longitudinal	fasciculus,	IFO:	inferior-fronto-occipital	fasciculus,	UNC:	uncinated	
fasciculus,	CGC:	cingulate	gyrus	part	of	cingulum,	CGH:	parahippocampal	part	of	 ingulum,	FMA:	forceps	major, 
FMI:	forceps	minor.	A=anterior,	S=superior,	L=lateral. 
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Abbreviations:	MCP:	middle	cerebellar	peduncle,	ML:	medial	lemniscus,	CST:	cortico-spinal	tract,	ATR:	an-
terior	thalamic	radiation,	STR:	superior	thalamic	radiation,	PTR:	posterior	thalamic	radiation,	SLF:	superior	
longitudinal	fasciculus,	ILF:	inferior	longitudinal	fasciculus,	IFO:	inferior-fronto-occipital	fasciculus,	UNC:	
uncinated	fasciculus,	CGC:	cingulate	gyrus	part	of	cingulum,	CGH:	parahippocampal	part	of	cingulum,	FMA:	
forceps	major,	FMI:	forceps	minor.	A=anterior,	S=superior,	L=lateral.
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Tract	 segmentations	were	 also	 used	 to	 acquire	 tract-specific	white	matter	 volumes,	
and-	by	combining	the	 tissue	and	tract	segmentations-	 tract-specific	WML	volumes.	
Tract-specific	 WML	 volumes	 were	 natural-log	 transformed,	 to	 account	 for	 their	
skewed	distribution.
The	cerebellum	could	not	be	fully	incorporated	in	the	field	of	view	of	the	diffusion-
MRI	scan,	 resulting	 in	partial	coverage	of	 the	medial	 lemniscus	at	 the	 lower	border	
of	the	scan.	To	overcome	this	problem	alternative	seed	masks	for	tractography	were	
selected	 until	 reasonable	 coverage	was	 achieved.21	This	 correction	was	 treated	 as	 a	
potential	confounder	in	all	models	that	included	the	medial	lemniscus	(see	statistical	
analysis).
Assessment of cognitive function
Cognitive	function	was	assessed	in	all	participants	with	 the	following	cognitive	test	
battery:	15-Word	Learning	Test	(15-WLT),	which	tests	immediate	and	delayed	recall	
to	investigate	memory;25	Stroop	tests	(reading,	color-naming,	interference),	which	tap	
into	information	processing	speed	and	executive	function;26,27	Letter-Digit	Substitution	
Task	and28	Word	Fluency	Test	(WFT);29,	which	both	test	executive	function,	and	the	
Purdue	Pegboard	test	to	measure	fine	motor	speed.30
To	 aid	 comparison	 across	 cognitive	 tests	 we	 generated	 z-scores	 for	 each	 cognitive	
test.	The	z-scores	for	the	Stroop	tests	were	inverted:	higher	scores	on	the	Stroop	test	
indicate	a	poorer	performance,	while	higher	scores	on	the	other	cognitive	tests	indicate	
better	 cognitive	 performance.	 In	 addition,	we	 also	 investigated	 global	 cognition	 by	
constructing	 a	 g-factor	 using	 a	 principal	 component	 analysis	 on	 the	 delayed	 recall	
score	of	the	15-Word	Learning	Test,	Stroop	interference	Test,	Letter-Digit	Substitution	
Task,	Word	Fluency	Test,	and	the	Purdue	Pegboard	test.31
Ascertainment of dementia and clinical stroke
Prevalent	dementia	and	clinical	stroke	were	ascertained	as	previously	described,32-34 
and	these	patients	were	excluded.
other measurements
The	following	cardiovascular	 risk	 factors,	based	on	 information	derived	 from	home	
interviews	 and	 physical	 examinations	 during	 the	 center	 visit,	were	 assessed.	Blood	
pressure	 was	measured	 twice	 in	 sitting	 position	 using	 a	 random-zero	 sphygmoma-
nometer	and	the	average	of	two	measurements	was	used	in	the	analyses.	Information	
on	the	use	of	antihypertensive	medication	was	collected	by	using	questionnaires	and	
by	checking	the	medication	cabinets	of	the	participants.	Total	serum	cholesterol	and	
high-density	 lipoprotein	 (HDL)	cholesterol	were	determined	 in	blood	serum,	 taking	
lipid-lowering	medication	into	account.	Smoking	was	assessed	by	interview	and	coded	
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as	never,	former	and	current.	Diabetes	mellitus	status	was	determined	based	on	fasting	
serum	glucose	level	(>=	7.0	mmol/l)	or,	if	unavailable,	non-fasting	serum	glucose	level	
(>=11.1	mmol/l)	 or	 the	 use	 of	 anti-diabetic	medication.19	The	 participants’	 attained	
level	of	education	was	collected	and	was	categorized	into	7	categories,	ranging	from	
primary	education	only	to	university	level.
Missing	values	on	cardiovascular	 risk	 factors	and	education	 (<3%	for	all	variables)	
were	imputed	by	multiple	imputation	(n=5),	based	on	age,	sex,	education,	serum	cho-
lesterol	level,	HDL	cholesterol	level,	systolic	blood	pressure,	diastolic	blood	pressure,	
antihypertensive	medication,	lipid-lowering	medication,	smoking	and	diabetes.
Apolipoprotein E (APOE)-ε4	allele	carriership	was	assessed	on	coded	genomic	DNA	
samples.35	APOE	genotype	was	in	Hardy-Weinberg	equilibrium.
Statistical analysis
First,	we	created	scatterplots	correlating	tract-specific	diffusion	parameters	with	global	
cognition	(g-factor),	adjusted	for	age	and	sex,	to	explore	linearity	of	the	associations.	
Next,	associations	of	tract-specific	diffusion	measurements	with	cognitive	performance	
were	evaluated	using	multivariable	linear	regression	models.	Standardized	betas	and	
95%	confidence	intervals	(CI)	were	estimated	on	standardized	FA	or	MD	within	each	
tract.	We	performed	analyses	in	three	models.	In	model	I,	analyses	were	adjusted	for	
age,	sex,	education,	intracranial	volume,	tract-specific	white	matter	volume,	and	tract-
specific	WML	volume.	 In	model	 II	we	additionally	adjusted	 for	 cardiovascular	 risk	
factors	and	APOE-ε4 allele	carriership,	to	study	whether	there	were	pathways	relating	
white	matter	microstructure	to	cognition,	other	than	those	involving	these	factors.	This	
is	relevant	since	vascular	factors	may	be	considered	either	confounders	or	part	of	the	
causal	chain	from	vascular	factors	through	white	matter	microstructure	to	cognition.	
We	 furthermore	 applied	 model	 III,	 which	 additionally	 adjusted	 for	 global	 FA	 (for	
analyses	with	 tract-specific	FA	as	determinant)	or	 for	global	MD	(for	analyses	with	
tract-specific	MD	as	determinant)	on	top	of	model	II,	to	study	whether	specific	tracts	
provided	additional	information	above	global	white	matter	diffusion-MRI	parameters.	
In	 all	 analyses,	 we	 treated	 the	 phase	 encoding	 direction	 of	 the	 diffusion	 scan	 as	 a	
potential	confounder.	For	analyses	in	which	the	medial	lemniscus	was	studied	we	ad-
ditionally	adjusted	for	the	variable	position	of	seed	masks,	as	explained	before.
We	compared	effect	sizes	across	associations	of	different	tracts	and	cognitive	tests	using	
Z-tests	(beta1–beta2)/(sqrt(standard	error1
2+standard	error2
2)	to	investigate	whether	the	
association	with	cognition	in	certain	tracts	was	significantly	different	across	tracts.	See	
Supplementary	Table	A.1	for	all	betas	and	standard	errors.	Moreover,	we	performed	a	
series	of	sensitivity	analyses,	excluding	the	participants	who	underwent	MRI-scanning	
on	average	1.9	years	prior	to	cognitive	assessment,	and	we	also	excluded	participants	
with	 a	 Mini	 Mental	 State	 Examination	 (MMSE)	 lower	 than	 26.	We	 corrected	 the	
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p-value	 (alpha	 level	of	0.05)	 for	multiple	comparisons	using	Šidák	correction,	after	
estimating	the	number	of	independent	tests,	resulting	in	a	threshold	for	significance	of	
p<0.0006.36,37	All	analyses	were	carried	out	using	R	version	2.15.0.
reSuLtS
table 1	presents	the	characteristics	of	the	study	population.	Mean	age	of	the	partici-
pants	was	63.7	±11.1	years,	and	55.5	%	were	women.	Scatterplots	correlating	tract-
specific	diffusion	parameters	with	global	cognition	(g-factor),	adjusted	for	age	and	sex	
are	shown	in	Supplementary fig. A.1 & A.2.
The	association	of	tract-specific	diffusion	parameters	and	global	cognition	is	presented	
in	table 2	and	in	figure 2.	Lower	FA	and	higher	MD	in	all	tracts	(except	for	brainstem	
tracts)	were	associated	with	lower	global	cognition.	For	FA,	white	matter	microstruc-
ture	in	the	association	tracts	followed	by	the	callosal	tracts	was	most	strongly	related	
with	 global	 cognition.	After	 adjusting	 for	 cardiovascular	 risk	 factors	 and	APOE-ε4 
allele	carriership	(model	II),	the	mean	difference	in	g-factor	(z-score)	per	SD	increase	
of	FA	in	the	association	tracts	ranged	from	0.09	(CI:0.06;0.12)	to	0.12	(CI:0.09;0.16),	
in	the	callosal	tracts	from	0.09	(CI:0.05;0.12)	to	0.11	(CI:0.08;0.14).	For	MD,	white	
matter	microstructure	in	the	projection	tracts,	followed	by	the	association	tracts	was	
most	strongly	related	with	global	cognition.	Mean	difference	in	z-score	for	the	g-factor	
per	SD	increase	of	MD	in	the	projection	tracts,	after	adjusting	for	cardiovascular	risk	
factors	 and	APOE-ε4	 allele	 carriership,	 ranged	 from	 -0.16	 (CI:-0.20;-0.13)	 to	 -0.18	
(CI:-0.22;-0.14),	 in	 the	 association	 tracts	 from	 -0.11	 (CI:-0.14;-0.08)	 to	 -0.16	 (CI:-
0.20;-0.12).	After	controlling	for	global	FA	or	global	MD	(model	III),	the	associations	
attenuated	but,	the	majority	of	the	associations	remained	significant.
table 3	 presents	 the	 associations	 of	 white	 matter	 microstructure	 with	 cognitive	
performance	 on	 separate	 cognitive	 tests	 after	 adjustment	 for	 age,	 sex,	 education,	
intracranial	volume,	tract-specific	white	matter	volume,	tract-specific	WML	volume,	
cardiovascular	risk	factors	and	APOE-ε4	allele	carriership	(model	II).	Higher	values	
of	FA,	 in	 all	 tracts	 (except	 the	brain	 stem	 tracts),	 but	mainly	 in	 the	 inferior	 fronto-
occipital	fasciculus,	inferior	longitudinal	fasciculus	(association	tracts),	forceps	minor	
(callosal	tract)	and	the	posterior	thalamic	radiation	(projection	tract),	were	generally	
associated	 with	 a	 better	 performance	 on	 the	 Stroop	 tests,	 Letter-Digit	 Substitution	
Task,	and	the	Purdue	Pegboard	test	and	to	a	lesser	degree	on	the	Word	Fluency	Test.	
Higher	values	of	MD	in	all	tracts,	but	mainly	in	the	projection	tracts,	(especially	in	the	
posterior	thalamic	radiation)	and	in	the	association	tracts,	in	particular	in	the	inferior	
fronto-occipital	 fasciculus	 were	 associated	 with	 poorer	 performance	 on	 the	 Stroop	
tests,	Letter-Digit	Substitution	Task,	and	the	Purdue	Pegboard	test,	and	also	to	a	lesser	
degree	on	the	Word	Fluency	Test.	Additionally	adjusting	for	global	FA	or	global	MD	
147
Altered	tract-specific	white	matter	microstructure	is	related	to	poorer	cognitive	performance
table 1. Population	characteristics
Characteristic total 
(N = 4400)
Age,	yrs 63.7	(11.1)
Sex,	women 2444	(55.5)
Cognitive	tests	resultsa
Word	Learning	Test	immediate	recall	(sum	of	3	trials) 23.3	(6.5)
Word	Learning	Test	delayed	recall 7.7	(2.9)
Stroop	test
Reading	subtask	of	Stroop	test,	s 17.0	(3.4)
Color	naming	subtask	of	Stroop	test,	s 23.2	(4.6)
Interference	subtask	of	Stroop	test,	s 47.7	(17.2)
Letter-Digit	Substitution	Task,	number	of	correct	digits 30.4	(7.1)
Word	Fluency	Test,	number	of	animals 23.0	(6.0)
Purdue	Pegboard	test,	number	of	pins	placed 10.5	(1.9)
Educationb 3	(1-4)
Systolic	blood	pressure,	mmHg 139.3	(21.5)
Diastolic	blood	pressure,	mmHg 83.1	(	10.8)
Blood	pressure	lowering	medication 1555	(35.3)
Serum	cholesterol,	mmol/l 5.5	(1.1)
HDL-cholesterol,	mmol/l 1.5	(0.4)
Lipid	lowering	medication 1231	(28.0)
Smoking
			Never 1363	(31.0)	
			Former 2130	(48.4)
			Current 907	(20.6)
Diabetes	mellitus 413	(9.4)
Apolipoprotein	E-ε4	allele	carriership 1184	(28.8)
Normal	appearing	white	matter	volume,	ml 404.1	(61.6)
Intra-cranial	volume,	ml 1340.0	(133.1)
White	matter	lesion	volumeb,	ml 2.9	(1.6-6.0)
Mean	FA 0.3	(0.02)
Mean	MD,	10-3 mm2/sec 0.7	(0.03)
Continuous	variables	are	presented	as	means	(standard	deviations)	and	categorical	variables	as	n	(percentages).	
Data	on	apolipoprotein E-ε4 allele	carriership	were	missing	in	287	persons.	Global	FA	and	global	MD	were	
missing	in	173	participants,	due	to	failed	segmentation.
aCognitive	tests	were	available	for	Word	Learning	Test	immediate	recall	in	n=4186,	Word	Learning	Test	de-
layed	 recall	 in	 n=4134,	 reading	 subtask	 of	 Stroop	 test	 in	 n=4207,	 color	 naming	 subtask	 of	 Stroop	 test	 in	
n=4207,	interference	subtask	of	Stroop	test	in	n=4200,	Letter-Digit	Substitution	Task	in	n=4234,	Word	Fluency	
Test	in	n=	4272,	and	Purdue	Pegboard	test	in	n=	4087.
bEducation	and	white	matter	lesion	volume	are	presented	as	median	(inter-quartile	range).
Abbreviations:	N;number	of	participants,	HDL;high-density	lipoprotein,	s;seconds,	FA;fractional	anisotropy,	
MD;mean	diffusivity	x	10-3 mm2/sec.	
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table 2. Associations	of	fractional	anisotropy	and	mean	diffusivity	with	global	cognition	(g-factor)
Fractional Anisotropy Mean Diffusivity
white matter tracts Model I Model II Model III Model I Model II Model III
Tracts in brainstem
Middle	cerebellar	
peduncle
-0.01 
(-0.05;0.03)	
-0.01 
(-0.05;0.03)	
-0.01 
(-0.05;0.03)	
-0.01 
(-0.04;0.02)	
0.00 
(-0.03;0.03)	
0.02	
(-0.01;0.05)	
Medial	lemniscus	a 0.03 
(0.00;0.06)	
0.03 
(0.00;0.06)	
0.01 
(-0.02;0.05)	
-0.05 
(-0.08;-0.02) 
-0.04 
(-0.07;-0.01)	
0.00 
(-0.03;0.03)	
Projection tracts 
Corticospinal	tract 0.01 
(-0.02;0.03)	
0.01 
(-0.02;0.04)	
-0.02	
(-0.05;0.01)	
-0.17 
(-0.20;-0.13) 
-0.16 
(-0.19;-0.12) 
-0.11 
(-0.17;-0.06) 
Anterior	thalamic	
radiation
0.07 
(0.04;0.10) 
0.07 
(0.04;0.10) 
0.04 
(0.00;0.08)	
-0.17 
(-0.21;-0.13) 
-0.16 
(-0.20;-0.12) 
-0.13 
(-0.19;-0.07) 
Superior	thalamic	
radiation
0.01 
(-0.02;0.04)	
0.01 
(-0.01;0.04)	
-0.02	
(-0.05;0.01)	
-0.17 
(-0.21;-0.13) 
-0.16 
(-0.20;-0.13) 
-0.13 
(-0.19;-0.07)
Posterior	thalamic	
radiation
0.11 
(0.08;0.14) 
0.10 
(0.07;0.14) 
0.09 
(0.05;0.13) 
-0.19 
(-0.23;-0.15) 
-0.18 
(-0.22;-0.14) 
-0.14 
(-0.19;-0.09) 
Association tracts
Superior	longitudinal	
fasciculus
0.09 
(0.06;0.12) 
0.09 
(0.06;0.12) 
0.06 
(0.01;0.11)	
-0.13 
(-0.16;-0.09) 
-0.13 
(-0.16;-0.09) 
-0.06 
(-0.13;0.00)	
Inferior	longitudinal	
fasciculus
0.11 
(0.08;0.14) 
0.10 
(0.07;0.13) 
0.09 
(0.05;0.13) 
-0.14 
(-0.18;-0.10) 
-0.13 
(-0.17;-0.10) 
-0.10 
(-0.16;-0.04)	
Inferior	fronto-
occipital	fasciculus
0.13 
(0.10;0.16) 
0.12 
(0.09;0.16) 
0.11 
(0.07;0.15) 
-0.17 
(-0.20;-0.13) 
-0.16 
(-0.20;-0.12) 
-0.13 
(-0.20;-0.07) 
Uncinate	fasciculus 0.06 
(0.03;0.09) 
0.06 
(0.02;0.09)	
-0.01 
(-0.05;0.04)	
-0.11 
(-0.14;-0.08) 
-0.11 
(-0.14;-0.08) 
-0.02	
(-0.08;0.04)	
Limbic system tracts
Cingulate	gyrus	part	of	
cingulum
0.07 
(0.05;0.10) 
0.07 
(0.04;0.10) 
0.04 
(0.01;0.07)	
-0.09 
(-0.11;-0.06) 
-0.08 
(-0.11;-0.05) 
0.00 
(-0.04;0.04)	
Parahippocampal	part	
of	cingulum
0.05 
(0.02;0.08) 
0.05 
(0.02;0.08) 
0.03 
(0.00;0.06)	
-0.07 
(-0.10;-0.04) 
-0.07 
(-0.10;-0.04) 
-0.03 
(-0.06;0.00)	
Callosal tracts
Forceps	major 0.09 
(0.06;0.12) 
0.09 
(0.05;0.12) 
0.06 
(0.02;0.10)	
-0.12 
(-0.16;-0.09) 
-0.12 
(-0.16;-0.08) 
-0.07 
(-0.12;-0.02)	
Forceps	minor 0.12 
(0.09;0.15) 
0.11 
(0.08;0.14) 
0.07 
(0.03;0.11)	
-0.15 
(-0.18;-0.12) 
-0.14 
(-0.18;-0.11) 
-0.07 
(-0.13;-0.02)	
Values	represent	the	mean	differences	in	z-score	(95%	CI)	of	the	g-factor	per	SD	increase	of	fractional	anisot-
ropy	or	mean	diffusivity.	Results	 in	bold	were	significant	after	correction	for	multiple	 testing	(p<6.0*10-4).	
Model	I:	Adjusted	for	age,	sex,	education,	intracranial	volume,	WM	and	log-transformed	WML	volumes	of	
the	 investigated	 tract.	Model	 II:	Model	 I,	and	additionally	adjusted	 for	cardiovascular	 risk	 factors	 (systolic	
blood	 pressure,	 diastolic	 blood	 pressure,	 antihypertensive	medication,	 serum	cholesterol,	HDL-cholesterol,	
lipid	lowering	medication,	smoking,	diabetes),	and	apolipoprotein E-ε4	allele	carriership.	Model	III:	Model	II,	
and	additionally	adjusted	for	mean	global	FA	or	mean	global	MD.
a	Additionally	adjusted	for	the	variable	position	of	the	seed	mask.	
Abbreviations:	g-factor;	general	cognitive	factor	(incorporating	Word	Learning	Test	delayed	recall,	interfer-
ence	subtask	of	Stroop	test,	Letter-Digit	Substitution	Test,	Word	Fluency	Test	and	Purdue	Pegboard	test),	WM;	
white	matter,	WML;	white	matter	lesion	volume,	FA;	fractional	anisotropy,	MD;	mean	diffusivity	x	10-3 mm2/
sec.	G-factor	available	in	N=3876.
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(table 4)	attenuated	most	of	the	associations,	but	the	majority	of	the	projection	and	
association	 tracts	 remained	 significant,	with	 again	 the	 strongest	 associations	 for	 the	
inferior	fronto-occipital	fasciculus	and	the	posterior	thalamic	radiation.	We	did	not	find	
any	association	between	 tract-specific	microstructure	 and	memory	 (15-Word	Learn-
ing	Tests).	Overall,	 the	 effect	 sizes	of	 the	projection,	 association	and	callosal	 tracts	
with	the	different	cognitive	tests	were	significantly	larger	than	the	effect	sizes	of	the	
brain	stem	and	the	limbic	system	(data	not	shown).	This	was	particularly	true	for	the	
posterior	thalamic	radiation	and	the	inferior	fronto-occipital	fasciculus,	which	showed	
strongest	effects	among	all	tracts.
Excluding	677	participants	who	underwent	MRI-scanning	on	average	1.9	years	prior	
to	cognitive	assessment	yielded	similar	findings	(data	not	shown).	Also,	excluding	par-
ticipants	with	a	Mini	Mental	State	Examination	lower	than	26	yielded	similar	results	
(data	not	shown).	There	was	no	significant	interaction	between	the	microstructure	of	
any	of	the	tracts	and	APOE-ε4	allele	carriership	after	correction	for	multiple	testing.
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figure 2. Diffusion-MRI	measures	and	global	cognition 
Mean	differences	in	z-score	of	global	cognition	for	all	14	white	matter	tracts	in	the	population,	presented	in	a	single	
subject	anatomy	for	visualization.	Colors	 reflect	 the	mean	differences	 in	z-score	per	SD	increase	of	FA	(row1)	or	
MD	 (row2),	 adjusted	 for	 age,	 sex,	 education,	 intracranial	 volume,	 tract-specific	WM	 volume,	 and	 tract-specific	
WML	 volume	 (model	 I).	 Model	 II	 is	 model	 I	 and	 additionally	 adjusted	 for	 cardiovascular	 risk	 factors,	 and	
apolipoprotein E-ε4 allele	carriership.	Model	III	adjusts	for	global	FA	or	global	MD	on	top	of	model	II. 
Higher	 strength	 of	 association	 is	 depicted	 in	 darker	 blue	 for	 positive	 associations,	 darker	 red	 for	 negative	
associations,	with	non-significant	associations	displayed	in	white. 
Abbreviations:	 FA;	 fractional	 anisotropy,	 MD;	 mean	 diffusivity,	 ICV;	 intracranial	 volume,	 WM;	 white	 matter,	
WML;	white	matter	lesion. 
 
  figure 2.	Diffusion-MRI	measures	and	global	cognition
Mean	differences	in	z-score	of	global	cognition	for	all	14	white	matter	tracts	in	the	population,	presented	in	a	
single	subject	anatomy	for	visualization.	Colors	reflect	the	mean	differences	in	z-score	per	SD	increase	of	FA	
(row1)	or	MD	(row2),	adjusted	for	age,	sex,	education,	intracranial	volume,	tract-specific	WM	volume,	and	
tract-specific	WML	volume	(model	I).	Model	II	is	model	I	and	additionally	adjusted	for	cardiovascular	risk	
factors,	and	apolipoprotein E-ε4	allele	carriership.	Model	III	adjusts	for	global	FA	or	global	MD	on	top	of	
model	II.
Higher	strength	of	association	is	depicted	in	darker	blue	for	positive	associations,	darker	red	for	negative	as-
sociations,	with	non-significant	associations	displayed	in	white.
Abbreviations:	FA;	fractional	anisotropy,	MD;	mean	diffusivity,	ICV;	intracranial	volume,	WM;	white	matter,	
WML;	white	matter	lesion.
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table 3. Associations	of	tract-specific	fractional	anisotropy	and	mean	diffusivity	with	separate	cognitive	tests
white matter tracts
fA
Immediate 
memory
delayed 
memory
Stroop 
1
Stroop 
2
Stroop 
3 LdSt
word 
fluency
Pudue 
Pegboard
Brainstem tracts
Middle	cerebellar	peduncle 0.01 0.01 -0.03 -0.01 0.03 0.01 -0.02 0.02
Medial	lemniscusa 0.01 0.01 0.04  0.03 0.01 0.05 0.04 -0.01
Projection tracts
Corticospinal	tract -0.02 -0.01 0.00 0.02 0.01 0.03 -0.01 0.01
Anterior	thalamic	radiation 0.03 0.02 0.05 0.08 0.07 0.07 0.02 0.05
Superior	thalamic	radiation 0.00 0.01 0.01 0.02 0.03 0.02 0.00 0.01
Posterior	thalamic	radiation 0.01 -0.01 0.06 0.09 0.10 0.12 0.05 0.12
Association tracts
Superior	longitudinal	fasciculus 0.01 0.00 0.09 0.10 0.10 0.09 0.04 0.09
Inferior	longitudinal	fasciculus 0.01 -0.01 0.07 0.10 0.11 0.10 0.05 0.09
Inferior	fronto-occipital	fasciculus 0.01 -0.01 0.10 0.12 0.12 0.13 0.09 0.11
Uncinate	fasciculus -0.01 -0.01 0.03 0.05 0.05 0.06 0.03 0.05
Limbic system tracts
Cingulate	gyrus	part	of	cingulum 0.00 -0.03 0.06 0.09 0.09 0.07 0.04 0.05
Parahippocampal	part	of	cingulum -0.01 0.00 0.04 0.05 0.06 0.03 0.08 0.04
Callosal tracts
Forceps	major 0.03 0.01 0.08 0.08 0.09 0.08 0.05 0.09
Forceps	minor 0.01 0.00 0.10 0.13 0.11 0.11 0.05 0.11
Md
Brainstem tracts
Middle	cerebellar	peduncle 0.00 0.00 -0.01 -0.01 -0.04 -0.01 0.00 0.01
Medial	lemniscusa 0.01 0.01 0.00 -0.02 -0.06 0.05 -0.02 -0.01
Projection tracts
Corticospinal	tract -0.04 -0.03 -0.09 -0.13 -0.13 -0.15 -0.10 -0.13
Anterior	thalamic	radiation -0.05 -0.05 -0.10 -0.13 -0.16 -0.14 -0.10 -0.10
Superior	thalamic	radiation -0.03 -0.03 -0.10 -0.13 -0.15 -0.15 -0.10 -0.12
Posterior	thalamic	radiation -0.05 -0.04 -0.11 -0.16 -0.18 -0.16 -0.11 -0.13
Association tracts
Superior	longitudinal	fasciculus -0.01 -0.02 -0.09 -0.11 -0.12 -0.13 -0.07 -0.09
Inferior	longitudinal	fasciculus -0.03 -0.02 -0.09 -0.12 -0.15 -0.12 -0.08 -0.10
Inferior	fronto-occipital	fasciculus -0.04 -0.03 -0.11 -0.14 -0.17 -0.14 -0.10 -0.14
Uncinate	fasciculus 0.01 -0.01 -0.04 -0.07 -0.10 -0.11 -0.07 -0.08
Limbic system tracts
Cingulate	gyrus	part	of	cingulum 0.01 0.01 -0.02 -0.04 -0.07 -0.07 -0.05 -0.06
Parahippocampal	part	of	cingulum -0.02 -0.04 -0.01 -0.02 -0.07 -0.04 -0.06 -0.02
Callosal tracts
Forceps	major -0.01 -0.02 -0.09 -0.08 -0.11 -0.10 -0.07 -0.09
Forceps	minor -0.03 -0.03 -0.09 -0.13 -0.13 -0.14 -0.09 -0.13
Values	represent	the	mean	differences	in	Z-score	of	each	cognitive	test	per	SD	increase	of	fractional	anisotropy	
or	mean	diffusivity.	The	colored	cells	represent	significant	associations	surviving	multiple	testing	(p<6.0*10-4)	
and	the	intensity	in	red	and	blue	reflects	the	magnitude	of	the	associations	whereby	darker	colors	reflect	stronger	
associations.	Results	are	adjusted	for	age,	sex,	education,	intracranial	volume,	WM	and	log-transformed	WML	
volumes	of	the	investigated	tract,	cardiovascular	risk	factors	(systolic	blood	pressure,	diastolic	blood	pressure,	
antihypertensive	medication,	serum	cholesterol,	HDL-cholesterol,	lipid	lowering	medication,	smoking,	diabetes,	
and	apolipoprotein E-ε4	allele	carriership.a	Additionally	adjusted	for	the	variable	position	of	the	seed	mask.
Abbreviations:	LDST;Letter-Digit	Substitution	Task,	SD;	standard	deviation,	WM;	white	matter,	WML;white	
matter	volume,	HDL;	high-density	lipoprotein.
Abbreviations of diffusion measurements:	FA.	fractional	anisotropy;	MD.	mean	diffusivity	x	10-3 mm2/sec.
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table 4. Associations	of	tract-specific	fractional	anisotropy	and	mean	diffusivity	with	separate	cognitive	tests	
adjusted	for	global	DTI
white matter tracts
fA
Immediate 
memory
delayed 
memory
Stroop 
1
Stroop 
2
Stroop 
3 LdSt
word 
fluency
Purdue 
Pegboard
Brainstem tracts
Middle	cerebellar	peduncle 0.02 0.02 -0.03 -0.01 0.03 0.01 -0.02 -0.03
Medial	lemniscusa 0.01 0.01 0.03 0.01 -0.01 0.03 0.03 -0.03
Projection tracts
Corticospinal	tract -0.02 -0.01 -0.03 -0.02 -0.02 0.00 -0.01 -0.02
Anterior	thalamic	radiation 0.04 0.04 0.03 0.05 0.04 0.04 0.01 0.00
Superior	thalamic	radiation 0.00 0.01 -0.01 -0.01 0.01 0.00 -0.01 -0.03
Posterior	thalamic	radiation 0.02 0.00 0.04 0.06 0.08 0.10 0.05 0.08
Association tracts
Superior	longitudinal	fasciculus -0.01 0.01 0.07 0.08 0.06 0.08 0.05 0.05
Inferior	longitudinal	fasciculus 0.02 0.00 0.04 0.07 0.11 0.10 0.05 0.06
Inferior	fronto-occipital	fasciculus 0.01 -0.01 0.09 0.10 0.10 0.12 0.11 0.08
Uncinate	fasciculus -0.04 -0.02 -0.02 -0.02 -0.01 0.00 0.02 -0.01
Limbic system tracts
Cingulate	gyrus	part	of	cingulum -0.01 -0.03 0.03 0.06 0.06 0.05 0.03 0.01
Parahippocampal	part	of	cingulum -0.02 -0.01 0.03 0.03 0.04 0.01 0.07 0.02
Callosal tracts
Forceps	major 0.02 0.02 0.06 0.05 0.07 0.05 0.06 0.05
Forceps	minor -0.01 -0.01 0.07 0.08 0.07 0.08 0.03 0.07
Md
Brainstem tracts
Middle	cerebellar	peduncle 0.01 0.00 0.00 0.00 -0.02 0.01 0.01 0.02
Medial	lemniscusa 0.01 0.01 0.02 0.02 -0.03 0.00 -0.01 0.03
Projection tracts
Corticospinal	tract -0.05 -0.04 -0.11 -0.09 -0.11 -0.10 -0.08 -0.11
Anterior	thalamic	radiation -0.09 -0.08 -0.10 -0.10 -0.18 -0.09 -0.08 -0.08
Superior	thalamic	radiation -0.06 -0.06 -0.12 -0.11 -0.17 -0.10 -0.09 -0.10
Posterior	thalamic	radiation -0.06 -0.06 -0.11 -0.14 -0.18 -0.10 -0.10 -0.09
Association tracts
Superior	longitudinal	fasciculus -0.01 -0.05 -0.08 -0.06 -0.09 -0.06 -0.06 -0.05
Inferior	longitudinal	fasciculus -0.04 -0.06 -0.10 -0.08 -0.19 -0.05 -0.04 -0.07
Inferior	fronto-occipital	fasciculus -0.08 -0.09 -0.13 -0.11 -0.20 -0.06 -0.10 -0.13
Uncinate	fasciculus 0.04 -0.01 0.01 0.03 -0.03 -0.02 -0.03 -0.01
Limbic system tracts
Cingulate	gyrus	part	of	cingulum 0.05 0.03 0.05 0.06 0.00 0.02 -0.02 0.01
Parahippocampal	part	of	cingulum -0.02 -0.06 0.01 0.02 -0.04 0.02 -0.04 0.00
Callosal tracts
Forceps	major -0.02 -0.02 -0.09 -0.04 -0.09 -0.04 -0.06 -0.04
Forceps	minor -0.03 -0.05 -0.07 -0.07 -0.06 -0.06 -0.03 -0.11
Values	represent	the	mean	differences	in	Z-score	of	each	cognitive	test	per	SD	increase	of	fractional	anisotropy	
or	mean	diffusivity.	The	colored	cells	represent	significant	associations	surviving	multiple	testing	(p<6.0*10-4),	
and	the	intensity	in	red	and	blue	reflects	the	magnitude	of	the	associations	whereby	darker	colors	reflect	stronger	
associations.	Results	are	adjusted	for	age,	sex,	education,	intracranial	volume,	WM	and	log-transformed	WML	
volumes	of	the	investigated	tract,	cardiovascular	risk	factors	(systolic	blood	pressure,	diastolic	blood	pressure,	
antihypertensive	medication,	serum	cholesterol,	HDL-cholesterol,	lipid	lowering	medication,	smoking,	diabetes,	
apolipoprotein E-ε4	allele	carriership,	and	additionally	for	global	DTI	parameters	(global	FA	or	global	MD).a 
Additionally	adjusted	for	the	variable	position	of	the	seed	mask.	Abbreviations:	LDST;Letter-Digit	Substitution	
Task,	SD;	standard	deviation,	WM;	white	matter,	WML;white	matter	volume,	HDL;	high-density	lipoprotein.	
Abbreviations of diffusion measurements:	FA.	fractional	anisotropy;	MD.	mean	diffusivity	x	10-3 mm2/sec.
Chapter	3.2
152
dISCuSSIoN
In	 this	 study	 among	 middle-aged	 and	 elderly	 persons,	 altered	 tract-specific	 white	
matter	microstructure	 in	 all	 supratentorial	 tracts,	was	 associated	with	poorer	 cogni-
tive	performance,	independent	from	age	and	macrostructural	white	matter	pathology.	
Specifically,	we	found	that	these	associations	were	driven	by	lower	FA	and	higher	MD,	
which	have	been	suggested	to	reflect	reduced	white	matter	microstructural	integrity.10 
Altered	supratentorial	tract-specific	white	matter	microstructure	was	related	to	poorer	
information	processing	speed,	executive	function	and	motor	speed,	but	not	to	memory.	
We	 found	 tract-specific	 differences	 for	 associations	with	 cognitive	 function:	 among	
the	fourteen	white	matter	tracts	the	microstructural	integrity	in	the	posterior	thalamic	
radiation	 (projection	 tract)	 and	 the	 inferior	 fronto-occipital	 fasciculus	 (association	
tract)	were	most	strongly	associated	with	cognitive	performance.
Strengths	of	this	study	include	the	large	sample	size	and	the	population-based	setting.	
Furthermore,	 we	 performed	 a	 tract-specific	 analysis	 in	 fourteen	main	 white	 matter	
tracts,	 and,	 the	 tract-specific	 measurements	 were	 performed	 with	 fully	 automated,	
publicly	 available	 methods.38	 Some	 limitations	 need	 to	 be	 considered.	 Due	 to	 the	
cross-sectional	design,	no	conclusions	can	be	drawn	on	 the	directionality	of	causal-
ity	of	 the	associations.	Furthermore,	 the	evaluation	of	cognitive	performance	in	 this	
study	 is	 less	extensive	compared	 to	 some	other	 studies.	However,	we	constructed	a	
g-factor	as	a	marker	of	global	cognition	using	5	different	cognitive	test	variables,	under	
the	assumption	that	these	tests	are	representative	of	various	cognitive	domains.	This	
facilitates	comparison	with	other	studies,	even	when	the	incorporated	cognitive	tests	
are	 slightly	 different,	 since	 g-factors	 constructed	 of	 different	 cognitive	 tests	 across	
different	test	batteries	are	highly	correlated	and	can	be	interpreted	as	stable	factors	in	a	
variety	of	cognitive	domains.39	We	performed	a	complete-case	analysis	to	construct	a	
g-factor	and	this	might	have	caused	some	selection	bias,	as	persons	who	did	not	have	
values	for	all	cognitive	tests	were	not	included.	Another	aspect	to	note	is	that	we	used	
median	FA	and	MD	in	each	white	matter	 tract.	While	 the	median	 is	more	 robust	 to	
variation	in	the	tails	of	the	measurement	distributions	compared	to	the	mean,	capturing	
an	entire	tract	in	a	single	measurement	discards	spatial	information	that	is	retained	in	
voxel-based	techniques.	Finally,	the	cerebellum	could	not	be	fully	incorporated	in	the	
field	of	view,	making	analyses	on	brain	stem	tracts	less	reliable.	Several	papers	have	
studied	 the	 association	 of	white	matter	microstructure	 and	 cognition.6,40-42	A	 global	
white	matter	effect	has	already	been	associated	with	cognition.	The	main	novelty	of	
our	paper	is	that	we	show	that	tract-specific	diffusion	MRI	measures	(when	adjusted	
for	global	diffusion-MRI	measures)	provide	more	information	above	global	diffusion-
MRI	measures.	Furthermore,	by	using	a	cognitive	test	battery	rather	than	a	single	test,	
our	study	is	not	limited	to	a	specific	cognitive	domain.
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In	a	previous	study	investigating	the	association	of	age	and	white	matter	microstruc-
ture,	in	the	same	community-dwelling	population,	a	widespread	altered	(except	for	the	
sensorimotor	tracts,	including	brainstem	tracts)	white	matter	microstructural	integrity	
with	 age	 was	 found.21	 In	 extension	 to	 this	 study,	 we	 now	 demonstrate	 that	 altered	
microstructural	 integrity	 of	 the	 same	 supratentorial	 tracts	 is	 associated	with	 poorer	
cognitive	performance,	 independent	 from	age	 and	 cardiovascular	 risk	 factors.	Also,	
after	excluding	participants	with	possible	mild	cognitive	impairment	(MMSE<26),	the	
associations	remained	significant.	The	association	between	tract-specific	white	matter	
microstructure	and	global	cognition	was	particularly	driven	by	information	processing	
speed,	executive	function	and	motor	speed,	but	not	by	memory.	Only	few	tract-specific	
studies	investigated	the	association	of	microstructural	integrity	of	brain	white	matter	
with	cognition	 in	 asymptomatic	participants.43-49	Some	studies	 concluded	 that	white	
matter	throughout	the	brain	was	associated	with	cognitive	performance	and	reported	
no	specific	role	for	any	white	matter	tract.49	Other	studies	found	a	tract-specific	effect	
in	which	altered	microstructural	integrity	in	association	and	callosal	tracts	associated	
with	 poorer	 information	 processing	 speed	 and	 executive	 function,43-45,47,48	 and	 with	
poorer	 motor	 speed,45	 which	 is	 in	 line	 with	 our	 findings.	 However,	 some	 previous	
studies	associated	altered	tract-specific	white	matter	microstructure	with	memory,	in	
contrast	to	our	results.45,46,50	Our	study	differs	from	these	studies	in	that	we	investigated	
a	larger	sample,	and	we	took	white	matter	atrophy	and	white	matter	lesion	volume	into	
account,	and	thus	adjusted	for	macrostructural	white	matter	changes,	which	may	have	
driven	the	association	with	memory	function	in	previous	research.	Furthermore,	other	
studies	incorporated	different	memory	tests	and	cognitive	domains	(e.g.	impaired	error	
monitoring)	and	different	white	matter	tracts	(e.g.	fornix).50
We	did	not	find	similar	associations	with	cognitive	function	across	all	tracts.	We	found	
the	 strongest	associations	between	white	matter	microstructure	and	cognition	 in	 the	
posterior	thalamic	radiation	and	the	inferior-occipital	fasciculus.	This	is	largely	in	line	
with	previous	studies	performed	in	specific	patient-populations	such	as	in	secondary-
progressive	multiple	sclerosis,	subcortical	ischemic	vascular	disease,51,52	and	coronary	
artery	disease.16	We	can	hypothesize	on	the	basis	of	this	finding	using	the	previously	
described	‘disconnection	hypothesis’53.	The	posterior	thalamic	radiation	connects	the	
thalamus	with	the	posterior	parietal	and	occipital	lobe54	and	plays	a	key	role	connecting	
visual	and	motor	processes.	The	 inferior	 fronto-occipital	 fasciculus	connects	 frontal	
cortical	regions	with	posterolateral	temporal	and	occipital	regions	and	is	involved	in	
language	function	and	in	visual	spatial	function	which	influences	coordinative	abili-
ties.45,55	Information	processing	speed	and	executive	function	are	partly	dependent	on	
language	 function	 and	 on	 visual	 capabilities;	motor	 speed	 depends	 on	 coordinative	
abilities.	Damage	to	the	tracts	integrating	these	processes	may	therefore	lead	to	poorer	
cognitive	performance	in	these	domains.
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The	role	of	APOE-ε4	allele	carriership	 in	white	matter	microstructural	 integrity	and	
cognition	is	still	under	debate.	We	found	no	significant	interaction	between	APOE-ε4 
allele	 carriership	 and	white	matter	microstructural	 integrity	 in	 the	 association	with	
cognition,	in	line	with	previous	studies.56,57	This	may	indicate	that	although	APOE-ε4 
allele	carriership	is	a	major	genetic	risk	factor	for	cognitive	impairment	and	Alzheim-
er’s	disease,	this	may	not	be	mediated	by	altered	white	matter	microstructural	integrity.
Lower	values	of	FA	in	the	association	tracts	were	most	strongly	associated	with	poorer	
cognitive	 performance.	 In	 contrast,	 higher	 values	 of	 MD	 in	 the	 projections	 tracts	
were	most	strongly	associated	with	impaired	cognition.	The	disparity	in	associations	
between	FA,	MD	and	cognitive	performance	might	 indicate	 that	FA	and	MD	reflect	
different	 pathophysiology.	The	 lack	 of	 specificity	 in	 the	 interpretation	 of	 diffusion-
MRI	parameters	prevents	clear-cut	conclusions	on	the	exact	mechanisms	underlying	
the	changes	in	diffusion-MRI	parameters.	It	can	be	hypothesized	that	FA	is	dominated	
by	tract	coherence	and	axonal	loss,	and	MD	by	(volume	of)	extracellular	fluid.6,9	Apart	
from	a	biological	difference,	MD	seems	to	be	more	sensitive	to	changes	in	regions	with	
crossing	 tracts,58	 and	 since	 voxels	 of	 projection	 tracts	 (corticospinal	 tract,	 superior	
thalamic	radiation)	contain	large	volumes	of	crossing-tract	anatomy,	this	might	explain	
part	of	the	disparity	observed.21	Our	observation	that	after	adjustments	for	global	dif-
fusion	parameters,	the	various	associations	remained	significant,	at	least	indicates	that	
there	is	variation	in	tracts	beyond	global	diffusion-MRI	parameters,	and	suggests	local	
or	functional	differences	in	patterns	of	white	matter	neurodegeneration.
Conclusions
In	conclusion,	tract-specific	diffusion-MRI	parameters	provide	insight	into	the	associa-
tion	between	white	matter	tracts	and	cognitive	performance	beyond	global	diffusion-
MRI	 parameters.	 This	 study	 provides	 novel	 etiological	 insight	 into	 the	 relation	 of	
the	 location	of	brain	damage	and	cognitive	performance;	 in	other	words	 it	provides	
insight	 in	which	 tract	 influences	which	specific	cognitive	domain.	Second,	our	find-
ings	may	 also	 have	 clinical	 implications.	 For	 instance,	 knowledge	 on	 tract-specific	
effects	on	cognition	may	inform	clinicians	to	predict	which	cognitive	domains	may	be	
most	affected	depending	on	the	location	of	a	stroke.	Finally,	given	the	importance	of	
recognizing	pathways	leading	to	cognitive	impairment	and	dementia,	our	results	may	
aid	 in	 developing	 new	 biomarkers	 for	 cognitive	 impairment	 and	 neurodegenerative	
diseases	and	may	lead	to	better	recognition	of	persons	at	risk.
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 Supplementary figure A1 Scatterplot	correlating	tract-specific	fractional	anisotropy	with	global	cognition	(g-
factor),	adjusted	for	age	and	sex. 
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Supplementary figure A2. Scatterplot	 correlating	 tract-specific	 mean	 diffusivity	 with	 global	 cognition	 (g-
factor),	adjusted	for	age	and	sex. 
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Supplementary figure A2. Scatterplot	 correlating	 tract-specific	 mean	 diffusivity	 with	 global	 cognition	 (g-
factor),	adjusted	for	age	and	sex. 
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factor),	adjusted	for	age	and	sex.
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ABStrACt
Background	 The	 ‘disconnectivity	 hypothesis’	 postulates	 that	 partial	 loss	 of	 con-
necting	white	matter	fibers	between	brain	regions	contributes	to	the	development	of	
dementia,	 including	Alzheimer’s	 disease	 (AD).	Using	 diffusion-magnetic	 resonance	
imaging	(MRI)	to	quantify	global	and	tract-specific	white	matter	microstructural	integ-
rity,	we	tested	this	hypothesis	in	a	longitudinal	population-based	setting.
Method	Global	and	tract-specific	measures	of	fractional	anisotropy	(FA)	and	mean	
diffusivity	 (MD)	 were	 obtained	 in	 4,415	 non-demented	 persons	 (mean	 age	 63.9	
years	 (SD	 11.0),	 55.0%	women)	 from	 the	 prospective	 population-based	 Rotterdam	
Study	with	brain	MRI	 (2005-2011).	We	modelled	 the	 association	of	 these	diffusion	
measures	with	risk	of	dementia	(follow-up	until	2016),	and	with	changes	on	repeated	
cognitive	assessment	over	5.4	years	of	 follow-up,	adjusting	 for	age,	 sex,	education,	
macrostructural	MRI	markers,	depressive	symptoms,	cardiovascular	risk	factors,	and	
APOE	genotype.
Findings	During	 a	mean	 follow-up	 of	 6.7	 years,	 101	 participants	 had	 incident	 de-
mentia,	 of	whom	83	had	AD.	Lower	global	values	of	FA	and	higher	values	of	MD	
associated	with	an	increased	risk	of	dementia	(adjusted	hazard	ratio	(95%	confidence	
interval)	per	 standard	deviation	 increase	 in	MD:	1.79	 (1.44-2.23)).	Similarly,	 lower	
global	values	of	FA	and	higher	values	of	MD	related	to	more	cognitive	decline	in	non-
demented	individuals	(difference	in	global	cognition	per	standard	deviation	increase	
in	MD	(95%	CI)	was:	 -0.04	 (-0.07;-0.01)).	Associations	were	most	profound	 in	 the	
projection,	association	and	limbic	system	tracts.
Interpretations	Structural	disconnectivity	is	associated	with	and	an	increased	risk	
of	dementia	and	more	pronounced	cognitive	decline	in	the	general	population.
Funding	 Internationale	 Stichting	Alzheimer	 Onderzoek,	 European	 Union	 Seventh	
Framework	Programma,VPH-Dare@IT	and	the	STW	perspectief	programme	Popula-
tion	Imaging	Genetics	(ImaGene).
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INtroduCtIoN
Dementia	 is	 among	 the	 leading	 causes	 of	 death	 and	 disability	 worldwide,	 and	 its	
socioeconomic	burden	on	society	will	continue	to	increase	as	the	number	of	persons	
suffering	from	dementia	is	predicted	to	nearly	triple	to	131.5	million	in	2050.1	Effec-
tive	preventive	and	curative	interventions	are	urgently	needed,	but	their	development	
and	timely	application	is	hampered	by	incomplete	understanding	of	pathophysiology,	
lack	of	markers	that	can	identify	changes	in	the	very	early,	subclinical	stages	of	disease	
and	lack	of	prognostic	markers.	Subclinical	brain	changes	are	thought	to	occur	years,	
if	 not	 decades,	 prior	 to	 onset	 of	 clinical	 symptoms,2	which	 is	 beyond	 the	 scope	 of	
currently	applied	subclinical	macrostructural	imaging	markers	of	neurodegeneration,	
such	as	hippocampal	volume	and	presence	of	white	matter	hyperintensities.
One	of	the	recent	insights	in	dementia	is	that	brain	damage	can	lead	to	disruption	of	
brain	networks,	so	called	disconnectivity.3-5	Disconnectivity,	which	can	be	investigated	
using	diffusion-magnetic	resonance	imaging	(MRI),	seems	to	occur	prior	to	changes	
in	conventional	structural	MRI	markers	such	as	white	matter	hyperintensities	load	in	
dementia,6	 and	 is	 thought	 to	 reflect	 early	 cerebral	white	matter	 damage.7,8	 Previous	
studies	have	shown	more	pronounced	disconnectivity	both	in	patients	with	dementia	
compared	to	healthy	controls,9,10	and	in	relation	to	more	rapid	progression	in	patients	
with	Alzheimer’s	 disease	 (AD).11	 However,	 evidence	 from	 longitudinal	 studies	 for	
a	 role	of	 preclinical	 disconnectivity	 in	 the	development	of	 dementia	 is	 scarce.	Two	
clinical	studies	among	patients	with	small	vessel	disease	found	that	network	disruption	
increases	the	risk	of	dementia,12,13	but	these	studies	were	hampered	by	limited	precision	
(observing	18	and	32	cases	of	dementia,	 respectively),	and	it	 remains	undetermined	
whether	findings	extend	to	the	wider	population	without	prior	TIA	or	stroke.
Therefore,	we	aimed	to	 test	 the	disconnectivity	hypothesis	by	 investigating	whether	
global	 and	 tract-specific	disconnectivity	are	associated	with	dementia	and	cognitive	
decline	in	a	population-based	setting.
MethodS
Study population
This	 study	 was	 embedded	 within	 the	 Rotterdam	 Study,	 a	 population-based	 cohort	
study	 including	 participants	 of	 45	 years	 and	 older	 living	 in	Ommoord,	 a	 suburb	 of	
Rotterdam.14	 The	 study	 started	 in	 1990	 with	 7,983	 participants	 and	 was	 extended	
with	3,011	participants	in	2000	and	with	3,932	participants	in	2006.	Participants	were	
examined	 at	 baseline	 with	 a	 home	 interview	 and	 an	 extensive	 set	 of	 examinations	
in	the	research	center.	Follow-up	examinations	were	repeated	every	3-4	years.	Also,	
all	participants	were	continuously	monitored	through	electronic	linkage	of	the	study	
Chapter	3.3
164
database	with	their	own	medical	records.	All	details	of	the	study	have	been	previously	
described.14	From	2005	onwards,	MRI-scanning	was	implemented	in	the	core	protocol.	
Between	2005	and	2011,	5,715	participants	without	contraindications	for	MRI	(metal	
implants,	 pacemaker,	 claustrophobia)	 were	 eligible	 for	 scanning,	 of	 whom	 4,888	
(86%)	underwent	a	multi-sequence	MRI	acquisition	of	the	brain,	and	4,813	(98%)	par-
ticipants	 completed	 the	diffusion-weighted	 sequences.	We	excluded	245	 individuals	
due	to	technical	scanning	issues,	e.g.	failed	segmentations,	as	well	as	38	participants	
with	prevalent	dementia	and	100	participants	with	insufficient	dementia	screening	at	
baseline,	resulting	in	a	study	sample	of	4,430	individuals.	Of	these	individuals,	4,317	
persons	had	detailed	cognitive	assessment	at	baseline	and	3,402	(79%)	had	repeated	
assessment	 during	 follow-up	 examination	 after	 on	 average	 5.4	 (SD	0.6)	 years.	The	
Rotterdam	Study	has	been	approved	by	the	medical	ethics	committee	according	to	the	
Population	Study	Act	Rotterdam	Study,	executed	by	the	Ministry	of	Health,	Welfare	
and	Sports	of	the	Netherlands.	All	participants	gave	written	informed	consent.
MrI acquisition and processing
Multi-sequence	MR	imaging	was	performed	on	a	1.5	tesla	MRI	scanner	(GE	Signa	Ex-
cite).	The	imaging	protocol	has	been	described	extensively	elsewhere.15	The	conven-
tional	scan	protocol	consisted	of	a	T1-weighted	image,	a	T2-weighted	fluid-attenuated	
inversion	recovery	(FLAIR)	sequence,	and	a	proton	density	weighted	image.
Scans	were	spatially	co-registered	using	rigid	registration.	Scans	were	segmented	with	
an	automated	 tissue	 segmentation	approach	 into	grey	matter,	white	matter,	 cerebro-
spinal	fluid	(CSF)	and	background	tissue,16,17	followed	by	a	white	matter	hyperinten-
sity	(WMH)	segmentation	based	on	the	tissue	segmentation	and	the	FLAIR	image.18 
Supratentorial	 intracranial	volume	(ICV),	 to	correct	for	head	size,	was	estimated	by	
summing	 total	 grey	 and	white	matter	 and	CSF	volumes.17	We	visually	 assessed	 the	
presence	of	 infarcts	on	conventional	MRI	sequences,	and	 in	case	of	 involvement	of	
cortical	grey	matter	we	classified	these	as	cortical	infarcts.
Diffusion-MRI processing and tractography
For	diffusion-MRI,	we	performed	a	 single	 shot,	diffusion-weighted	 spin	echo	echo-
planar	 imaging	 sequence.	 Maximum	 b-value	 was	 1000	 s/mm2	 in	 25	 non-collinear	
directions;	 three	volumes	were	acquired	without	diffusion	weighting	(b-value	=	0	s/
mm2).	All	diffusion	data	were	pre-processed	using	a	standardized	pipeline.19	In	short,	
eddy	current	and	head-motion	correction	were	performed	on	 the	diffusion	data.	The	
resampled	data	was	used	 to	fit	diffusion	 tensors	 to	compute	mean	 fractional	 anisot-
ropy	(FA)	and	mean	diffusivity	(MD)	in	the	normal-appearing	white	matter,	through	
combination	with	the	tissue	segmentation.	The	diffusion	data	was	also	used	to	segment	
white	 matter	 tracts	 using	 a	 diffusion	 tractography	 approach	 described	 previously.20 
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We	segmented	15	different	white	matter	tracts	(12	bilateral,	3	singular)	and	obtained	
mean	 FA	 and	 MD	 in	 these	 tracts,	 with	 subsequent	 combination	 of	 left	 and	 right	
measures.20	In	general,	lower	FA	and	higher	MD	values	are	considered	indicative	of	
lower	microstructural	integrity	and	as	such	reflecting	disconnectivity.	Missing	data	for	
tract-specific	measurements	due	to	tractography	or	segmentation	failures	were	limited	
to	33-78	participants	(0.8-1.8%)	per	tract.	Tracts	were	categorized,	based	on	anatomy	
or	 presumed	 function,	 into	 brainstem	 tracts	 (middle	 cerebellar	 peduncle,	 medial	
lemniscus),	projection	tracts	(corticospinal	tract,	anterior	thalamic	radiation,	superior	
thalamic	radiation,	posterior	thalamic	radiation),	association	tracts	(superior	longitu-
dinal	fasciculus,	inferior,	longitudinal	fasciculus,	inferior	fronto-occipital	fasciculus,	
uncinated	fasciculus),	limbic	system	tracts	(cingulate	gyrus	part	of	cingulum,	parahip-
pocampal	part	of	cingulum)	and	callosal	tracts	(forceps	major,	forceps	minor).20
We	obtained	tract	volumes	and	tract	WMH	volumes	by	combining	the	tissue	and	tract	
segmentations.	Tract-specific	WMH	volumes	were	natural-log	transformed,	to	account	
for	their	skewed	distribution.
Between	February	2007	and	May	2008,	an	erroneous	swap	of	the	phase	and	frequency	
encoding	directions	for	the	diffusion	acquisition	led	to	a	mild	ghosting	artifact,	which	
was	addressed	by	adjustment	in	the	analysis.20	There	was	only	partial	coverage	of	one	
of	the	brainstem	tracts	(medial	lemniscus)	due	to	incomplete	coverage	of	the	cerebel-
lum	 in	 the	 field	 of	 view,	 and	we	 used	 alternative	 seed	masks	 for	 tractography	 and	
adjustment	in	the	model	to	overcome	this	problem.20
dementia screening and surveillance
All	participants	were	screened	for	dementia	at	baseline	and	during	subsequent	center	
visits	 using	 the	Mini-Mental-State	 Examination	 (MMSE)	 and	 the	 Geriatric	Mental	
Schedule	 (GMS)	 organic	 level.21	 Participants	with	 an	MMSE	 score	 <26	 or	 a	GMS	
score	 >0	 underwent	 further	 cognitive	 examination	 and	 informant	 interview,	 includ-
ing	 the	 Cambridge	 Examination	 for	 Mental	 Disorders	 of	 the	 Elderly.	 In	 addition,	
the	entire	cohort	was	under	continuous	surveillance	for	dementia	 through	electronic	
linkage	of	the	study	database	with	medical	records	from	general	practitioners	and	the	
regional	 institute	 for	outpatient	mental	health	care.	Clinical	neuroimaging	was	used	
when	required	for	dementia	subtype	diagnosis.	A	consensus	panel	led	by	a	consultant	
neurologist	 established	 the	 final	 diagnosis	 in	 accordance	 with	 standard	 criteria	 for	
dementia	(DSM-III-R)	and	Alzheimer’s	disease	(NINCDS-ADRDA).	Follow-up	until	
1st	January	2016	was	virtually	complete	(96%	of	potential	person	years).	Participants	
were	censored	at	date	of	dementia	diagnosis,	death,	loss	to	follow-up,	or	1st	January	
2016,	whichever	came	first.
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Assessment of cognitive function
During	center	visits,	all	participants	underwent	routine	cognitive	assessment	compris-
ing	a	word	fluency	test	(number	of	animal	species	within	1	minute),	15-word	learning	
test	(immediate	and	delayed	recall	of	15	items),	letter-digit	substitution	task	(LDST,	
number	 of	 correct	 digits	 in	 1	 minute),	 Stroop	 test	 (error	 adjusted	 time	 in	 seconds	
taken	 for	 completing	 the	 reading,	 colour	 naming,	 and	 interference	 tasks),	 and	 the	
Purdue	Pegboard	 task	for	manual	dexterity.21	To	obtain	a	composite	measure	of	 test	
performance,	 we	 calculated	 the	 G-factor	 by	 principal	 component	 analysis,21	 which	
explained	49-54%	of	variance	 in	cognitive	 test	scores	at	each	examination	round	 in	
our	population.	For	each	participant,	Z-scores	were	calculated	for	each	test	separately,	
by	dividing	the	difference	between	individual	test	score	and	population	mean	by	the	
population	 standard	 deviation.	 Scores	 for	 the	 Stroop	 tasks	 were	 inverted	 such	 that	
higher	scores	indicated	better	performance.
other measurements
Information	on	 smoking	habits,	 educational	 attainment,	 and	use	of	antihypertensive	
and	 lipid-lowering	 medication	 was	 ascertained	 at	 baseline	 by	 structured	 question-
naires.	Blood	 pressure	was	measured	 twice	 in	 sitting	 position	 using	 a	 random-zero	
sphygmomanometer	 and	 the	mean	 of	 two	 readings	was	 used	 in	 the	 analyses.	Total	
serum	cholesterol	and	high-density	lipoprotein	(HDL)	cholesterol	were	determined	in	
fasting	blood	samples.	Presence	of	type	2	diabetes	at	baseline	was	determined	on	the	
basis	of	 fasting	 serum	glucose	 level	 (>=	7.0	mmol/l)	 or,	 if	 unavailable,	 non-fasting	
serum	glucose	level	(>=11.1	mmol/l)	or	the	use	of	anti-diabetic	medication.22	Body-
mass	index	(BMI)	was	calculated,	dividing	weight	in	kilograms	by	the	squared	height	
in	meters.	History	of	stroke	was	assessed	by	interview,	and	verified	in	medical	records,	
and	participants	were	continuously	monitored	for	 incident	stroke	through	computer-
ized	 linkage	of	medical	 records	from	general	practitioners	and	nursing	home	physi-
cians	with	the	study	database.	We	used	the	validated	Dutch	version	of	the	Center	for	
Epidemiology	Depression	Scale	(CES-D)	for	assessment	of	depressive	symptoms.23
APOE	 genotype	 was	 determined	 using	 polymerase	 chain	 reaction	 on	 coded	 DNA	
samples	(original	cohort),	and	using	a	bi-allelic	TaqMan	assay	(rs7412	and	rs429358;	
expansion	 cohort).	 In	 179	 participants	 with	 missing	 APOE	 status	 from	 this	 blood	
sampling,	genotype	was	determined	by	genetic	imputation	(Illumina	610K	and	660K	
chip;	 imputation	with	Haplotype	Reference	Consortium	 reference	panel	 [v1.0]	with	
Minimac	3).
Statistical analysis
Analyses	included	all	eligible	participants,	with	the	exception	of	15	participants	whose	
diffusion	 measures	 deviated	 >7	 standard	 deviations	 from	 the	 mean,	 leaving	 4,415	
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participants	 for	analysis.	We	used	Cox	proportional	hazard	models	 to	determine	 the	
association	 of	 global	 and	 tract-specific	 diffusion-MRI	measures	 (FA	 and	MD)	with	
incident	dementia.	The	proportional	hazard	assumption	was	met.	We	assessed	risk	of	
dementia	 per	 standard	 deviation	 increase	 in	 FA	 and	MD.	We	 repeated	 the	 analyses	
1)	 for	Alzheimer	 disease	 only,	 2)	 after	 excluding	 participants	with	 prevalent	 stroke	
while	 censoring	 at	 time	of	 incident	 stroke,	 3)	 excluding	persons	with	MRI-defined,	
subclinical	cortical	infarcts	at	baseline,	and	4)	stepwise	excluding	the	first	five	years	of	
follow-up	from	the	analysis.
We	 then	determined	 the	association	of	global	and	 tract-specific	diffusion-MRI	mea-
sures	with	change	in	cognitive	performance	using	linear	regression	models.	Cognitive	
test	scores	at	follow-up	were	adjusted	for	baseline	cognitive	test	results.	These	analy-
ses	were	repeated	after	exclusion	of	all	participants	who	developed	dementia	during	
follow-up.	All	 models	 were	 adjusted	 for	 age,	 sex,	 education,	 intracranial	 volume,	
white	matter	volume,	and	the	log-transformed	volume	of	white	matter	hyperintensities	
and	the	correction	for	swapping	gradients	and	varying	field	of	view	(model	I),	and	ad-
ditionally	for	education,	depressive	symptoms	(CES-D	score),	and	cardiovascular	risk	
factors	(systolic	blood	pressure,	diastolic	blood	pressure,	antihypertensive	medication,	
serum	 cholesterol,	 HDL-cholesterol,	 lipid-lowering	 medication,	 diabetes,	 smoking,	
and	BMI),	and	APOE-ε4	allele	carriership	(model	II).
For	 the	 tract-specific	 analyses,	 we	 corrected	 the	 p-value	 (alpha	 level	 of	 0.05)	 for	
multiple	comparisons	with	the	number	of	independent	tests	on	the	basis	of	the	vari-
ance	of	the	eigenvalues	of	the	correlation	matrix	of	all	30	variables	used	in	the	main	
analysis	 (i.e.	FA	and	MD	for	 the	15	 tracts).	The	 following	 formula	was	used:	Meff= 
1	+(M-1)(1-var	(λobs)/M)	in	which	M	is	 the	number	of	variables,	λobs	 is	 the	variance	
of	 the	 eigenvalues	 of	 the	 correlation	matrix,and	Meff	 is	 the	 number	 of	 independent	
variables.24,25	This	resulted	in	an	Meff	of	17.45,	which	then,	using	the	Šidák	formula	(α	
sidak	=	1	-	((1	-	α)^(1/Meff))),	translated	into	a	significance	level	of	p<0.0029	for	the	
tract-specific	analyses	with	dementia	as	outcome.24
For	 the	 analyses	 assessing	 global	 diffusion-MRI	measures	with	 the	 separate	 cogni-
tive	tests	as	outcome,	the	above-mentioned	method	generated	a	significance	level	of	
p<0.008.	 For	 analyses	 assessing	 tract-specific	 diffusion-MRI	 measures	 with	 global	
cognition	and	separate	cognitive	tests	as	outcome,	the	adjusted	p-value	was	p<0.0022.
All	 analyses	were	 carried	out	 using	SPSS	Statistics	 21.0	 (IBM	Corp,	Armonk,	NY,	
USA)	 or	 R	 version	 3.0.3	 (packages	 “GenABEL”,	 “survival,	 “stargazer”	 and	 “data.
table”).
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table 1	presents	the	baseline	characteristics	of	the	study	population.	Mean	age	of	the	
4,415	participants	was	63.9	years	(SD	±11.1	years),	and	55.0%	were	women.	During	a	
median	follow-up	of	6.8	years	(IQR	5.8-8	.0	years),	101	persons	developed	dementia,	
of	whom	83	had	AD.
table 1. Population	characteristics
Characteristic N= 4,415
Age,	years 63.9	(±11.0)
Female	 2,426	(55.0	%)
Smoking	
			Never 1367	(31.0%)
			Former 2120	(48.0%)
			Current 928	(21.0%)
Education
			Lower	education 1266	(28.7%)
			Middle	education 2107	(47.7%)
			Higher	education 1042	(23.6%)
Systolic	blood	pressure,	mmHg 140.0	(±21.5)
Diastolic	blood	pressure,	mmHg 83.2	(±10.9)
Antihypertensive	medication 1573	(35.6)
Total	cholesterol,	mmol/L 5.5	(±1.1)
HDL	cholesterol,	mmol/L 1.5	(±0.4)
Lipid-lowering	medication 1113	(25.2%)
Diabetes	mellitus 531	(12.0%)
BMI,	kg/m2 27.4	(±4.1)
Center	for	Epidemiology	Depression	Scale	score 8	(2-12)
APOE-ε4	carriership 1216	(28.3%)
Mean	FA 0.34	(±0.02)
Mean	MD 0.74	(±0.03)
Intracranial	volume,	mL 1142.0	(±116.4)
White	matter	volume,	mL 409.3	(±60.7)
White	matter	hyperintensities	volume,	mL 2.90	(1.6-6.3)
Continuous	variables	are	presented	as	means	(±standard	deviations)	and	categorical	variables	as	n	(percent-
ages),	except	for	white	matter	hyperintensities	volume	and	Center	for	Epidemiology	Depression	Scale	score,	
which	are	presented	as	median	(inter-quartile	range).
Abbreviations: N:number of participants, HDL:high-density lipoprotein, BMI: body mass index, s;seconds, 
FA:fractional anisotropy, MD:mean diffusivity x 10-3 mm2/sec, mL: milliliter.
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Lower	microstructural	integrity,	reflected	in	lower	values	of	global	FA	and	higher	values	
of	global	MD	was	associated	with	a	higher	risk	of	dementia	(fully	adjusted	hazard	ratio	
[HR],	95%	confidence	interval	(CI),	per	SD	increase	in	FA:	0.65	(0.52-0.80),	and	for	MD:	
1.79	(1.44-2.23)	(figure 1, Supplementary table S1).	Results	were	similar	for	AD	only,	
and	unaltered	after	excluding	participants	with	prevalent	stroke	while	censoring	at	time	of	
incident	 stroke,	or	 excluding	participants	with	 subclinical	MRI-defined	cortical	 infarcts	
(figure 1, Supplementary table S1).	Stepwise	exclusion	of	the	first	five	years	of	follow-
up	from	the	analysis	did	not	alter	the	risk	estimates	(figure 2, Supplementary table S2).
In	tract-specific	analyses,	the	strongest	associations	with	dementia	risk	were	observed	
for	MD	 in	 the	projection	 tracts,	 association	 tracts	 and	 limbic	 system	 tracts	 (per	SD	
increase	HR	of	2.35	(1	.53;3.62)	for	the	superior	thalamic	radiation,	1.79	(1.36;2.37)	
for	the	inferior	fronto-occipital	fasciculus,	and	1.62	(1.41;1.86)	for	the	parahippocam-
pal	part	of	the	cingulum	respectively	(table 2, figure 3)).	Similarly,	lower	FA	in	the	
association	 tracts	 and	 in	 the	 limbic	 system	 tracts	 were	most	 profoundly	 associated	
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with	a	higher	risk	of	dementia	(per	SD	increase	HR	0.59	(0.45;0.76)	for	the	uncinated	
fasciculus	 and	HR	 0.67	 (0.53;0.84)	 for	 the	 parahippocampal	 part	 of	 the	 cingulum,	
respectively,	in	the	fully	adjusted	model	(table 2)).
The	association	between	global	white	matter	microstructure	and	cognitive	decline	is	
presented	in	table 3.	Higher	values	of	global	MD	were	associated	with	greater	decline	
in	global	cognition,	driven	by	worse	performance	on	the	Word	Fluency	Test	and	Stroop	
reading	and	interference	subtasks.	Results	were	unaltered	by	exclusion	of	all	incident	
dementia	 cases	 (Supplementary table S3).	 Similar	 associations,	 albeit	 somewhat	
attenuated,	were	observed	for	FA.
table 2. Tract-specific	white	matter	microstructure	and	incident	dementia
Fractional Anisotropy Mean Diffusivity
white matter tracts Model I Model II Model I Model II
Brainstem tracts
Middle	cerebellar	peduncle 1.05	(0.85;1.30) 1.08	(0.87;1.35) 1.05	(0.85;1.30) 1.04	(0.83;1.30)
Medial	lemniscus	 1.09	(0.86;1.39) 1.11	(0.86;1.44) 1.06	(0.88;1.28) 1.06	(0.87;1.29)
Projection tracts 
Corticospinal	tract 1.17	(0.95;1.44) 1.19	(0.96;1.47) 1.52 (1.13;2.06) 1.52 (1.11;2.08)
Anterior	thalamic	radiation 0.85	(0.66;1.09) 0.87	(0.67;1.13) 1.68 (1.23;2.30)* 1.73 (1.26;2.38)*
Superior	thalamic	radiation 1.17	(0.95;1.45) 1.20	(0.97;1.50) 2.29 (1.49;3.52)* 2.35 (1.53;3.62)*
Posterior	thalamic	radiation 0.69 (0.52;0.90) 0.74 (0.56;0.97) 1.41 (1.15;1.72)* 1.42 (1.15;1.75)*
Association tracts
Superior	longitudinal	fasciculus 0.77	(0.60;1.00) 0.79	(0.60;1.04) 1.65 (1.30;2.11)* 1.65 (1.28;2.14)*
Inferior	longitudinal	fasciculus 0.79	(0.62;1.01) 0.84	(0.65;1.09) 1.73 (1.36;2.21)* 1.69 (1.31;2.18)*
Inferior	fronto-occipital	fasciculus 0.66 (0.50;0.86)* 0.71 (0.53;0.93) 1.75 (1.34;2.27)* 1.79 (1.36;2.37)*
Uncinate	fasciculus 0.60 (0.47;0.77)* 0.59 (0.45;0.76)* 1.67 (1.39;2.00)* 1.73 (1.42;2.10)*
Limbic system tracts
Cingulate	gyrus	part	of	cingulum 0.69	(0.54;0.87) 0.71 (0.55;0.90) 1.55 (1.26;1.92)* 1.58 (1.26;1.97)*
Parahippocampal	part	of	cingulum 0.67 (0.54;0.84)* 0.67 (0.53;0.84)* 1.61 (1.41;1.85)* 1.62 (1.41;1.86)*
fornix 0.76 (0.59;0.99) 0.78	(0.60;1.02) 1.13	(0.80;1.58) 1.06	(0.75;1.50)
Callosal tracts
Forceps	major 0.77 (0.59;1.00) 0.79	(0.61;1.04) 1.15	(0.93;1.41) 1.12	(0.90;1.38)
Forceps	minor 0.78	(0.60;1.01) 0.80	(0.61;1.06) 1.38 (1.12;1.71) 1.39 (1.11;1.75)
Data	are	presented	as	Hazard	ratios	(95%	CI)	per	standard	deviation	increase	of	FA	and	MD.	Results	in	bold	
were	significant	at	p<0.05	and	those	that	were	starred	*	at	p<0.0029.	Model	I:	adjusted	for	age,	sex,	education,	
intracranial	volume,	white	matter	volume	and	the	log	transformed	white	matter	lesion	volume	of	the	investigat-
ed	tract.	Model	II:	Model	I,	and	additionally	adjusted	for	CES-D	score,	and	cardiovascular	risk	factors	(systolic	
blood	 pressure,	 diastolic	 blood	 pressure,	 antihypertensive	medication,	 serum	cholesterol,	HDL-cholesterol,	
lipid	lowering	medication,	diabetes,	smoking,	BMI)	and	apolipoprotein E-ε4 allele	carriership.
Abbreviations: FA: fractional anisotropy, MD; mean diffusivity, WML: white matter lesion, BMI: Body Mass 
Index, CES-D: Center for Epidemiology Depression Scale score.
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radiation, SLF: superior longitudinal fasciculus, ILF: inferior longitudinal fasciculus, IFO: inferior-fronto-
occipital fasciculus, UNC: uncinate fasciculus, CGC: cingulate gyrus part of cingulum, CGH: parahippocam-
pal part of cingulum.
table 3. Global	white	matter	microstructure	and	cognitive	decline
fA Md
G-factor 0.02	(-0.004;0.041) -0.04 (-0.07;-0.01)
Immediate	memory -0.002	(-0.04;0.03) -0.03	(-0.07;0.02)
Delayed	memory 0.007	(-0.03;0.04) -0.03	(-0.07;-0.01)
Stroop	1 0.04 (0.01;0.07)* -0.06 (-0.09;-0.02)*
Stroop	2 0.02	(-0.001;0.05) -0.02	(-0.05;0.02)
Stroop	3 0.04 (0.01;0.07)* -0.09 (-0.12;-0.05)*
Letter-Digit	Substitution	Task 0.004	(-0.02;0.03) -0.004	(-0.04;0.03)
Word	Fluency	Test 0.03	(0.001;0.06) -0.06 (-0.10;-0.02)*
Purdue	Pegboard 0.03 (0.005;0.06) -0.04	(-0.07;-0.00)
Data	are	presented	as	mean	difference	in	Z-score	(95%	CI)	per	standard	deviation	increase	of	FA	and	MD.	
Results	in	bold	were	significant	at	p<0.05	and	those	that	were	starred	*	at	p<0.008.
Model	 adjusted	 for	 age,	 sex,	 education,	 intracranial	volume,	white	matter	volume	and	 the	 log	 transformed	
white	matter	lesion	volume,	CES-D	score,	and	additionally	adjusted	for	cardiovascular	risk	factors	(systolic	
blood	 pressure,	 diastolic	 blood	 pressure,	 antihypertensive	medication,	 serum	cholesterol,	HDL-cholesterol,	
lipid	lowering	medication,	diabetes,	smoking,	BMI)	and	apolipoprotein E-ε4 allele	carriership.
Abbreviations: FA: fractional anisotropy, MD; mean diffusivity, WML: white matter lesion, BMI: Body Mass 
Index, CES-D score: Center for Epidemiology Depression Scale.
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In	 this	 longitudinal	population-based	study,	we	found	 that	structural	disconnectivity	
is	 associated	with	 increased	 risk	 of	 dementia	 and	with	more	 pronounced	 cognitive	
decline.	These	 associations	were	most	 profound	 for	 the	 projection,	 association	 and	
limbic	system	tracts,	and	extended	into	the	pre-clinical	phase	of	the	disease.
Longitudinal	 studies	 provide	 higher	 evidence	 for	 causal	 relations.	Our	main	 results	
provide	 evidence	 for	 the	 ‘disconnection	hypothesis’,	which	 states	 that	 loss	of	brain	
connections	 precedes	 cognitive	 decline	 and	 dementia.	 In	 line	 with	 this	 hypothesis,	
our	results	suggest	 that	disconnectivity	plays	a	role	already	in	 the	preclinical	stages	
of	dementia.	The	findings	 in	 this	 study	are	consistent	with	previous	clinical	 studies	
concluding	that	diffusion-MRI	measures	in	persons	with	cerebral	small	vessel	disease	
add	in	the	prediction	of	cognitive	decline	and	dementia.12,13	We	can	now	further	extend	
this	conclusion	to	the	general	population.
Various	potential	pathways	could	lead	to	disconnectivity.	A	vascular	pathway	has	been	
proposed	in	which	reduction	in	white	matter	perfusion,	e.g.	due	to	impaired	autoregu-
lation	may	result	in	white	matter	damage.26	Oligodendrocytes	might	shrink	because	of	
hypoxia	and	ischaemia	in	white	matter,	with	subsequent	loss	of	myelin.27,28	However,	
in	our	fully	adjusted	model	we	corrected	for	several	cardiovascular	risk	factors	and	the	
estimates	did	not	change	substantially.	This	may	be	explained	by	residual	confounding	
(due	 to	 age-specific	 effects	 of	 vascular	 factors	 or	 subclinical	 vascular	 factors),	 or	 a	
more	complex,	multifaceted	pathway,	in	which	there	is	a	complex	interplay	of	tradi-
tional	vascular	risk	factors,	hypoxia,	and	neuro-inflammation.29	Inflammation-induced	
disconnectivity	may	be	caused	by	inflammation-related	cytokines	(TNF-	α,	IL-8,	IL-
10,	IFN-	γ)	and	growth	factors	(IGFBP2,	PDGF-BB)	which	have	been	associated	with	
a	lower	integrity	of	myelin	sheaths.30,31.Yet,	reverse	causality	as	an	explanation	for	our	
findings	is	very	unlikely	since	the	risk	estimates	did	not	change	after	excluding	the	first	
five	years	of	 follow-up.	Also,	disconnectivity	associated	with	cognitive	decline	also	
in	individuals	who	did	not	develop	dementia	during	the	study	duration,	suggesting	an	
association	already	in	the	preclinical	phase	of	dementia	and	with	normal	aging.
We	found	that	structural	disconnectivity,	indicated	by	a	low	FA	and	high	MD	through-
out	the	brain,	but	in	particular	in	the	projection,	association	and	limbic	system	tracts,	
related	 to	a	higher	 risk	of	dementia.	This	 is	 in	 line	with	previous	 research	 in	cross-
sectional	studies	which	found	lower	FA	in	white	matter	tracts	including	the	association	
tracts32,33	and	projection	tracts34,35	associated	with	dementia.	Lower	FA	values	in	limbic	
system	tracts	(in	particular	in	the	parahippocampal	cingulum)	and	the	association	with	
dementia,	more	specifically	AD,	has	been	most	consistently	reported	in	previous	stud-
ies.34,36,37
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A	 small	 number	of	 studies	 reported	higher	FA	values	 in	 specific	 regions	 in	AD.38,39 
This	 counterintuitive	finding	may	be	 explained	 by	 selective	 degeneration	 of	 a	 fiber	
population	in	regions	with	crossing	white	matter	tracts,	leading	to	paradoxical	higher	
FA.40	MD	 is	 therefore	 thought	 to	be	 a	more	 sensitive	 and	 reliable	measure	 in	 these	
crossing	fiber	regions	(and	therefore	also	globally),41	and	presumably	more	sensitive	to	
white	matter	damage.9,10	Moreover,	in	a	small	group	of	patients	with	AD,	increases	in	
MD	preceded	changes	in	FA	which	only	occurred	in	a	more	progressive	disease	state.9 
Accordingly,	in	our	study	we	found	stronger	associations	with	MD	than	with	FA.
The	 exact	 pathological	 substrate	 underlying	 the	 changes	 in	 FA	 and	MD	 leading	 to	
disconnectivity	 is	 still	 unknown.	 There	 is	 pathological	 evidence	 that	 changes	 in	
diffusion-MRI	measures	correlate	with	myelin	damage	and	axonal	count,42	that	myelin	
is	 increasingly	 suggested	 as	 an	 important	 factor	 in	AD	 pathology	 and	 that	 myelin	
breakdown	 is	 at	 the	 core	 of	 the	 earliest	 changes	 involved	 in	 dementia.43	 However,	
the	presence	of	other	possible	processes	 such	 as	 inflammation	generates	difficulties	
to	assigning	change	in	diffusion-MRI	measures	to	a	specific	underlying	pathological	
process	causing	the	observed	structural	disconnectivity.44
Strengths	of	the	study	are	the	population-based	setting,	the	large	sample	size,	the	auto-
mated	publicly	available	diffusion	MRI	processing	methods	that	facilitate	replication6,	
and	the	longitudinal	assessment	of	cognitive	performance	with	meticulous	follow-up	
for	dementia.	Some	limitations	need	to	be	considered.	First,	the	averaging	of	FA	and	
MD	measures	 over	 the	 normal-appearing	 white	 matter	 for	 analyses	 discards	 some	
spatial	information.	Second,	given	the	long	preclinical	phase	of	dementia,	our	median	
follow-up	time	of	6.8	years	 is	still	 relatively	short,	and	longer	duration	studies	with	
repeated	imaging	are	required	to	further	map	changes	in	diffusion-MRI	in	the	process	
of	neurodegeneration.	Nevertheless,	our	results	were	unaffected	by	excluding	the	first	
five	years	of	 follow-up,	and	 independent	of	macrostructural	white	matter	pathology	
(white	matter	hyperintensity	volume).	Third,	although	we	found	associations	similar	
for	all-cause	dementia	and	clinical	AD,	confirmation	of	subtype	diagnosis	by	biomark-
ers	or	pathological	examination	was	not	available.
In	 conclusion,	 structural	 disconnectivity	 increases	 the	 risk	 of	 dementia	 and	 more	
pronounced	cognitive	decline.	Our	study	suggests	 that	diffusion-MRI	may	be	useful	
in	risk	prediction.
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Supplementary table S1.	Global	white	matter	microstructure	and	incident	dementia
        Model fA Md
All	dementia	(n=101)	 	 	 	 model		I 0.65 (0.53;0.80) 1.77 (1.43;2.17)
	 	 	 	 	 	 	 	 model		II 0.65 (0.52;0.80) 1.79 (1.44;2.23)
AD	(n=83)	 	 	 	 	 	 model		I 0.70 (0.55;0.88) 1.71 (1.35;2.16)
	 	 	 	 	 	 	 	 model		II 0.69 (0.54;0.88) 1.76 (1.38;2.24)
Censoring	for	stroke	(n=98)		 	 model		I 0.65 (0.53;0.80) 1.75 (1.41;2.16)
	 	 	 	 	 	 	 	 model		II 0.64 (0.52;0.80) 1.76 (1.42;2.20)
Exclusion	cortical	infarcts	(n=97)	 model		I 0.63 (0.51;0.78) 1.75 (1.41;2.17)
	 	 	 	 	 	 	 	 model		II 0.61 (0.49;0.77) 1.79 (1.43;2.24)
Data	are	presented	as	Hazard	ratios	(95%	CI)	per	standard	deviation	increase	of	FA	and	MD.	Results	in	bold	
were	significant	at	p<0.05.
Model	I:	adjusted	for	age,	sex,	education,	intracranial	volume,	white	matter	volume	and	the	log	transformed	
white	matter	hyperintensity	volume.
Model	II:	Model	I,	and	additionally	adjusted	for	CES-D	score,	cardiovascular	risk	factors	(systolic	blood	pres-
sure,	diastolic	blood	pressure,	antihypertensive	medication,	serum	cholesterol,	HDL-cholesterol,	lipid	lower-
ing	medication,	diabetes,	smoking,	BMI),	and	apolipoprotein E-ε4 allele	carriership.
Abbrevations: FA: fractional anisotropy, MD; mean diffusivity, BMI: Body Mass Index, CES-D: Center for 
Epidemiology Depression Scale score, n=number of cases.
Supplementary table S2.	Global	white	matter	microstructure	and	incident	dementia,	incrementally	excluding	
the	first	five	years	of	follow-up
excluding  
≤ 1 year
excluding  
≤ 2 years
excluding  
≤ 3 years
excluding  
≤ 4 years
excluding  
≤ 5 years
(n=4374/88) (n=4305/74 ) (n=4224/56) (n=4131/41) (n=3872/25)
FA 0.63 (0.50;0.78) 0.70 (0.54;0.89) 0.64 (0.48;0.86) 0.73	(0.52;1.03) 0.60 (0.39;0.91)
MD 1.77 (1.41;2.21) 1.56 (1.20;2.04) 1.64 (1.21;2.22) 1.49 (1.02;2.16) 1.58	(0.98;2.54)
Data	are	presented	as	Hazard	ratios	(95%	CI)	per	standard	deviation	increase	of	FA	and	MD	after	excluding	the	
first	5	years	of	follow-up.	Results	in	bold	p<0.05.	Adjusted	for	age,	sex,	education,	intracranial	volume,	white	
matter	volume	and	the	log	transformed	white	matter	hyperintensity	volume.
Abbreviations: FA: fractional anisotropy, MD; mean diffusivity, n; sub-population/number of cases.
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Supplementary table S3.	Global	white	matter	microstructural	integrity	and	cognitive	decline	(after	exclusion	
of	all	incident	dementia	cases)
fA Md
G-factor 0.01	(-0.01;0.04) -0.03 (-0.06;-0.001)
Immediate	memory -0.007	(-0.04;0.03) -0.01	(-0.06;0.03)
Delayed	memory 0.002	(-0.03;0.03) -0.02	(-0.06;0.02)
Stroop	1 0.04 (0.01;0.07)* -0.06 (-0.09;-0.02)*
Stroop	2 0.03 (0.003;0.05) -0.02	(-0.05;-0.01)
Stroop	3 0.04 (0.009;0.06) -0.08 (-0.12;-0.04)*
Letter-Digit	Substitution	Task 0.005	(-0.02;0.03) -0.004	(-0.04;0.02)
Word	Fluency	Test 0.03 (0.002;0.06) -0.06 (-0.10;-0.02)*
Purdue	Pegboard 0.03 (0.002;0.06) -0.03	(-0.06;0.009)
Data	are	presented	as	mean	difference	in	Z-score	(95%	CI)	per	standard	deviation	increase	of	FA	and	MD.	
Results	in	bold	were	significant	at	p<0.05	and	those	that	were	starred	*	at	p<0.008.
Model	 adjusted	 for	 age,	 sex,	 education,	 intracranial	volume,	white	matter	volume	and	 the	 log	 transformed	
white	matter	hyperintensity	volume,	and	additionally	adjusted	for	CES-D	score,	cardiovascular	 risk	factors	
(systolic	blood	pressure,	diastolic	blood	pressure,	antihypertensive	medication,	serum	cholesterol,	HDL-cho-
lesterol,	lipid	lowering	medication,	diabetes,	smoking,	BMI)	and	apolipoprotein E-ε4 allele	carriership.
Abbreviations: FA: fractional anisotropy, MD; mean diffusivity, BMI: Body Mass Index, CES-D score: Center 
for Epidemiology Depression Scale score.
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ABStrACt
To	study	the	relation	between	the	microstructure	of	white-matter	in	the	brain	and	hear-
ing	function	in	older	adults	we	carried	out	a	population-based,	cross-sectional	study.	
In	2562	participants	of	the	Rotterdam	Study,	we	conducted	diffusion	tensor	imaging	
to	 determine	 the	microstructure	 of	 the	white-matter	 tracts.	We	performed	pure-tone	
audiogram	and	digit-in-noise	tests	to	quantify	hearing	acuity.	Poorer	white-matter	mi-
crostructure,	especially	in	the	association	tracts,	was	related	to	poorer	hearing	acuity.	
After	differentiating	the	separate	white-matter	tracts	in	the	left	and	right	hemisphere,	
poorer	white-matter	microstructure	in	the	right	superior	longitudinal	fasciculus	and	the	
right	uncinate	fasciculus	remained	significantly	associated	with	worse	hearing.	These	
associations	 did	 not	 significantly	 differ	 between	middle-aged	 (51-69	 years	 old)	 and	
older	(70-100	years	old)	participants.	Progressing	age	was	thus	not	found	to	be	an	ef-
fect	modifier.	In	a	voxel-based	analysis	no	voxels	in	the	white	matter	were	significantly	
associated	with	hearing	impairment.
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INtroduCtIoN
Progressive	 sensorineural	 hearing	 impairment	 is	 a	 common	 feature	 of	 aging.	 It	 is	
characterized	 by	 a	 gradual	 decline	 of	 hearing	 thresholds	 and	 worse	 understanding	
of	 speech,	which	 seriously	affects	 the	quality	of	 life.1	Although	cochlear	damage	 is	
generally	believed	to	cause	age-related	hearing	impairment,	there	is	strong	evidence	
that	 age-related	 hearing	 impairment	 also	 has	 a	 central	 component	 in	 its	 pathogen-
esis.2	Moreover,	 age-related	 hearing	 impairment	 seems	 to	 interact	 with	 the	 general	
cognitive	 function.3	Multiple	 hypotheses	 on	 the	mechanism	between	hearing	 acuity	
and	brain	alterations	have	been	outlined.	The	“common	cause	hypothesis”	describes	a	
mutual	factor	that	affects	both	hearing	acuity	as	well	as	brain	alterations.	This	mutual	
factor	could	possibly	be	age,	cognition,	or	an	underlying	pathological	factor	such	as	
cardiovascular	 damage.4	There	 are	 also	2	 alternative	hypotheses.	The	 “information-
degradation	 hypothesis”	 describes	 an	 indirect	 effect	 between	 hearing	 and	 the	 brain	
through	a	shift	of	cognitive	functions.	The	“sensory-deprivation	hypothesis”	describes	
a	direct	causal	relationship	in	which	worse	hearing	acuity	leads	to	brain	alterations.5 
Previous	 studies	 using	 brain	 imaging	 have	 demonstrated	 that	 hearing	 acuity	 in	 the	
aged	and	middle-aged	population	relates	to	morphological	brain	changes	(e.g.,	gray-	or	
white-matter	atrophy.6,7,8,9		In	a	previous	study	in	almost	3000	people	conducted	by	our	
group	 white-matter	 atrophy,	 but	 not	 gray-matter	 atrophy,	 was	 associated	 with	 age-
related	hearing	impairment.9 However,	apart	from	the	association	with	gross	morpho-
logical	changes,	no	conclusion	on	 the	underlying	white	matter	microstructure	could	
be	made.	White-matter	microstructure	degenerates	with	aging10,11	and	rates	and	timing	
of	degradation	vary	regionally.12	Reduced	organization	of	white-matter	microstructure	
could	repress	communication	between	neurocognitive	networks.13	Previously,	auditory	
and	language	functions	have	been	ascribed	to	frontotemporal	and	parietal	white-matter	
connections14,	 especially	 in	 the	 left	 hemisphere	 due	 to	 functional	 lateralization.	 In	
recent	years,	diffusion	tensor	imaging	(DTI)	has	increasingly	been	used	to	study	brain	
white-matter	tracts.	This	technique	allows	for	estimation	of	the	microscopic	organiza-
tion	 of	 neural	 tracts	 by	 providing	 information	 on	 the	 diffusion	 properties	 of	 water	
molecules	in	the	tissue.15	Parameters	that	are	frequently	derived	from	DTI	include	frac-
tional	anisotropy	(FA)	and	mean	diffusivity	(MD).	Worsening	of	white-matter	integrity	
is	generally	reflected	in	a	lower	FA	and	higher	MD.11  The	study	of	Chang	et	al.was	one	
of	the	first	to	investigate	the	relation	between	white-matter	tracts	and	hearing	function	
using	DTI	and	pure-tone	audiometry.16	They	found	a	lower	FA	in	the	central	auditory	
system	in	participants	with	sensorineural	hearing	impairment.	However,	they	limited	
their	region	of	interest	to	the	higher	auditory	system	rather	than	the	whole	brain.	Due	
to	a	small	sample	size,	they	were	not	able	to	correct	for	confounders.	Lin	et	al.	also	
studied	this	relation	by	comparing	age-matched	participants	with	hearing	impairment	
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and	 participants	with	 normal	 hearing,	 using	DTI	 and	 pure-tone	 audiometry.17	 They	
also	studied	the	auditory	pathway	instead	of	the	whole	brain	and	had	similar	results.	
Moreover,	they	found	a	linear	relation	between	FA	and	the	degree	of	hearing	impair-
ment.	Husain	et	al.	conducted	a	third	cross-sectional	study	and	performed	DTI	on	the	
white	matter	association	tracts.7 They	found	a	different	FA	for	both	hemispheres.	The	
association	tracts	into	and	out	of	the	right	temporal	and	frontal	cortex	had	poorer	white-
matter	microstructure	 in	participants	with	worse	hearing	 thresholds	when	compared	
with	participants	with	normal	hearing.	The	same	tracts	in	the	left	hemisphere	were	not	
associated	with	hearing	impairment.	These	3	studies	have	in	common	that	the	study	
samples	were	small	(maximum	n	=	47),	age	ranges	were	wide	(between	8	and	85	years	
old),	and	authors	only	focused	on	specific	regions	of	interest	(ROI)	in	the	brain	known	
for	their	auditory	function	instead	of	whole	brain	analysis.	On	the	contrary,	Profant	et	
al.	 found	no	significant	associations	between	 the	organization	of	white-matter	 tracts	
and	age-related	hearing	impairment.18	They	also	investigated	specific	ROIs,	and	they	
used	an	equally	small	sample	size,	but	they	studied	relatively	old	participants	(mean	
age	in	the	older	group	was	70.4	±	1.3	years).
Although	most	of	these	studies	show	that	microstructural	changes	in	white	matter	and	
hearing	 loss	 are	 correlated,	 some	 essential	 issues	 remain	 to	 be	 investigated.19 First,	
ROI’s	have	not	consequently	been	defined,	which	makes	direct	comparison	of	results	
impossible.	It	would	be	useful	to	additionally	study	potential	changes	in	brain	regions	
beyond	those	used	for	auditory	processing.	Second,	different	hearing	outcomes	have	
been	used	(e.g.,	speech	vs.	high	frequency	thresholds)	and	speech-in-noise	ability	was	
not	tested.	Third,	the	relationship	between	cognitive	decline,	aging,	and	hearing	im-
pairment	and	their	effect	on	brain	structure	and	function	is	hard	to	investigate	because	
of	confounding	effects.	A	population-based	study	could	provide	an	unbiased	evaluation	
of	the	association	between	white-matter	microstructure	and	age-related	hearing	acuity.
To	address	 the	above	 issues,	we	conducted	a	 large	population-based	 study	on	com-
munity-dwelling	older	adults.	Our	primary	objective	was	 to	analyze	 the	association	
between	the	global	and	tract-specific	white-matter	microstructure	and	hearing	acuity	
using	DTI.	Second,	we	aimed	 to	 investigate	 the	effect	of	 aging	on	 this	possible	as-
sociation,	because	aging	is	associated	with	both	white	matter	degeneration	and	worse	
hearing	 acuity.	 In	 the	 analyses,	we	used	both	 auditory	 thresholds	 (low,	 speech,	 and	
high	frequencies)	and	the	ability	for	speech	recognition	in	noise,	and	we	accounted	for	
possible	 cognitive	 and	 cardiovascular	 covariates.	We	 hypothesized	 that	 participants	
with	worse	hearing	acuity	would	have	a	lower	FA	and	higher	MD,	which	corresponds	
with	poorer	white-matter	microstructure	in	the	tracts.	We	assumed	different	outcomes	
for	 different	 tracts,	 based	 on	 anatomy	 and	 function,	 with	 stronger	 relations	 for	 as-
sociation	tracts	directly	or	indirectly	involved	in	auditory	processing	such	as	the	su-
perior	longitudinal	fasciculus,	the	inferior	fronto-occipital	fasciculus	and	the	uncinate	
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fasciculus.	 Furthermore,	 since	we	 hypothesized	 that	 aging	 could	 amplify	 the	 effect	
between	white-matter	microstructure	and	hearing	acuity,	we	expected	to	find	a	larger	
effect	in	older	than	in	middle-aged	participants.
MethodS
Study population
This	cross-sectional	study	is	based	on	participants	of	the	population-based	Rotterdam	
Study,	an	ongoing	prospective	cohort	study	on	healthy	aging.20	The	Rotterdam	Study	
includes	inhabitants	of	45	years	and	older	of	Ommoord,	a	Rotterdam	district.	It	cur-
rently	includes	14,926	participants.	Participants	undergo	several	measurements	every	
3-5	years.	From	2005	onward,	MRI	scanning	was	added	 to	 the	study	protocol21	and	
from	2011	onward,	audiometry	was	incorporated	as	well.	We	considered	eligible	par-
ticipants	with	brain	MRI,	including	a	diffusion-weighted	sequence,	and	audiometry	(N	
=	2665).	We	excluded	those	with	cortical	infarcts	on	the	scan	(N	=	61),	with	dementia	
(N	=	25)	or	with	conductive	hearing	loss	(N	=	17),	leaving	2562	participants	for	analy-
sis.	Dementia	was	ascertained	as	previously	described	using	a	3-step	protocol.22	We	
excluded	104	participants	from	the	analyses	concerning	the	digits-in-noise	(DIN)	test.	
They	failed	to	complete	the	DIN-test	or	the	result	was	more	than	4	standard	deviations	
from	the	mean,	making	results	less	accurate.23	The	Rotterdam	Study	has	been	approved	
by	the	Medical	Ethics	Committee	of	the	Erasmus	MC	and	by	the	Ministry	of	Health,	
Welfare	and	Sports	of	the	Netherlands,	implementing	the	Wet	Bevolkingsonderzoek:	
ERGO	(Population	Studies	Act:	Rotterdam	Study).	All	participants	provided	written	
informed	consent	to	participate	in	the	study	and	to	obtain	information	from	their	treat-
ing	physicians.
MrI acquisition and processing
Multisequence	MRI	 imaging	was	performed	 in	a	1.5	Tesla	MRI	scanner	 (GE	Signa	
Excite).	The	MRI	protocol	included	a	T1-weighted	image	(T1w,	repetition	time	13.8	
milliseconds	 [ms],	 echo	 time	2.80	ms,	 inversion	 time	400	ms,	96	 slices	of	1.6	mil-
limeter	[mm],	matrix	256	x	256),	a	T2-weighted	fluid-attenuated	inversion	recovery	
(FLAIR)	sequence	(repetition	time	8000	ms,	echo	time	120	ms,	inversion	time	2000	
ms,	64	slices	of	2.5	mm,	matrix	320	x	224),	a	proton	density-weighted	image	(repeti-
tion	time	21,300	ms,	echo	time	17.3	ms,	90	slices	of	1.6	mm,	matrix	416	x	256),	and	
a	spin	echo	planar	diffusion-weighted	image	(repetition	time	8575	ms,	echo	time	82.6	
ms,	35	slices	of	3.5	mm,	matrix	64	x	96).	Maximum	b-value	was	1000	s/mm2	in	25	
noncollinear	directions.	Three	volumes	were	acquired	without	diffusion	weighing	(b-
value	=	0	s/mm2).21
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A	number	of	preprocessing	steps	were	performed	before	analysis.21	In	short,	structural	
scans	 for	 each	 participant	were	 spatially	 coregistered	 using	 rigid	 registration.	After	
brain	masking	 and	 nonuniformity	 correction	 scans	were	 segmented	 in	 gray	matter,	
white	matter,	cerebrospinal	fluid,	and	background	tissue	using	a	supervised	approach	
based	 on	 a	 k-nearest	 neighbor	 segmentation	 approach24,25	 on	 the	 T1-weighted	 and	
proton	density	images.	Intracranial	volume,	with	the	exclusion	of	the	cerebellum	and	
surrounding	cerebrospinal	fluid,	was	defined	by	the	sum	of	gray	and	white	matter	and	
cerebrospinal	fluid	volumes.	The	brain	tissue	segmentation	method	was	followed	by	
a	white-matter	lesion	segmentation.	This	was	performed	with	an	in-house	developed	
automated	segmentation	method	using	a	2-step	protocol	which	relies	on	the	brain	tis-
sue	segmentation	and	the	FLAIR	image.26	We	used	Elastix27	 to	correct	 the	diffusion	
images	for	subject	motion	and	eddy	currents,	using	an	affine	registration.	Tensors	were	
estimated	using	a	Levenberg-Marquardt	algorithm	in	ExploreDTI.28	The	same	motion	
corrected	diffusion	data	were	also	used	 to	estimate	 the	probabilistic	model	 required	
for	 ProbTrackx	 tractography.29	 We	 performed	 tractography	 in	 native	 space,	 using	
standard	space	seed,	target,	stop,	and	exclusion	masks	as	described	previously.30 The	
probabilistic	 tractography	 algorithm	was	 run	with	 default	 settings	 (step	 length	 0.5,	
curvature	 threshold	 0.2,	maximum	 steps	 200).	Also,	 the	 diffusion	model	 estimation	
(Bedpostx)	was	run	with	default	options.	Cortical	infarcts	were	visually	defined	as	fo-
cal	parenchymal	lesions	<3	mm	and	>15	mm	with	involvement	of	cortical	gray	matter	
and	with	signal	characteristics	equal	to	CSF	on	all	sequences	and	with	a	hyperintensive	
rim	on	the	FLAIR	image.31	We	computed	global	mean	FA	and	MD	in	the	normal	ap-
pearing	white	matter.	FA	is	 the	degree	of	anisotropy	and	 is	given	as	a	 ratio	 ranging	
from	0	(isotropic	or	non-directional)	to	1	(unidirectional).	MD	is	expressed	in	square	
millimeters	 per	 second.	 Furthermore,	we	 used	 the	 diffusion	 data	 to	 segment	 15	 (of	
which	12	segmented	bilaterally)	white-matter	 tracts	using	probabilistic	 tractography	
as	previously	described.32	Tracts	were	grouped	based	on	anatomy	or	presumed	func-
tional	groups	into	brainstem	tracts	(middle	cerebellar	peduncle	and	medial	lemniscus),	
projection	 tracts	 (corticospinal	 tract,	 anterior	 thalamic	 radiation,	 superior	 thalamic	
radiation,	 and	posterior	 thalamic	 radiation),	 association	 tracts	 (superior	 longitudinal	
fasciculus,	 inferior	 longitudinal	 fasciculus,	 inferior	 fronto-occipital	 fasciculus,	 and	
uncinated	fasciculus),	limbic	system	tracts	(cingulate	gyrus	part	of	cingulum,	parahip-
pocampal	 part	 of	 cingulum,	 and	 fornix),	 and	 callosal	 tracts	 (forceps	major,	 forceps	
minor)	 in	 the	 left	 and	 right	hemisphere.32	Due	 to	 tractography	 failures	or	 (visually)	
rejected	segmentations,	tract-specific	measurements	were	missing	for	on	average	6.9	
participants	 (ranging	 from	0	 to	61	participants)	per	 tract.	We	obtained	 tract-specific	
diffusion	measures	(mean	FA	and	mean	MD	per	 tract.32	We	standardized	global	and	
tract-specific	 diffusion	measures	 (z-scores).	We	 obtained	 tract-specific	white-matter	
volumes	and	tract-specific	white-matter	lesion	volumes	(natural	log-transformed)	by	
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combining	tissue	and	tract	segmentations.	Varying	seed	masks	were	used	to	account	
for	partial	coverage	of	the	medial	lemniscus	(one	of	the	brainstem	tracts),	and	this	was	
considered	as	a	potential	confounder	 in	 the	analyses	 in	which	 the	medial	 lemniscus	
was	investigated.
Voxel-based analysis
Voxel-based	analysis	(VBA)	of	DTI	data	was	performed	according	to	the	voxel-based	
morphometry	method33	as	previously	described.34	FSL	software35 was	used	for	VBA	
data	processing.	All	FA	and	MD	maps	were	nonlinearly	registered	to	the	standard	FA	
template	from	the	FSL	package	with	a	1	x	1	x	1	mm3	voxel	resolution.	 In	addition,	
the	Rotterdam	Study	tract	template	that	was	used	for	analyzing	the	DTI	measures	per	
tract	was	mapped	to	MNI	space,	to	assess	location	of	association	and	compare	VBA	
results	with	global	DTI	measures.	Participant-specific	tract	segmentation	masks32	were	
registered	to	MNI	template	in	the	same	way	as	FA	and	MD	maps	and	then	merged	to	1	
tract	template	image.	We	used	90%	probability	thresholds	to	define	the	tract	templates.
Audiometry
All	 audiometry	 was	 performed	 in	 a	 soundproof	 booth	 by	 a	 single	 qualified	 health	
professional.	A	 clinical	 audiometer	 (Decos	 audiology	workstation,	 version	 210.2.6,	
with	AudioNigma	interface),	TDH-39P	earphones	and	B71	bone	conductor	were	used.	
Pure-tone	audiometry	thresholds	were	measured	according	to	the	International	Orga-
nization	 for	Standardization	8253-1	 (International	Organization	 for	Standardization,	
2010).	Air	conduction	(0.25,	0.50,	1,	2,	4,	and	8	kHz)	and	bone	conduction	(only	2	
frequencies	due	to	limited	time:	0.5	and	4	kHz)	were	tested	for	both	the	ears.	Masking	
was	done	according	 to	 the	method	of	Hood.36	Bone	conduction	 thresholds	at	4	kHz	
were	compensated	with	+10	decibel	(dB)	afterward.38	We	determined	the	best	hearing	
ear	 by	 calculating	 the	 average	 threshold	 over	 all	 frequencies.	 If	 both	 the	 ears	were	
equal,	right	or	left	was	alternately	chosen.	Of	the	best	hearing	ear,	we	then	determined	
the	low	(average	of	0.25,	0.50	and	1	kHz),	speech	(average	of	0.50,	1,	2	and	4	kHz),	
and	 high	 frequency	 hearing	 thresholds	 (average	 of	 2,	 4	 and	 8	 kHz).	We	 excluded	
participants	with	 an	 air-bone	 gap	 of	 15	 dB	or	more	 to	 eliminate	 clinically	 relevant	
conductive	hearing	loss.	In	addition,	the	DIN-test	was	performed	to	detect	the	speech	
recognition	ability	in	noise.39	Again,	this	was	done	for	the	best	hearing	ear.	The	test	
measures	a	speech	reception	threshold	by	letting	participants	repeat	digit	triplets	in	an	
automated	adaptive	procedure	and	changing	the	signal	to	noise	ratio	according	to	the	
correctness	of	the	answer.	The	speech	reception	threshold	represents	a	speech-in-noise	
ratio	for	50%	correctly	repeated	triplets.	A	higher	value	represents	a	worse	ability	of	
understanding	speech	in	noise.	To	avoid	confounding	for	peripheral	hearing	acuity,	we	
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additionally	adjusted	 for	 the	high	frequency	hearing	 thresholds	 in	 the	analyses	with	
the	DIN-test.
To	avoid	confounding	for	peripheral	hearing	acuity	we	additionally	adjusted	for	 the	
high	frequency	hearing	thresholds	in	the	analyses	with	the	DIN-test.
other covariates
Information	on	various	covariates	was	collected	through	a	home	interview	at	enroll-
ment	 of	 the	 study,	 or	 by	 recurrent	 physical	 examination	 and	 blood	 sampling	 at	 the	
study	center.	Education	was	qualified	as	having	completed	primary	level,	secondary	
level,	 or	 higher	 education.	 Mini-Mental	 State	 Examination	 (MMSE)	 score,	 body	
mass	index,	systolic	and	diastolic	blood	pressure,	diabetes	mellitus,	cholesterol	ratio,	
smoking	habits,	and	alcohol	consumption	were	reassessed	every	follow-up	visit.	Dia-
betes	mellitus	was	stated	present	when	fasting	glucose	was	7	mmol/L	or	more,	or	(if	
unavailable)	when	nonfasting	glucose	was	11	mmol/L	or	more,	or	when	participants	
used	 antidiabetics.	Cholesterol	 ratio	was	 calculated	via	 the	quotient	 of	 serum	 total-
cholesterol	and	high-density	cholesterol.	Smoking	was	categorized	as	never,	former,	or	
current.	Alcohol	consumption	was	categorized	as	non-drinker,	light	consumer	(1	unit	
of	alcohol	per	day	for	women	and	1-2	units	of	alcohol	per	day	for	men)	or	above	aver-
age	consumer	(more	than	1	unit	of	alcohol	per	day	for	women	and	more	than	2	units	
of	alcohol	per	day	for	men.40	We	used	the	data	on	covariates	from	the	same	follow-up	
round	as	the	MRI	and	audiometry	measurements.	Except	for	the	MMSE-score,	which	
was	registered	1	round	earlier.
Statistical analysis
Associations	between	DTI	measurements	(FA	and	MD)	and	hearing	acuity	were	ex-
plored	using	multivariable	linear	regression	models.	Global	and	tract-specific	FA	and	
MD	were	 regarded	as	 independent	variables,	and	pure-tone	 thresholds	and	score	on	
the	DIN-test	 as	dependent	variables.	We	calculated	 regression	coefficients	 and	95%	
confidence	intervals	(CIs).	Significance	was	set	at	p	<	0.05	for	the	analyses	concerning	
global	DTI	measurements.	To	account	for	multiple	testing	in	the	tract-specific	analy-
ses,	we	used	the	Sidak-correction,	which	was	set	at	p	<	0.00248	for	 the	analyses	 in	
which	we	averaged	left	and	right	tract-specific	measures	and	set	at	p	<	0.00156	for	the	
tract-specific	analyses	of	left	and	right	separately.	To	adjust	for	the	covariates,	we	used	
2	models.	Model	1	was	the	‘simple’	model	and	adjusted	for	age,	gender,	time	between	
DTI	and	audiometry,	 intracranial	volume,	white-matter	volume	and	white-matter	 le-
sions	(log-transformed,	global,	or	tract-specific).	Model	2	was	extended	with	possible	
confounders	on	the	association	between	altered	white-matter	tracts	and	hearing	acuity.	
Specifically,	 we	 investigated	 the	 impact	 of	 potential	 vascular	 confounders,	 known	
for	their	association	with	altered	white	matter32		and	hearing	acuity.1 Model	2	further	
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adjusted	for:	education,	MMSE-score,	body	mass	index,	systolic	and	diastolic	blood	
pressure,	the	presence	of	diabetes	mellitus,	cholesterol	ratio,	and	smoking	and	alcohol	
consumption.	For	analyses	involving	the	medial	lemniscus,	we	additionally	adjusted	
for	the	varying	position	of	seeds	masks.	In	the	analyses	on	the	DIN-test,	we	adjusted	
for	high	frequency	hearing	loss	as	well.	We	repeated	the	analyses	after	stratification	
between	middle-aged	(51-69	year	old)	and	older	participants	(70-100	years	old).	We	
examined	 the	 presence	 of	 multicollinearity	 and	 found	 no	 variance	 inflation	 factor	
larger	than	4.	For	the	VBA	linear	regression	models	were	fitted	with	voxel	values	of	
FA	and	MD	measures	as	dependent	variables	and	pure-tone	thresholds	and	score	on	
the	DIN-test	 as	 independent	 variables.	 Furthermore,	we	 corrected	 the	VBA	models	
like	 the	 DTI	models	 (mentioned	 previous).	 For	 this	 analysis,	 all	 voxels	 within	 the	
white-matter	mask	were	used.	To	estimate	the	threshold	for	significance,	a	nonpara-
metric	permutation	test	was	performed	independently	for	FA	and	MD.	We	shuffled	the	
data	randomly	5000	times	and	performed	VBA.	For	every	permutation,	we	saved	the	
minimum	p-value.	Subsequently,	we	took	the	5th	percentile	of	this	minimum	p-value	
distribution	 to	 compute	 the	 family-wise	 error	 p-value	 threshold,	 which	was	 1.21	 x	
10-7 for	FA	and	1.23	x	10-7	for	MD.41	To	map	the	significant	voxels	to	the	tract	loca-
tion,	we	created	a	tract	study-specific	atlas.	Subject-specific	tract	segmentations32	were	
registered	 to	MNI	 template	using	FSL	software.	All	 these	 transformed	 images	were	
merged	and	divided	by	number	of	participants	to	make	a	probabilistic	tracts	template.	
Due	to	between-participants	variation	in	tract	location,	probabilistic	templates	allowed	
us	to	map	voxels	with	different	certainty.
Missing	 data	 were	 minimal	 (0.4%	 of	 total	 data)	 and	 were	 imputed	 in	 SPSS	 using	
fivefold	 multiple	 imputation	 with	 an	 iterative	Markov	 chain	Monte	 Carlo	 method,	
based	on	determinant,	outcome,	and	included	variables.	Distribution	of	covariates	was	
similar	in	the	imputed	and	the	nonimputed	data	set.	We	pooled	the	data	by	aggregating	
the	file	in	SPSS	before	analyzing	it	in	R.	Data	analysis	was	performed	using	IBM	SPSS	
Statistics	version	21	(IBM,	Armonk,	NY,	USA),	and	R	version	3.1.2	(R	Foundation	for	
Statistical	Computing,	Vienna,	Austria).
reSuLtS
The	 demographic	 characteristics	 of	 the	 2562	 participants	 are	 provided	 in	table 1. 
Hearing	thresholds	on	the	pure-tone	audiogram	were	higher	toward	the	higher	frequen-
cies,	as	typically	seen	in	age-related	hearing	impairment	(figure 1).
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table 1. Demographic	characteristics	of	the	study	population	(N	=	2,562).
Characteristic
Age,	years 69.3	±	9.6
Gender,	female 1,412	(55.1%)
Education,	primary 176	(6.9%)
Education,	secondary 1,762	(68.8%)
Education,	higher 597	(23.3%)
MMSE	score	(median,	IQR) 29	(27;29)
Body	mass	index,	kg/m2 27.3	±	4.0
Systolic	blood	pressure,	mmHg 144	±	21.4
Diastolic	blood	pressure,	mmHg 84	±	11.0
Diabetes	mellitus,	yes 332	(13.0%)
Cholesterol	ratio 3.90	±	1.21
Smoking,	never 863	(33.7%)
Smoking,	former 1,323	(51.6%)
Smoking,	current 368	(14.4%)
Alcohol,	never 354	(13.1%)
Alcohol,	light	drinker 2,077	(77.9%)
Alcohol,	above	average 222	(8.7%)
FA,	global	white	matter 0.34	±	0.016
MD,	global	white	matter	(x	10-3 mm2/s) 0.75	±	0.027
PTA	low	frequencies,	dB 17.2	±	10.7
PTA	speech	frequencies,	dB 24.8	±	13.6
PTA	high	frequencies,	dB 37.9	±	19.5
DIN-score*	(median,	IQR) -5.0	(-6.4;-2.4)
dB	=	Decibel;	DIN	=	Digits-in-noise	test;	FA	=	Fractional	anisotropy;	IQR	=	Inter	quartile	range;	MD	=	Mean	
diffusivity;	MMSE	=	Mini-Mental	State	Examination;	PTA	=	Pure-tone	audiometry.
*For	DIN	N	=	2,408.
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figure 1. Mean	hearing	thresholds	on	the	pure-tone	audiogram	of	all	participants 
(N	=	2,562).  
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Error	bars	indicate	95%	CI.dBHL	=	Decibel	Hearing	Level;	Hz	=	Hertz. 
The	association	between	global	DTI	measures	 and	hearing	acuity	 is	 presented	 in	
Table	 2.	 To	 compare	 the	 effect	 of	 the	 DTI	 measures,	 the	 betas	 of	 the	 most	
important	covariates	(age,	gender,	and	MMSE-score)	are	also	shown.	A	lower	FA	
was	 significantly	 associated	 with	 worse	 hearing	 acuity,	 that	 is,	 higher	 hearing	
thresholds	 on	 the	 pure-tone	 audiogram	 (beta	 per	 SD	 decrease	 in	 FA	 =	 0.69	 dB,	
95%	CI	0.24;	1.14)	and	worse	performance	on	the	DIN-test	(beta	per	SD	decrease 
in	FA	=	0.19	signal	to	noise	ratio,	95%	CI	0.05;	0.32).	Adjusting	for	the	covariates	
in	model	2	showed	stronger	associations	(beta	per	SD	decrease	in	FA	=	0.86	dB	on	
the	pure-tone	audiogram,	95%	CI	0.41;	1.30	and	0.23	signal	to	noise	ratio	on	the	
DIN-test,	 95%	 CI	 0.09;	 0.37).	 A	 higher	 MD	 was	 significantly	 associated	 with	
worse	 hearing	 acuity	 on	 the	 pure-tone	 audiogram	 for	 the	 speech	 and	 higher	
frequencies	 in	 model	 2.	 MD	 and	 the	 outcomes	 of	 the	 DIN-test	 were	 not	
significantly	associated.	Subsequently,	we	analyzed	the	association	between	tract-
specific	DTI	measurements	and	hearing	acuity	(Supplemental	Tables	1	and	2).	The	
association	 of	 a	 lower	 FA	 and	 worse	 hearing	 acuity	 was	 primarily	 found	 in	 the	
association	tracts:	superior	longitudinal	fasciculus,	inferior	longitudinal	fasciculus,	
inferior	 fronto-occipital	 fasciculus,	 and	 uncinate	 fasciculus	 (Table	 3).	 However,	
only	the	association	between	the	superior	longitudinal	fasciculus	and	worse	hearing	
on	 the	 pure-tone	 audiogram	 and	 the	 association	 between	 the	 uncinate	 fasciculus	
and	 worse	 performance	 on	 the	 DIN-test	 were	 still	 significant	 after	 the	 multiple	
testing	correction	(p	<	0.0024). 
figure 1. Mean	hearing	thresholds	on	the	pure-tone	audiogram	of	all	participants	(N	=	2,562).	Error	bars	indi-
cate	95%	CI.dBHL	=	Decibel	Hearing	Level;	Hz	=	Hertz.
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The	association	between	global	DTI	measures	and	hearing	acuity	is	presented	in	table 
2.	To	compare	the	effect	of	the	DTI	measures,	the	betas	of	the	most	important	covari-
ates	 (age,	 gender,	 and	MMSE-score)	 are	 also	 shown.	A	 lower	 FA	was	 significantly	
associated	with	worse	hearing	acuity,	 that	 is,	higher	hearing	thresholds	on	the	pure-
tone	audiogram	(beta	per	SD	decrease	in	FA	=	0.69	dB,	95%	CI	0.24;	1.14)	and	worse	
performance	on	the	DIN-test	(beta	per	SD	decrease	in	FA	=	0.19	signal	to	noise	ratio,	
95%	CI	0.05;	0.32).	Adjusting	for	the	covariates	in	model	2	showed	stronger	associa-
tions	(beta	per	SD	decrease	in	FA	=	0.86	dB	on	the	pure-tone	audiogram,	95%	CI	0.41;	
1.30	and	0.23	signal	to	noise	ratio	on	the	DIN-test,	95%	CI	0.09;	0.37).	A	higher	MD	
was	significantly	associated	with	worse	hearing	acuity	on	the	pure-tone	audiogram	for	
the	speech	and	higher	frequencies	in	model	2.	MD	and	the	outcomes	of	the	DIN-test	
were	not	significantly	associated.	Subsequently,	we	analyzed	the	association	between	
tract-specific	DTI	measurements	and	hearing	acuity	(Supplemental tables 1 and 2).	
The	association	of	a	 lower	FA	and	worse	hearing	acuity	was	primarily	 found	 in	 the	
association	 tracts:	 superior	 longitudinal	 fasciculus,	 inferior	 longitudinal	 fasciculus,	
inferior	fronto-occipital	fasciculus,	and	uncinate	fasciculus	(table 3).	However,	only	
the	association	between	the	superior	longitudinal	fasciculus	and	worse	hearing	on	the	
pure-tone	audiogram	and	the	association	between	the	uncinate	fasciculus	and	worse	
performance	on	the	DIN-test	were	still	significant	after	the	multiple	testing	correction	
(p	<	0.0024).
When	 differentiating	 the	 tracts	 between	 left	 and	 right	 hemisphere	 (Supplemental 
tables 3 and 4),	 a	 lower	FA	of	 the	 right	 superior	 longitudinal	 fasciculus	 remained	
significantly	(p	<	0.00156)	associated	with	worse	hearing	on	the	pure-tone	audiogram.	
A	higher	MD	of	the	right	uncinate	fasciculus	was	also	significantly	(p	<	0.00156)	asso-
ciated	with	worse	hearing	on	the	pure-tone	audiogram,	whereas	the	MD	of	the	left	and	
right	uncinate	fasciculus	combined	was	not	(Supplemental table 2).	Both	significant	
tracts	 (superior	 longitudinal	 fasciculus	 and	 uncinate	 fasciculus)	 are	 displayed	 by	 a	
tractographic	reconstruction	in	figure 2	and	figure 3.	To	address	our	second	objective	
-examining	whether	there	is	a	different	effect	caused	by	progressive	aging-	we	stratified	
our	results	into	a	middle-aged	(51-69	years	old,	n	=	1390)	and	older	(70-100	years	old,	
n	=	1172)	group.	The	associations	between	global	DTI	measurements	and	pure-tone	
audiogram	were	significant	in	the	middle-aged	group,	but	not	in	the	older	group.	On	
the	other	hand,	the	associations	between	global	DTI	measurements	and	the	DIN-test	
were	significant	in	the	older	group,	but	not	in	the	middle-aged	group.	However,	inter-
action	was	not	 significant	 (Supplemental table 5).	Finally,	we	performed	VBA	on	
the	white-matter	tracts	to	examine	whether	specific	tract-subregions	showed	primarily	
associations	with	worse	hearing	acuity.	FA	and	MD	in	the	voxel-based	analysis	were	
not	associated	with	hearing	acuity	on	both	the	pure-tone	audiogram	and	the	DIN-test.
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table 2. Association	between	global	DTI	measures	and	hearing	acuity.
PtA
(N = 2,562)
dIN
(N = 2,408)
ALL LOW SPEECH HIGH
↓	in	FA
(model	1)
 0.69 (0.24; 1.14)
 0.002
 0.42 (0.00; 0.84)
 0.049
 0.72 (0.24; 1.20)
 0.003
0.97 (0.34; 1.59)
0.002
0.19 (0.05; 0.32)
0.008
↑	in	Age,	
per	year
 0.92 (0.86; 0.99)
 0.000
 0.53 (0.47; 0.60)
 0.000
 0.81 (0.74; 0.89)
 0.000
 1.31 (1.21; 1.40) 
 0.000
-0.02	(-0.04;	0.00)
0.054
Gender,	male  2.46 (1.51; 3.41)
 0.000
-1.32 (-2.20;-0.47)
 0.003
 2.29 (1.27; 3.30)
 0.000
 6.25 (4.94; 7.57)
 0.000
-0.38 (-0.67;-0.08)
0.011
↓	in	FA
(model	2)
 0.86 (0.41; 1.30)
 0.000
 0.56 (0.14; 0.97)
 0.008
 0.87 (0.40; 1.36)
 0.000
1.15 (0.53; 1.78)
0.000
0.23 (0.09; 0.37)
0.001
↑	in	Age,	
per	year
 0.90 (0.83; 0.98)
 0.000
 0.51 (0.45; 0.58)
 0.000
 0.80 (0.72; 0.88)
 0.000
 1.30 (1.19; 1.40)
 0.000
-0.02	(-0.04;	0.00)
0.059
Gender,	male  1.97 (0.99; 2.95) 
 0.000
-1.68 (-2.59;-0.77) 
 0.000
 1.85 (0.80; 2.90) 
 0.001
 5.63 (4.26; 6.99)
 0.000
-0.39 (-0.70; -0.09)
0.010
↑	in	MMSE,
per	point
-0.40 (-0.64;-0.16)
 0.001
-0.27 (-0.49;-0.04)
 0.018
-0.33 (-0.59;-0.08)
 0.010
-0.53 (-0.87;-0.19)
 0.002
-0.17 (-0.24; -0.09)
0.000
↑	in	MD	
(model	1)
	0.43	(-0.09;0.94)	
 0.103
	0.16	(-0.32;0.63)
	0.524
	0.41	(-0.14;0.96)
 0.140
	0.70	(-0.14;0.96)
 0.055
0.03	(-0.13;0.18)
0.733
↑	in	Age,	
per	year
 0.92 (0.85; 0.99)
 0.000
 0.53 (0.47; 0.60)
 0.000
 0.81 (0.74; 0.89)
 0.000
 1.30 (1.20; 1.40)
 0.000
-0.22	(-0.04;	0.00)
0.075
Gender,	male  2.46 (1.51; 3.41)
 0.000
-1.33 (-2.22;-0.45)
 0.003
 2.28 (1.26; 3.30)
 0.000
 6.26 (4.94; 7.59)
 0.000
-0.39 (-0.69; -0.10)
0.008
↑	in	MD	
(model	2)
 0.58 (0.07; 1.09)
 0.026
	0.29	(-0.18;0.77)
	0.228
 0.57 (0.02; 1.12) 
 0.042
 0.87 (0.15; 1.58)
 0.017
0.07	(-0.09;0.23)
0.377
↑	in	Age,	
per	year
 0.90 (0.82; 0.97)
 0.000 
 0.51 (0.44; 0.58)
 0.000
 0.80 (0.72; 0.88)
 0.000
 1.29 (1.18; 1.39) 
 0.000
-0.02	(-0.04;	0.00)
0.069
Gender,	male  1.99 (1.00; 2.97)
 0.000
-1.68 (-2.59;-0.76)
 0.000
 1.87 (0.81; 2.92)
 0.001
 5.66 (4.29; 7.03)
 0.000
-0.40 (-0.71; -0.10)
0.009
↑	in	MMSE,
per	point
-0.39 (-0.63;-0.15)
 0.001
-0.26 (-0.49;-0.04)
 0.021
-0.33 (-0.59; -0.07)
 0.013
-0.52 (-0.86;-0.18)
 0.002
-0.16 (-0.24; -0.09)
0.000
Outcomes	indicate	the	change	in	hearing	threshold	(in	decibel)	for	the	PTA	and	the	change	in	speech	reception	
threshold	for	the	DIN-test	per	standard	deviation	change	of	the	DTI	measures	and	most	important	covariates.	
Significant	findings	(p	<	0.05)	are	shown	in	bold	and	confidence	intervals	(95%)	are	shown	in	brackets.
DIN	=	Digits-in-noise	test;	DTI	=	Diffusion	tensor	imaging;	FA	=	Fractional	anisotropy;	MD	=	Mean	diffusiv-
ity;	MMSE	=	Mini-Mental	State	Examination;	PTA	=	Pure-tone	audiometry.
All	=	average	threshold	0.25	/	0.50	/	1	/	2	/	4	/	8	kHz,	low	=	average	threshold	0.25	/	0.50	/	1	kHz,	speech	=	
average	threshold	0.50	/	1	/	2	/	4	kHz,	high	=	average	threshold	2	/	4	/	8	kHz.
Model	1	is	corrected	for	time	between	DTI	and	audiometry,	white	matter	volume	(ml),	white	matter	lesion	
volume	(log-transformed),	and	intracranial	volume	(ml).	Model	2	is	corrected	as	model	1	plus	systolic	and	
diastolic	blood	pressure,	body	mass	index,	diabetes	mellitus,	cholesterol	ratio,	education,	score	on	the	Mini-
Mental	State	Examination,	smoking,	and	alcohol	consumption.
In	the	DIN-analyses	high	frequency	hearing	loss	was	also	accounted	for.
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To	address	our	second	objective	–	examining	whether	there	is	a	different	effect	caused	
by	progressive	aging–	we	stratified	our	 results	 into	a	middle-aged	(51-69	years	old,	
n	=	1,390)	and	older	(70-100	years	old,	n	=	1,172)	group.	The	associations	between	
global	DTI	measurements	 and	 pure-tone	 audiogram	were	 significant	 in	 the	middle-
aged	group,	but	not	 in	the	older	group.	On	the	other	hand,	 the	associations	between	
global	DTI	measurements	and	the	DIN-test	were	significant	in	the	older	group,	but	not	
in	 the	middle-aged	 group.	However,	 interaction	was	 not	 significant	 (Supplemental 
table 5).
table 3. Association	between	the	FA	of	the	association	tracts	and	hearing	acuity.
PtA
(N = 2,562)
dIN
(N = 2,408)
ALL LOW SPEECH HIGH
SLF	
(model	1)
	0.70	(0.20;	1.19)
 0.005
	0.37	(-0.09;	0.83)
 0.114
	0.62	(0.09;	1.15)
	0.021
	1.02	(0.34;	1.71)
 0.003
	0.00	(-0.15;	0.15)
 0.994
SLF	
(model	2)
 0.84 (0.35; 1.34)*
 0.000
	0.49	(0.03;	0.95)
 0.036
	0.76	(0.24;	1.29)
 0.004
 1.20 (0.52; 1.89)*
 0.000
	0.04	(-0.11;	0.19)
 0.571
ILF	
(model	1)
	0.58	(0.11;	1.05)
 0.015
	0.42	(-0.02;	0.85)
 0.060
	0.57	(0.07;	1.07)
	0.026
	0.74	(0.09;	0.74)
	0.026
	0.08	(-0.07;	0.22)
	0.287
ILF	
(model	2)
	0.62	(0.16;	1.09)
 0.008
	0.46	(0.03;	0.89)
 0.037
	0.62	(0.12;	1.12)
 0.015
	0.79	(0.14;	1.44)
 0.017
	0.10	(-0.05;	0.24)
	0.182
IFO	
(model	1)
	0.59	(0.10;	1.08)
 0.018
	0.43	(-0.03;	0.89)
 0.066
	0.65	(0.12;	1.17)
 0.016
	0.75	(0.07;	1.44)
 0.031
	0.13	(-0.03;	0.28)
	0.102
IFO	
(model	2)
	0.67	(0.18;	1.16)
 0.007
	0.50	(0.04;	0.95)
 0.033
	0.73	(0.20;	1.25)
 0.006
	0.84	(0.16;	1.53)
 0.015
	0.15	(0.00;	0.30)
 0.049
UNC	
(model	1)
	0.28	(-0.21;	0.77)
	0.257
	0.19	(-0.26;	0.65)
 0.405
	0.34	(-0.19;	0.86)
	0.208
	0.37	(-0.31;	1.05)
	0.283
	0.19	(0.04;	0.34)
 0.011
UNC	
(model	2)
	0.41	(-0.08;	0.90)
 0.097
	0.30	(-0.16;	0.75)
 0.198
	0.46	(-0.06;	0.98)
 0.084
	0.52	(-0.15;	1.20)
	0.128
 0.23 (0.08; 0.38)*
 0.002
Outcomes	indicate	the	change	in	hearing	threshold	(in	decibel)	for	the	PTA	and	the	change	in	speech	recep-
tion	threshold	for	the	DIN-test	per	standard	deviation	decrease	of	FA.	Significant	results	(α	<	0.05)	are	shown	
in	normal	font,	results	that	survived	multiple	testing	(p	<	0.00156)	are	shown	in	bold	and	with	*.	Confidence	
intervals	(95%)	are	shown	in	brackets.
DIN	=	Digits-in-noise	test;	DTI	=	Diffusion	tensor	imaging;	FA	=	Fractional	anisotropy;	IFO	=	Inferior	fronto-
occipital	fasciculus;	ILF	=	Inferior	longitudinal	fasciculus;	PTA	=	Pure-tone	audiometry;	SLF	=	Superior	lon-
gitudinal	fasciculus;	UNC	=	Uncinate	fasciculus.
All	=	average	threshold	0.25	/	0.50	/	1	/	2	/	4	/	8	kHz,	low	=	average	threshold	0.25	/	0.50	/	1	kHz,	speech	=	
average	threshold	0.50	/	1	/	2	/	4	kHz,	high	=	average	threshold	2	/	4	/	8	kHz.
Model	1	is	corrected	for	age,	sex,	time	between	DTI	and	audiometry,	white	matter	volume,	white	matter	lesions	
volume	(log-transformed),	and	intracranial	volume	(ml).	Model	2	is	corrected	as	model	1	plus	systolic	and	
diastolic	blood	pressure,	body	mass	index,	diabetes	mellitus,	cholesterol	ratio,	education,	score	on	Mini-Mental	
State	Examination,	smoking,	and	alcohol	consumption.
In	the	DIN-analyses	high	frequency	hearing	loss	was	also	accounted	for.
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Finally,	we	performed	VBA	on	 the	white	matter	 tracts	 to	 examine	whether	 specific	
tract-subregions	showed	primarily	associations	with	worse	hearing	acuity.	FA	and	MD	
in	the	voxel-based	analysis	were	not	associated	with	hearing	acuity	on	both	the	pure-
tone	audiogram	and	the	DIN-test.
dISCuSSIoN
Our	objective	was	 to	 investigate	 the	 association	between	brain	white-matter	micro-
structure	 and	 hearing	 acuity	 in	middle-aged	 and	 older	 adults	 in	 a	 large	 population-
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figure 2. Tractographic	reconstruction	of	the	right	superior	longitudinal	fasciculus,	sagittal	
view. 
 
 
 
 
figure 3. Tractographic	reconstruction	of	the	right	uncinate	fasciculus,	sagittal	view. 
 
 
 
figure 2.	Tractographic	reconstruction	of	the	right	superior	longitudinal	fasciculus,	sagittal	view.
White	matter	microstructcure	and	hearing	acuity 
204 
 
figure 2. Tractographic	reconstruction	of	the	right	superior	longitudinal	fasciculus,	sagittal	
view. 
 
 
 
 
figure 3. Tractographic	reconstruction	of	the	right	uncinate	fasciculus,	sagittal	view. 
 
 
 
figure 3.	Tractographic	reconstruction	of	the	right	uncinate	fasciculus,	sagittal	view.
195
White	matter	microstructure	and	hearing	acuity	in	older	adults
based	study.	We	found	that	poorer	white-matter	microstructure,	in	particular	in	asso-
ciation	 tracts,	 was	 significantly	 associated	 with	 worse	 hearing	 acuity.	 Altered	
white-matter	microstructure	in	the	right	superior	longitudinal	fascisulus	and	the	right	
uncinate	fasciculus	were	associated	with	worse	hearing	acuity,	when	differentiating	for	
the	white-matter	tracts	in	the	left	and	right	hemisphere.	Progressive	aging	did	not	seem	
to	be	an	effect	modifier.	In	the	VBA	there	were	no	single	voxels	in	the	white-matter	
tracts	that	were	significantly	associated	with	hearing	acuity.	Our	results	contribute	to	
the	discussion	on	how	white-matter	microstructure	and	hearing	acuity	are	related.	We	
found	an	association	in	specific	auditory	and	language-related	tracts.	This	could	argue	
against	 the	 “common	 cause	 hypothesis”.	Otherwise,	we	would	 have	 expected	more	
widespread	 changes	 throughout	 the	 brain.	Moreover,	we	 corrected	 our	 analyses	 for	
potential	 confounders	and	possible	components	of	 the	“common	cause	hypothesis”,	
such	as	age	and	hypertension.	The	fact	that	we	still	found	significant	associations	be-
tween	poorer	white-matter	microstructure	and	worse	hearing	acuity	makes	the	“com-
mon	cause	hypothesis”	as	the	main	explanation	less	likely.	We	acknowledge	that	we	
might	not	have	included	several	unknown	confounders.	Altered	white-matter	micro-
structure	was	both	associated	with	worse	hearing	on	the	pure-tone	audiogram	as	well	
as	worse	hearing	on	the	DIN-test,	which	reflects	central	auditory	processing	and	cogni-
tive	skills.41 The	brain	alterations	may	thus	have	an	effect	on	higher	auditory	and	cogni-
tive	functions.	This	would	plead	for	the	“information-degradation	hypothesis”	over	a	
mere	loss	of	sensory	deprivation	with	worse	hearing.	To	further	explore	the	stated	hy-
potheses,	a	comparative	neuroimaging	study	in	hearing	impaired	participants	with	or	
without	hearing	aids	may	help	narrow	possible	pathways.	Different	white-matter	tracts	
have	a	variable	susceptibility	to	age-related	structural	decline.10	This	could	be	caused	
by	the	location	and	function	of	the	tracts.	It	also	suggests	that	different	tracts	may	play	
a	 different	 role	 in	 age-related	 diseases.	We	 found	 that	 primarily	 association	 tracts,	
among	these	the	superior	longitudinal	fasciculus	and	uncinate	fasciculus,	were	related	
to	hearing	acuity.	Association	tracts	connect	the	different	cortical	regions	of	the	same	
hemisphere	 and	 are	 typically	 located	 in	watershed	 areas,	 implying	 that	 their	 blood	
supply	relies	on	small	and	deep	lenticulostriate	arteries.	Association	tracts	may	there-
fore	be	more	vulnerable	 to	 insults	and	vascular	damage.42	The	superior	 longitudinal	
fasciculus	 connects	 the	 frontal	 lobe	 with	 the	 temporal,	 parietal	 and	 occipital	 lobe.	
Multiple	processes,	such	as	language,	emotion,	and	attention	have	been	ascribed	to	the	
superior	longitudinal	fasciculus.43	The	uncinate	fasciculus	is	an	association	tract	that	
connects	the	limbic	regions	in	the	frontal	lobe	to	the	temporal	lobe.44	Its	function	is	not	
exactly	clear,	however	it	seems	to	be	involved	in	limbic	tasks	such	as	emotional	pro-
cessing	and	memory,	 including	 linguistic-related	 tasks	 such	as	naming	people45,	 se-
mantic	processing	such	as	mnemonic	associations46	and	better	overall	language	devel-
opment	 in	 children.47	 This	 is	 interesting,	 since	 we	 found	 an	 association	 with	 the	
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uncinate	fasciculus	and	our	speech-in-noise	test.	A	lower	FA	in	the	right	superior	lon-
gitudinal	 fasciculus	 in	 hearing	 impaired	 participants	 was	 also	 found	 by	 Husain	 et	
al.7 They	also	found	associations	with	the	inferior	fronto-occipital	tract,	the	corticospi-
nal	tract,	and	the	anterior	thalamic	radiation.	However,	the	authors	only	published	p-
values	and	no	raw	data,	making	direct	comparison	of	effect	sizes	not	possible.	They	did	
not	find	an	association	with	 the	uncinate	 fasciculus.	They	did	not	perform	a	 test	on	
speech	 recognition	 in	noise,	 such	as	 the	DIN-test,	 for	which	we	primarily	 found	an	
association	with	the	uncinate	fasciculus.	This	association	could	suggest	that	this	tract	
is	involved	in	higher	order	auditory	function,	including	certain	verbal	memory	func-
tions	needed	to	recall	the	digits	in	noise.	Our	second	objective	was	to	investigate	the	
effect	 of	 aging	 on	 the	 association	 between	white-matter	microstructure	 and	 hearing	
acuity.	We	hypothesized	a	possible	progression	of	white	matter	damage	in	worse	hear-
ing	acuity	with	age.	Besides	correcting	for	age	as	a	possible	confounder	in	multivari-
able	models	 1	 and	 2,	we	 also	 stratified	 our	 results	 between	middle-aged	 and	 older	
participants	to	investigate	if	age	is	a	possible	effect	modifier.	We	found	no	significant	
interaction,	despite	the	fact	that	increased	FA	was	significantly	associated	with	a	worse	
outcome	on	the	DIN-test	 in	the	older	group,	whereas	in	the	middle-aged	group,	this	
significant	association	was	found	in	the	pure-tone	thresholds.	Thus,	progressive	aging	
does	not	seem	to	act	as	an	effect	modifier.	Profant	et	al.	 likewise	noticed	 the	differ-
ences	in	the	relation	between	FA	and	hearing	acuity	among	younger	and	older	partici-
pants.18 Although	they	compared	their	older	group	with	a	much	younger	group	(mean	
age	67.9	vs.	 24.3)	 than	ours,	 they	 also	did	not	find	 a	 significant	 effect.	We	 suggest	
further	research	on	this	relation	by	performing	longitudinal	studies,	since	cross-sec-
tional	studies	do	not	allow	age	changes	within	individuals	to	be	studied.	To	our	knowl-
edge,	we	performed	the	largest	study	so	far	on	tract-specific	white-matter	microstruc-
ture	 and	 hearing	 acuity.	 Furthermore,	 we	 tried	 to	 optimize	 the	 design.	 First,	 we	
investigated	the	whole	brain	instead	of	the	central	auditory	system	and	thereby	pro-
vided	an	overview	of	the	brain.	Second,	we	explored	both	peripheral	and	central	hear-
ing	function.	A	pure-tone	audiogram	reflects	more	on	the	peripheral	auditory	function,	
whereas	 a	 speech-in-noise	 test	 informs	 on	 higher	 functions	 of	 the	 auditory	 system.	
Third,	the	tract-specific	measurements	were	performed	with	fully	automated	and	pub-
licly	available	methods.10 Finally,	we	corrected	for	cognition	and	cardiovascular	risk	
factors.19	Still,	our	study	has	several	limitations.	Within	the	tracts	that	we	have	studied,	
there	was	no	specific	auditory	tract.	This	we	tried	to	preempt	by	additionally	perform-
ing	 an	 analysis	 on	 the	 voxel	 level	 using	 voxel-based	 morphometry.	 No	 significant	
voxels	were	found	when	we	used	90%	probability	thresholds	to	define	the	tract	tem-
plates	(corresponding	voxels	had	to	belong	to	a	tract	in	90%	of	the	participants).	When	
lowering	these	thresholds	to	10%,	we	found	significant	voxels	in	areas	that	belong	to	
the	right	superior	fasciculus	and	right	inferior	longitudinal	fasciculus.	However,	this	
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means	that	in	only	10%	of	the	participants	this	was	a	predefined	white-matter	tract	by	
the	anatomical	template.	We	made	the	choice	for	a	90%	threshold	so	we	were	sure	that	
we	looked	at	white-matter	tracts	and	not	at	voxels	possibly	belonging	to	other	brain	
areas.	An	 explanation	 for	finding	different	 results	with	 the	 tract-specific	 and	voxel-
based	analysis	may	be	that	due	to	multiple	comparisons	corrections,	the	threshold	for	
the	 voxel-based	 analysis	 is	 too	 conservative.	 To	 detect	 significant	 voxels,	 a	 bigger	
sample	size	would	be	required.	To	decrease	the	number	of	tests,	another	method	with	
low	resolution	can	be	used,	such	as	for	example	tract	profiles	estimation48 Third,	our	
study	was	performed	with	25	diffusion	gradient	directions,	and	this	may	have	lowered	
the	precision	to	detect	crossing	fiber	populations.	However,	probabilistic	tractography	
was	performed	with	a	good	reproducibility	of	0.89.32	Therefore,	we	are	confident	that	
we	 could	 reconstruct	 the	 tracts	 of	 our	 interest	 accurately.	Unfortunately,	 it	was	 not	
possible	to	differentiate	in	our	specific-tract	data	for	subcomponents,	for	example,	the	
3	 segments	 of	 the	 SLF	 that	 are	 presumed	 to	 have	 different	 functions.49	 Finally,	 the	
study	design	is	cross-sectional,	making	it	impossible	to	state	a	conclusion	on	the	direc-
tion	of	the	effect.	Therefore,	longitudinal	research	is	required.
CoNCLuSIoN
In	2562	participants	of	the	Rotterdam	Study,	poorer	white-matter	microstructure	was	
associated	with	worse	 hearing	 acuity,	 specifically	 in	 the	 right	 superior	 longitudinal	
fasciculus	 and	uncinate	 fasciculus.	Progressive	 aging	was	not	 found	 to	be	 an	 effect	
modifier.
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ABStrACt
Objective	 To	 investigate	 the	 association	 of	 cerebral	 white	 matter	 microstructural	
integrity	with	mortality.
Methods	We	included	4294	individuals,	free	from	stroke	and	dementia	(mean	age	63.6	
years,	44%	male)	from	the	population-based	Rotterdam	Study	(2006-2011).	Diffusion-
MRI	was	used	to	assess	the	microstructural	integrity	of	the	white	matter,	both	globally	
and	for	specific	white	matter	 tracts.	Fractional	anisotropy	(FA)	and	mean	diffusivity	
(MD)	were	the	parameters	used	to	quantify	white	matter	integrity.	All-cause	mortality	
and	cause-specific	mortality	was	recorded	with	a	median	follow-up	time	of	5.4	year	
and	4.6	years,	 respectively.	Cox	 regression	models,	adjusted	 for	age,	 sex,	APOE-ε4	
allele	carriership,	cardiovascular	risk	factors	and	macrostructural	MRI	changes,	were	
used	to	estimate	hazard	ratios.
Results	During	the	follow-up	time	216	(5.0%)	participants	died	from	all	causes,	31	
(0.7%)	from	cardiovascular	causes	and	102	(2.4%)	individuals	died	of	non-cardiovas-
cular	causes.	Each	standard	deviation	 (SD)	decrease	 in	FA	and	each	SD	increase	 in	
MD	was	associated	with	a	1.37	fold	(95%CI:	1.20,	1.57)	and	a	1.49	fold	(95%CI:	1.28,	
1.75)	higher	hazard	of	all-cause	mortality,	 respectively.	The	associations	were	more	
prominent	with	cardiovascular	mortality	rather	than	non-cardiovascular	mortality.	In	
tract-specific	 analyses,	 we	 observed	 that	 association	 tracts	 were	 more	 prominently	
related	to	mortality.
Conclusions	Our	findings	suggest	that	impairments	in	cerebral	white	matter,	even	at	
early	stages,	are	not	limited	to	adverse	brain	outcomes	and	they	are	related	to	mortality	
especially	from	cardiovascular	causes.
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INtroduCtIoN
Brain	white	matter	plays	a	major	role	in	brain	functioning	e.g.	in	cognitive	function	and	
motor	function.1,2	One	of	the	manifestations	of	white	matter	damage	is	the	emergence	
of	white	matter	hyperintensities,	a	common	finding	on	MRI.3	Several	studies	reported	
a	link	between	presence	of	white	matter	hyperintensities	and	adverse	health	outcomes,	
as	 well	 as	 shorter	 survival.4-6	 However,	 it	 seems	 that	 white	matter	 hyperintensities	
could	constitute	only	the	“tip	of	the	iceberg”	of	white	matter	pathology,	and	changes	in	
the	microstructure	of	white	matter	develop	long	before	appearance	of	white	matter	hy-
perintensities	on	MRI.7	Diffusion-MRI	is	a	sensitive	MRI	technique,	to	quantify	subtle	
changes	in	the	white	matter	microstructure.	Fractional	anisotropy	(FA)	and	mean	dif-
fusivity	(MD)	are	commonly	used	diffusion-MRI	parameters.	Generally,	lower	FA	and	
higher	MD	are	associated	with	poorer	white	matter	microstructural	integrity.	Given	the	
prominent	role	of	white	matter	hyperintensities	not	only	in	development	and	progres-
sion	of	brain	disorders	as	dementia	and	stroke8,9	but	also	in	poor	survival10,	it	is	of	great	
importance	to	study	early	changes	in	white	matter	before	white	matter	hyperintensities	
form.11	Therapeutic	approaches	and	life	style	changes	in	early	phase	might	help	to	pre-
vent	further	progression	of	impairments	in	white	matter	microstructural	integrity.11,12
We	hypothesized	that	early	stage	white	matter	pathologies	are	associated	with	shorter	
survival.	We	 investigated	 the	 association	 of	 cerebral	 microstructural	 integrity	 with	
mortality.	Previous	studies	showed	that	different	white	matter	tracts	have	differences	in	
vulnerability	to	degeneration.13,14	Therefore,	we	assessed	whether	regional	differences	
in	white	matter	microstructural	integrity	had	differential	effects	on	mortality.
MethodS
Population
The	present	study	is	embedded	within	the	framework	of	the	Rotterdam	Study,	an	on-
going	prospective	population-based	study,	among	inhabitants	of	Ommoord,	a	district	
of	Rotterdam	 in	 the	Netherlands.	The	 design	 of	 the	Rotterdam	Study	 has	 been	 de-
scribed	previously.15,16	Since	2005,	brain	MRI	is	implemented	into	the	study	protocol	
of	the	Rotterdam	Study.	Between	2006	and	2011,	out	of	5430	non-demented	eligible	
participates,	4841	persons	underwent	a	structural	and	diffusion-MRI	of	the	brain.	We	
excluded	53	scans	due	to	incomplete	acquisitions,	112	scans	due	to	artifacts	hampering	
automated	processing,	135	scans	due	to	failed	tissue	segmentation,	and	160	scans	due	
to	presence	of	cortical	infarcts	(MRI-defined).	We	additionally	excluded	participants	
with	history	of	clinical	stroke	(n=87).	Persons	with	cortical	infarcts	and	stroke	were	
excluded	from	all	analyses	because	tissue	loss	and	the	gliosis	surrounding	infarcts	may	
influence	image	registration	resulting	in	unreliable	WMH	segmentation	volumes.	This	
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resulted	 in	 4294	participants	 for	 both	 global	 and	 tract-specific	 analyses	 (age	 range:	
45.7-100.0).
Standard Protocol Approvals, registrations, and Patient Consents
The	Rotterdam	Study	has	been	approved	by	the	medical	ethics	committee	according	
to	 the	 Population	 Study	Act	Rotterdam	Study,	 executed	 by	 the	Ministry	 of	Health,	
Welfare	and	Sports	of	the	Netherlands.	A	written	informed	consent	was	obtained	from	
all	participants.15
MrI acquisition, processing and inspection
Brain	MRI	scanning	was	performed	on	a	1.5T	MRI	scanner	(GE	Signa	Excite).	Scan	
protocol	 and	 sequence	 details	 are	 described	 extensively	 elsewhere.16	 For	 the	 diffu-
sion	scan,	a	single	shot,	diffusion	weighted	spin	echo	echo-planar	imaging	sequence	
was	 performed	 (maximum	 b-value	was	 1000	 s/mm2	 in	 25	 non-collinear	 directions,	
three	volumes	were	acquired	without	diffusion	weighting	(b-value	=	0	s/mm2)).16	The	
T1-weighted,	 proton,	 density-weighted	 and	 the	 fluid-attenuated	 inversion	 recovery	
scans	 were	 used	 for	 automated	 segmentation	 of	 grey	 matter,	 white	 matter,	 white	
matter	 hyperintensities	 (WMH),	which	was	 extended	with	 a	 post-processing	WMH	
segmentation	 approach.17-19	All	 segmentation	 results	were	 visually	 inspected	 and,	 if	
needed	manually	corrected.	Supratentorial	 intracranial	volume	 (ICV)	was	estimated	
by	summing	grey	and	white	matter,	and	CSF	volumes.17	Cortical	infarcts	were	rated	
on	structural	sequences,	and	in	case	of	involvement	of	cortical	grey	matter,	they	were	
classified	as	cortical	infarcts.	Lacunes	were	defined	as	focal	hyperintensities	(size	≥3	
and	<	15	mm)	with	the	signal	intensity	of	CSF	on	all	sequences,	and	when	located	su-
pratentorially	with	a	hyperintense	rim	on	fluid-attenuated	inversion	recovery	(FLAIR)	
sequence.	To	differentiate	lacunar	infarcts	from	dilated	perivascular	spaces,	symmetry	
of	 the	 lesions,	 sharp	demarcation	 and	absence	of	 a	hyperintense	 rim	on	 the	FLAIR	
sequence	supported	presence	of	a	dilated	perivascular	space.20	Cerebral	microbleeds	
were	rated	on	a	three-dimensional	T2*-weighted	gradient-recalled	echo	MRI	scan	as	
focal	areas	of	very	low	signal	intensity.16
 Diffusion-MRI processing and tractography
All	diffusion	data	were	pre-processed	using	a	standardized	pipeline	(including	correc-
tion	for	motion	and	eddy	currents),	obtaining	global	mean	FA	and	MD	in	the	normal-
appearing	white	matter	(voxels	with	WMH	were	excluded	from	the	global	analysis).	
White	matter	 tracts	were	segmented	using	a	probabilistic	diffusion	 tractography	ap-
proach	described	previously.21	In	tract-specific	analyses	voxels	with	WMH	were	not	
excluded.	We	segmented	14	different	white	matter	tracts	(11	tracts	were	present	in	the	
left	 and	 right	 hemispheres),	 and	 obtained	 participant	 specific	median	 scores	 for	 FA	
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and	MD	inside	each	white	matter	tracts,	with	subsequent	combination	of	left	and	right	
measures.	The	resulting	tract-specific	means	were	standardized.21	Tracts	were	catego-
rized	 based	 on	 anatomy,	 into	 brainstem	 tracts,	 projection	 tracts,	 association	 tracts,	
limbic	system	tracts,	and	callosal	tracts.22	The	tract	segmentations	were	used	to	obtain	
tract-specific	white	matter	volumes,	and	by	combining	tissue	and	tract	segmentations	
we	obtained	tract-specific	WMH	volumes.
Mortality
Deaths	(in	and	out-hospital)	were	reported	on	a	weekly	basis	 through	the	automatic	
linkage	with	General	Practitioner	 (GP)	files.	 In	addition,	central	 registry	of	 the	mu-
nicipality	 in	Rotterdam	was	 checked	bimonthly	 for	 information	on	vital	 status.	 For	
participants	moved	outside	the	research	area,	the	GPs	were	the	primary	source	of	infor-
mation,	complemented	by	the	municipality	records	in	the	place	of	residence.	This	also	
includes	 people	 in	 nursing	homes.	For	 cause-specific	mortality,	 research	physicians	
reviewed	all	available	information	(from	general	practitioner	and	hospital	records)	and	
coded	the	events	according	to	the	International	Classification	of	Diseases,	10th	edition	
(ICD-10).	Death	due	to	cardiovascular	mortality	was	classified	as	ICD-10	codes	I00-
I99	and	death	due	 to	other	 reasons	was	 recorded	as	non-cardiovascular	mortality.	A	
consensus	panel,	led	by	a	physician	with	expertise	in	cardiovascular	disease,	decided	
the	 final	 cause	 of	 death	 according	 to	 ICD-10	 codes	 using	 standardized	 definitions.	
Follow-up	was	completed	until	July	4,	2014	and	January	1,	2013	for	total	mortality	and	
cause-specific	mortality,	respectively.23
Cardiovascular risk factors
After	a	resting	period	of	five	minutes,	blood	pressure	was	measured	twice	in	a	single	
visit	 using	 a	 random-zero	 sphygmomanometer.	 Total	 and	 high	 density	 lipoprotein	
(HDL)	cholesterol	levels	were	determined	using	an	automated	enzymatic	method.	In-
formation	on	smoking	and	antihypertensive	and	lipid	lowering	medication	was	based	
on	 home	 interviews.	 Smoking	was	 categorized	 in	 never,	 former	 and	 current	 smok-
ing.	Cardiovascular	disease	was	considered	as	a	history	of	myocardial	 infarction,	or	
coronary	revascularization	procedures.23	Diabetes	mellitus	was	defined	by	use	of	blood	
glucose	lowering	medication	or	a	fasting	serum	glucose	level	equal	to	or	greater	than	
7.0	mmol/l.7	Apolipoprotein	E	 (APOE)	 ε4	 allele	 carriership	was	 assessed	 on	 coded	
genomic	DNA	samples.
Statistical analysis
Due	to	a	skewed	distribution	of	volume	of	WMH,	we	natural-log	transformed	WMH	
volumes.	Associations	of	white	matter	microstructural	integrity	(global	and	tract-spe-
cific)	with	all-cause	mortality	were	evaluated	using	Cox	proportional	hazard	models.	
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To	 take	 into	 account	 the	 competing	 risk,	 for	 cardiovascular	 and	non-cardiovascular	
mortality	we	used	a	competing	risk	approach	(R	package	“riskRegression”).
We	performed	the	analyses	in	four	models.	In	the	first	model	we	adjusted	for	age,	and	
sex.	In	the	second	model,	analyses	were	adjusted	additionally	for	cardiovascular	risk	
factors	 including	 systolic	 blood	 pressure,	 diastolic	 blood	 pressure,	 antihypertensive	
medication,	 total	 and	HDL	cholesterol,	 lipid-lowering	medication,	 smoking,	history	
of	 coronary	 heart	 disease,	 diabetes	mellitus,	 body	mass	 index,	 and	APOE-ε4	 allele	
carriership.	In	the	third	model,	we	adjusted	for	age,	sex,	macrostructural	white	matter	
changes	((tract-specific)	white	matter	volume,	and	log	transformed	(tract-specific)	vol-
ume	of	white	matter	hyperintensities),	intracranial	volume,	presence	of	microbleeds,	
and	 presence	 of	 lacunar	 infarcts.	 In	 both	 the	 global	 and	 tract-specific	 analysis	 we	
adjusted	for	WMH	volume	to	control	for	possible	partial	volume	effects	and	to	single	
out	 real	microstructural	 changes.7	Model	 four	was	 adjusted	 for	 all	 covariates	 from	
first,	 second	 and	 third	 models.	 Tract-specific	 analyses	 were	 performed	 with	 model	
three.21	Since	the	cerebellum	could	not	always	be	fully	incorporated	in	the	diffusion	
scan	leading	to	a	varying	coverage	of	the	brainstem	tracts	(mainly	medial	lemniscus),	
we	additionally	controlled	for	 this	 factor	 in	 the	 tract-specific	analyses	of	 the	medial	
lemniscus.22	Linearity	and	proportionality	assumptions	were	met	for	all	analyses.	We	
performed	multiple	imputation	for	missing	data	in	the	covariates	(<	12%	for	all	covari-
ates),	using	a	Markov	Chain	Monte	Carlo	method	and	we	used	the	imputed	data	for	
all	the	analyses.
We	inspected	the	mortality	rates	per	1000	person-years	in	tertiles	of	FA	and	MD,	and	
to	 take	 into	account	 the	differences	 in	age	and	sex,	we	made	tertiles	of	FA	and	MD	
based	on	the	residuals	of	FA	and	MD	regressed	against	age	and	sex.	We	additionally	
used	 the	Kaplan-Meier	method	 to	estimate	cumulative	mortality	curves	of	all-cause	
mortality	associated	with	the	tertiles	of	FA	and	MD.	To	investigate	whether	damage	to	
the	microstructural	integrity	of	white	matter	is	associated	with	mortality	due	to	causes	
other	than	neurological	diseases,	we	performed	a	series	of	sensitivity	analyses.	First,	
participants	with	interim	dementia	or	clinically	reported	stroke	were	censored	to	rule	
out	the	influence	of	new	cases	of	dementia	and	stroke	during	follow-up	on	the	associa-
tion	of	FA	and	MD	with	all-cause	mortality.24	Second,	we	repeated	the	association	of	
FA	and	MD	with	cardiovascular	mortality	after	excluding	deaths	due	to	stroke.
For	the	tract-specific	analysis	we	used	Šidák	correction	to	correct	for	multiple	com-
parisons,	 after	 estimating	 the	 number	 of	 independent	 tests,25	 resulting	 in	 p<	0.0037	
as	the	significance	threshold	for	an	alpha	value	of	0.05.	All	analyses	were	carried	out	
using	SPSS	20.0.2	for	Windows	or	R	version	2.15.0.
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reSuLtS
Baseline	characteristics	of	 the	participants	are	presented	in	table 1.	Comparing	eli-
gible	and	non-eligible	participants,	we	observed	that	excluded	participants	were	older	
and	had	higher	loads	of	cardiovascular	risk	factors	(table e-1).
During	the	median	[interquartile	range]	follow-up	time	of	5.4	[3.6-5.9]	years,	216	(5%)	
participants	 died.	 For	 cause-specific	 mortality,	 during	 the	 median	 [interquartile	 range]	
follow-up	time	of	4.6	[3.3-5.7]	years,	31	(0.7%)	individuals	died	of	cardiovascular	causes	
table 1. Baseline	characteristics
Baseline characteristics N= 4294
Age,	years 63.6	(11.0)
Age	of	death,	years 72.6	(11.9)
Men	 1906	(44.4)
Systolic	blood	pressure,	mmHg 139.0	(21.5)
Diastolic	blood	pressure,	mmHg 83.1	(10.8)
Antihypertensive	medication 1463	(34.1)
Total	cholesterol,	mmol/l 5.5	(1.0)
HDL	cholesterol,	mmol/l 1.4	(0.4)
Lipid-lowering	medication 1014	(23.6)
Smoking	
	Current 878	(20.4)
	Former 2060	(48.0)
History	of	coronary	heart	disease 256	(6.0)
Diabetes	mellitus 393	(9.2)
Body	mass	index,	kg/m2 27.4	(4.1)
APOE-ε4	allele	carrier 1140	(28.4)
White	matter	volume,	mL 403.3	(60.8)
Volume	of	white	matter	hyperintensities,	mL 4.4	(2.4,8.8)
Intracranial	volume,	mL 1340.0	(132.9)
Cerebral	microbleeds 779	(18.1)
Lacunar	infarcts 93	(2.2)
Fractional	anisotropy 0.34	(0.01)
Mean	diffusivity,	10-3 mm2/s 0.74	(0.03)
Categorical	variables	are	presented	as	numbers	(percentages),	continuous	variables	as	means	(standard	devia-
tions)	and	volume	of	white	matter	hyperintensities	is	presented	as	median	(interquartile	range).
The	following	variables	had	missing	data:	blood	pressure	(n=90),	blood	pressure	lowering	medication	(n=78),	
smoking	(n=69),	lipid-lowering	medication	(n=	48),	HDL:	high	density	lipoprotein	cholesterol	(n=520),	total	
cholesterol	 (n=	518),	body	mass	 index	 (n=82),	diabetes	 (n=125),	history	of	coronary	heart	disease	 (n=44),	
APOE-ε4	allele	carrier	(n=273).
Abbreviation:	APOE:	Apolipoprotein	E.Comparing	eligible	 and	non-eligible	participants,	we	observed	 that	
excluded	participants	were	older	and	had	higher	loads	of	cardiovascular	risk	factors	(table e-1).
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and	102	(2.4%)	participants	died	from	non-cardiovascular	causes.	All-cause	mortality	rates	
in	participants	with	low,	middle	and	high	tertiles	of	FA	and	MD	are	shown	in	figure 1.
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During	the	median	[interquartile	range]	follow-up	time	of	5.4	[3.6-5.9]	years,	216	
(5%)	 participants	 died.	 For	 cause-specific	 mortality,	 during	 the	 median	
[interquartile	 range]	 follow-up	 time	 of	 4.6	 [3.3-5.7]	 years,	 31	 (0.7%)	 individuals	
died	 of	 cardiovascular	 causes	 and	 102	 (2.4%)	 participants	 died	 from	 non-
cardiovascular	 causes.	 All-cause	mortality	 rates	 in	 participants	 with	 low,	middle	
and	high	tertiles	of	FA	and	MD	are	shown	in	figure 1.  
 
 
In	 model	 I,	 adjusted	 for	 age	 and	 sex,	 decrease	 in	 FA	 and	 increase	 in	 MD	 was	
associated	 with	 higher	 hazard	 of	 all-cause	 mortality.	 Adjustments	 for	
cardiovascular	 risk	factors,	macrostructural	MRI	changes	and	presence	of	lacunar	
infarcts	and	microbleeds	attenuated	the	associations	minimally	(table 2).  
 
Each	 SD	 decrease	 in	 FA	 was	 associated	 with	 1.99-fold	 increased	 hazard	 of	
cardiovascular	mortality	(95%	CI:	1.44,	2.77),	 in	the	age	and	sex	adjusted	model.	
Further	adjustments	did	not	change	our	findings.	There	was	no	association	between	
FA	and	non-cardiovascular	mortality	(all	p>0.05).	Similarly,	each	SD	higher	MD	
was	 associated	 with	 1.84-fold	 increased	 hazard	 of	 cardiovascular	 mortality	
(95%CI:	 1.26,	 2.68).	 After	 adjustments	 for	 cardiovascular	 risk	 factors	 and	
macrostructural	MRI	changes	and	presence	of	lacunar	infarcts	and	microbleeds,	the	
associations	attenuated	and	were	no	longer	significant	(p=	0.207).	Higher	MD	was	
associated	 with	 increased	 hazard	 of	 non-cardiovascular	 mortality	 (HR:	 1.31,	
95%CI:	 1.04,	 1.65),	 but	 the	 association	 was	 no	 longer	 significant	 after	 further 
adjustments	(table 3).  
 
 
 
 
figure 1
In	model	I,	adjusted	for	age	and	sex,	decrease	in	FA	and	increase	in	MD	was	associated	
with	higher	hazard	of	all-cause	mortality.	Adjustments	for	cardiovascular	risk	factors,	
macrostructural	MRI	changes	and	presence	of	lacunar	infarcts	and	microbleeds	attenu-
ated	the	associations	minimally	(table 2).
table 2. The	association	between	white	matter	microstructural	integrity	and	mortality
All-cause mortality
Hazard ratio* (95% CI)
N=4294 (216) p value
fractional anisotropy 
			Model	I 1.37	(1.20,	1.57) <0.001
			Model	II 1.31	(1.15,	1.49) <0.001
			Model	III 1.27	(1.10,	1.48) 0.001
			Model	IV 1.24	(1.10,	1.43) 0.004
Mean diffusivity
			Model	I 1.49	(1.28,	1.75) <0.001
			Model	II 1.39	(1.19,	1.63) <0.001
			Model	III 1.39	(1.17,	1.66) <0.001
			Model	IV 1.32	(1.11,	1.56) 0.002
*Hazard	 ratios	and	95%	CI	are	calculated	per	 standard	deviation	decrease	 in	 fractional	anisotropy	and	per	
standard	deviation	increase	in	mean	diffusivity.
Model	I:	Adjusted	for	age,	and	sex.
Model	II:	Model	I	+	systolic	blood	pressure,	diastolic	blood	pressure,	antihypertensive	medication,	smoking,	
total	cholesterol,	high	density	lipoprotein	cholesterol,	lipid-lowering	medication,	diabetes	mellitus,	history	of	
coronary	heart	disease,	APOE-ε4	allele	carrier,	and	body	mass	index.	
Model	III:	Model	I	+	intracranial	volume,	white	matter	volume,	logarithm	of	white	matter	lesion	volume,	pres-
ence	of	microbleeds,	and	presence	of	lacunar	infarcts.
Model	IV:	Model	I+	II	+	III
Abbreviation:	CI:	confidence	interval,	APOE:	Apolipoprotein	E.
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Each	SD	decrease	 in	 FA	was	 associated	with	 1.99-fold	 increased	 hazard	 of	 cardio-
vascular	mortality	(95%	CI:	1.44,	2.77),	 in	 the	age	and	sex	adjusted	model.	Further	
adjustments	did	not	change	our	findings.	There	was	no	association	between	FA	and	
non-cardiovascular	mortality	(all	p>0.05).	Similarly,	each	SD	higher	MD	was	associ-
ated	with	1.84-fold	increased	hazard	of	cardiovascular	mortality	(95%CI:	1.26,	2.68).	
After	 adjustments	 for	 cardiovascular	 risk	 factors	 and	macrostructural	MRI	 changes	
and	presence	of	lacunar	infarcts	and	microbleeds,	the	associations	attenuated	and	were	
no	longer	significant	(p=	0.207).	Higher	MD	was	associated	with	increased	hazard	of	
non-cardiovascular	mortality	(HR:	1.31,	95%CI:	1.04,	1.65),	but	the	association	was	
no	longer	significant	after	further	adjustments	(table 3).
table 3. The	association	of	white	matter	microstructural	integrity	and	cardiovascular	and	non-cardiovascular	
mortality
Cardiovascular mortality Non-cardiovascular mortality
Hazard ratio* (95% CI)
N=4294 (31) p value
Hazard ratio* (95% CI)
N=4294 (102) p value
fractional anisotropy 
			Model	I 1.99	(1.44,	2.77) <0.001 1.19	(0.98,	1.44) 0.079
			Model	II 1.81	(1.28,	2.57) 0.001 1.13	(0.93,	1.38) 0.206
			Model	III 1.62	(1.12,	2.34) 0.010 1.07	(0.87,	1.33) 0.513
			Model	IV 1.53	(1.04,	2.24) 0.029 1.04	(0.84,	1.28) 0.735
Mean diffusivity
			Model	I 1.84	(1.26,	2.68) 0.001 1.31	(1.04,	1.65) 0.021
			Model	II 1.66	(1.10,	2.49) 0.015 1.22	(0.97,	1.54) 0.085
			Model	III 1.48	(0.96,	2.30) 0.077 1.12	(0.86,	1.46) 0.381
			Model	IV 1.34	(0.85,	2.13) 0.207 1.07	(0.82,	1.38) 0.620
*Hazard	 ratios	and	95%	CI	are	calculated	per	 standard	deviation	decrease	 in	 fractional	anisotropy	and	per	
standard	deviation	increase	in	mean	diffusivity.	
Model	I:	Adjusted	for	age,	and	sex.
Model	II:	Model	I	+	systolic	blood	pressure,	diastolic	blood	pressure,	antihypertensive	medication,	smoking,	
total	cholesterol,	high	density	lipoprotein	cholesterol,	lipid-lowering	medication,	diabetes	mellitus,	history	of	
coronary	heart	disease,	APOE-ε4	allele	carrier,	and	body	mass	index.	
Model	 III:	Model	 I	+	 intracranial	 volume,	white	matter	 volume,	 logarithm	of	white	matter	 lesion	volume,	
presence	
of	microbleeds,	and	presence	of	lacunar	infarcts.	
Model	IV:	Model	I+	II	+	III
Abbreviation:	CI:	confidence	interval;	APOE:	Apolipoprotein	E.
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Kaplan-Meier	survival	curves	showed	that	individuals	with	low	FA	and	high	MD	had	
the	highest	cumulative	mortality	rate	(figure e-1).
In	 the	 tract-specific	 analyses,	we	observed	 that	 for	 all	 tracts,	MD	was	more	promi-
nently	related	to	mortality	than	FA.	For	FA,	after	correcting	for	multiple	testing,	lower	
microstructural	 integrity	 in	 the	different	white	matter	 tracts	was	not	associated	with	
mortality.	For	MD,	 the	association	between	lower	 tract-specific	white	matter	micro-
structural	integrity	and	mortality	seemed	to	be	present	throughout	the	brain;	however,	
it	was	more	prominent	in	the	association	tracts	(table 4	and	figure e-2).
Excluding	participants	with	 interim	dementia	or	 stroke	did	not	change	our	observa-
tions	(table e-2).	Similarly,	excluding	stroke	death	did	not	change	the	association	of	
FA	and	MD	with	cardiovascular	mortality	(table e-3).
table 4. Associations	of	tract-specific	white	matter	microstructural	integrity	and	mortality
fractional Anisotropy Mean diffusivity
Hazard	ratio*	(95%	CI) Hazard	ratio*	(95%	CI)
Tracts in brainstem
Middle	cerebellar	peduncle 1.04	(1.27,	0.86) 1.08	(0.95,	1.22)
Medial	lemniscus	a 1.03	(1.22,	0.87)  1.21 (1.06, 1.37)*
Projection tracts
Corticospinal	tract 1.06	(1.22,	0.93)  1.29 (1.11, 1.49)*
Anterior	thalamic	radiation 1.05	(1.23,	0.89) 1.17 (1.00, 1.37)
Superior	thalamic	radiation 1.06	(1.22,	0.93) 1.21 (1.05, 1.38)
Posterior	thalamic	radiation 1.19	(1.43,	1.00) 1.10	(0.95,	1.27)
Association tracts
Superior	longitudinal	fasciculus 1.20 (1.41, 1.03)  1.28 (1.13, 1.46)*
Inferior	longitudinal	fasciculus 1.09	(1.30,	0.92)  1.28 (1.09, 1.49)*
Inferior	fronto-occipital	fasciculus 1.25 (1.49, 1.04) 1.24	(1.05,	1.45)
Uncinate	fasciculus 1.27 (1.49, 1.06)  1.35 (1.15, 1.57)*
Limbic system tracts 
Cingulate	gyrus	part	of	cingulum 1.09	(1.28,	0.93)  1.27 ( 1.10, 1.47)*
Parahippocampal	part	of	cingulum 1.14	(1.30,	0.97) 1.00	(0.91,	1.10)
Callosal tracts
Forceps	major 1.28 (1.52, 1.06) 1.08	(0.96,	1.23)
Forceps	minor 1.23 (1.49, 1.02) 1.24 (1.06, 1.45)
*Hazard	ratios	and	95%	CI,	calculated	per	standard	deviation	decrease	in	fractional	anisotropy	and	increase	in	mean	
diffusivity,	adjusted	for	age,	sex,	intracranial	volume,	white	matter	volume,	volume	of	white	matter	hyperintensities,	
presence	of	microbleeds,	and	presence	of	lacunar	infarcts.	
Results	in	bold	are	significant	at	p<0.05.
Results	in	bold	and	*	were	significant	after	correction	for	multiple	testing	(p<	3.7	×	10-3).	
Abbreviation:	CI:	confidence	interval.
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dISCuSSIoN
We	 showed	 that	 among	 community-dwelling	 individuals,	 lower	microstructural	 in-
tegrity	 of	 cerebral	white	matter	 is	 related	 to	 an	 increased	mortality,	 independent	 of	
cardiovascular	 risk	 factors,	macrostructural	MRI	changes	 (white	matter	volume	and	
the	log	transformed	volume	of	white	matter	hyperintensities),	and	presence	of	lacunar	
infarcts	 and	microbleeds.	The	 association	was	more	 prominent	with	 cardiovascular	
mortality	rather	than	non-cardiovascular	mortality.	Furthermore,	we	found	that	lower	
white	matter	microstructure	in	the	association	tracts	most	strongly	related	to	mortality.
White	matter	is	a	key	component	of	the	brain	consisting	of	glial	cells	and	myelinated	
axons	 that	 transmit	 signals	mostly	 between	 various	 regions	 of	 the	 brain	 and	 spinal	
cord.2	White	matter	accounts	for	nearly	half	of	the	brain	volume	and	its	microstructural	
integrity	 is	 crucial	 for	 normal	 brain	 function.7	White	matter	 damage	 represented	 as	
white	matter	 hyperintensities	 and	white	matter	 atrophy	 is	 reported	 to	 be	 related	 to	
a	higher	risk	of	mortality.4,10,26	The	association	between	more	subtle,	microstructural	
changes	in	white	matter	can	provide	a	better	insight	into	cerebral	white	matter	pathol-
ogy,	but	this	has	not	yet	been	investigated	in	a	population-based	setting.	Virtanen	et	al.,	
in	pre-operative	patients	with	peripheral	arterial	disease,	showed	that	microstructural	
changes	in	white	matter	are	linked	to	a	worse	cardiorespiratory	and	metabolic	profile	
and	an	increased	risk	of	mortality.27	In	this	study	we	showed	that	this	finding	can	be	
extended	to	the	general	population	free	of	dementia	and	stroke.
We	observed	 that	poorer	white	matter	microstructural	 integrity	was	 associated	with	
higher	 all-cause,	 cardiovascular,	 and	 non-cardiovascular	mortality,	 but	most	 promi-
nently	with	cardiovascular	mortality.	A	possible	explanation	for	this	observation	could	
be	 that	 white	 matter	 is	 more	 prone	 to	 vascular	 insults.28,29	 Shared	 cardiovascular	
risk	 factors	 such	as	hypertension	and	diabetes	might	play	a	 role	 in	 this	association.	
Adjusting	 for	 cardiovascular	 risk	 factors	 attenuated	 the	 associations;	 but	 the	 find-
ings	 persisted.	This	might	 indicate	 that	 at	 least	 part	 of	 the	 association	 is	 driven	 by	
cardiovascular	 risk	 factors	 that	 could	 not	 be	measured,	 or	 represent	 the	 very	 initial	
phase	of	atherosclerotic	processes.	Rather	than	cardiovascular	risk	factors,	one	of	the	
important	pathologies	that	would	influence	white	matter	integrity	is	neurodegenerative	
diseases	such	as	Alzheimer’s	disease.	Although	we	excluded	the	dementia	cases	from	
the	analyses,	we	cannot	 exclude	 the	possibility	 that	 impairment	 in	 the	white	matter	
integrity	could	be	related	to	(preclinical)	neurodegenerative	processes,	in	particular	in	
the	association	tracts.
Available	 literature	 suggests	 that	 damage	 to	 cerebral	white	matter	 is	 not	 only	 asso-
ciated	with	 deterioration	 in	 cerebral	 functions	 such	 as	 cognition,	 sensory	 or	motor	
function	but	also	with	disturbances	in	regulation	of	endocrine	and	autonomic	nervous	
systems	throughout	the	body.30	Disturbances	in	white	matter	microstructural	integrity	
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may	 therefore	 influence	 a	 variety	 of	 functions	 throughout	 the	 body	 that	may	 result	
in	a	higher	 risk	of	mortality,	 also	due	 to	causes	other	 than	neurological	diseases.6,30 
This	 is	 in	 line	with	our	observation	 that	adjusting	 for	macrostructural-MRI	changes	
(white	matter	volume,	and	log	transformed	volume	of	white	matter	hyperintensities)	
and	excluding	neurological	diseases	(interim	stroke	and	dementia)	did	not	change	our	
findings.	Moreover,	the	association	between	white	matter	microstructure	and	cardio-
vascular	mortality	 persisted	 even	 after	 excluding	 cerebrovascular	 related	mortality,	
indicating	that	the	association	was	not	mainly	driven	by	cerebrovascular	diseases.
In	the	tract	specific	analyses,	we	observed	that	MD	was	more	prominently	associated	
with	mortality	than	FA.	The	disparity	in	associations	between	FA,	MD	and	mortality	
might	indicate	that	FA	and	MD	reflect	different	pathophysiologies.	The	exact	processes	
underlying	the	changes	in	FA	and	MD	are	still	not	known.	However,	it	is	hypothesized	
that	 FA	 is	 dominated	 by	 tract	 coherence	 and	 axonal	 loss,	 and	MD	 by	 (volume	 of)	
interstitial	or	extracellular	fluid.31,32	Besides	a	biological	difference,	MD	seems	to	be	a	
more	sensitive	diffusion-MRI	measure	in	regions	with	crossing	tracts.33
The	 associations	 found	with	MD	were	widespread	 in	 the	 brain,	 but	more	 apparent	
to	 the	 association	 tracts,	 which	 may	 be	 explained	 by	 the	 variable	 susceptibility	 to	
vascular	damage	between	different	 tracts.	Previous	 research	has	shown	 that	 there	 is	
a	differential	vulnerability	of	white	matter	 tracts	 in	aging.	The	association	tracts	are	
more	prone	to	insult	and	degeneration	in	later	life;	however,	the	exact	mechanism	ex-
plaining	this	differential	sensitivity	remains	unclear.13,14	A	possible	explanation	could	
be	the	location	of	the	association	tracts	in	watershed	areas,	making	these	tracts	more	
vulnerable	to	insult	and	vascular	damage	leading	to	faster	degeneration.
Strengths	of	this	study	include	the	large	sample	size	and	its	population-based	design.	
Furthermore,	the	availability	of	extensive	data	on	cardiovascular	risk	factors	and	mac-
rostructural	MRI-markers	enabled	us	to	control	for	potential	confounders.	Limitations	
of	this	study	should	be	acknowledged.	In	the	tract-specific	analysis	we	used	median	FA	
and	MD	and	this	disposes	spatial	information	compared	to	a	voxel-based	technique.	
Also,	varying	field	of	views	relative	to	the	cerebellum	resulted	in	less	accurate	measure-
ments	and	therefore	less	reliable	conclusions	on	brain	stem	tracts.	The	diffusion	tensor	
model	in	regions	with	crossing	fibers	can	result	in	unreliable	diffusion-MRI	measures	
particularly	 for	FA.	 In	 contrast	 to	FA,	MD	seems	 to	 be	 a	more	 reliable	measure	 in	
crossing	fiber	 regions.33	Although	we	 used	 probabilistic	 tractography,	 and	 excluded	
tracts	veering	off	into	neighboring	tract,	our	results	with	FA	might	have	been	influenced	
in	crossing	fiber	regions.	Furthermore,	we	computed	tract-specific	volumes	to	correct	
analyses	for	tract-specific	atrophy	and	for	partial	volume	effects	in	the	segmentations.	
However,	we	cannot	totally	rule	out	the	influence	of	partial	volume	averaging	of	CSF	
on	our	results.	Follow-up	time	for	cause-specific	mortality	was	shorter	than	mortality	
from	all	causes;	this	might	have	led	to	an	underestimation	of	the	association	between	
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white	matter	integrity	and	cause-specific	mortality.	Although	our	findings	were	inde-
pendent	 of	 several	 cardiovascular	 risk	 factors,	 roles	 of	 other	 potential	 confounders	
such	 as	 physical	 activity,	 dietary	 factors,	 inflammation,	 and	 carotid	 disease	 on	 the	
association	between	white	matter	integrity	and	mortality	need	to	be	further	tested.
Our	findings	suggest	that	the	adverse	effects	of	impairments	in	cerebral	white	matter	
integrity,	even	at	early	stages,	are	not	limited	to	neurocognitive	outcomes	and	they	can	
also	put	individuals	at	higher	risk	of	mortality	especially	from	cardiovascular	causes.	
This	might	call	for	further	studies	unravelling	the	mechanisms	behind	the	link	between	
white	matter	integrity	and	survival.
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table e-1. Baseline	characteristics	of	included	and	excluded	participants
Baseline characteristics Participated
N= 4294
Not participated
N=1136
P-value
Age,	years 63.6	(11.0) 68.0	(12.2) <0.001
Men	 1906	(44.4) 470	(41.4) 0.128
Systolic	blood	pressure,	mmHg 139.0	(21.5) 144.6	(24.5) 0.017
Diastolic	blood	pressure,	mmHg 83.1	(10.8) 83.6	(11.8) 0.548
Antihypertensive	medication 1463	(34.1) 555	(48.9) 0.005
Total	cholesterol,	mmol/l 5.5	(1.0) 5.3	(1.1) <0.001
HDL	cholesterol,	mmol/l 1.4	(0.4) 1.4	(0.4) 0.009
Lipid-lowering	medication 1014	(23.6) 368	(33.2) <0.001
Smoking	
			Current 878	(20.4) 236	(21.3) <0.001
			Former 2060	(48.0) 545	(48.0)
History	of	coronary	heart	disease 256	(6.0) 105	(9.2) 0.100
Diabetes	mellitus 393	(9.2) 145	(12.8) 0.009
Body	mass	index,	kg/m2 27.4	(4.1) 27.9	(5.1) <0.001
table e-2. The	association	of	white	matter	microstructural	integrity	and	mortality	excluding	participants	with	
interim	stroke	and	dementia
total mortality
Hazard ratio* (95% CI)
N=4219 (198) p value
fractional anisotropy 
			Model	I 1.35	(1.17,	1.56) <0.001
			Model	II 1.31	(1.14,	1.51) <0.001
			Model	III 1.27	(1.09,	1.49) 0.003
Mean diffusivity
			Model	I 1.51	(1.27,	1.79) <0.001
			Model	II 1.44	(1.21,	1.72) <0.001
			Model	III 1.43	(1.18,	1.72) <0.001
*Hazard	 ratios	and	95%	CI	are	calculated	per	 standard	deviation	decrease	 in	 fractional	anisotropy	and	per	
standard	deviation	increase	in	mean	diffusivity.	
Model	I:	Adjusted	for	age,	and	sex.
Model	II:	Model	I	+	systolic	blood	pressure,	diastolic	blood	pressure,	antihypertensive	medication,	smoking,	
total	cholesterol,	high	density	lipoprotein	cholesterol,	lipid-lowering	medication,	diabetes	mellitus,	history	of	
coronary	heart	disease,	APOE-ε4	allele	carrier,	and	body	mass	index.	
	Model	III:	Model	I	+	intracranial	volume,	white	matter	volume,	logarithm	of	volume	of	white	matter	hyperin-
tensities,	presence	of	microbleeds,	and	presence	of	lacunar	infarcts.	
Abbreviation:	CI:	confidence	interval,	APOE:	Apolipoprotein	E.
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table e-3. The	association	of	white	matter	microstructural	 integrity	and	cardiovascular	mortality	excluding	
death	from	stroke
Cardiovascular mortality
Hazard ratio* (95% CI)
N=4289 (26) p value
fractional anisotropy
			Model	I 1.85	(1.29,	2.67) 0.001
			Model	II 1.61	(1.10,	2.35) 0.014
			Model	III 1.61	(1.07,	2.41) 0.023
Mean diffusivity
			Model	I 1.89	(1.24,	2.88) 0.003
			Model	II 1.66	(1.04,	2.65) 0.032
			Model	III 1.63	(1.01,	2.65) 0.046
*Hazard	 ratios	and	95%	CI	are	calculated	per	 standard	deviation	decrease	 in	 fractional	anisotropy	and	per	
standard	deviation	increase	in	mean	diffusivity.
Model	I:	Adjusted	for	age,	and	sex.
Model	II:	Model	I	+	systolic	blood	pressure,	diastolic	blood	pressure,	antihypertensive	medication,	smoking,	
total	cholesterol,	high	density	lipoprotein	cholesterol,	lipid-lowering	medication,	diabetes	mellitus,	history	of	
coronary	heart	disease,	APOE-ε4	allele	carrier,	and	body	mass	index.
Model	III:	Model	I	+	intracranial	volume,	white	matter	volume,	logarithm	of	volume	of	white	matter	hyperin-
tensities,	presence	of	microbleeds,	and	presence	of	lacunar	infarcts.
Abbreviation:	CI:	confidence	interval,	APOE:	Apolipoprotein	E.
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ABStrACt
Background	General	 cognition	 in	 adults	 shows	 variation	 due	 to	 brain	 and	 cogni-
tive	reserve,	and	degenerative	components.	A	recent	genome-wide	association	study	
identified	genetic	variants	for	general	cognitive	function	in	148	independent	loci.	The	
relation	of	these	variants	with	cognitive	decline,	the	incidence	of	dementia,	parkinson-
ism	and	stroke,	and	brain	imaging	is	still	unknown.	Here,	we	aimed	to	elucidate	these	
associations.
Methods	This	 study	was	 conducted	within	 the	 population-based	Rotterdam	Study	
(mean	age	65.3±9.9	years,	58.0%	women).	We	used	lead	variants	for	general	cognitive	
function	to	construct	a	polygenic	score	(PGS).	Additionally,	we	excluded	genetic	vari-
ants	previously	associated	with	intracranial	volume	and	educational	attainment	at	mul-
tiple	significance	thresholds	to	eliminate	the	brain	and	cognitive	reserve	component.
Results	A	higher	PGS	including	all	lead	variants	(N=170)	was	related	to	a	cognitive	
decline,	higher	educational	attainment	and	larger	intracranial	volume.	No	association	
was	found	with	daily	functioning,	or	the	incidence	of	dementia,	parkinsonism	or	stroke.	
Excluding	genetic	variants	associated	with	the	cognitive	and	brain	reserve	component	
caused	an	attenuation	of	nearly	all	associations	found.
Conclusion	 This	 study	 suggests	 that	 genetic	 variants	 associated	 with	 general	
cognitive	function	represent	both	reserve	and	degenerative	components	of	cognitive	
performance.
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INtroduCtIoN
General	 cognitive	 function	 represents	 the	 ability	 to	 perform	 tasks	 across	 different	
cognitive	domains.	The	development	of	the	nervous	system	shapes	an	important	part	
of	the	inter-individual	variation	in	general	cognitive	function,	with	neurodegenerative	
processes	 increasingly	contributing	 later	 in	 life.1,2	The	developmental	component	of	
cognition	can	be	 referred	 to	as	 reserve	and	 is	subdivided	 into	cognitive	 reserve	and	
brain	reserve.	Cognitive	reserve	stands	for	a	more	efficient	use	of	neural	networks,	or	
use	of	alternate	networks,	and	is	estimated	with	educational	attainment;	brain	reserve	
represents	a	quantitative	buffer	of	neural	networks,	of	which	intracranial	volume	is	a	
marker.3	As	such,	general	cognition	is	a	mixed	construct	consisting	of	both	reserve	and	
degenerative	components1,	that	has	relevance	for	clinical	outcomes	with	an	important	
cognitive	component,	such	as	daily	functioning,	dementia,	parkinsonism,	and	stroke.
Recently,	 the	highly	polygenic	architecture	of	general	cognitive	 function	was	partly	
elucidated	 by	 the	 identification	 of	 genetic	 variants	 in	 148	 independent	 loci	 (Davies	
et	 al.	 in	 press)	One	 approach	 to	 provide	more	 insight	 into	 underlying	 pathways,	 is	
to	unravel	 the	relation	of	 these	variants	with	markers	of	both	reserve	and	degenera-
tive	components	of	general	cognitive	function.	The	association	of	these	variants	with	
specific	clinical	outcomes	 linked	 to	accelerated	cognitive	decline	could	additionally	
contribute	to	understanding	these	pathways.
Brain	changes	may	be	a	plausible	biological	substrate	to	explain	possible	underlying	
pathways	between	these	genetic	variants	and	cognitive	performance,	and	subsequent	
clinical	 outcomes.	 Structural	 brain	 magnetic	 resonance	 imaging	 (MRI),	 including	
diffusion-MRI,	is	a	suitable	method	for	investigating	brain	changes	that	are	important	
for	cognition	and	related	outcomes.4-7
In	this	population-based	study,	we	aimed	to	elucidate	the	association	of	the	recently	
identified	genetic	variants	for	general	cognitive	function	with	cognitive	decline,	mea-
sures	of	daily	functioning,	the	risk	of	neurological	disorders,	and	structural	neuroimag-
ing.
MethodS
Study population
This	study	was	conducted	within	the	framework	of	the	Rotterdam	Study,	an	ongoing	
population-based	cohort	study	located	in	the	Netherlands	with	the	aim	to	investigate	
causes	and	determinants	of	diseases	in	the	elderly.8	This	cohort	was	initiated	in	1990	
and	extended	in	2000	and	2006,	with	a	total	of	14926	participants	aged	45	years	and	
older	who	undergo	examinations	every	three	to	four	years.	Assessment	of	dementia,	
parkinsonism	including	PD,	and	stroke	has	been	performed	since	the	start	of	the	study.	
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In	 2002,	 an	 extensive	 cognitive	 test	 battery	 was	 added	 to	 the	 core	 protocol.	 MRI	
scanning	was	implemented	in	the	study	protocol	from	2005	onwards.9	Out	of	14926	
subjects,	genotyping	was	successfully	performed	in	11496	participants.	figure 1	gives	
an	overview	of	the	selection	of	participants	for	the	different	analyses,	presented	in	a	
flowchart.	After	application	of	the	exclusion	criteria,	different	subgroups	of	participants	
remained	 for	 different	 analyses	 (figure 1).	According	 to	 the	 Population	 Study	Act	
Rotterdam	Study,	the	Ministry	of	Health,	Welfare	and	Sports	of	the	Netherlands	has	
given	approval	for	the	Rotterdam	Study.	All	participants	have	given	written	informed	
consent.8
Genotyping
The	Illumina	550K,	550K	duo	and	610	quad	arrays	were	used	for	genotyping.	Samples	
with	 a	 call	 rate	 below	97.5%	were	 removed,	 as	well	 as	 gender	mismatches,	 excess	
autosomal	heterozygosity,	duplicates	or	family	relations,	ethnic	outliers,	variants	with	
call	 rates	 lower	 than	 95.0%,	 failing	 missingness	 test,	 Hardy-Weinberg	 equilibrium	
p-value	 smaller	 than	 10-6	 and	 allele	 frequencies	 smaller	 than	 1%.	 Genotypes	 were	
imputed	using	MaCH/minimac	software	to	the	1000	Genomes	phase	I	version	3	refer-
ence	panel.
Polygenic score
We	made	a	polygenic	score	(PGS)	for	all	participants	using	the	178	lead	single	nucleo-
tide	polymorphisms	(SNPs)	with	the	corresponding	effect	sizes	as	described	by	Davies	
et al.(in	press)	Variants	that	were	not	available	in	the	reference	panel	and	variants	with	
an	 r2<0.30	were	 excluded	 (N=7	 and	N=1,	 respectively).	 For	 the	 remaining	 genetic	
variants	 (N=170),	 the	 allele	 dosage	was	multiplied	 by	 the	 reported	 effect	 estimate.	
Subsequently,	 the	 weighted	 effects	 of	 all	 variants	 were	 added	 up	 and	 the	 resulting	
polygenic	scores	were	standardized	into	Z-scores.
Furthermore,	we	 aimed	 to	 differentiate	 the	 reserve	 component	 of	 general	 cognitive	
function	 from	 the	 degenerative	 effects.	 Therefore,	 we	 calculated	 additional	 PGSs	
where	variants	associated	with	educational	attainment	and	 intracranial	volume	were	
removed	using	multiple	p-value	 thresholds.	For	each	variant,	we	used	 the	 lowest	p-
value	threshold	for	either	educational	attainment	or	intracranial	volume.	The	p-values	
were	 extracted	 from	 the	 summary	 statistics	 of	 a	 GWAS	 on	 educational	 attainment	
performed	in	120000	individuals,	and	a	GWAS	on	intracranial	volume	performed	in	
32438	individuals.10	For	all	170	variants	included	in	the	abovementioned	PGS,	informa-
tion	was	available	in	both	the	educational	attainment	and	intracranial	volume	GWAS.	
The	different	p-value	 thresholds	 for	 the	association	with	educational	attainment	and	
intracranial	 volume,	with	 the	 corresponding	 number	 of	 variants	 that	 remained,	 and	
the	 explained	variance	of	 the	G-factor	 in	 our	 dataset	 are	 shown	 in	Supplementary 
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table S1.	When	applying	the	strictest	p-value	threshold	(p>0.05),	36	genetic	variants	
remained.
Cognitive test battery
The	Mini-Mental	 State	Examination	 (MMSE)	was	 assessed	 as	 a	measure	 of	 global	
cognitive	function.	Additionally,	cognitive	function	was	assessed	using	multiple	cog-
nitive	tests:	the	15-word	learning	test	(15-WLT),	the	Stroop	test	(consisting	of	reading,	
color	naming	and	interference	tasks,	error-adjusted	scores),	the	Letter-Digit	Substitu-
tion	Task	 (LDST),	 the	Word	Fluency	Test	 (using	animal	categories)	and	 the	Purdue	
pegboard	(PPB)	task	for	the	left	hand,	right	hand	and	both	hands.2,11-14	A	measure	of	
general	 cognitive	 function	 (“G-factor”)	 was	 obtained	 through	 principal	 component	
analysis	on	the	delayed	recall	score	of	 the	15-WLT,	Stroop	interference	 test,	Letter-
Digit	Substitution	Task,	Word	Fluency	Task	and	the	Purdue	Pegboard	test,	as	described	
previously.2	The	G-factor	explained	53.4%	and	51.9%	of	the	variance	in	cognitive	test	
scores	 in	our	population	at	baseline	and	follow-up	visit,	 respectively.	Z-scores	were	
calculated	in	order	to	make	comparable	test	results.	Self-reported	years	of	education	
was	used	as	a	measure	of	educational	attainment.
Assessment of daily functioning
Two	components	of	daily	 functioning	were	assessed:	basic	activities	of	daily	 living	
(BADL)	and	instrumental	activities	of	daily	living	(IADL).	The	Dutch	version	of	the	
Stanford	Health	Assessment	Questionnaire	was	used	 to	measure	BADL15	and	IADL	
was	measured	 using	 the	Dutch	 version	 of	 the	 Instrumental	Activities	 of	Daily	Liv-
ing	 scale.16	To	 prevent	 selective	 loss	 of	 data,	 IADL	 items	 scored	 as	 non-applicable	
were	imputed	using	the	variables	age,	sex,	BADL	scores	and	all	other	available	IADL	
items.	Both	BADL	and	IADL	scores	were	standardized	into	Z-scores.	Lower	scores	
correspond	to	better	daily	functioning.
Assessment of clinical outcomes
The	assessment	of	dementia,	parkinsonism	(including	PD)	and	stroke	were	previously	
described	 in	detail.17-19	 In	summary,	history	of	 these	clinical	outcomes	was	assessed	
during	the	baseline	interview.	Participants	were	screened	at	baseline	and	subsequent	
center	visits	for	dementia	with	the	MMSE	and	the	Geriatric	Mental	Schedule	organic	
level,	and	for	signs	of	parkinsonism.	Participants	with	a	positive	screening	were	further	
examined	and	were	evaluated	by	a	panel	led	by	an	experienced	neurologist	who	made	
the	definitive	diagnosis.	After	enrollment,	participants	were	continuously	monitored	
for	 dementia,	 parkinsonism	 and	 stroke	 through	 automated	 linkage	 of	 the	 study	 da-
tabase	with	 files	 from	 general	 practitioners.	 Follow-up	 for	 parkinsonism	 (including	
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PD)	was	available	until	the	1st	January	2015	and	for	dementia	and	stroke	until	the	1st 
January	2016.
MrI acquisition and processing
We	performed	a	multi-sequence	brain	MRI	scan	on	a	1.5	tesla	research	dedicated	MRI	
scanner	 (GE	 Signa	 Excite).	 Imaging	 details	 are	 provided	 elsewhere.26	 In	 short,	 the	
scan	 protocol	 included	 a	T1-weighted	 image,	 a	T2-weighted	 fluid-attenuated	 inver-
sion	 recovery	 (FLAIR)	 sequence,	 a	proton	density	weighted	 image	and	a	 spin	echo	
echo	planar	diffusion	weighted	 image	for	 the	diffusion-MRI.	Scans	were	segmented	
into	 grey	matter,	white	matter,	white	matter	 lesion	 volume,	 cerebrospinal	 fluid	 and	
background	 tissue.20,21	We	estimated	 supratentorial	 intracranial	volume	by	 summing	
total	grey	and	white	matter	volume	and	cerebrospinal	fluid.20
For	the	diffusion-MRI,	three	volumes	were	performed	without	diffusion	weighting	(b-
value=0	s/mm2,	maximum	b-value	was	1000	s/mm2).	Diffusion	tensors	were	computed	
using	ExploreDTI	to	obtain	fractional	anisotropy	(FA)	and	mean	diffusivity	(MD)	in	
normal-appearing	white	matter	voxels.	We	segmented	fifteen	white	matter	 tracts	us-
ing	probabilistic	tractography	and	atlas-based	masking.22	Tracts	were	grouped	based	
on	 anatomic	 location	or	 presumed	 function	 into	brain	 stem	 tracts,	 projection	 tracts,	
association	tracts,	limbic	system	tracts	and	callosal	tracts.	Tract-specific	FA	and	MD	
but	also	white	matter	volumes	and	white	matter	lesion	volumes	in	specific	tracts	were	
obtained	as	previously	described.22
In	general,	a	lower	FA	and	a	higher	MD	are	indicative	of	lower	microstructural	white	
matter	integrity
data analysis
Linear	regression	models	were	used	to	assess	the	associations	between	the	PGS	and	
cognitive	function	and	daily	functioning	cross-sectionally	and	longitudinally	by	means	
of	change	in	cognitive	and	daily	functioning	over	time.	Cox	proportional	hazard	mod-
els	were	used	to	study	the	association	between	the	PGS	and	the	incidence	of	dementia,	
parkinsonism,	and	stroke.	The	proportional	hazards	assumption	and	linearity	assump-
tion	were	met.	We	used	linear	regression	models	to	study	the	relation	between	the	PGS	
and	volumetric	brain	outcomes	and	white	matter	microstructural	integrity.	All	models	
were	adjusted	for	age	and	sex.	Models	assessing	change	in	cognitive	function	or	daily	
functioning	over	time	were	additionally	adjusted	for	baseline	measurements,	and	time	
between	baseline	and	follow-up	visit.	Models	 that	assessed	the	relation	between	the	
PGS	and	volumetric	brain	outcomes	were	adjusted	for	intracranial	volume	when	the	
outcome	was	 not	 intracranial	 volume,	 and	 additionally	 for	 white	 matter	 and	 white	
matter	lesion	volume	in	the	analyses	with	white	matter	microstructural	integrity.	The	
abovementioned	analyses	were	repeated	for	all	genetic	variants	separately.
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Since	outcomes	for	the	different	analyses	may	be	correlated,	we	used	permutation	test-
ing	in	order	to	assess	the	number	of	independent	outcomes	for	each	subsection.	Based	
on	this	information,	we	defined	the	multiple	testing	p-value	thresholds	for	the	different	
analyses,	namely	p<0.0038	for	the	cross-sectional	and	p<0.0040	for	the	longitudinal	
analyses	of	cognitive	performance	and	daily	functioning;	p<0.0101	for	the	volumetric	
and	global	diffusion-MRI	brain	measures,	and	p<0.0022	for	the	tract-specific	diffusion-
MRI	analyses;	and	p<0.0129	for	the	clinical	outcomes.	For	the	analyses	of	the	genetic	
variants	separately,	we	additionally	used	the	Bonferroni	correction	for	multiple	test-
ing,	using	the	formula	k/170	with	k	representing	the	p-value	threshold	as	obtained	by	
permutation	testing.	Analyses	were	performed	using	the	IBM	SPSS	Statistics	21	and	
R	3.4.0	software.
reSuLtS
Genotyping	data	was	 available	 for	11496	 individuals,	with	 a	mean	age	of	65.3±9.9	
years,	of	which	58.0%	was	women.	A	flowchart	for	the	inclusion	of	participants	in	the	
different	analyses	is	shown	in	figure 1.	An	overview	of	the	characteristics	of	the	study	
population	for	the	different	analyses	are	shown	in	table 1. 
Cognitive performance and daily functioning
figure 2, panel A	 shows	 the	 association	 between	 the	 genetic	 variants	 for	 general	
cognitive	 function	and	cognitive	performance,	daily	 functioning	and	educational	at-
tainment.	An	increase	in	the	PGS	was	significantly	associated	with	a	higher	G-factor	
(β=0.08,	p=9.6x10-14),	as	well	as	with	individual	cognitive	tests,	except	for	 the	PPB	
test.	The	PGS	was	also	significantly	associated	with	more	years	of	education	(β=0.29,	
table 1. Study	characteristics*
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C
og
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n 
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A
d
L 
N
=5
26
2
Br
ai
n 
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in
g 
N
=3
71
0
dementia Parkinson’s disease Parkinsonism Stroke 
N
=1
10
70
n=
14
44
N
=1
05
88
n=
12
6
N
=1
08
26
n=
25
8
N
=1
13
91
n=
12
20
Age, years 64.0±9.1 64.0 
(11.0)
64.8±9.5 72.0±8.0 64.6±9.4 69.2±8.7 64.9±9.7 70.7±8.8 65.1±9.8 70.4±8.7
Female, % 
(N)
57.4  
(3022)
55.0  
(2039)
57.6  
(6376)
68.0  
(982)
57.3  
(6065)
46.8  
(59)
57.4  
(6219)
52.3	 
(135)
58.2	 
(6436)
58.9  
(718)
follow-up 
time, years 6.1±0.6 - 12.2±6.4 11.3±6.3 12.4±6.5 7.8±5.9 12.3±6.5 7.7±5.8 12.3±6.6 9.4±5.9
*Values	are	expressed	in	mean±standard	deviation	unless	stated	otherwise;	N	is	the	total	number	of	people	for	whom	
this	characteristic	is	assessed;	n	is	the	number	of	cases.	
Abbreviations:	activities	of	daily	living	(ADL).
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p=5.2x10-7).	No	association	with	daily	functioning	was	found.	All	associations	attenu-
ated	after	removing	variants	associated	with	the	reserve	component	of	cognition.	No	
individual	variant	was	significantly	associated	with	any	of	the	outcomes.
figure 2, panel B	shows	that	the	PGS	was	associated	with	less	decline	in	cognitive	
function	(βΔG-factor=0.027,	p=1.5x10
-3).	The	PGS	was	also	associated	with	less	decline	
in	BADL,	 although	 this	was	 not	 significant	 after	multiple	 comparison	 adjustments.	
Removing	variants	associated	with	educational	attainment	and	intracranial	volume	re-
sulted	in	an	attenuation	of	the	effects.	In	the	single-variant	analysis,	no	variant	reached	
statistical	 significance	 for	 the	 association	with	 cognitive	 decline	 or	 change	 in	 daily	
functioning.
Clinical outcomes
No	significant	association	was	found	between	the	PGS	and	any	of	the	clinical	outcomes	
(figure 3).	Out	of	all	170	individual	variants,	none	was	significantly	associated	with	
the	risk	of	one	of	dementia,	parkinsonism	or	stroke.	An	increased	risk	for	dementia	
was	found	after	excluding	variants	associated	with	the	reserve	component	at	a	p>0.05	
threshold	 (hazard	 ratio	 1.06,	 p=0.040),	 although	 this	 did	 not	 survive	 correction	 for	
multiple	testing.
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and	stroke.  
 
 
 
 
  
figure 3.	Polygenic	scores	for	general	cognitive	function	and	disease-free	probability	for	dementia,	parkinson-
ism	and	stroke.
Kaplan-Meier	 curves	 presenting	 the	 association	 between	 low	 (i.e.	 below	 the	median)	 and	 high	 (above	 the	
median)	polygenic	scores	and	the	disease-free	probability	over	time	for	dementia,	parkinsonism,	and	stroke.	
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Brain MrI markers
figure 4	shows	the	results	of	the	association	of	PGS	with	brain	tissue	volumes	and	
global	white	matter	microstructural	 integrity.	We	 found	 that	 a	 higher	PGS	was	 sig-
nificantly	 related	 to	 a	 larger	 intracranial	 volume	 (b=0.05,	 p=7.5x10-4),	 but	 not	with	
the	other	volumetric	and	global	white	matter	microstructural	integrity	(figure 4).	At	
a	 nominal	 significance	 level,	 a	 higher	 PGS	was	 associated	with	 a	 higher	 FA	 in	 the	
medial	lemniscus,	and	a	lower	MD	in	the	inferior-fronto-occipital	fasciculus	and	the	
posterior	 thalamic	 radiation,	 but	 this	 did	 not	 survive	 correction	 for	multiple	 testing	
(data	not	shown).	Removing	genetic	variants	associated	with	the	reserve	component	
of	cognition	caused	a	weakening	of	the	associations.	No	individual	variant	reached	the	
significance	threshold	for	the	association	with	any	of	the	brain	imaging	markers.
Association	between	genetic	variants	for	general	cognitive	function	and	cognitive	func-
tion	and	daily	functioning	at	one	point	in	time,	as	well	as	years	of	education	(panel	A),	
and	change	in	cognitive	performance	and	daily	functioning	over	time	(panel	B),	adjusted	
for	 age	 and	 sex.	 Two	 polygenic	 scores	 are	 presented,	 one	 including	 all	 independent	
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figure 4. Association	between	genetic	variants	 for	general	cognitive	function	and	several	
brain	imaging	markers.	 
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white	matter	microstructural	integrity	markers.	Two	polygenic	scores	are	presented,	one	including	all	
independent	lead	variants,	and	one	only	including	variants	with	a	p>0.05	for	the	association	with	the	
reserve	 component	 of	 cognition,	 which	 consists	 of cognitive	 reserve	 (educational	 attainment)	 and	
brain	reserve	(intracranial	volume).	Also,	the	five top	genetic	variants	for	the	association	with	these	
brain	 imaging	markers	 are	 presented.	 Positive	 associations	 depicted	 in	 blue	 correspond	 to	 a	 larger	
volume	 or	 a	 better	 white	 matter	 microstructural	 integrity.	 Larger	 blocks	 indicate	 higher	 t-values.	
Significance	 levels	are	 indicated	by	asterisks:	*p<0.05,	nominally	significant;	**p<0.0101,	adjusted	
for	 the	 number	 of	 independent	 traits	 as	 calculated	 through	 10,000	 permutations;	 ***p<5.9	 x	 10-5 
(0.0101/170),	additionally	adjusted	for	the	number	of	genetic	variants. 
  
figure 4.	Association	between	genetic	variants	for	general	cognitive	function	and	several	brain	imaging	markers.	
Association	 between	genetic	 variants	 for	 general	 cognitive	 function	 and	 both	 volumetric	 and	 global	white	
matter	microstructural	integrity	markers.	Two	polygenic	scores	are	presented,	one	including	all	independent	
lead	variants,	and	one	only	including	variants	with	a	p>0.05	for	the	assoc ation	with	the reserve	component	of	
cognition,	which	consists	of	cognitive	 eserve	(educational attainment)	and	brain	reserve	(intracranial	volume).	
Also,	the	five	top	genetic	variants	f r	the	association	with	these	brain	im ging	markers	are	presented.	Positive	
associations	depicted	in	blue	correspond	to	a	larger	volume	or	a	better	white	matter	microstructural	integrity.	
Larger	blocks	indicate	higher	t-values.	Significance	levels	are	indicated	by	asterisks:	*p<0.05,	nominally	sig-
nificant;	**p<0.0101,	adjusted	for	the	number	of	independent	traits	as	calculated	through	10,000	permutations;	
***p<5.9	x	10-5	(0.0101/170),	additionally	adjusted	for	the	number	of	genetic	variants.
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lead	variants,	 and	one	only	 including	variants	with	 a	p>0.05	 for	 the	 association	with	
the	 reserve	 component	 of	 cognition,	which	 consists	 of	 cognitive	 reserve	 (educational	
attainment)	 and	 brain	 reserve	 (intracranial	 volume).	 Larger	 blocks	 indicate	 higher	 t-
values.	Higher	scores	indicate	better	performance,	except	for	the	Stroop	test,	the	Basic	
Activities	 of	 Daily	 Living	 and	 Instrumental	Activities	 of	 Daily	 Living.	 Significance	
levels	are	 indicated	by	asterisks:	*p<0.05,	nominally	significant;	**p<0.0038	(figure 
2, panel A)	or	p<0.0040	(figure 2, panel B),	adjusted	for	the	number	of	independent	
traits	as	calculated	 through	10000	permutations;	***p<2.2	x	10-5	 (figure 2, panel A;	
0.0038/170)	or	p<2.4	x	10-5	(figure 2, panel B;	0.0040/170),	additionally	adjusted	for	
the	number	of	genetic	variants.
dISCuSSIoN
In	this	population-based	study	among	middle-aged	and	elderly	persons,	a	PGS	based	
on	 recently	 identified	genetic	variants	 for	global	cognition	was	associated	with	bet-
ter	 global	 cognitive	 performance,	 better	 performance	 on	 individual	 cognitive	 tests,	
less	cognitive	decline,	more	years	of	education	and	a	larger	intracranial	volume.	We	
found	no	significant	association	with	(decline	in)	daily	functioning,	the	incidence	of	
dementia,	parkinsonism	and	 stroke,	or	with	any	of	 the	other	global	or	white	matter	
tract-specific	brain	imaging	markers.
Cognitive	decline	is	an	important	marker	for	the	progression	of	neurodegenerative	dis-
eases.23-25	Therefore,	we	related	the	genetic	variants	for	global	cognition	to	longitudinal	
assessments	of	cognitive	and	functional	outcomes	in	our	study	and	found	that	a	PGS	
based	on	these	genetic	variants	was	associated	with	cognitive	performance	both	cross-
sectionally	 and	 longitudinally.	This	 indicates	 that	 the	 genetic	 variants	 can	 partially	
explain	 inter-	 as	well	 as	 intra-individual	 differences	 in	 cognition,	 and	 is	 supportive	
that	a	degenerative	pathway	underlies	these	identified	genetic	variants.	However,	no	
significant	relation	was	found	between	the	PGS	and	the	risk	of	dementia,	parkinsonism	
or	stroke	in	this	study.	If	anything,	we	saw	a	nominally	significant	association	with	the	
incidence	of	dementia,	but	the	direction	of	effect	was	not	as	expected,	i.e.	a	higher	PGS	
associated	with	better	cognitive	function	showed	an	increase	in	dementia	risk.	However,	
since	this	association	did	not	survive	correction	for	multiple	testing,	no	strong	conclu-
sions	should	be	drawn	from	this	finding,	and	validation	in	other	studies	is	needed.	To	
our	knowledge	there	are	as	yet	no	other	studies	that	have	investigated	the	association	
between	these	genetic	variants	and	cinical	outcomes.	Previous	studies	did	show	an	as-
sociation	between	cognitive	function	and	dementia,	parkinsonism,	Parkinson’s	disease	
(PD)	and	stroke,	both	before	and	after	diagnosis.7,24,26-29	Also,	disease-specific	genetic	
variants	for	these	disorders	have	been	associated	with	cognitive	functioning.30-33		This	
may	 indicate	 that	 cognitive	decline	as	 seen	 in	 abovementioned	 (prodromal)	 clinical	
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outcomes	is	mainly	caused	by	disease-specific	variants	rather	than	variants	for	general	
cognitive	function.	In	addition,	it	is	possible	that	our	study	did	not	have	enough	power	
to	detect	a	significant	association	with	the	incidence	of	the	clinical	outcomes	due	to	the	
relatively	small	number	of	cases.
We	also	found	that	a	higher	PGS	was	related	to	a	larger	intracranial	volume	and	higher	
educational	 attainment,	 both	 reflecting	 early	 brain	 growth	 and	 therefore	 suitable	 as	
markers	for	brain	and	cognitive	reserve.34,35	Brain	reserve	is	partially	determined	by	
genetics36-38	and	is	suggested	to	be	protective	against	cognitive	decline.39
Thus,	our	findings	are	supportive	that	the	genetic	variants	act	through	both	the	reserve	
and	neurodegenerative	pathway.	However	due	 to	absence	of	an	association	between	
the	PGS	and	clinical	outcomes,	we	attempted	to	enrich	the	degenerative	component	of	
the	PGS	by	filtering	out	genetic	variants	hat	are	associated	with	intracranial	volume	
and	educational	attainment.	By	applying	this	filter,	nearly	all	associations	for	the	dif-
ferent	 analyses	were	 attenuated,	 supporting	 the	 suggestion	 that	 the	 genetic	 variants	
mainly	represent	the	reserve	component	of	cognitive	performance.	However,	removing	
genetic	variants	associated	with	the	reserve	component	may	also	eliminate	degenera-
tive	components	of	 the	PGS	if	some	variants	are	pleiotropic,	possibly	 leading	 to	an	
underpowered	study	for	detecting	an	effect	of	the	PGS.	A	more	robust	method	would	be	
to	run	a	genome-wide	association	study	(GWAS)	with	cognitive	decline	as	an	outcome	
instead	of	using	cross-sectional	measurements	of	cognitive	performance,	preferably	in	
an	elderly	population	since	neurodegeneration	mainly	occurs	 later	 in	 life.	However,	
longitudinal	measurements	such	as	those	in	the	present	study	are	only	available	in	a	
fraction	 of	 the	 samples	with	 cross-sectional	 assessments,	which	 at	 present	 impedes	
GWAS	discoveries	for	cognitive	decline.	
Strengths	of	this	study	are	the	population-based	setting,	the	longitudinal	assessment	of	
cognitive	function	and	daily	functioning,	the	availability	of	structural	brain	imaging,	
and	the	 long	follow-up	period	for	dementia,	parkinsonism	and	stroke.	We	also	need	
to	consider	 limitations.	 It	should	be	noted	 that	 the	Rotterdam	Study	was	part	of	 the	
discovery	cohort	for	 the	general	cognitive	function	GWAS	(Davies	et	al).	However,	
since	this	was	only	a	small	proportion	of	the	total	sample	size	(2.0%),	we	do	not	expect	
that	 this	 influenced	our	findings	 to	a	 large	amount.	This	also	 leads	 to	 the	 limitation	
that	the	effect	estimates	in	the	summary	statistics	of	the	GWAS	are	based	on	the	effect	
estimates	of	many	different	populations,	and	they	may	not	be	the	correct	estimates	for	
the	Dutch	population	as	present	in	the	Rotterdam	Study.
In	 conclusion,	we	 found	 that	 the	PGS	of	 general	 cognitive	 function	was	 associated	
with	 cognitive	 performance,	 cognitive	 decline,	 intracranial	 volume	 and	 educational	
attainment,	but	not	with	daily	functioning,	neurological	disorders,	or	the	other	brain	
imaging	markers.	Based	on	our	results	we	postulate	that	the	genetic	variants	identified	
for	general	cognitive	function	are	acting	mainly	through	the	reserve	pathway	of	cogni-
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tion,	 but	 also	 affect	 the	 degenerative	 pathway.	 Further	 genetic	 studies	 of	 cognitive	
decline	in	elderly	individuals	can	provide	more	insight	into	the	degenerative	pathway.
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Supplementary table S1.	P-value	thresholds	for	the	association	with	educational	attainment	and	intracranial	
volume,	and	corresponding	number	of	genetic	variants	remaining.
threshold p-value for the association with educational 
attainment and intracranial volume
Number of variants 
remaining
explained variance 
G-factor
No	threshold 170 0,00656
P>5e-8 149 0,00593
P>1e-7 146 0,00607
P>1e-6 144 0,00594
P>1e-5 135 0,00507
P>1e-4 121 0,00431
P>1e-3 101 0,00299
P>0.01 70 0,00186
P>0.05 36 0,00062
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ABStrACt
Background	Identifying	persons	at	risk	for	cognitive	decline	may	aid	in	early	detec-
tion	of	persons	at	risk	of	dementia	and	to	select	 those	that	would	benefit	most	from	
therapeutic	or	preventive	measures	for	dementia.
Objective	In	this	study	we	aimed	to	validate	whether	cognitive	decline	in	the	general	
population	can	be	predicted	with	multi-variate	data	using	a	previously	proposed	super-
vised	classification	method:	Disease	State	Index	(DSI).
Methods	We	included	2,542	participants,	non-demented	and	without	mild	cognitive	
impairment	at	baseline,	from	the	population-based	Rotterdam	Study	(mean	age	60.9	
±	9.1	years).	Participants	with	significant	global	cognitive	decline	were	de-	fined	as	
the	 5%	 of	 participants	 with	 the	 largest	 cognitive	 decline	 per	 year.	We	 trained	DSI	
to	predict	occurrence	of	significant	global	cognitive	decline	using	a	 large	variety	of	
baseline	 features.	 Prediction	 performance	 was	 assessed	 as	 area	 under	 the	 receiver	
operating	characteristic	curve	(AUC),	using	500	repetitions	of	2-fold	cross-validation	
experiments.
Results	A	mean	AUC	(95%	confidence	interval)	for	DSI	prediction	was	0.78	(0.77	-	
0.79)	using	only	age	as	input	feature.	When	using	all	available	features,	a	mean	AUC	
of	0.77	(0.75	-	0.78)	was	obtained.	Without	age,	and	with	age-corrected	features	and	
feature	selection	on	MRI	features,	a	mean	AUC	of	0.70	(0.63	-	0.76)	was	obtained,	
showing	the	potential	of	other	features	besides	age.
Conclusion	The	best	 performance	 in	 the	prediction	of	 global	 cognitive	decline	 in	
the	 general	 population	by	DSI	was	 obtained	using	only	 age	 as	 input	 feature.	Other	
features	showed	potential,	but	did	not	improve	prediction.	Future	studies	should	evalu-
ate	whether	 the	 performance	 could	 be	 improved	 by	 new	 features,	 e.g.,	 longitudinal	
features,	and	other	prediction	methods.
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INtroduCtIoN
It	is	well	established	that	neuropathological	brain	changes	related	to	dementia	accumu-
late	over	decades,	and	that	the	disease	has	a	long	preclinical	phase.	This	may	facilitate	
early	disease	detection	and	prediction.1	A	large	amount	of	body	of	literature	on	potential	
features	and	risk	factors	for	dementia	exists.	However,	clinicians	often	struggle	to	inte-
grate	all	the	data	obtained	from	a	single	patient	for	diagnostic	or	prognostic	purposes.	
Therefore,	there	is	a	need	for	information	technologies	and	computer-based	methods	
that	support	clinical	decision	making.2	Disease	State	Index	(DSI)	is	a	supervised	ma-
chine	learning	method	intended	to	aid	clinical	decision	making.3	This	method	compares	
a	variety	of	patient	variables	with	those	variables	from	previously	diagnosed	cases,	and	
computes	an	index	that	measures	the	similarity	of	the	patient	to	the	diagnostic	group	
studied.	The	DSI	method	has	 previously	 been	 tested	 in	 specific	 patient	 populations	
and	has	shown	to	perform	reasonably	well	in	the	early	prediction	of	progression	from	
mild	cognitive	impairment	(MCI)	to	Alzheimer’s	disease	and	has	been	successful	in	
the	classification	of	different	dementia	subtypes	[3–6].	In	a	recent	study	DSI	has	been	
validated	in	a	population-based	setting	to	predict	late-life	dementia.7	Identification	of	
persons	at	risk	for	global	cognitive	decline	may	aid	in	early	detection	of	persons	at	risk	
of	dementia	and	may	help	to	develop	therapeutic	or	preventive	measures	to	postpone	
or	even	prevent	further	cognitive	decline	and	dementia.8	This	is	especially	important	
since	 previous	 research	 has	 shown	 that	 preventive	 interventions	 for	 dementia	were	
more	effective	in	persons	at	risk	than	in	unselected	populations.9,	10	We	therefore	used	
DSI	to	predict	global	cognitive	decline	in	the	general	population	to	select	the	persons	
at	risk.	The	main	aim	of	this	study	was	to	investigate	whether	multi-variate	data	can	
predict	global	cognitive	decline	in	the	general	population.	If	a	high	risk	group	can	be	
selected	from	the	general	population,	a	population	screening	program	for	this	group	
might	facilitate	early	detection	of	dementia.	We	evaluated	the	prediction	performance	
using	several	sets	of	clinical	features	and	features	derived	brain	images	acquired	with	
magnetic	resonance	imagaging	(MRI),	to	assess	whether	the	prediction	is	dependent	
on	the	combination	of	the	input	features.	DSI	was	chosen	as	a	classification	method	
because	this	method	is	able	to	handle	datasets	with	missing	data,	which	is	often	the	
case	 in	population	study	datasets.	Also,	 this	method	has	been	succesfully	applied	in	
previous	studies	and	performed	comparable	to	other	state-of-the-art	classificiers.4,	7,	11
MAterIALS ANd MethodS
Study population
We	 included	 participants	 from	 three	 independent	 cohorts	 within	 the	 Rotterdam	
Study	 (RS),	 a	 prospective	 population-based	 cohort	 study	 in	 a	 suburb	 of	Rotterdam	
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that	investigates	the	determinants	and	occurrence	of	diseases	in	the	middle-aged	and	
elderly	population.12	Brain	MRI-scanning	was	implemented	in	the	study	protocol	since	
2005.13	The	Rotterdam	Study	has	been	approved	by	the	medical	ethics	committee	ac-
cording	 to	 the	Population	Study	Act	Rotterdam	Study,	 executed	 by	 the	Ministry	 of	
Health,Welfare	and	Sports	of	the	Netherlands.	Written	informed	consent	was	obtained	
from	 all	 participants.14 We	 used	 data	 from	 RS	 cohorts	 I,	 II	 and	 III,	 of	 which	 each	
consists	of	multiple	 subcohorts.	 In	 this	 study	a	 subcohort	of	RS	cohort	 I,	 II	 and	 III	
were	 used,	 to	 which	we	 refer	 as	 sI,	 sII	 and	 sIII,	 respectively.	 Baseline	 features	 of	
sI	 were	 collected	 during	 2009-2011	 and	 sII	 were	 collected	 during	 2004-2006.	 The	
participants	of	the	both	cohorts	were	55	years	or	older.	For	RS	cohort	III	participants	
were	45	years	or	older	at	 time	of	 inclusion.	Baseline	features	of	sIII	were	collected	
during	2006-2008.	Participants	with	prevalent	dementia,	mild	 cognitive	 impairment	
(MCI)	and	MRI	defined	cortical	infarcts	at	baseline	were	excluded	for	all	analyses.	In	
total,	4328	participants	with	baseline	information	on	cognition,	MRI	and	other	features	
were	included.	Baseline	MRI	was	acquired	on	average	0.3±	0.45	years	after	collecting	
the	non-imaging	features.	Furthermore,	diffusion-MRI	was	acquired.	However,	for	a	
subset	of	680	participants	in	RS	cohort	II	diffusion-MRI	data	was	obtained	on	average	
3.5±0.2	years	later	than	the	other	baseline	MRI	features.	Longitudinal	data	on	global	
decline	was	available	for	2542	out	of	4328	participants.	The	follow-up	cognitive	as-
sessment	was	on	average	5.7±0.6	years	after	the	baseline	visit.
disease State Index
Prediction	was	performed	with	DSI.3	This	 classifier	derives	 an	 index	 indicating	 the	
disease	state	of	the	partici-	pant	under	investigation	based	on	the	available	features	of	
that	participant.	DSI	has	two	major	advantages:	1)	it	can	cope	with	missing	data	and	
2)	it	gives	an	interpretable	result	because	DSI	also	provides	a	decision	tree	that	can	be	
quite	well	explained.
DSI	 classifier	 is	 composed	of	 the	 components:	fitness	 and	 relevance.3 Let N	 be	 the	
total	number	of	negatives,	P	the	total	number	of	positives,	FN(x)	the	number	of	false	
negatives,	 and	FP(x)	 the	number	of	 false	positives,	when	x	 is	used	as	classification	
cut-off.	Then	the	fitness	function	is	estimated	for	each	feature	i as:
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DSI	is	a	value	between	zero	and	one;	somebody	is	classified	as	positive	if	DSI	>	0.5	
and	as	negative	if	DSI	<	0.5.	DSI	is	an	ensemble	classifier,	meaning	that	it	combines	
multiple	independent	classifiers	(fitness	functions)	defined	for	each	feature	separately.	
Because	 of	 that,	DSI	 can	 tolerate	missing	 data.	 Features	 can	 be	 grouped	 in	 a	 hier-
archical	manner.	The	final	DSI	 is	 a	 combination	of	 the	 levels	 in	 the	hierarchy.	The	
fitness,	relevance	and	their	combination	as	a	composite	DSI	are	repeated	recursively	
by	grouping	the	data	until	a	single	DSI	value	is	obtained.11	Therefore,	the	final	DSI,	
which	is	used	for	the	classification,	depends	on	the	hierarchy	structure,	as	a	different	
structure	leads	to	a	different	averaging	of	the	feature	combinations.	The	top-level	part	
of	the	hierarchy	defined	for	this	study	is	shown	in	figure 1.
Baseline features
figure 1	shows	the	used	categories	of	features	in	hierarchical	manner.	Please	note	that	
not	all	individual	features	are	shown	in	this	figure.	The	sections	below	describe	all	the	
used	features	(indicated	in	bold	font)	in	detail.
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MrI features
Multi-sequence	MR	imaging	was	performed	on	a	1.5	Tesla	MRI	scanner	(GE	Signa	
Excite).	The	imaging	protocol	and	sequence	details	were	described	extensively	else-
where.13	Morphological	 imaging	was	performed	with	T1-	weighted,	proton	density-
weighted	and	fl	uid-attenuated	inversion	recovery	(FLAIR)	sequences.	These	sequences	
were	used	for	an	automated	tissue	segmentation	approach	to	segment	scans	into	grey	
matter,	white	matter,	cere-	brospinal	fl	uid	(CSF)	and	background	tissue.15 Intracra-
nial volume (ICV)	 (excluding	the	cerebellum	and	surrounding	CSF	cerebellar)	was	
estimated	by	summing	total	grey	and	white	matter	and	CSF.	Brain	 tissue	segmenta-	
tion	was	complemented	with	a	white matter lesion	segmentation	based	on	the	tissue	
segmentation	and	the	FLAIR	image	with	extraction	of	white	matter	lesion	voxels	by	
intensity	 thresholding.16	 We	 obtained	 (sub)cortical struc- ture volumes,	 cortical 
thickness,	and	curvature	of	 the	cortex	and	hippocampal	volume	using	the	publicly	
avail-	able	FreeSurfer	5.1	software	[17–19].	For	cerebral blood ﬂ ow	measurements,	
we	performed	a	2D	phase-contrast	imaging	as	previously	described.20	In	short,	blood	
fl	ow	velocity	(mm/sec)	was	calculated	based	on	regions	of	interest	(ROI)	drawn	on	the	
phase-contrast	images	in	the	carotid	arteries	and	basilar	artery	at	a	level	just	under	the	
skull	base.	The	value	of	mean	signal	intensity	in	each	ROI	refl	ected	the	fl	ow	veloc-
ity	with	 the	 cross-sectional	 area	 of	 the	 vessel.	 Flow	was	 calculated	 by	multiplying	
Predicting	cognitive	decline	using	the	Disease	State	Index		 
265 
 
figure 1.	Feature	categories	shown	in	a	hierarchy	as	used	by	the	DSI.	Please	note	that	not	
all	individual	features	are	included in	this	graph 
  
 
 
  
figure 1.	Feature	categories	shown	in	a	hierarchy	as	used	by	the	DSI.	Please	note	that	not	all	individual	fea-
tures	are	included	in	this	graph
251
Predicting	global	cognitive	decline	in	the	general	population	using	the	Disease	State	Index
the	average	velocity	with	the	cross-sectional	area	of	the	vessel.20	A	3D	T2*-weighted	
gradient-recalled	echo	was	used	 to	 image	cerebral microbleeds.	Microbleeds	were	
defined	as	 focal	 areas	of	very	 low	signal	 intensity,	 smaller	 than	10	mm	 in	 size	 and	
were	rated	by	one	of	five	trained	raters	who	were	blinded	to	other	MRI	sequences	and	
to	clinical	data.21,	22 Lacunar infarcts	were	defined	as	focal	parenchymal	lesions	>3	
mm	and	<	15	mm	in	size	with	 the	same	signal	characteristics	as	cerebrospinal	fluid	
on	all	sequences	and	with	a	hyperintense	rim	on	the	FLAIR	image	(supratentorially).	
Probabilistic	 tractography	 was	 used	 to	 segment	 15	 different	 white	 matter	 tracts	 in	
diffusion-weighted	MR	brain	 images,	 and	we	obtained	mean fA,	mean Md,	axial 
and	radial diffusivity	inside	each	white	matter	tract.23
Cardiovascular risk factors
Cardiovascular	risk	factors	were	based	on	information	derived	from	home	interviews	
and	physical	examinations	during	the	center	visit.	Blood pressure	was	measured	twice	
at	the	right	brachial	artery	in	sitting	position	using	a	random-zero	sphygmomanometer.	
We	used	 the	mean	of	 two	measurements	 in	 the	analyses.	 Information	on	 the	use	of	
antihypertensive medication	was	obtained	by	using	questionnaires	and	by	checking	
the	medication	 cabinets	 of	 the	 participants.	Hypertension	was	 defined	 as	 a	 systolic	
blood	pressure	>140	mmHg	or	a	diastolic	blood	pressure
>90	mmHg	or	the	use	of	anti-hypertensive	medication	at	baseline.	Serum total cho-
lesterol and high-density lipoprotein (hdL) cholesterol	were	measured	in	fasting	
serum,	taking	lipid-lowering	medication	into	account.
Smoking	was	assessed	by	interview	and	coded	as	never,	former	and	current.	Body-
mass index (BMI)	is	defined	as	weight	kilograms	divided	by	height	in	meters	squared.	
diabetes mellitus	status	was	defined	as	a	fasting	serum	glucose	level	(>7.0	mmol/l)	
or,	if	unavailable,	non-fasting	serum	glucose	level	(>11.1	mmol/l)	or	the	use	of	anti-
diabetic	medication.14 Alcohol consumption	was	acquired	in	a	questionnaire.	Preva-
lent stroke	was	ascertained	as	previously	described.24 educational level	was	assessed	
during	a	home	interview	and	was	categorized	into	7	categories,	ranging	from	primary	
education	only	to	university	level.14
APOE-ε4 allele carriership
APoe-E4 allele carriership	was	assessed	on	coded	genomic	DNA	samples.25	APOE-
genotype	was	in	Hardy-	Weinberg	equilibrium.	APOE-E4	allele	carriership	was	coded	
positive	in	case	of	one	or	two	APOE-E4	alleles.
Gait features
Gait	was	assessed	by	three	walking	tasks	over	a	walkway:	“normal	walk”,	“turn”	and	
“tandem	walk”	(heel	to	toe).26	Using	a	principal	component	analysis	we	obtained	the	
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following	gait	 factors	which	we	used	by	DSI:	rhythm,	Variability,	Phases,	Pace,	
Base of Support,	tandem,	and	turning.27
Baseline cognitive function
We	 included	 the	 following	 objective memory	 and	 non-memory	 cognitive	 tests:	
15-word Learning test imme- diate	 and	delayed recall,28 Stroop tests	 (reading,	
color-naming	 and	 interference),29,	 30 the Letter-digit Substitution task,31 word 
fluency test,32	 and	 the	Purdue Pegboard test.33 Subjective cognitive complaints 
were	 evaluated	 by	 interview.	This	 interview	 included	 three	 questions	 on	mem-	 ory	
(difficulty	remembering,	forgetting	what	one	had	planned	to	do,	and	difficulty	finding	
words),	 and	 three	 questions	 on	 everyday	 functioning	 (difficulty	managing	 finances,	
problems	using	a	telephone,	and	difficulty	getting	dressed).34
Outcome: definition of cognitive decline
A	g-factor	was	constructed	by	a	principal	component	analysis	on	 the	delayed	recall	
score	of	 the	15-Word	Learning	Test,	Stroop	 interference	Test,	Letter-Digit	Substitu-
tion	Task,	Word	Fluency	Test,	and	the	Purdue	Pegboard	test.34	Cognitive	decline	was	
defined	by	the	g-factor	from	the	follow-up	visit	minus	the	g-factor	from	the	baseline	
visit	resulting	in	a	delta	g-factor.	Since	the	follow-up	time	was	not	the	same	for	each	
participant,	 the	 delta	 g-factor	 was	 divided	 by	 the	 follow-up	 time	 to	 obtain	 global	
cognitive	decline	per	year.	Significant	global	cognitive	decline	(yes/no)	was	defined	as	
belonging	to	the	5%	of	participants	with	the	highest	cognitive	decline	(delta	g-factor)	
per	 year.	 In	 the	 used	 dataset,	 consisting	 of	 2,542	 participants,	 this	 resulted	 in	 127	
participants	with	a	positive	class	label.
evaluation experiments
Prediction performance evaluation
The	 performance	 of	 DSI	 in	 predicting	 occurrence	 of	 global	 cognitive	 decline	 was	
evaluated	using	cross-validation.	The	area	under	 the	 receiver-operator	curve	 (AUC)	
was	 determined	 using	 500	 repetitions	 of	 2-fold	 cross-validation	 (CV)	 experiments.	
This	means	that	with	each	repetition	50%	of	the	study	dataset	was	used	for	training	
and	the	other	50%	was	used	for	testing,	and	vice	versa,	keeping	the	class	ratio	in	the	
training	and	test	set	equal.	We	report	the	mean	AUC,	and	the	uncertainty	of	the	mean	
expressed	by	its	95%	confidence	interval,	derived	from	the	1000	resulting	AUC	values.	
The	 confidence	 interval	was	determined	with	 the	 corrected	 resampled	 t-test	 for	CV	
estimators	of	the	generalization	error.35	AUCs	were	considered	significantly	different	if	
the	95%	confidence	interval	of	their	difference	did	not	contain	zero.
Since	 global	 cognitive	 decline	 per	 year	 is	 age	 dependent,	we	 expect	 that	 age	 is	 an	
important	feature	for	the	prediction.	We	therefore	include	age	as	feature	in	the	model.	
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However,	since	other	 features	might	depend	on	age,	correcting	 these	features	might	
improve	the	prediction	performance.36	We	therefore	also	assessed	the	prediction	per-
formance	using	age-corrected	features.	We	corrected	the	non-binary	features	for	age	
using	a	linear	regression	model.37	We	evaluated	four	different	models:
I	 age	was	included	and	no	age-correction	was	performed	on	thenon-binary	features
II	 age	was	excluded	and	no	age-correction	was	performed	on	the	non-binary	features
III	 age	was	included	and	non-binary	features,	except	age,	were	corrected	for	age
IV	age	was	excluded	and	non-binary	features,	except	age,	were	corrected	for	age.
To	assess	whether	the	performance	of	DSI	was	dependent	on	the	combination	of	input	
features,	we	evaluated	various	feature	combinations.	In	each	cross-validation	experi-
ment	the	feature	set	was	expanded	with	a	feature	or	category	of	features.	We	analyzed	
four	of	such	cumulative	feature	sets,	differing	in	the	order	in	which	the	feature	set	was	
expanded.	Additionally,	we	analyzed	MRI	features	separately	and	a	set	including	all	
features	but	age.
relevance analysis
To	gain	insight	into	the	relevance	weight	that	DSI	assigns	to	each	feature,	we	calcu-
lated	the	feature	relevance	distribution	over	the	500	repetitions	of	2-fold	CV,	for	the	
top-level	feature	categories	of	the	hierarchy:	age,	sex,	cognitive	tests,	cardiovascular	
risk	factors,	gait,	education,	genetics,	and	MRI	features.
feature selection on MrI features
In	this	study,	hundreds	of	MRI	features	were	extracted	from	images.	It	is	likely	that	
many	of	those	features	are	not	very	efficient	in	detecting	cognitive	decline.	Typically	
feature	 selection	 is	applied	 to	exclude	poor	 features	which	may	 induce	noise	 to	 the	
classifier.	In	DSI,	weighting	with	relevance	supresses	the	effect	of	such	features.	If	the	
number	of	features	is	high,	their	cumulative	effect	may,	however,	be	remarkable.	Pre-
vious	results	have	shown	that	when	including	many	features	with	a	low	relevance,	the	
performance	of	DSI	may	decrease.7	We	therefore	included	an	experiment	evaluating	
the	effect	of	feature	selection	on	MRI	features	using	their	relevance.	Due	to	averaging,	
feature	noise	reduces	in	higher	levels	of	the	feature	hierarchy.	The	relevance	of	top-
level	feature	categories	may	therefore	be	higher	than	lower-level,	individual	features.	
Therefore,	due	to	the	selection	on	the	individual	features,	the	top-level	features	may	
drop	out,	despite	 their	high	relevance.	To	prevent	entire	 top-level	 feature	categories	
to	drop	out	of	 the	model,	we	chose	 to	only	apply	feature	selection	on	 the	MRI	fea-
tures,	which	made	 up	 80%	of	 all	 input	 features,	 before	 selection.	The	 relevance	 of	
the	MRI	features	was	determined	on	the	entire	dataset,	before	training.	MRI	features	
were	selected	by	thresholding	the	relevance.	Subsequently,	an	AUC	distribution	was	
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determined	 in	10	repetitions	of	2-fold	CV.	The	following	relevance	 thresholds	were	
chosen:	t ∈ {0.0,	0.01,	.	.	.	,	0.09,	0.1}.	For	each	threshold	we	assessed	three	feature	
sets	in	which	the	relevance-based	feature	selection	on	the	MRI	features	was	applied:	
1)	all	features,	2)	all	features	but	age,	and	3)	MRI	features	only.
Sub-group analyses
As	subjects	close	to	the	decision	boundary	(DSI	∼0.5)	are	more	likely	to	be	misclassi-
fied,	we	evaluated	classification	performance	when	only	accepting/providing	the	clas-
sification	for	test	subjects	with	low	(<0.2)	or	high	(>0.8)	DSI.	In	this	way,	the	subjects	
with	0.2	<	DSI	<	0.8	are	disregarded,	which,	in	a	clinical	case,	would	mean	that	there	
is	no	diagnosis	possible	for	these	cases.	We	computed	the	AUC	of	this	sub-group	for	
DSI	using	all	available	features,	both	with	age-correction	and	without	age-correction.
Furthermore,	we	performed	a	sensitivity	analysis	in	which	the	diffusion-MRI	of	680	
participants	in	RS	cohort	II	were	ignored,	because	this	data	was	obtained	on	average	
3.47±	0.15	years	later	than	the	other	baseline	MRI	features.
reSuLtS
table 1	 presents	 the	 characteristics	 of	 the	 study	 population.	 The	 mean	 age	 of	 the	
participants	was	60.9	±	9.1	years	and	55.6%	were	females.
Prediction performance
figure 2a	shows	the	mean	AUC	(95%	confidence	interval)	for	several	combinations	
of	 features	 in	predicting	global	cognitive	decline,	without	correcting	 the	non-binary	
features	for	age.	Each	color	represents	an	expanding	set	of	used	input	features,	where	
the	most	left	set	is	only	MRI	features	and	the	most	right	set	is	all	features	except	age.	
When	using	only	MRI	features,	the	AUC	was	0.75	(0.70	-	0.80).	When	using	only	age	
as	baseline	feature,	the	AUC	was	0.78	(0.74	-	0.83).	Using	additional	features	on	top	of	
age	resulted	in	an	equal	or	slightly	lower	AUC	(differences	not	statistically	significant).	
When	using	all	available	features	with	DSI,	the	AUC	was	0.77	(0.72	-	0.82).	The	mean	
AUC	of	DSI	without	age	as	baseline	predictor	was	0.75	(0.70	-	0.80).
figure 2b	shows	the	mean	AUC	(95%	confidence	interval)	for	the	same	combinations	
of	features	as	in	figure 2a,	but	here	the	non-binary	features	were	corrected	for	age.	
The	AUC	for	MRI	features	only	was	significantly	lower	with	age-correction	compared	
to	without	age	correction,	with	an	AUC	of	0.55	 (0.50	 -	0.61).	For	 the	other	 feature	
sets,	 the	AUC	of	 the	models	where	age	correction	was	applied	was	not	 statistically	
significantly	different,	compared	to	not	using	age	correction.	When	the	effect	of	age	
was	totally	removed	from	the	model,	i.e.	model	iv,	the	AUC	was	0.65	(0.58	-	0.73).
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table 1 Baseline	characteristics
feature
Positive Control
Rnac Rnac Rac(N=127) N=2415)
Age,	years 0.38 - 71.2	(10.1) 60.3	(8.7)
Sex,	female 0.01 - 73	(54.5%) 1340	(55.6%)
Objective	cognitive	test	results 0.28 0.16 - -
Word	Learning	Test	immediate	recall 0.09 0.02 7.7	(2.2) 8.1	(2.0)
Word	Learning	Test	delayed	recall 0.05 0.04 7.9	(2.9) 8.2	(2.8)
Reading	subtask	of	Stroop	test,	s 0.20 0.03 17.2	(2.7) 16.3	(2.9)
Color	naming	subtask	of	Stroop	test,	s 0.18 0.06 23.6	(3.6) 22.3	(4.0)
Interference	subtask	of	Stroop	test,	s 0.32 0.10 53.8	(20.3) 44.0	(13.0)
Letter-Digit	Substitution	Task,	number	of	
correct	digits
0.15 0.00 29.7	(6.7) 32.2	(6.2)
Word	Fluency	Test,	number	of	animals 0.04 0.08 23.2	(5.7) 23.8	(5.7)
Purdue	Pegboard	test,	number	of	pins	placed 0.15 0.07 10.3	(2.1) 10.9	(1.7)
Mini-mental-state	examination 0.14 0.11 27.8	(1.7) 28.4	(1.5)
Education1 0.07 0.07 3	(1-3) 3	(2-5)
Cardiovascular	risk	factors 0.34 0.27 - -
Alcohol1,	glasses	per	week 0.06 0.04 3.5	(0.3-5.5) 5.5	(1.0-5.5)
Systolic	blood	pressure,	mmHg 0.24 0.04 146.2	(20.3) 135.9	(19.6)
Diastolic	blood	pressure,	mmHg 0.00 0.02 82.8	(9.4) 82.4	(10.6)
Blood	pressure	lowering	medication 0.26 - 51	(38.3%) 284	(11.9%)
Body	Mass	Index,	kg/m2 0.07 0.07 28.2	(4.4) 27.4	(4.1)
Serum	cholesterol,	mmol/L 0.11 0.12 5.4	(0.9) 5.6	(1.1)
HDL-cholesterol,	mmol/L 0.04 0.09 1.4	(0.4) 1.5	(0.4)
Lipid	lowering	medication 0.13 - 46	(34.6%) 510	(21.3%)
Smoking 0.08 0.08 - -
Never - - 49	(36.6%) 746	(31.2%)
Former - - 54	(40.3%) 1154	(48.2%)
Current - - 31	(23.1%) 492	(20.6%)
Diabetes	mellitus,	presence 0.09 - 24	(18.2%) 220	(9.2%)
APOE-E4	allele	carriership 0.02 - 39	(30.2%) 639	(28.3%)
MRI	features 0.41 0.25 - -
Intra-cranial	volume,	mL 0.03 0.00 1137	(119) 1144	(113)
Brain	tissue	volume 0.38 0.08 - -
White	matter	volume,	mL 0.13 0.01 390	(60) 419	(57)
Gray	matter	volume,	mL 0.10 0.01 522	(54) 537	(52)
CSF	volume,	mL 0.29 0.07 223	(53) 186	(46)
Brain	region	volume 0.35 0.12 - -
Hippocampus	volume,	mL 0.23 0.09 6.4	(0.8) 6.8	(0.7)
White	matter	lesion	volume1,	mL 0.31 0.08 4.5	(2.5-9.4) 2.4	(1.4-4.3)
Cerebral	microbleeds,	presence 0.09 - 33	(24.6%) 370	(15.6%)
Lacunar	infarcts,	presence 0.04 - 10	(7.5%) 72	(3.0%)
Global	FA 0.17 0.07 0.3	(0.02) 0.3	(0.01)
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relevance analysis
figure 3	shows	the	relevance	weight	per	feature	category	when	the	non-categorical	
features	were	corrected	 for	age	prior	 to	computing	DSI	and	without	age-correction.	
Without	age-correction,	the	features	with	the	best	discriminating	abilities	according	to	
their	relevance	weights	were	MRI	features	(0.42	(0.33	-	0.51)),	age	(0.39	(0.27	-	0.51)),	
cognitive	tests	(0.35	(0.24	-	0.45))	and	cardiovascular	risk	factors	(0.34	(0.26	-	0.43)).	
When	correcting	the	non-	binary	features,	except	age,	for	age,	the	most	discriminating	
features	were	age	(0.39	(0.27	-	0.51)),	MRI	features	(0.37	(0.24	-	0.51)),	and	cognitive	
tests	(0.32	(0.17	-	0.47)).
feature selection on MrI features
Feature	selection	for	MRI	features	had	no	effect	on	the	AUC	in	any	of	the	three	feature	
sets,	when	the	non-binary	features	were	not	corrected	for	age	(figure 4A).	The	AUC	
did	increase	after	MRI	feature	selection	when	the	non-binary	features,	except	age,	had	
been	corrected	for	age	(figure 4B),	with	the	optimal	t	being	0.07	(see	figure 4b).	For	
t	=	0.07,	the	AUC	increased	from	0.55	(0.50	-	0.61)	to	0.62	(0.58	-	0.67)	when	only	
MRI	features	were	included	in	the	model.	When	using	all	features,	the	AUC	increased	
from	0.75	(0.70	-	0.79)	to	0.77	(0.73	-	0.82),	and	when	using	all	features	but	age,	the	
AUC	increased	from	0.65	(0.58	-	0.73)	to	0.70	(0.63	-	0.76).
Sub-group analyses
When	only	taking	into	account	the	extreme	cases,	i.e.	cases	for	which	0.2	<	DSI	<	0.8	
(∼40%	of	the	total	dataset,	i.e.∼1000	subjects),	the	mean	AUC	increased	to	0.82	(0.76	
-	0.88)	using	age	as	input	feature	only.	Again	in	this	group,	additional	features	did	not	
significantly	improve	the	performance	of	DSI	(results	not	shown).	Ignoring	the	diffusion-
MRI	features	of	680	participants	of	whom	this	data	was	acquired	on	average	3.47	± 0.15 
years	later	than	the	assessment	of	the	other	baseline	MRI	features	did	not	change	AUC	
significantly	compared	to	the	performance	in	the	total	population	(results	not	shown).
table 1 Baseline	characteristics	(continued)
feature
Positive Control
Rnac Rnac Rac(N=127) N=2415)
Global	MD,10−3 mm2/s 0.33 0.07 0.8	(0.03) 0.7	(0.03)
Global	cortical	thickness,	mm 0.08 0.01 2.4	(0.2) 2.5	(0.1)
Gait 0.19 0.17 - -
Baseline	features	of	the	study	population	and	their	relevances.	The	relevances	were	computed	on	the	entire	
dataset.	Continuous	variables	are	presented	as	mean	(standard	deviation)	and	categorical	variables	as	n	(per-
centages).Abbreviations:	N;	number	of	participants,	HDL;	high-density	lipoprotein,	s;	seconds,	FA;	fractional	
anisotropy,	MD;	mean	diffusivity	10−3	mm2/s.	CSF;	cerebrospinal	fluid.	Symbols: Rnac;	relevance	when	feature	
was	not	corrected	for	age,	Rac;	relevance	when	feature	was	age-corrected.	1Education,	alcohol	and	white	matter	
lesion	volume	are	presented	as	median	(inter-quartile	range).
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figure 2A.	Mean	AUC	 for	 several	 combinations	 of	 features	without	 correcting	
the	 non-binary	 features	 for	 age. figure 2B is	 with	 the	 non-binary	 features	
corrected	for	age. Features	are	accumulated	in	four	different	orders,	indicated	by	
color	and	symbol.	The	bars	indicate	the	confidence	interval.	Short-hand	notations	
are	used	for	several	features:	cognitive	tests	(ct),	cardiovascular	risk	factors	(cvr),	
MRI	features	(mri),	genetics	(APOE-E4	carrier-ship)	(gen),	and	educational	level	
(edu). 
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figure 2A.	Mean	AUC	for	several	combinations	of	features	without	correcting	the	non-binary	features	for	age.
Features	are	accumulated	in	four	different	orders,	indicated	by	color	and	symbol.	The	bars	indicate	the	confi-
dence	interval.	Short-hand	notations	are	used	for	several	features:	cognitive	tests	(ct),	cardiovascular	risk	fac-
tors	(cvr),	MRI	features	(mri),	genetics	(APOE-E4	carrier-ship)	(gen),	and	educational	level	(edu)
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figure 2B 
 
 
figure 3.	Mean	relevance	weight	R and	95%	confidence	interval	for	the	top-level	
features	categories. The	blue	line	shows	the	case	where	the	non-binary	features	
were	non	corrected	for	age	and	the	golden	line	shows	the	case	where	the	non-
binary	features	were	age-corrected. 
 
 
figure 2B	is	with	the	non-binary	features	corrected	for	age.	Features	are	accumulated	in	four	different	orders,	
indicated	by	color	and	symbol.	The	bars	indicate	the	confidence	interval.	Short-hand	notations	are	used	for	
several	features:	cognitive	tests	(ct),	cardiovascular	risk	factors	(cvr),	MRI	features	(mri),	genetics	(APOE-E4	
carrier-ship)	(gen),	and	educational	level	(edu).
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figure 3.	Mean	relevance	weight	R	and	95%	confidence	interval	for	the	top-level	features	categories.	The	blue	
line	shows	the	case	where	the	non-binary	features	were	non	corrected	for	age	and	the	golden	line	shows	the	
case	where	the	non-binary	features	were	age-corrected.
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figure. 4A.	Mean	AUC	for	several	combinations	of	features	where	the	MRI	features	were	selected	based	on	
their	relevance	without	correcting	the	non-binary	features	for	age.
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figure. 4A.	Mean	AUC	for	several	combinations	of	features	where	the	MRI	
features	were	selected	based	on	their	relevance without	correcting	the	non-binary	
features	for	age. figure 4B is	with	the	non-binary	features	corrected	for	age.	
Features	with	R < t were	excluded. 
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figure 4B	is	with	the	non-binary	features	corrected	for	age.	Features	with	R < t	were	excluded.
dISCuSSIoN
The	 objective	 of	 this	 study	 was	 to	 assess	 whether	 global	 cognitive	 decline	 can	 be	
predicted	using	multi-variate	 data	with	 the	 previously	 proposed	DSI.	We	 found	 the	
best	 prediction	 performance,	 evaluated	with	AUC,	 using	 only	 age	 as	 input	 feature.	
Adding	more	 features	 to	DSI	 did	 not	 improve	 its	 performance	 in	 predicting	 global	
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cognitive	decline	as	defined	in	this	study.	Overall	performance	of	DSI	in	the	prediction	
of	global	cognitive	decline	(mean	AUC	0.78)	was	comparable	to	previously	reported	
performances	 of	 DSI	 for	 prediction	 of	 dementia7	 in	 the	 population-based	 CAIDE	
study,	consisting	of	2000	participants	who	were	randomly	selected	from	four	separate,	
population-based	samples,	originally	studied	in	midlife	(1972,	1977,	1982,	or	1987),38 
and	 to	other	population-based	prediction	models	of	dementia.39	 In	 this	 study	we	 in-
cluded	a	large	number	of	heterogeneous	features.	Age	was	the	most	important	feature	
for	predicting	global	cognitive	decline	using	DSI,	yielding	the	highest	AUC.	This	was	
further	supported	by	the	observation	that	the	performance	of	DSI	reduced	when	using	
all	features	except	age.	Our	finding	that	age	is	the	single	strongest	predictor	for	cogni-
tive	decline	is	in	line	with	published	prediction	models	for	dementia,	that	invariably	
assign	the	highest	weight	to	age.40	We	found	that	the	relevance	R,	which	indicates	how	
well	a	feature	can	discriminate	between	persons	who	will	develop	cognitive	decline	
and	those	who	will	not,	was	highest	for	MRI	features	(0.42)	followed	by	age	(0.39).	
DSI,	 however,	 performed	worse	when	using	only	MRI	 features,	 compared	 to	 using	
only	age.	We	speculate	that	the	high	relevance	of	the	MRI	features	may	be	explained	
by	age-specific	effects	that	are	captured	in	these	MRI	features,	which	is	supported	by	
our	 finding	 that	MRI	 feature	 relevance	 (0.37)	 and	DSI	 performance	 dropped	when	
adjusting	MRI	features	for	age.	When	the	non-binary	features	were	age-corrected	and	
age	was	not	included	in	the	model,	the	mean	AUC	was	0.65,	still	significantly	better	
than	chance	(0.5),	indicating	that	relevant	information	for	predicting	global	cognitive	
decline	 could	 be	 present	 in	 the	 other	 features.	 In	 this	 study,	 however,	 they	 did	 not	
improve	 the	 predicting	 performance	when	 added	 to	 age.	To	 our	 surprise	we	 found	
that	APOE-4	allele	carrier-ship	had	a	low	relevance	weight	and	did	not	improve	the	
performance	 of	 DSI,	 even	 though	 it	 is	 the	 best	 known	 genetic	 risk	 factor	 for	AD.	
This	is	in	contrast	to	a	previous	study	focusing	on	the	progression	from	MCI	to	AD,	
which	found	APOE-genotype	to	have	high	predictive	value.41	It	may	be	that	our	study	
population	was	 too	 young	 to	 show	 effect	 of	APOE	 on	 prediction	 (mean	 age	 60.9),	
since	 the	 risk	progression	effect	of	APOE-4	allele	carriership	has	been	described	 to	
peak	 between	 ages	 70	 and	75	 years.42	The	 relevance-based	 feature	 selection	 on	 the	
MRI	features	showed	an	increase	in	the	AUC,	but	only	when	the	nonbinary	features	
were	 corrected	 for	 age.	A	 possible	 explanation	 is	 that	 without	 age	 correction,	 the	
AUC	is	strongly	driven	by	the	age-factor	that	is	present	in	the	MRI	features.	In	this	
case,	less	and	different	features	were	excluded	compared	to	the	age-corrected	models,	
causing	the	selection	to	have	no	effect	on	the	prediction	performance.	However,	after	
removal	of	these	age-specific	effects	by	age	correction,	performance	can	be	increased	
by	removal	of	irrelevant	features.	When	age	was	totally	excluded	from	the	model	iv	
(age	was	excluded	and	age	correction	was	applied	to	the	non-binary	features),	an	AUC	
of	0.70	was	obtained,	 showing	 the	potential	of	 the	other	 features.	One	 limitation	of	
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this	analysis	 is	 that	 the	 relevance	computation	and	 threshold	 selection	was	done	on	
the	entire	dataset,	i.e.	the	training	data	was	included	in	these	computations.	Therefore,	
AUC	increase	due	to	application	of	the	relevance	threshold	might	be	overestimated,	
but	can	be	seen	as	an	upper	limit.	The	overall	conclusions	do	not	change.
To	our	knowledge,	this	is	the	first	population-based	study	testing	the	supervised	ma-
chine	 learning	DSI	 tool	 for	 prediction	of	 global	 cognitive	decline.	Strengths	of	 our	
study	 include	 the	 population-based	 design,	 large	 sample	 size	 and	 availability	 of	 an	
extensive	set	of	features.	However,	limitations	of	our	dataset	need	to	be	considered.	
We	constructed	a	g-factor	as	a	measure	of	global	cognition	and	participants	without	
complete	cognitive	data	were	excluded.This	might	have	caused	some	selection	bias	
towards	 relatively	healthy	subjects.	Also,	mortality	and	drop-out	was	not	 taken	 into	
account.	 Persons	who	 are	 lost	 to	 follow-up	usually	 have	 a	 poorer	 health	 status	 and	
are	therefore	more	likely	to	develop	cognitive	decline	or	die	before	onset	of	cognitive	
decline.	The	exclusion	of	these	ssumingly	more	severe	cases	might	have	lowered	the	
performance	of	DSI.	The	 result	 that	 age	 is	 the	main	predictor	 for	 cognitive	decline	
indicates	that	the	age	distribution	of	the	subjects	with	cognitive	decline	differs	from	
the	entire	set	of	subjects.	Hence	age	could	be	used	to	select	people	at	risk	of	cognitive	
decline.	However,	when	screening	for	significant	cognitive	decline,	an	age-dependent	
threshold	on	cognitive	decline	might	be	needed,	e.g.	using	 the	5%	percentile	of	 the	
cognitive	decline	as	function	of	age,	to	detect	young	people	at	risk	of	developing	de-
mentia.	The	usage	of	such	an	age-dependent	threshold	will	be	part	of	future	research.
Finally,	it	should	be	noted	that	cognitive	decline	is	not	equivalent	to	neurodegenera-
tion/dementia	and	may	result	from	other	causes	260	as	well,	due	to	conditions	affecting	
the	participant’s	cognition	at	the	time	of	the	cognitive	assessment,	normal	human	vari-
ability	and	normal	aging.	Nevertheless,	being	able	to	predict	cognitive	decline	would	
be	a	step	forward	in	selecting	people	for	therapy	or	prevention.
Conclusion and future work
Based	 on	 our	 results	we	 can	 conclude	 that	 age	 is	 the	most	 important	 predictor	 for	
cognitive	decline	in	the	general	population	using	DSI.	Other	features	showed	having	
potential,	 but	 did	 not	 improve	 prediction	 performance.	A	 next	 step	 could	 be	 to	 use	
longitudinal	 features	 in	DSI,	as	 these	might	 improve	 its	prediction	performance.	To	
validate	whether	our	findings	 are	not	due	 to	 limitations	of	DSI,	 also	other	methods	
need	to	be	evaluated	in	this	prediction	challenge.	Finally,	to	be	able	to	detect	younger	
people	at	risk	of	significant	global	cognitive	decline	in	future	studies,	thresholds	for	
cognitive	decline	should	be	carefully	chosen	depending	on	the	population,	for	example	
be	age-adjusted.
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General discussion
The	main	objectives	of	my	thesis	were	to	study	determinants	of	white	matter	micro-
structural	 changes	 as	 assessed	 with	 Diffusion-Tensor-Imaging	 (DTI),	 and	 to	 study	
the	role	of	white	matter	microstructural	changes	in	age	related	brain	diseases	such	as	
cognitive	decline,	dementia,	and	neurovascular	disease.
In	 this	 chapter,	 I	 will	 first	 discuss	 my	 main	 findings	 and	 I	 will	 consider	 possible	
pathways	 underlying	 the	 found	 associations	 and	 additionally	 some	 methodological	
considerations.	Next,	 I	will	 discuss	 the	 implications	 of	 the	 findings	with	 respect	 to	
clinical	practice	and	finally	I	will	discuss	future	perspectives.
Main findings
determinants of white matter microstructural integrity
Chapter 2	 in	 this	 thesis	describes	 the	different	determinants	of	white	matter	micro-
structural	 changes	 globally	 but	 also	 in	 specific	 tracts.	 I	 started	 with	 a	 longitudinal	
analysis	for	the	establishment	of	reference	values	of	change	in	DTI-measures	in	aging.	
Since	the	brain	is	not	an	isolated	organ	but	is	connected	with	all	other	organs	in	our	
body,	I	was	also	interested	in	the	systemic	influences	on	the	brain	by	different	organ	
systems,	 such	 as	 the	 kidneys,	 the	 lungs	 and	 the	 thyroid	 gland.	To	 explore	whether	
microvascular	pathology	could	be	one	of	the	possible	pathways	leading	to	lower	white	
matter	microstructural	integrity	I	also	studied	the	association	between	retinal	vessels	
and	microstructural	changes	in	this	chapter.
I	found	lower	white	matter	microstructural	integrity	in	most	parts	of	the	brain	normal-
appearing	white	matter	after	 two	years	of	 follow-up	 in	normal	aging.	Also,	 reduced	
kidney	function	associated	with	lower	white	matter	microstructural	integrity	through-
out	the	brain.	Retinal	vessel	diameters	was	linked	to	white	matter	microstructure	by	
means	that	larger	venules	and	narrower	arteries	associated	with	a	poorer	white	matter	
microstructural	 integrity.	 Reduced	 lung	 function	 was	 linked	 to	 lower	 white	 matter	
microstructural	 integrity	 in	 particular	 in	 the	 association	 tracts.	 In	 the	 last	 chapter	 I	
found	 an	 age-dependent	 association	 between	 thyroid	 hormones	 and	 white	 matter	
microstructural	integrity:	in	younger	individuals	higher	levels	of	free	thyroxine	(FT4)	
were	associated	with	larger	total	brain	volumes	(mainly	white	matter	volume)	and	a	
better	white	matter	microstructural	integrity	and	in	older	persons	higher	FT4	associated	
with	smaller	total	brain	volumes	and	a	poorer	white	matter	microstructural	integrity.
The	 results	 reported	 in	 chapter 2	 indicate	 that	 aging	 and	 systemic	 influences	 of	
(subclinical)	disease	outside	the	brain	are	consistently	associated	with	reduced	white	
Chapter	4
270
matter	microstructural	integrity.	What	underlies	these	associations?	There	are	various	
potential	pathways,	supported	by	the	different	chapters	in	my	thesis.
First,	 a	 vascular	 etiologic	 pathway	 has	 often	 been	 hypothesized.1	 Vascular	 brain	
pathology	 may	 lead	 to	 a	 reduction	 in	 white	 matter	 perfusion,	 for	 example	 due	 to	
impaired	 autoregulation,	 resulting	 in	 white	 matter	 damage.2-5	 Another	 mechanism	
may	 be	 that	 the	 presence	 of	 vascular	 factors,	 not	 causing	 direct	 damage,	 interact	
with	 another	 degenerative	 process	 and	worsen	 pathologic	 effects.6	Yet	 another	 pos-
sibility	is	that	shared	vascular	risk	factors	such	as	hypertension	and	diabetes	explain	
the	association	between	(subclinical)	disease	outside	 the	brain	and	subclinical	brain	
changes.	This	latter	mechanism	is	especially	feasible	in	situations	in	which	small	ves-
sels	 for	 example	 in	 the	 kidney	 or	 retina	 and	 brain	 are	 similar	with	 anatomical	 and	
hemodynamic	 similarities.7	My	 findings	 in	 chapter 2.2	 indeed	 confirmed	 a	 role	 of	
vascular	factors.	The	association	between	kidney	function	and	cerebral	white	matter	
microstructure	 attenuated	 after	 adjusting	 for	 cardiovascular	 risk	 factors,	 indicating	
that	the	association	was	partly	driven	by	cardiovascular	factors.	Furthermore,	I	found	
effect-modification	 by	 hypertension	 in	 the	 association	 between	kidney	 function	 and	
lower	white	matter	microstructural	integrity.	In	addition,	my	findings	in	chapter 2.3 
in	which	retinal	vessel	calibres	associated	with	white	matter	microstructural	integrity,	
suggest	a	microvascular	pathway	underlying	the	white	matter	microstructural	changes.	
However,	both	 in	chapter 2.1,	 focussing	on	aging	and	white	matter	microstructure,	
and	in	chapter 2.5	assessing	the	relation	of	thyroid	hormones	and	brain	morphology,	
adjusting	for	cardiovascular	risk	factors	did	not	change	the	estimates	marginally.	This	
may	be	explained	by	residual	confounding	(e.g.	unmeasured	factors,	age-specific	ef-
fects	of	vascular	 factors	or	 subclinical	vascular	 factors	or	a	genetic	predisposition).	
However,	 a	 non-vascular	 pathway	 should	 be	 considered	 as	well.	 For	 example,	 free	
radical	injury	has	been	suggested	to	associate	with	white	matter	changes	on	DTI.8	This	
could	be	one	of	the	alternative	pathways	explaining	the	association	of	thyroid	func-
tion	with	lower	white	matter	volume	and	lower	white	matter	microstructural	integrity	
in	elderly.	Oxidative	stress	has	also	been	proposed	as	one	of	 the	possible	 factors	 in	
the	pathophysiology	of	age-related	diseases	such	as	dementia.9,10	Alternatively,	direct	
toxic	 influences	on	 the	brain	 for	example	due	 to	high	 thyroid	hormone	 levels	could	
underlie	 some	 of	 the	 found	 associations.	Hypoxia,	 resulting	 in	metabolic	 decreases	
and	decline	 of	 cerebral	 perfusion	 is	 another	 possible	 pathway	 causing	morphologic	
brain	changes,11	as	we	suggested	in	chapter 2.4	in	which	reduced	lung	function	was	
associated	with	lower	white	matter	microstructural	integrity.	Also,	systemic	inflamma-
tion	which	may	induce	chronic	inflammation	of	the	vessel	wall	leading	to	lower	white	
matter	microstructural	integrity	is	another	potential	mechanism	leading	to	white	matter	
microstructural	damage	as	described	in	chapter 2.4.12,13
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Apart	 from	 all	 above	mentioned	 possible	 pathways,	 a	 more	 complex,	 multifaceted	
pathway	needs	to	be	considered	in	which	there	is	an	interplay	between	vascular	fac-
tors,	hypoxia,	and	inflammation.14	Future	research	can	help	to	elucidate	these	possible	
pathways.	Longitudinal	analyses	are	needed	to	draw	conclusions	on	directionality	of	
associations.	More	 in-depth	measurements	 of	 cerebral	 perfusion	 and	 autoregulation	
may	 shed	more	 light	 on	 the	 hypotheses	 on	 hypoperfusion	 and	 hypoxia.	Mediation	
analyses	with	the	inclusion	of	possible	mediators	such	as	inflammatory	markers	can	
help	to	study	disease	causal	pathways.	Also,	hypothesis-free	genome-wide	association	
studies	can	uncover	novel	genes	and	pathways	involved	in	age-related	brain	pathology.
white matter microstructural integrity and cognitive decline, mild cognitive 
impairment, dementia and hearing loss
When	focusing	on	white	matter	microstructure	and	age-related	brain	diseases,	my	most	
important	finding	was	that	white	matter	microstructural	integrity	both	globally	and	in	
various	tracts	related	to	cognitive	function	and	risk	of	dementia,	and	that	this	associa-
tion	was	more	pronounced	for	some	tracts	than	for	others.	I	found	that	reduced	white	
matter	microstructural	 integrity	 throughout	 the	 brain,	 but	mainly	 in	 the	 association	
and	projection	tracts	related	to	poorer	cognition.	In	a	longitudinal	analysis,	I	found	a	
similar	pattern,	again	that	in	particular	the	association,	projection	and	limbic	system	
tracts	related	to	risk	of	dementia	and	with	more	pronounced	cognitive	decline.	In	addi-
tion,	the	white	matter	microstructure	of	in	particular	the	association	tracts	was	related	
to	mortality.	The	found	associations	remained	after	adjusting	for	macrostructural	white	
matter	changes	such	as	white	matter	atrophy	and	white	matter	hyperintensity	and	thus	
support	 the	 hypothesis	 that	 white	matter	 microstructural	 integrity	 is	 an	 earlier	 and	
potentially	more	sensitive	marker	of	white	matter	damage.
what underlies these associations?
The	role	of	vascular	factors	in	the	association	of	white	matter	microstructural	integrity	
and	 age-related	 brain	 diseases	 seems	 evident.	 Indeed,	 in	 chapter 3.1,	 I	 found	 that	
cardiovascular	 risk	 factors	were	 related	 to	mild	cognitive	 impairment,	a	 transitional	
stage	between	aging	and	dementia.	Besides	cardiovascular	risk	factors,	also	markers	
of	 small	 vessel	 disease	 such	 as	white	matter	 hyperintensities	were	 related	 to	MCI,	
and	 these	 results	 indicate	 the	 important	 role	 of	 vascular	 factors	 in	 early	 phases	 of	
age-related	diseases	such	as	dementia.	Also,	in	an	additional	analysis	in	chapter 3.3 
(data	not	published)	we	found	overall	and	age-specific	associations	of	cardiovascular	
risk	factors	(i.e.	hypertension,	hypercholesterolaemia,	current	smoking,	diabetes,	and	
body	mass	index)	with	global	white	matter	microstructural	integrity	from	middle	age	
on	as	depicted	in	figure 1.	In	addition,	low	white	matter	microstructural	integrity	was	
mainly	related	to	cardiovascular	mortality	as	described	in	chapter 3.5.	However,	some	
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of	 the	 found	associations	did	not	attenuate	after	adjustments	 for	cardiovascular	 risk	
factors,	as	we	described	in	chapter 3.2 and 3.3	in	which	we	focused	on	tract-specifi	c	
white	matter	microstructural	integrity	and	the	association	with	cognition	and	dementia.	
Also,	adjusting	for	cardiovascular	risk	factors	did	not	change	the	estimates	substan-
tially	 studying	 white	 matter	 microstructural	 integrity	 and	 hearing	 loss	 in	 chapter 
3.4.	Hearing	loss	possibly	adds	to	the	cognitive	load	of	a	vulnerable	brain	leading	to	
white	matter	microstructural	brain	changes.15	Also	other	mechanisms,	as	we	described	
above,	should	be	considered	in	contributing	to	the	found	associations	and	this	need	to	
be	further	investigated	in	future	research.
Cognitive	 performance	 consists	 of	 developmental	 and	 degenerative	 components.16 
Recently,	 the	 highly	 polygenic	 architecture	 of	 cognition	 was	 partly	 elucidated	 by	
the	identifi	cation	of	genetic	variants	in	ninety-nine	independent	loci	(Davies	et	al,	in	
press).	We	aimed	to	elucidate	the	associations	of	the	genetic	variants	underlying	cog-
nition	with	cognitive	decline,	daily	functioning,	dementia,	parkinsonism	and	stroke.	
Brain	changes	may	be	an	intermediate	between	the	genetic	variants	and	the	diff	erent	
endpoints	and	therefore	we	also	studied	the	link	between	the	genetic	variants	and	brain	
imaging	markers	including	DTI-measures	globally	and	tract-specifi	c.	A	higher	poly-
genic	score	(PGS)	was	associated	with	cognitive	decline.	No	association	was	found	
with	daily	 functioning,	 the	 incidence	of	dementia,	parkinsonism	or	stroke.	A	higher	
PGS	was	related	to	a	larger	intracranial	volume	and	higher	educational	attainment	and	
associated	with	a	better	white	matter	microstructure	in	the	posterior	thalamic	radiation,	
inferior-fronto-occipital	fasciculus	and	in	the	parahippocampal	part	of	the	cingulum.	
These	 white	 matter	 tracts	 have	 been	 associated	 with	 cognitive	 performance	 previ-
ously.17	This	study	suggests	that	the	studied	genetic	variants	associated	with	cognition	
represent	both	developmental	and	degenerative	components	of	cognitive	performance.	
This	indicates	that	the	results	in	chapter 3.2 and 3.3	assessing	the	relation	of	white	
matter	microstructural	integrity	and	cognition	and	dementia,	apart	from	neurodegen-
eration	can	also	be	partly	explained	by	developmental	infl	uences.
To	 investigate	 the	 potential	 clinical	 use	 of	 advanced	 imaging	markers	we	 aimed	 to	
evaluate	 a	 previously	 proposed	 prediction	 tool,	 namely	 the	 Disease	 State	 Index	
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(DSI)18,	 to	 predict	 cognitive	 decline	 using	 (advanced)	 imaging	 and	 non-imaging	
features,	including	global	and	tract-specific	DTI	-measures.	Though	for	several	of	the	
brain	imaging	markers	that	were	introduced	in	the	DSI,	independent	associations	with	
risk	of	 cognitive	decline	 and	dementia	had	been	described,19-21	 their	 added	value	 in	
the	prediction	model	was	disappointingly	low.	Best	performance	of	the	prediction	of	
global	cognitive	decline	was	obtained	using	only	age	as	 input	feature.	Adding	addi-
tional	input	features	to	the	DSI	did	not	improve	prediction	of	global	cognitive	decline	
in	 the	 general	 population.	This	 is	 in	 concordance	with	 a	 previous	 population	based	
study,	concluding	that	MRI	markers	on	top	of	age	and	other	conventional	risk	variables	
did	not	improve	the	prediction	of	all	cause	dementia.22	This	indicates	that	more	work	is	
needed	in	the	domain	of	disease	prediction	modeling	of	dementia	and	other	age-related	
brain	diseases,	and	that	specifically	in	the	field	of	 imaging	markers	we	may	need	to	
focus	more	on	either	fine-grained	advanced	imaging	features	such	as	functional	MRI	
measures,	multimodality	imaging23	or	the	use	of	other	analytical	approaches	such	as	
deep	learning	algorithms24	in	medical	image	analysis.
Methodological considerations related to studies in this thesis
Population-based study design
The	 studies	 discussed	 in	 this	 thesis	were	 conducted	within	 the	Rotterdam	 Study,	 a	
prospective	population	based	cohort	study	starting	 in	1990,	 including	 inhabitants	of	
the	district	Ommoord	of	the	city	Rotterdam,	aged	45	years	and	over,	designed	to	study	
determinants	and	prognosis	of	chronic	diseases	in	elderly.25	Participants	are	considered	
to	be	a	random	sample	from	the	general	population,	which	reduces	the	possibility	of	
selection	bias	and	thus	increases	generalizability	of	the	results.	However,	it	must	be	
noted	that	the	participants	of	the	Rotterdam	Study	are	mostly	Caucasians,	making	the	
results	only	generalizable	to	similar	populations.	In	order	to	participate,	in	particular	
for	the	MRI,	inhabitants	of	Ommoord	needed	to	visit	the	research	centre.	Therefore,	
the	healthy	volunteer	effect	(another	form	of	selection	bias)	cannot	be	ruled	out,	since	
it	 is	 likely	 that	 participants	with	poorer	 health	did	not	 participate.	The	 inclusion	of	
relatively	healthy	persons	however	will	most	likely	lead	to	an	underestimation	of	the	
found	effect	estimates.	The	entire	cohort	of	the	Rotterdam	study	is	under	continuous	
surveillance	for	outcomes	such	as	dementia	and	mortality	through	electronic	linkage	
of	 the	 study	 database	 with	 medical	 records	 from	 the	 general	 practitioners	 and	 the	
regional	institute	for	outpatient	mental	health	care.	This	minimizes	loss	to	follow-up	
and	reduces	the	healthy	volunteer	effect.	The	longitudinal	analyses	presented	in	this	
thesis,	studying	the	association	between	white	matter	microstructure	and	dementia	or	
mortality,	are	therefore	less	likely	influenced	by	selection	bias.
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Differential	misclassification	or	measurement	error	is	a	form	of	information	bias	which	
might	have	influenced	our	resuls,	since	it	is	likely	that	DTI-measures	were	less	accu-
rately	measured	in	older	persons,	in	persons	with	preclinical	dementia	or	brain	atrophy	
due	to	motion	artifacts.
Confounding,	a	 situation	 in	which	an	association	between	exposure	and	outcome	 is	
distorted	by	the	presence	of	another	third	variable26,	can	be	prevented	by	restriction,	
stratification	or	adjustment.	In	this	thesis	we	performed	multivariable	adjusted	regres-
sion	models	to	account	for	several	potential	confounders,	mainly	vascular	factors.	Yet,	
variables	included	in	the	model	that	do	not	meet	the	criteria	for	potential	confounders	
(e.g.	intermediates)	can	introduce	over-adjustments	bias.27	This	may	have	influenced	
our	 results,	 since	white	matter	microstructural	 changes	may	be	 intermediates	 in	 the	
relation	 between	 vascular	 factors	 and	 different	 outcomes	 such	 as	 dementia.	 I	 pres-
ent	a	basic	model	and	additionally	a	model	including	vascular	factors	in	most	of	the	
presented	 studies	 in	 this	 thesis	 to	 assess	 the	 potential	 role	 of	 this	 over-adjustments	
bias	effect.	Most	of	the	studies	described	in	this	thesis	were	performed	with	data	that	
was	acquired	cross-sectionally.	Due	to	the	cross-sectional	design,	no	conclusions	can	
be	drawn	on	the	directionality	of	causality	of	the	associations	presented	in	this	thesis.	
However,	chapter 3.3	 is	 a	 longitudinal	 study	 on	 the	 relation	 between	white	matter	
microstructural	 integrity	 and	 dementia	 and	 cognitive	 decline.	 To	 address	 potential	
reverse	causality,	we	 repeated	 this	 analysis	 after	 stepwise	exclusion	of	 the	first	five	
years	of	follow-up.	The	risk	estimates	did	not	change,	therefore	it	is	very	unlikely	that	
the	associations	were	driven	by	(subclinical)	dementia	cases	(reverse	causality).
The	studies	described	in	this	thesis	were	conducted	within	large	sample	sizes	and	this	
reduces	the	chance	on	false	positive	findings	in	comparison	to	smaller	imaging	studies.
Imaging protocol
From	 2005	 onwards,	MRI	was	 implemented	 in	 the	 study	 protocol	 and	 a	 dedicated	
research	scanner,	undergoing	a	QA	protocol	keeping	the	system	unchanged	(no	major	
updates	 or	 upgrades)	was	 installed	 in	 the	Rotterdam	Study	 research	 center.28	 Since	
this	is	a	population-based	study	there	is	a	restriction	of	time,	costs	and	inconvenience	
for	the	participants	which	needs	to	be	balanced	with	the	relevance	and	quality	of	the	
acquired	imaging	data.	In	the	design	of	the	scan	protocol	the	time	constraint,	contrast	
and	resolution	requirements	were	taking	into	account.	Back	in	2005,	when	the	MRI	
protocol	was	designed,	 the	number	of	gradient	directions	was	chosen	 to	best	fit	 the	
optimized	protocol	 proposed	by	 Jones	 et	 al.29	 taking	 time	 limits	 and	 the	number	of	
slices	permitted	into	account.	Acquisition	parameters	have	been	left	unchanged	since	
the	start	of	the	study	to	ensure	longitudinal	data	stability	and	comparability	over	time.	
We	acknowledge	the	fact	that	the	spatial	resolution	for	the	diffusion	acquisition	used	
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in	this	thesis	was	relatively	lower	than	current	standards	and	we	are	aware	of	the	lower	
precision	to	detect	crossing	fiber	populations	using	25	gradient	directions.	However,	
probabilistic	tractography	within	the	Rotterdam	Study	was	performed	with	fully	auto-
mated	methods,	publicly	available	methods30	with	a	good	reproducibility.	The	median	
R^2	of	the	reproducibility	of	the	FA	measurements	was	0.89,	in	participants	scanned	
twice	within	two	weeks.31	Therefore	there	is	no	reason	to	assume	that	our	diffusion-
weighted	MRI	protocol	severely	affected	the	ability	to	accurately	reconstruct	tracts	of	
interest.	We	however	used	aggregated	diffusion	measures	and	averaging	of	FA	and	MD	
measures	and	this	might	discard	some	spatial	information.
underlying tissue properties
The	 diffusion	 of	water	molecules	 in	 the	 brain	 is	 dependent	 on	multiple	 factors,	 in-
cluding	the	underlying	white	matter	microstructural	integrity,	which	is	believed	to	be	
predominantly	determined	by	the	alignment	and	diameter	of	white	matter	 tracts	and	
their	myelin.32	The	diffusion	profiles	of	water	molecules	in	the	brain,	based	on	diffu-
sion-weighted	MRI	measures,	 give	 indirect	 information	 about	 the	underlying	 tissue	
or	white	matter	microstructural	integrity	of	the	brain.	Fractional	anisotropy	(FA)	and	
mean	diffusivity	(MD)	are	the	two	most	commonly	used	diffusion-weighted	MRI	mea-
sures.	However,	to	what	extent	diffusion	tensor	imaging	measures	may	be	informative	
about	the	exact	underlying	tissue	structure	is	still	under	debate.	Generally	it	is	assumed	
that	lower	FA	and	higher	MD	are	associated	with	lower	white	matter	microstructural	
integrity	and	there	is	pathological	evidence	that	changes	in	these	DTI-measures	cor-
relate	with	myelin	damage	and	axonal	loss.32	Previously	it	was	suggested	that	axial	and	
radial	diffusivity	(two	other	DTI-measures)	could	disentangle	whether	changes	in	the	
white	matter	microstructure	were	due	to	axonal	loss	or	due	to	myelin	loss.	However,	
the	presence	of	other	possible	processes	 such	 as	 inflammation	generates	difficulties	
to	assigning	change	in	diffusion-MRI	measures	to	a	specific	underlying	pathological	
process	(e.g.	myelin	loss)	causing	the	observed	lower	microstructural	integrity.33 Yet 
based	on	previous	research	(including	animal	studies)34,	the	found	associations	in	this	
thesis,	but	 also	on	 the	 fact	 that	white	matter	microstructural	 changes	precede	white	
matter	macrostructural	 changes35	we	can	assume	 that	 changes	 in	diffusion-weighted	
MRI	measures	are	pointing	towards	brain	pathology	of	any	kind.
Furthermore,	it	is	now	widely	recognized	that	voxels	with	complex	configurations	are	
a	challenge	for	DTI.	The	“crossing	fiber	problem”	typically	refers	to	the	situation	with	
two	or	more	differentially	oriented	fiber	bundles	contributing	to	the	diffusion-weighted	
MRI	signal	leading	to	incorrect	DTI	estimates	and	failure	of	the	tractography.	Previous	
research	showed	that	up	to	90%	of	the	cerebral	white	matter	voxels	contain	crossing	
fibres.36	 Interpretation	 of	DTI-measures	 therefore	must	 be	 done	with	 caution.	Until	
now	 the	 crossing	fiber	 problem	 appears	 to	 be	 a	 fundamental	 limitation	 of	DTI	 that	
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comes	with	the	complexity	of	brain	tissue,	rather	than	a	technical	problem	that	can	be	
overcome	with	a	higher	spatial	resolution.37
Differential effect and vulnerability of white matter tracts
Previous	studies	found	a	differential	vulnerability	to	decline	for	different	white	matter	
tracts	and	stated	that	the	association	tracts	are	most	vulnerable	to	decline	and	aging.38,39 
Also	in	this	thesis	I	found	that	the	microstructural	integrity	of	primarily	the	association	
tracts	 was	 associated	 with	 the	 studied	 determinants	 and	 outcomes	 in	 this	 thesis.	A	
possible	explanation	could	be	the	location	of	the	association	tracts	in	watershed	areas,	
making	these	tracts	more	vulnerable	to	vascular	damage	leading	to	more	pronounced	
loss	of	white	matter	microstructural	 integrity.	Tract-specific	analyses	may	thus	have	
added	value	in	providing	novel	etiological	insight	into	structural	brain	pathology,	the	
location	of	brain	microstructural	damage	with	relation	to	age-related	brain	outcomes	
and	may	help	to	unravel	underlying	pathways.	In	this	thesis	I	also	found	that	different	
association	 tracts	were	 related	 to	 different	 outcomes.	For	 example	 the	white	matter	
microstructure	of	association	 tracts	 related	 to	hearing	 impairment	were	 in	particular	
the	superior	longitudinal	fasciculus	and	the	uncinate	fasciculus,	while	the	white	matter	
microstructure	of	the	inferior-fronto-occipital	fasciculus	associated	most	strongly	with	
cognitive	performance.	This	possibly	points	towards	disease-specific	effects	which	can	
be	 detected	 using	 tract-specific	 analyses,	 with	 interesting	 possibilities	 towards	 risk	
stratification	and	early	disease	prevention.
However,	 future	 studies	 are	 needed	 to	 replicate	 our	 findings	 to	 see	 whether	 these	
tract-specific	differences	are	true	findings	initiated	by	disease	or	initiated	by	technical	
issues	(e.g.	the	association	tracts	are	larger	tracts,	making	tractography	less	sensitive	
to	partial	volume	effects	compared	to	smaller	tracts).40
Clinical implications and future research
In	 this	 thesis	 I	 contributed	 to	 the	 establishment	 of	 reference	 values	 of	 change	 in	
DTI-measures	 in	 aging.	 Furthermore,	 I	 highlight	 the	 added	 value	 of	 (tract-specific)	
DTI-measures	over	 conventional	MRI	markers	 to	 study	determinants	 and	outcomes	
of	 white	 matter	 disease.	 This	 further	 supports	 the	 observation	 that	 macrostructural	
markers	only	represent	the	tip	of	the	iceberg	of	the	white	matter	damage.	More	etio-
logical	 knowledge	 can	 be	 obtained	 using	 (tract-specific)	DTI.	 I	 found	 tract-specific	
differences;	among	the	15	white	matter	tracts,	the	association	tracts	most	often	related	
to	 age-related	 brain	 outcomes	 such	 as	 cognitive	 performance.	This	may	have	 clini-
cal	 implications,	 since	knowledge	on	 tract-specific	effects	on	cognition	may	 inform	
clinicians	to	predict	which	cognitive	domains	may	be	most	affected	depending	on	the	
location	of	(focal)	white	matter	damage,	e.g.	in	chronic	pathology	or	in	an	acute	setting	
such	as	an	acute	stroke.	Also,	given	the	importance	of	recognizing	pathways	leading	to	
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age-related	brain	diseases	our	results	may	aid	in	developing	new	biomarkers	and	may	
lead	to	better	recognition	of	persons	at	risk.
Reduced	kidney	function	and	lung	function	were	both	associated	with	cognitive	im-
pairment.	Based	on	 the	 results	presented	 in	 this	 thesis	we	suggest	 that	white	matter	
microstructural	changes	possibly	mediate	 the	association	between	different	determi-
nants	(e.g.	kidney	function	and	lung	function)	and	age-related	brain	diseases	such	as	
cognitive	impairment.	The	traditional	approach	to	mediation	analysis	is	to	adjust	for	
the	mediator	 in	 regression	 analysis.	However,	 recently	 alternative	 analytic	methods	
have	 been	 introduced	 to	 improve	 the	 interpretation	 of	mediation	 analyses.41	 Future	
research	 should	 incorporate	 these	methods	 to	 investigate	whether	 changes	 in	white	
matter	microstructural	integrity	actual	mediate	the	association	of	several	determinants	
with	age-related	outcomes.
Although	 several	 associations	were	 found	between	white	matter	microstructure	 and	
age-related	brain	diseases,	this	does	not	necessarily	indicate	that	these	markers	are	of	
value	in	disease	prediction	as	shown	in	the	DSI	study	we	performed.	Thus,	a	logical	
next	step	before	clinical	implementation	of	imaging	markers	is	to	investigate	the	added	
value	 of	 imaging	markers	 including	DTI	 for	 the	 prediction	 of	 age-related	 diseases.	
Prediction	models	other	than	the	DSI	tool,	in	the	general	population	but	also	in	specific	
patient	populations,	need	to	be	tested	and	used	as	reference	model	to	verify	whether	
imaging	markers	including	DTI-measures	when	added	to	the	model	can	improve	pre-
diction	of	age-related	diseases	such	as	dementia.
Also,	 prediction	of	 age-related	diseases	 is	 calling	 for	more	 advanced	 analytical	 ap-
proaches	such	as	deep	learning	algorithms	or	machine	learning	methods,	since	extract-
ed,	often	aggregated	imaging	markers	so	far	do	not	improve	prediction	performance	
on	top	of	age.
Concluding remarks
In	this	thesis	I	contributed	to	the	establishment	of	reference	values	of	change	in	DTI-
measures	in	aging.	I	investigated	different	determinants	of	white	matter	microstructural	
changes,	and	studied	the	relation	of	white	matter	microstructure	with	age-related	brain	
diseases.	 In	 this	 chapter	 I	gave	an	overview	of	 the	main	 results,	discussed	method-
ological	considerations	regarding	the	performed	studies	and	mentioned	some	clinical	
implications	and	directions	for	future	research.	The	white	matter	microstructure	of	the	
association	tracts	seems	to	be	most	sensitive	to	decline.	Although	several	associations	
were	 found	between	white	matter	microstructure	and	age-related	brain	diseases,	 the	
use	 of	 (global	 and	 tract-specific)	DTI-measures	 to	 support	 clinical	 decision-making	
and	prediction	of	age-related	brain	diseases	needs	further	steps,	which	should	focus	on	
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prediction	modelling,	 inclusion	of	more	fine-grained	imaging	features,	or	 the	use	of	
other	analytical	and	methodological	approaches.
279
General	discussion
refereNCeS
 1. Gons	RA,	van	Oudheusden	LJ,	de	Laat	KF,	et	al.	Hypertension	is	related	to	the	microstructure	of	the	
corpus	callosum:	the	RUN	DMC	study.	J Alzheimers Dis.	2012;32(3):623-631.
	 2.	 Burzynska	AZ,	Preuschhof	C,	Backman	L,	et	al.	Age-related	differences	in	white	matter	microstruc-
ture:	region-specific	patterns	of	diffusivity.	Neuroimage.	2010;49(3):2104-2112.
 3. Maillard	 P,	 Seshadri	 S,	 Beiser	 A,	 et	 al.	 Effects	 of	 systolic	 blood	 pressure	 on	 white-matter	 in-
tegrity	 in	 young	 adults	 in	 the	 Framingham	Heart	 Study:	 a	 cross-sectional	 study.	Lancet Neurol. 
2012;11(12):1039-1047.
 4. Yau	PL,	Hempel	R,	Tirsi	A,	Convit	A.	Cerebral	white	matter	and	retinal	arterial	health	in	hyperten-
sion	and	type	2	diabetes	mellitus.	Int J Hypertens.	2013;2013:329602.
 5. Wolters	FJ,	de	Bruijn	RF,	Hofman	A,	Koudstaal	PJ,	Ikram	MA,	Heart	Brain	Connection	Collabora-
tive	Research	G.	Cerebral	Vasoreactivity,	Apolipoprotein	E,	and	the	Risk	of	Dementia:	A	Population-
Based	Study.	Arterioscler Thromb Vasc Biol.	2016;36(1):204-210.
 6. Honig	 LS,	 Tang	 MX,	Albert	 S,	 et	 al.	 Stroke	 and	 the	 risk	 of	 Alzheimer	 disease.	 Arch Neurol. 
2003;60(12):1707-1712.
 7. O’Rourke	MF,	Safar	ME.	Relationship	between	aortic	stiffening	and	microvascular	disease	in	brain	
and	kidney:	cause	and	logic	of	therapy.	Hypertension.	2005;46(1):200-204.
 8. Back	SA,	Kroenke	CD,	Sherman	LS,	et	al.	White	matter	lesions	defined	by	diffusion	tensor	imaging	
in	older	adults.	Ann Neurol.	2011;70(3):465-476.
 9. Zhou	X,	Li	Y,	Shi	X,	Ma	C.	An	overview	on	therapeutics	attenuating	amyloid	beta	level	in	Alzheim-
er’s	disease:	targeting	neurotransmission,	inflammation,	oxidative	stress	and	enhanced	cholesterol	
levels.	Am J Transl Res.	2016;8(2):246-269.
 10. von	Arnim	CAF,	Gola	U,	Biesalski	HK.	More	than	the	sum	of	its	parts?	Nutrition	in	Alzheimer’s	
disease.	Nutrition.	2010;26(7-8):694-700.
 11. Antonelli	Incalzi	R,	Marra	C,	Giordano	A,	et	al.	Cognitive	impairment	in	chronic	obstructive	pulmo-
nary	disease--a	neuropsychological	and	spect	study.	J Neurol.	2003;250(3):325-332.
	 12.	 Benedetti	F,	Poletti	S,	Hoogenboezem	TA,	et	al.	Inflammatory	cytokines	influence	measures	of	white	
matter	integrity	in	Bipolar	Disorder.	J Affect Disord.	2016;202:1-9.
 13. Raj	D,	Yin	 Z,	 Breur	M,	 et	 al.	 Increased	White	Matter	 Inflammation	 in	Aging-	 and	Alzheimer’s	
Disease	Brain.	Front Mol Neurosci.	2017;10:206.
 14. Heppner	 FL,	 Ransohoff	 RM,	 Becher	 B.	 Immune	 attack:	 the	 role	 of	 inflammation	 in	Alzheimer	
disease.	Nat Rev Neurosci.	2015;16(6):358-372.
 15. Livingston	G,	Sommerlad	A,	Orgeta	V,	et	al.	Dementia	prevention,	intervention,	and	care.	Lancet. 
2017;390(10113):2673-2734.
 16. Gerstorf	D,	Ram	N,	Hoppmann	C,	Willis	SL,	Schaie	KW.	Cohort	differences	in	cognitive	aging	and	
terminal	decline	in	the	Seattle	Longitudinal	Study.	Dev Psychol.	2011;47(4):1026-1041.
 17. Cremers	LG,	 de	Groot	M,	Hofman	A,	 et	 al.	Altered	 tract-specific	white	matter	microstructure	 is	
related	to	poorer	cognitive	performance:	The	Rotterdam	Study.	Neurobiol Aging.	2016;39:108-117.
 18. Pekkala	 T,	 Hall	 A,	 Lotjonen	 J,	 et	 al.	 Development	 of	 a	 Late-Life	 Dementia	 Prediction	 Index	
with	 Supervised	 Machine	 Learning	 in	 the	 Population-Based	 CAIDE	 Study.	 J Alzheimers Dis. 
2017;55(3):1055-1067.
 19. Wolters	 FJ,	 Zonneveld	 HI,	 Hofman	A,	 et	 al.	 Cerebral	 Perfusion	 and	 the	 Risk	 of	 Dementia:	 A	
Population-Based	Study.	Circulation.	2017;136(8):719-728.
Chapter	4
280
	 20.	 Debette	S,	Beiser	A,	DeCarli	C,	 et	 al.	Association	of	MRI	markers	of	vascular	brain	 injury	with	
incident	 stroke,	 mild	 cognitive	 impairment,	 dementia,	 and	mortality:	 the	 Framingham	Offspring	
Study.	Stroke.	2010;41(4):600-606.
	 21.	 Akoudad	S,	Wolters	FJ,	Viswanathan	A,	et	al.	Association	of	Cerebral	Microbleeds	With	Cognitive	
Decline	and	Dementia.	JAMA Neurol.	2016;73(8):934-943.
	 22.	 Stephan	BC,	Tzourio	C,	Auriacombe	S,	et	al.	Usefulness	of	data	from	magnetic	resonance	imaging	
to	improve	prediction	of	dementia:	population	based	cohort	study.	BMJ.	2015;350:h2863.
	 23.	 Liu	X,	Chen	K,	Wu	T,	Weidman	D,	Lure	F,	Li	J.	Use	of	multimodality	imaging	and	artificial	intel-
ligence	for	diagnosis	and	prognosis	of	early	stages	of	Alzheimer’s	disease.	Transl Res.	2018.
	 24.	 Litjens	G,	Kooi	T,	Bejnordi	BE,	et	al.	A	survey	on	deep	learning	in	medical	image	analysis.	Med 
Image Anal.	2017;42:60-88.
	 25.	 Ikram	MA,	Brusselle	GGO,	Murad	SD,	 et	 al.	The	Rotterdam	Study:	 2018	 update	 on	 objectives,	
design	and	main	results.	Eur J Epidemiol.	2017;32(9):807-850.
	 26.	 Hajian	Tilaki	K.	Methodological	issues	of	confounding	in	analytical	epidemiologic	studies.	Caspian 
J Intern Med.	2012;3(3):488-495.
	 27.	 Jager	KJ,	Zoccali	C,	Macleod	A,	Dekker	FW.	Confounding:	what	it	is	and	how	to	deal	with	it.	Kidney 
Int.	2008;73(3):256-260.
	 28.	 Ikram	MA,	van	der	Lugt	A,	Niessen	WJ,	et	al.	The	Rotterdam	Scan	Study:	design	update	2016	and	
main	findings.	Eur J Epidemiol.	2015;30(12):1299-1315.
	 29.	 Jones	DK,	Simmons	A,	Williams	SC,	Horsfield	MA.	Non-invasive	assessment	of	axonal	fiber	con-
nectivity	in	the	human	brain	via	diffusion	tensor	MRI.	Magn Reson Med.	1999;42(1):37-41.
 30. de	Groot	M,	Vernooij	MW,	Klein	 S,	 et	 al.	 Improving	 alignment	 in	Tract-based	 spatial	 statistics:	
evaluation	and	optimization	of	image	registration.	Neuroimage.	2013;76:400-411.
 31. de	Groot	M,	 Ikram	MA,	Akoudad	S,	et	al.	Tract-specific	white	matter	degeneration	 in	aging:	 the	
Rotterdam	Study.	Alzheimers Dement.	2015;11(3):321-330.
	 32.	 Beaulieu	C.	The	basis	of	anisotropic	water	diffusion	in	the	nervous	system	-	a	technical	review.	NMR 
Biomed.	2002;15(7-8):435-455.
 33. Wood	TC,	Simmons	C,	Hurley	SA,	et	al.	Whole-brain	ex-vivo	quantitative	MRI	of	the	cuprizone	
mouse	model.	PeerJ.	2016;4:e2632.
 34. van	Tilborg	E,	van	Kammen	CM,	de	Theije	CGM,	van	Meer	MPA,	Dijkhuizen	RM,	Nijboer	CH.	A	
quantitative	method	for	microstructural	analysis	of	myelinated	axons	in	the	injured	rodent	brain.	Sci 
Rep.	2017;7(1):16492.
 35. de	Groot	M,	Verhaaren	BF,	de	Boer	R,	et	 al.	Changes	 in	normal-appearing	white	matter	precede	
development	of	white	matter	lesions.	Stroke.	2013;44(4):1037-1042.
 36. Jeurissen	B,	Leemans	A,	Tournier	JD,	Jones	DK,	Sijbers	J.	Investigating	the	prevalence	of	complex	
fiber	configurations	in	white	matter	tissue	with	diffusion	magnetic	resonance	imaging.	Hum Brain 
Mapp.	2013;34(11):2747-2766.
 37. Schilling	K,	Gao	Y,	 Janve	V,	Stepniewska	 I,	Landman	BA,	Anderson	AW.	Can	 increased	 spatial	
resolution	solve	the	crossing	fiber	problem	for	diffusion	MRI?	NMR Biomed.	2017;30(12).
 38. Bender	AR,	Volkle	MC,	Raz	N.	Differential	aging	of	cerebral	white	matter	in	middle-aged	and	older	
adults:	A	seven-year	follow-up.	Neuroimage.	2016;125:74-83.
 39. Kochunov	P,	Williamson	DE,	Lancaster	J,	et	al.	Fractional	anisotropy	of	water	diffusion	in	cerebral	
white	matter	across	the	lifespan.	Neurobiol Aging.	2012;33(1):9-20.
 40. Vos	SB,	Jones	DK,	Viergever	MA,	Leemans	A.	Partial	volume	effect	as	a	hidden	covariate	in	DTI	
analyses.	Neuroimage.	2011;55(4):1566-1576.
281
General	discussion
 41. Valeri	L,	VanderWeele	TJ.	SAS	macro	for	causal	mediation	analysis	with	survival	data.	Epidemiol-
ogy.	2015;26(2):e23-24.

 ChApter 5
Summary & Samenvatting

285
Summary	&	Samenvatting	
eNGLISh SuMMAry
As	 our	 life	 expectancy	 rises,	 the	 prevalence	 of	 common	 age-related	 brain	 diseases	
such	 as	 cognitive	 decline,	 dementia	 and	neurovascular	 disease	will	 increase.	Effec-
tive	preventive	and	curative	interventions	are	scarce,	whilst	causative	factors	remain	
largely	unknown.	The	role	of	cerebral	white	matter	 in	age-related	diseases	has	been	
established.	However,	macrostructural	white	matter	changes,	which	are	visible	on	a	
conventional	MRI,	constitute	only	 the	 tip	of	 the	 iceberg	of	 the	white	matter	pathol-
ogy	that	have	occurred.	Recently,	it	has	become	possible	to	investigate	white	matter	
microstructural	 changes,	 thought	of	 as	an	earlier	 and	more	 sensitive	markers,	using	
diffusion-weighted	MRI.	It	is	hypothesized	that	white	matter	microstructural	damage	
lead	to	loss	of	communication	between	different	cortical	networks,	resulting	in	‘dis-
connectivity’	leading	to	age-related	brain	diseases.	Population	data	on	determinants	of	
white	matter	microstructural	changes	globally	but	in	particular	in	specific	white	matter	
tracts	in	middle-aged	and	elderly	persons	were	scarce.
The	aims	of	the	studies	described	in	this	thesis	were	to	study	determinants	of	global	and	
tract-specific	white	matter	microstructural	damage,	and	to	investigate	the	link	between	
white	matter	microstructural	damage	and	age-related	brain	diseases.	The	studies	were	
embedded	within	the	Rotterdam	Study,	which	is	a	large	population-based	cohort	study	
since	1990,	investigating	causes	and	consequences	of	diseases	in	the	elderly.
In	chapter 2	determinants	(in	which	we	focused	on	aging	and	systemic	influences	on	
the	brain)	of	white	matter	microstructural	changes	were	described.	To	establish	refer-
ence	 values	 of	 change	 in	 diffusion-weighted	MRI	measures	 in	 aging	we	performed	
a	 longitudinal	 analysis	 in	chapter 2.1.	 I	 found	 loss	of	white	matter	microstructural	
integrity	widespread	 in	 the	brain.	Global	 fractional	 anisotropy	 (FA)	decreased,	MD	
increased	after	2	years	of	follow-up.	The	small	vessels	in	kidney	and	retina	are	simi-
lar	with	anatomical	and	hemodynamic	 similarities.	 In	chapter 2.2 and chapter 2.3 
I	 found	 that	 both	 kidney	 function	 and	 retinal	 vessel	 calibers	 associated	with	white	
matter	microstructural	integrity	respectively.	The	association	between	reduced	kidney	
function	and	poorer	white	matter	microstructure	was	throughout	the	brain	and	partly	
driven	by	cardiovascular	risk	factors.	In	chapter 2.3	I	found	that	wider	venules	and	
narrower	arterioles	were	related	to	reduced	white	matter	microstructural	integrity.	This	
suggests	 that	white	matter	microvascular	 damage	 is	more	widespread	 than	 visually	
detectable	as	white	matter	hyperintensities.	In	chapter 2.4	focusing	on	lung	function	
and	 white	 matter	 microstructure	 we	 found	 tract-specific	 differences.	 Reduced	 lung	
function	 related	 to	 a	 low	white	matter	microstructural	 integrity,	 in	 particular	 in	 the	
association	tracts.	This	may	be	explained	by	the	location	of	the	association	tracts	in	
watershed	areas	making	these	tracts	more	susceptible	to	vascular	damage.	In	chapter 
2.5	the	association	between	thyroid	hormones	and	brain	changes	was	assessed.	I	found	
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an	age-dependent	effect	of	 free	 thyroxine	(FT4).	Higher	FT4	 levels	were	associated	
with	larger	brain	volumes	and	higher	white	matter	microstructural	integrity	in	younger	
individuals,	 but	 not	 in	 the	 elderly.	Adjusting	 for	 cardiovascular	 risk	 factors	 did	 not	
change	the	estimates	marginally	pointing	towards	other	pathways	explaining	the	found	
association.
Chapter 3	of	this	thesis	was	dedicated	to	the	relation	of	white	matter	microstructural	
integrity	 and	 age-related	 brain	 diseases.	Higher	 age,	 stroke	 and	 cardiovascular	 risk	
factors	were	related	to	mild	cognitive	impairment	(MCI)	in	chapter 3.1.	In	addition,	
persons	with	MCI,	in	particular	amnestic	MCI	had	larger	white	matter	hyperintensity	
load,	poorer	global	white	matter	microstructural	 integrity	and	more	 lacunar	 infarcts	
than	cognitively	healthy	participants.	These	results	highlight	the	importance	of	vascular	
factors	in	early	phases	of	dementia.	Next,	in	chapter 3.2	I	investigated	the	link	between	
white	matter	microstructure	and	cognition	and	found	that	reduced	white	matter	micro-
structural	integrity	throughout	the	brain,	but	mainly	in	the	association	and	projection	
tracts	related	to	poorer	cognition.	A	similar	pattern	was	found	in	chapter 3.3	in	which	
white	matter	microstructural	integrity	across	the	whole	brain,	but	in	particular	in	the	
association,	projection	and	limbic	system	tracts	related	to	risk	of	dementia	and	with	
more	pronounced	cognitive	decline.	These	results	indicate	that	there	is	an	association	
already	in	the	preclinical	phase	of	dementia	and	suggest	that	diffusion-weighted	MRI	
may	be	useful	in	risk	stratification	or	even	prediction.	Since	hearing	loss	is	considered	
a	risk	factor	for	dementia,	we	also	studied	the	relation	of	white	matter	microstructural	
integrity	and	hearing	acuity	in	middle-aged	and	elderly	persons.	In	chapter 3.4	I	found	
that	poorer	white-matter	microstructure,	in	particular	in	auditory	and	language-related	
association	tracts,	was	significantly	associated	with	worse	hearing	acuity.	In	chapter 
3.5	I	investigated	how	white	matter	microstructural	integrity	was	related	to	all-cause	
and	cardiovascular	mortality	in	persons	free	from	stroke	and	dementia.	Persons	with	a	
lower	microstructural	integrity,	mainly	in	the	association	tracts,	were	at	a	higher	risk	of	
mortality.	The	associations	were	most	profound	for	cardiovascular	mortality	indicating	
that	white	matter	microstructural	integrity	is	prone	to	vascular	insults.	In	chapter 3.6 
I	aimed	to	elucidate	the	associations	of	the	genetic	variants	underlying	cognition	with	
cognitive	decline,	daily	functioning,	dementia,	parkinsonism,	stroke	and	brain	imaging	
markers.	The	genetic	variants	associated	with	cognition	related	to	cognitive	decline,	
larger	intracranial	volume,	higher	educational	attainment	and	associated	with	a	better	
white	matter	microstructure.	This	study	suggests	that	these	genetic	variants	represent	
both	 the	 developmental	 and	 degenerative	 components	 of	 cognitive	 performance.	 In	
chapter 3.7	 I	 tried	 to	make	 the	first	 step	 to	 the	 clinical	 implication	 of	 brain	 imag-
ing	markers	and	aimed	to	evaluate	a	previously	proposed	prediction	tool	namely	the	
Disease	State	Index	(DSI)	to	predict	cognitive	decline	using	imaging	and	non-imaging	
features.	Best	performance	of	the	prediction	of	global	cognitive	decline	was	obtained	
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using	only	age	as	input	feature.	Adding	additional	imaging	markers	did	not	improve	
prediction.	This	calls	 for	other	prediction	 tools,	more	advanced	 imaging	markers	or	
other	analytical	approaches	in	the	prediction	of	age-related	diseases.
Finally	 in	chapter 4	 I	discuss	 the	main	findings	of	 this	 thesis,	methodological	con-
siderations,	 clinical	 implications,	 and	 I	make	 recommendations	 for	 future	 research.	
My	 conclusions	were	firstly	 that	 systemic	 influences	 relate	 to	 a	 lower	white	matter	
microstructural	 integrity	 via	 different	 pathways.	 Proposed	mechanisms	 are	 vascular	
factors,	hypoxia,	oxidative	stress,	inflammation,	genetics,	or	a	multifaceted	interplay	of	
the	previous	mentioned	mechanisms.	Secondly,	white	matter	microstructural	integrity	
(mainly	in	the	association	tracts)	plays	a	role	in	several	age-related	brain	diseases	such	
as	cognitive	decline,	mild	cognitive	impairment,	dementia	and	hearing	loss.	Thirdly,	
using	a	previously	proposed	prediction	tool,	using	imaging	features	on	top	of	age	did	
not	improve	the	prediction	of	cognitive	decline,	calling	for	other	prediction	tools,	more	
advanced	imaging	markers	or	other	analytical	approaches	in	prediction	modelling.
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NederLANdSe SAMeNVAttING
De	 levensverwachting	van	mensen	neemt	 toe	en	als	 een	gevolg	daarvan	zullen	ook	
vaak	voorkomende	aan	veroudering-gerelateerde	hersenziekten	zoals	cognitieve	ach-
teruitgang,	 dementie	 en	 vasculaire	 hersenziekten	 gaan	 toenemen.	 Er	 is	 nog	 relatief	
weinig	 bekend	 over	 de	 oorzaken	 van	 aan	 veroudering-gerelateerde	 ziekten	 en	 ook	
preventieve	en	curatieve	interventies	zijn	schaars.	Dat	de	witte	stof	van	de	hersenen	
een	 rol	 speelt	 in	 aan	veroudering-relateerde	hersenziekten	 is	 inmiddels	 aangetoond.	
Macrostructurele	witte	stof	veranderingen,	welke	zichtbaar	zijn	op	een	conventionele	
MRI,	laten	vaak	maar	een	klein	gedeelte	zien	van	de	opgetreden	witte	stof	schade.	Met	
behulp	van	een	geavanceerde	magnetic	resonance	imaging	(MRI)	techniek,	namelijk	
een	diffusie-gewogen	MRI	kan	men	tegenwoordig	in	een	vroeg	stadium	al	kleine	ver-
anderingen	van	de	witte	stof	opsporen	die	nog	niet	voor	het	blote	oog	waarneembaar	
zijn	en	die	dus	kunnen	dienen	als	vroege	markers	voor	witte	stof	schade.	De	hypothese	
is	dat	deze	microstructurele	witte	stof	veranderingen	ervoor	zorgen	dat	verschillende	
corticale	 gebieden	 in	 de	 hersenen	 minder	 goed	 met	 elkaar	 kunnen	 communiceren,	
resulterend	in	disconnectiviteit	wat	uiteindelijk	kan	leiden	tot	cognitieve	klachten	en	
andere	 aan	 veroudering-gerelateerde	 hersenziekten.	 Bevolkingsstudies	 in	 personen	
van	middelbare	en	oudere	leeftijd	die	deze	microstructurele	veranderingen	van	de	witte	
stof	globaal,	maar	ook	in	specifieke	witte	stof	banen	hebben	bestudeerd	zijn	schaars.
Het	 doel	 van	 het	 onderzoek	 beschreven	 in	 dit	 proefschrift	was	 om	met	 behulp	 van	
diffusie-gewogen	MRI	verschillende	factoren	van	microstructurele	witte	stof	verande-
ringen	te	onderzoeken	en	de	relatie	van	deze	microstructurele	witte	stof	veranderingen	
met	 aan	 veroudering-gerelateerde	 hersenziekten	 in	 beeld	 te	 brengen.	Dit	 onderzoek	
heb	ik	uitgevoerd	binnen	de	Rotterdam	Studie,	een	grote	bevolkingsstudie	uitgevoerd	
onder	inwoners	van	middelbare	en	oudere	leeftijd	van	de	wijk	Ommoord	in	Rotterdam.
In	hoofdstuk 2	beschrijf	ik	verschillende	determinanten	(met	focus	op	de	invloed	van	
ouder	worden	en	op	systemische	 invloeden	op	het	brein)	van	microstructurele	witte	
stof	 veranderingen.	 Om	 referentie	 waarden	 van	 verandering	 van	 diffusie-gewogen	
MRI	maten	in	verouderende	hersenen	vast	te	kunnen	stellen	heb	ik	in	hoofdstuk 2.1 
een	longitudinale	studie	verricht.	Ik	vond	een	verslechterde	microstructurale	witte	stof	
integriteit	in	vrijwel	het	gehele	brein.	Global	fractionele	anisotropie	(FA)	nam	af,	de	
gemiddelde	diffusiviteit	(MD)	nam	toe	na	2	jaar.
De	kleinste	bloedvaten	 in	de	nier,	 retina	en	de	hersenen	 tonen	veel	 anatomische	en	
hemodynamische	overeenkomsten.	In	hoofdstuk 2.2 en 2.3	respectievelijk	vond	ik	dat	
zowel	nierfunctie	als	de	diameters	van	de	retinale	vaten	geassocieerd	zijn	met	micro-
structurele	witte	stof	veranderingen.	De	associatie	tussen	verminderde	nierfunctie	en	
een	verminderde	witte	stof	integriteit	was	diffuus	aanwezig	in	het	brein,	dus	niet	in	be-
paalde	witte	stof	banen	in	het	bijzonder,	en	werd	deels	verklaard	door	cardiovasculaire	
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risicofactoren.	In	hoofdstuk 2.3	vond	ik	dat	wijdere	retinale	venulen	(kleine	aders)	en	
nauwere	arteriolen	(kleine	slagaders)	gerelateerd	zijn	aan	een	verminderde	microstruc-
turele	witte	stof	integriteit.	Dit	suggereert	dat	microvasculaire	witte	stof	veranderingen	
uitgebreider	 zijn	 dan	wordt	 gezien	 als	witte	 stof	 hyperintensiteit.	 In	hoofdstuk 2.4 
onderzocht	 ik	 de	 relatie	 tussen	 longfunctie	 en	witte	 stof	microstructurele	 integriteit	
en	 vond	 ik	 verschillen	 tussen	witte	 stof	 banen.	Verminderde	 longfunctie	 relateerde	
aan	een	verminderde	witte	stof	microstructurele	integriteit,	en	dan	met	name	van	de	
associatie	 vezels.	 Dit	 zou	mogelijk	 verklaard	 kunnen	worden	 door	 de	 anatomische	
locatie	van	de	associatie	vezels	in	waterscheidingsgebieden,	waardoor	deze	witte	stof	
vezels	mogelijk	meer	 gevoelig	 zijn	 voor	 vasculaire	 schade.	 In	hoofdstuk 2.5	 vond	
ik	 een	 leeftijdsafhankelijk	 effect	 van	 het	 schildklierhormoon	 vrij	 thyroxine	 (FT4).	
Hogere	waarden	van	FT4	waren	geassocieerd	met	grotere	brein	volumes	en	een	betere	
microstructuur	van	de	witte	stof	in	jongere	personen,	maar	niet	in	oudere	mensen.	De	
resultaten	werden	niet	beïnvloed	door	het	corrigeren	voor	cardiovasculaire	factoren	en	
dit	wijst	erop	dat	ook	andere	mechanismen	een	rol	spelen	in	de	gevonden	associatie.
hoofdstuk 3	in	dit	proefschrift	is	gewijd	aan	de	relatie	tussen	witte	stof	microstructuur	
en	 aan	 leeftijds-gerelateerde	 hersenziekten.	Hogere	 leeftijd,	 een	 herseninfarct	 in	 de	
voorgeschiedenis	en	het	hebben	van	cardiovasculaire	risicofactoren	waren	gerelateerd	
aan	milde	cognitieve	stoornis	(MCI)	in	hoofdstuk 3.1.	Daarbij	hadden	personen	met	
MCI,	in	het	bijzonder	amnestische	MCI	een	groter	witte	stof	hyperintensiteit	volume,	
een	slechtere	globale	microstructurele	witte	stof	integriteit	en	meer	lacunaire	infarcten	
dan	cognitief	gezonde	mensen.	Deze	resultaten	onderstrepen	het	belang	van	vasculaire	
factoren	in	de	vroege	fase	van	dementie.	Vervolgens	heb	ik	in	hoofdstuk 3.2	gekeken	
naar	de	relatie	tussen	witte	stof	microstructuur	en	cognitief	functioneren.	Verminderde	
witte	stof	microstructuur	in	het	gehele	brein,	maar	met	name	in	de	associatie	en	pro-
jectie	vezels	relateerde	aan	een	verminderd	cognitief	functioneren.	Een	vergelijkbaar	
patroon	werd	gevonden	in	hoofdstuk 3.3	waarin	een	slechtere	witte	stof	microstruc-
tuur	 in	 vrijwel	 het	 gehele	 brein	 maar	 ook	 met	 name	 in	 de	 associatie,	 projectie	 en	
limbische	vezels	 relateerde	 aan	 een	verhoogd	 risico	 op	dementia	 en	 een	verhoogde	
afname	in	cognitief	functioneren.	Deze	resultaten	indiceren	dat	er	al	een	associatie	is	in	
de	preklinische	fase	van	dementie	en	suggereren	dat	diffusie-gewogen	MRI	bruikbaar	
kan	zijn	voor	risico	predictie.
Gehoorverlies	wordt	gezien	als	een	risicofactor	voor	dementia	en	daarom	heb	ik	ook	
de	relatie	tussen	witte	stof	microstructuur	en	gehoorverlies	bestudeerd	in	middelbare	
en	oudere	personen.	In	hoofdstuk 3.4	vond	ik	dat	een	slechtere	witte	stof	microstruc-
tuur,	met	name	in	aan	gehoor	en	spraak	gerelateerde	associatie	vezels	associeerde	met	
een	slechtere	gehoorfunctie.
In	hoofdstuk 3.5	 heb	 ik	 onderzocht	 hoe	microstructurele	witte	 stof	 integriteit	 rela-
teerde	aan	sterfte	in	personen	zonder	beroerte	of	dementia.	Personen	met	een	mindere	
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witte	 stof	microstructurele	 integriteit	 hadden	 een	 hoger	 risico	 op	 sterfte,	met	 name	
cardiovasculaire	 sterfte	en	dit	onderstreept	nog	verder	dat	de	microstructuur	van	de	
witte	stof	gevoelig	is	voor	vasculaire	schade.
In	hoofdstuk 3.6	was	het	doel	om	de	associaties	van	genetische	varianten	onderlig-
gend	aan	cognitie	te	bestuderen	met	cognitieve	achteruitgang,	dagelijks	functioneren,	
dementie,	 parkinsonisme,	 beroerte	 en	MRI	 markers	 van	 het	 brein.	 De	 bestudeerde	
genetische	 varianten	 hingen	 samen	 met	 cognitieve	 achteruitgang,	 een	 groter	 brein	
volume	en	een	betere	educatie.	Dit	suggereert	dat	deze	genetische	varianten	zowel	de	
ontwikkelingscomponent	als	de	degeneratieve	component	van	cognitie	representeren.	
Mijn	bevindingen	in	hoofdstuk 3.2 en 3.3,	gericht	op	de	relatie	tussen	witte	stof	mi-
crostructuur	en	cognitie	en	dementie,	worden	dus	mogelijk	naast	neurodegeneratie	ook	
deels	verklaard	door	ontwikkelingsfactoren.
In	hoofdstuk 3.7	wilde	ik	de	eerste	stap	maken	naar	de	klinische	bruikbaarheid	van	
brein	MRI	markers	en	had	ik	als	doel	om	een	eerder	voorgestelde	predictie	methode	
genaamd	de	‘Disease	State	Index’	te	gebruiken	om	cognitieve	achteruitgang	te	voor-
spellen	 aan	de	 hand	van	verschillende	markers	 inclusief	MRI	markers.	 Ik	 vond	dat	
leeftijd	 de	 belangrijkste	 predictor	 was	 en	 dat	 andere	 predictors	 geen	 toegevoegde	
waarde	 hadden	 in	 de	 voorspelling	 van	 cognitieve	 achteruitgang	 bovenop	 leeftijd.	
Dit	geeft	aan	dat	voor	de	predictie	van	aan	verouderings-gerelateerde	hersenziekten	
andere	predictie	methoden,	meer	geavanceerdere	MRI	markers	of	andere	analytische	
methoden	nodig	zijn.
Tenslotte,	in	hoofdstuk 4	bespreek	ik	de	belangrijkste	bevindingen,	de	methodologi-
sche	 limitaties	en	de	klinische	 implicaties	van	dit	proefschrift	 en	geef	 ik	 suggesties	
voor	 verder	 onderzoek.	 Mijn	 belangrijkste	 conclusies	 zijn:	 ten	 eerste:	 systemische	
invloeden	buiten	het	brein	zijn	consistent	geassocieerd	met	een	mindere	witte	stof	mi-
crostructurele	integriteit.	Mogelijke	mechanismen	zijn	via	vasculaire	factoren,	hypo-
xie,	oxidatieve	stress,	inflammatie,	een	genetische	predispositie	of	een	samenspel	van	
deze	mogelijke	mechanismen.	Ten	tweede,	de	witte	stof	microstructuur	van	met	name	
de	associatie	vezels	spelen	een	rol	in	vele	aan	veroudering	gerelateerde	hersenziekten	
zoals	cognitieve	achteruitgang,	MCI,	dementie	en	gehoorsverlies.	Ten	derde,	gebruik-
makend	van	een	eerder	voorgestelde	predictie	methode,	was	leeftijd	de	belangrijkste	
predictor	voor	cognitieve	achteruitgang	en	hadden	MRI	markers	bovenop	leeftijd	geen	
toevoegde	waarde.	Dit	 roept	 aan	 tot	 andere	predictie	methoden,	meer	geavanceerde	
imaging	maten	of	andere	analytische	methoden.
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